About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
2917 genotypes with 5063 annotations displayed of selected term and subterms
Searched Term: abnormal liver morphology
Allelic Composition
(Genetic Background)		 Annotated Term Reference
\1700034E13Rikem1(IMPC)Mbp/\1700034E13Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700034E13Rikem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\1700069L16Rikem1(IMPC)Mbp/\1700069L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700069L16Rikem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\2010003K11Rikem1Cya/\2010003K11Rikem1Cya
(C57BL/6-2010003K11Rikem1Cya/Cya) 		increased liver cholesterol level J:326325
increased liver triglyceride level J:326325
increased liver weight J:326325
increased susceptibility to diet-induced hepatic steatosis J:326325
\2610008E11Rikem1(IMPC)Mbp/\2610008E11Rikem1(IMPC)Mbp
(C57BL/6N-2610008E11Rikem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\2700097O09Riktm1.1(KOMP)Vlcg/\2700097O09Riktm1.1(KOMP)Vlcg
(C57BL/6N-2700097O09Riktm1.1(KOMP)Vlcg/MbpMmucd) 		abnormal liver morphology J:211773
\3930402G23Rikem1.1Gonz/\3930402G23Rikem1.1Gonz
(C57BL/6J-3930402G23Rikem1.1Gonz) 		abnormal liver morphology J:340239
increased liver cholesterol level J:340239
increased liver free fatty acids level J:340239
increased liver triglyceride level J:340239
increased susceptibility to hepatic steatosis J:340239
\4933434E20Riktm1a(EUCOMM)Wtsi/\4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
\a/\a
\Rmi1Gt(pUHachi)0283Imeg/\Rmi1+
(involves: C57BL/6 * KK) 		decreased liver weight J:168271
\A1cftm1c(EUCOMM)Hmgu/\A1cftm1c(EUCOMM)Hmgu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6N * DBA) 		decreased liver triglyceride level J:281365
decreased liver weight J:281365
increased liver glycogen level J:281365
\Ay/\a
\Rmi1Gt(pUHachi)0283Imeg/\Rmi1+
(involves: C57BL/6 * KK) 		decreased liver weight J:168271
\Ay/\A
(involves: C57BL/6) 		increased liver weight J:131039
\Abca1tm1Wpfl/\Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J) 		macrovesicular hepatic steatosis J:64390
\Abca1tm1Wpfl/\Abca1tm1Wpfl
\Npc1m1N/\Npc1m1N
(involves: 129P2/OlaHsd * BALB/c) 		increased liver cholesterol level J:130969
\Abca5tm1Akya/\Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR) 		abnormal liver morphology J:99152
\Abcb1atm1Bor/\Abcb1atm1Bor
\Npc1m1N/\Npc1m1N
(involves: 129/Ola * BALB/c) 		increased liver cholesterol level J:76395
\Abcb4tm1Bor/\Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N)) 		abnormal bile canaliculus morphology J:15531, J:21232
abnormal hepatocyte morphology J:15531
abnormal portal triad morphology J:21232
enlarged liver J:21232
hepatic necrosis J:21232
increased hepatocellular carcinoma incidence J:21232
\Abcb4tm1Bor/\Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N) 		abnormal hepatocyte morphology J:175015
focal hepatic necrosis J:175015
\Abcb4tm1Bor/\Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J) 		abnormal liver morphology J:105357
enlarged liver J:105357
increased hepatocellular carcinoma incidence J:217802
liver cirrhosis J:217802
liver fibrosis J:217802
\Abcb4tm1Bor/\Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor) 		liver fibrosis J:199949
\Abcb4tm1Bor/\Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c) 		liver fibrosis J:168123
\Abcb4tm1Bor/\Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor) 		increased hepatocellular carcinoma incidence J:217802
liver cirrhosis J:217802
liver fibrosis J:217802
\Abcb4tm1Bor/\Abcb4tm1Bor
\Portm1Wolf/\Portm1Wolf
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N) 		increased liver weight J:215915
liver fibrosis J:215915
\Abcb7tm1Mdf/Y
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(either: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA)) 		abnormal hepatocyte mitochondrial morphology J:106838
abnormal hepatocyte morphology J:106838
abnormal liver morphology J:106838
increased polyploid hepatocyte number J:106838
\Abcb10tm1.2Tafu/\Abcb10tm1.2Tafu
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal hepatocyte morphology J:223428
abnormal liver morphology J:223428
\Abcb11tm1Wng/\Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal bile canaliculus morphology J:67548
abnormal hepatocyte morphology J:67548
decreased liver glycogen level J:67548
enlarged liver J:67548
\Abcc2tm1Ahs/\Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB) 		increased liver weight J:107822
\Abcd3tm1Safe/\Abcd3tm1Safe
(involves: 129S4/SvJae * C57BL/6J) 		enlarged liver J:217065
\Abcg1tm1Asch/\Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:122438
\Abcg1tm1Dgen/\Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen) 		hepatic steatosis J:117028
increased liver cholesterol level J:117028
increased liver triglyceride level J:117028
\Abcg2em1Omw/\Abcg2em1Omw
(C57BL/6J-Abcg2em1Omw) 		hepatic steatosis J:292268
\Abcg2tm1.1Ssf/\Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB) 		abnormal hepatocyte mitochondrial morphology J:201884
abnormal hepatocyte morphology J:201884
decreased liver glycogen level J:201884
\Abcg5tm1Plo/\Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J) 		enlarged liver J:87209
\Abcg5tm1Plo/\Abcg5tm1Plo
(involves: 129P2/OlaHsd) 		increased liver weight J:112995
\Abcg8tm1b(KOMP)Wtsi/\Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Abhd5tm1.1Lqyu/\Abhd5tm1.1Lqyu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:199570
abnormal liver morphology J:199570
enlarged liver J:199570
hepatic steatosis J:199570
increased liver cholesterol level J:199570
increased liver free fatty acids level J:199570
increased liver triglyceride level J:199570
increased liver weight J:199570
liver fibrosis J:199570
macrovesicular hepatic steatosis J:199570
microvesicular hepatic steatosis J:199570
pale liver J:199570
\Abhd5tm1.1Rze/\Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:160725
increased liver triglyceride level J:160725
\Abhd5tm1Rze/\Abhd5tm1Rze
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased liver triglyceride level J:197835
\Abhd6tm1a(EUCOMM)Hmgu/\Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		abnormal liver morphology J:234876
decreased liver triglyceride level J:234876
decreased liver weight J:234876
\Abhd17cem1(IMPC)Mbp/\Abhd17cem1(IMPC)Mbp
(C57BL/6N-Abhd17cem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Abl1tm1Mlg/\Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J) 		abnormal hepatocyte morphology J:72875
\abn/\abn
(STOCK tlow) 		enlarged liver J:28671
\Acacatm1Jkus/\Acacatm1Jkus
\Tg(Fabp1-cre)1Mmt/0
(involves: 129X1/SvJ * C57BL/6J * SJL) 		decreased liver triglyceride level J:118861
\Acacatm2Sjw/\Acacatm2Sjw
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB) 		decreased liver triglyceride level J:110200
decreased susceptibility to hepatic steatosis J:110200
\Acacbtm1Sjw/\Acacbtm1Sjw
(Not Specified) 		decreased liver glycogen level J:68427
decreased liver triglyceride level J:68427
\Acad8m1Ytc/\Acad8m1Ytc
(involves: C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:222356
macrovesicular hepatic steatosis J:222356
microvesicular hepatic steatosis J:222356
\Acadltm1Uab/\Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac) 		hepatic steatosis J:51660
macrovesicular hepatic steatosis J:72193, J:51660
microvesicular hepatic steatosis J:51660
\Acadmtm1Uab/\Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6) 		macrovesicular hepatic steatosis J:115759
microvesicular hepatic steatosis J:115759
\Acadsdel-J/\Acadsdel-J
(involves: BALB/cByJ) 		hepatic steatosis J:14707
\Acadvltm1Uab/\Acadvltm1Uab
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic steatosis J:72193
\Acadvltm1Vje/\Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6) 		macrovesicular hepatic steatosis J:106714
\Acancmd/\Acancmd
(STOCK T tlow Itpr3tf) 		dark liver J:5952
enlarged liver J:5952
\Acbd5tm1a(EUCOMM)Wtsi/\Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc) 		abnormal hepatocyte morphology J:299448
abnormal liver morphology J:299448
\Acot7tm1.1Mwol/\Acot7tm1.1Mwol
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		hepatic steatosis J:203753
increased liver triglyceride level J:203753
\Acot11tm1Deco/\Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:182660
\Acot12em1Holi/\Acot12em1Holi
(involves: C57BL/6J * C57BL/6N) 		increased hepatocellular carcinoma incidence J:335836
increased liver cholesterol level J:335836
increased liver triglyceride level J:335836
liver fibrosis J:335836
\Acot13tm1Deco/\Acot13tm1Deco
(involves: 129 * C57BL/6) 		decreased liver cholesterol level J:183258
decreased liver triglyceride level J:183258
decreased susceptibility to diet-induced hepatic steatosis J:183258
\Acox1em1(IMPC)Bay/\Acox1em1(IMPC)Bay
(C57BL/6N-Acox1em1(IMPC)Bay/Bay) 		abnormal liver morphology J:211773
\Acox1lampe1/\Acox1lampe1
(involves: C57BL/6J) 		abnormal hepatocyte morphology J:174942
abnormal liver morphology J:174942
enlarged liver J:174942
increased hepatocellular carcinoma incidence J:174942
microvesicular hepatic steatosis J:174942
\Acox1tm1Jkr/\Acox1+
(involves: 129P2/OlaHsd * C57BL/6J) 		microvesicular hepatic steatosis J:35794
\Acox1tm1Jkr/\Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:35794
increased hepatoma incidence J:48180
increased liver weight J:35794
microvesicular hepatic steatosis J:48180
pale liver J:35794
\Acox2em1Jynz/\Acox2em1Jynz
(involves: C57BL/6N) 		increased liver tumor incidence J:323193
\Acoxlem1(IMPC)Mbp/\Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Acsl5tm1.1(KOMP)Vlcg/\Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd) 		decreased liver weight J:211773
\Acta1tm1Jll/\Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss) 		decreased liver glycogen level J:78070
\Actn4tm1a(EUCOMM)Wtsi/\Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Acvr2btm1Enl/\Acvr2btm1Enl
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J)) 		abnormal liver morphology J:42018
\Acvrl1tm1Enl/\Acvrl1+
(involves: C57BL/6) 		dilated liver sinusoidal space J:82115
enlarged liver J:82115
\Ad/\Ad
(involves: Chr 7 marker stock * Wild stock) 		abnormal liver morphology J:6095
\Ad/\Ad+
(involves: Chr 7 marker stock * Wild stock) 		abnormal liver morphology J:6095
\Adatm1Mw/\Adatm1Mw
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:25085
abnormal liver morphology J:25085
decreased hepatocyte number J:25085
hepatic necrosis J:25085
increased hepatocyte karyomegaly J:25085
small liver J:25085
\Adatm1Vlr/\Adatm1Vlr
(either: 129P2/OlaHsd-Adatm1Vlr or (involves: (129P2/OlaHsd * FVB/N)) 		hepatic necrosis J:26731
\Adam29em1Otin/\Adam29em1Otin
(C57BL/6-Adam29em1Otin) 		abnormal hepatocyte morphology J:353244
decreased susceptibility to diet-induced hepatic steatosis J:353244
\Adamts3tm1.2Itl/\Adamts3tm1.2Itl
(involves: BALB/cJ * C57BL/6NTac * SJL) 		liver degeneration J:245044
small liver J:245044
\Adamts3tm1b(KOMP)Wtsi/\Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi) 		abnormal liver parenchyma morphology J:239583
\Adarem1Stsn/\Adartm1Olds
(involves: 129S/SvEv * C57BL/6J) 		abnormal liver morphology J:308678
\Adartm1.1Phs/\Adartm2Phs
\Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		liver hypoplasia J:142338
\Adartm1Knk/\Adartm1Knk
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal liver morphology J:87714
\Adartm1Phs/\Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver development J:87715
small liver J:87715
\Adartm1Phs/\Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal liver development J:87715
small liver J:87715
\Adartm2Knk/\Adar+
(chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal liver development J:65981
\Adartm2Phs/\Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver development J:87715
small liver J:87715
\Adartm2Phs/\Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal liver development J:87715
small liver J:87715
\Adck2tm1(KOMP)Vlcg/\Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg) 		increased liver free fatty acids level J:280282
macrovesicular hepatic steatosis J:280282
\Adcy3Jll/\Adcy3+
(C57BL/6J-Adcy3Jll) 		decreased susceptibility to diet-induced hepatic steatosis J:223554
\Adcy9tm1b(EUCOMM)Wtsi/\Adcy9tm1b(EUCOMM)Wtsi
(C57BL/6N-Adcy9tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Adcyap1tm1Nms/\Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6)) 		decreased liver glycogen level J:71968
microvesicular hepatic steatosis J:71968
\Add2tm1Llp/\Add2tm1Llp
(involves: 129S4/SvJae * C57BL/6J) 		increased liver iron level J:71029
\Adgrl4em1(IMPC)Mbp/\Adgrl4em1(IMPC)Mbp
(C57BL/6N-Adgrl4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Adigtm1.1(KOMP)Vlcg/\Adigtm1.1(KOMP)Vlcg
(B6J.B6N-Adigtm1.1(KOMP)Vlcg) 		decreased susceptibility to diet-induced hepatic steatosis J:304292
\Adip1LG/J/?
\Capn10tm1Chev/\Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1) 		increased liver weight J:153477
\Adipoqtm1Far/\Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J) 		increased liver triglyceride level J:111346
increased susceptibility to diet-induced hepatic steatosis J:111346
\Adipoqtm1Far/\Adipoqtm1Far
\Dgat1tm1Far/\Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
decreased susceptibility to diet-induced hepatic steatosis J:111346
\Adipor1tm1Dgen/\Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc) 		increased liver triglyceride level J:122027
\Adipor1tm1Tka/\Adipor1tm1Tka
\Adipor2tm1Tka/\Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		increased liver triglyceride level J:117919
\Adipor2tm1Dgen/\Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen) 		decreased liver triglyceride level J:122027
\Adktm1Bois/\Adktm1Bois
(involves: 129P3/JEmsJ * C57BL/6) 		hepatic steatosis J:81518
macrovesicular hepatic steatosis J:81518
microvesicular hepatic steatosis J:81518
pale liver J:81518
\Admtm1Hku/\Admtm1Hku
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver vasculature morphology J:89608
\Adnp2em3(IMPC)Tcp/\Adnp2+
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Adnp2em3(IMPC)Tcp/\Adnp2em3(IMPC)Tcp
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Adra1btm1Cta/\Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver glycogen level J:87718
\Adrb2em1(IMPC)Mbp/\Adrb2em1(IMPC)Mbp
(C57BL/6N-Adrb2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Aebp1tm1Mdl/\Aebp1tm1Mdl
(involves: 129S2/SvPas * C57BL/6) 		abnormal liver morphology J:70416
\Afdnem1(IMPC)Mbp/\Afdn+
(C57BL/6N-Afdnem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Afptm1(Cebpa)Ndw/\Afp+
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:103404
\Agatm1Vk/\Agatm1Vk
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		multifocal hepatic necrosis J:91114
\Agap2tm1Kye/\Agap2tm1Kye
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA/2) 		decreased liver cholesterol level J:174775
decreased liver free fatty acids level J:174775
decreased liver triglyceride level J:174775
\Agltm1a(EUCOMM)Wtsi/\Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		abnormal hepatocyte morphology J:212003
enlarged liver J:212003
increased liver glycogen level J:212003
liver fibrosis J:212003
\Agltm1Geno/\Agltm1Geno
(C57BL/6J-Agltm1Geno) 		abnormal hepatocyte morphology J:218471
dark liver J:218471
enlarged liver J:218471
increased liver glycogen level J:218471
\Agpat2em1(IMPC)Ccpcz/\Agpat2+
(C57BL/6NCrl-Agpat2em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Agpat2Gt(OST438470)Lex/\Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal liver morphology J:186035
enlarged liver J:186035
microvesicular hepatic steatosis J:186035
pale liver J:186035
\Agpat2tm1Garg/\Agpat2tm1Garg
(involves: 129S6/SvEvTac) 		hepatic steatosis J:146649
increased liver triglyceride level J:231617, J:146649
increased liver weight J:231617, J:146649
\Agpat2tm1Garg/\Agpat2tm1Garg
\Mogat1tm1Far/\Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac) 		increased liver triglyceride level J:231617
increased liver weight J:231617
\Agpat5Gt(OST62319)Lex/\Agpat5Gt(OST62319)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		hepatic steatosis J:103485
\Agrptm1Dgen/\Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver triglyceride level J:199803
\Agttm1Ii/\Agttm1Ii
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver weight J:30061
\Ahrtm1Bra/\Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:83597
liver hyperplasia J:33827
microvesicular hepatic steatosis J:33827
pale liver J:33827
small liver J:33827
\Ahrtm1Bra/\Ahrtm1Bra
(B6.129-Ahrtm1Bra) 		abnormal hepatocyte morphology J:64483
abnormal liver sinusoid morphology J:64483
decreased liver weight J:64483
\Ahrtm1Gonz/\Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N) 		abnormal hepatocyte morphology J:44690, J:25048
abnormal liver morphology J:44690, J:25048
decreased liver weight J:25048
increased hepatoma incidence J:44690
increased liver adenoma incidence J:44690
liver fibrosis J:44690, J:25048
\Ahrtm1Yfk/\Ahrtm1Yfk
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * ICR) 		hepatic steatosis J:82937
\Ahrtm2Bra/\Ahrtm2Bra
(involves: 129/Sv * C57BL/6) 		decreased liver weight J:83597
\Ahrtm4.1Bra/\Ahrtm4.1Bra
(involves: 129/Sv * C57BL/6) 		microvesicular hepatic steatosis J:141978
small liver J:141978
\Aidatm1.1Scli/\Aidatm1.1Scli
(involves: C57BL/6 * FVB/N) 		increased liver glycogen level J:262001
increased liver weight J:262001
increased susceptibility to diet-induced hepatic steatosis J:262001
\Aif1ltm1b(EUCOMM)Wtsi/\Aif1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Aif1ltm1b(EUCOMM)Wtsi/Bay) 		abnormal liver morphology J:211773
\Aiptm1Bra/\Aip+
(Not Specified) 		decreased liver weight J:167350
\Aiptm2Bra/\Aiptm2Bra
(involves: 129) 		decreased liver weight J:167350
\Akap13em1(IMPC)Mbp/\Akap13em1(IMPC)Mbp
(C57BL/6N-Akap13em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Akr1b7tm1.1Anm/\Akr1b7tm1.1Anm
(involves: 129) 		hepatic steatosis J:208505
increased liver triglyceride level J:208505
increased liver weight J:208505
\Akt1tm1Mbb/\Akt1tm1Mbb
(involves: 129P2/OlaHsd) 		decreased hepatocyte number J:96823
\Akt1tm2.1Mbb/\Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		decreased liver triglyceride level J:182721
decreased susceptibility to diet-induced hepatic steatosis J:182721
\Akt2tm1.1Mbb/\Akt2+
\Lepob/\Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
decreased liver weight J:155432
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
(involves: 129P2/OlaHsd) 		decreased liver triglyceride level J:160759
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
\Lepob/\Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
decreased liver weight J:155432
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
\Ptentm1Hwu/\Ptentm1Hwu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		abnormal liver morphology J:218587
decreased susceptibility to hepatic steatosis J:218587
\Akt2tm1.2Mbb/\Akt2tm1.2Mbb
\Lepob/\Lepob
\Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		decreased liver triglyceride level J:155432
decreased liver weight J:155432
\Akt2tm1.2Mbb/\Akt2tm1.2Mbb
\Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		decreased liver triglyceride level J:155432
\Aladem1(IMPC)Tcp/\Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Cmmr) 		abnormal liver morphology J:211773
\Albem1(icre)Gpt/\Alb+
\Cers5em1Gpt/\Cers5em1Gpt
(C57BL/6JGpt-Albem1(icre)Gpt Cers5em1Gpt) 		liver fibrosis J:345383
\Albtm1(cre/ERT2)Mtz/\Alb+
\Fth1tm1.1Lck/\Fth1tm1.1Lck
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal liver iron level J:166515
\Albtm1(cre/ERT2)Mtz/\Alb+
\Krastm4Tyj/\Kras+
\Ptentm2Mak/\Ptentm2Mak
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:254370
\Albtm1(cre/ERT2)Mtz/\Alb+
\Polr2mtm1.1Rgr/\Polr2mtm1.1Rgr
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased hepatocyte karyomegaly J:291184
\Albtm1(cre/ERT2)Mtz/\Albtm1(cre/ERT2)Mtz
\Slc2a2tm2Thor/\Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased liver cholesterol level J:197607
decreased liver triglyceride level J:197607
increased liver glycogen level J:197607
\Aldh1l2tm2e(KOMP)Wtsi/\Aldh1l2tm2e(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		hepatic steatosis J:299012
\Aldobtm1(KOMP)Vlcg/\Aldobtm1(KOMP)Vlcg
(C57BL/6NTac-Aldobtm1(KOMP)Vlcg) 		abnormal liver morphology J:220330
abnormal portal triad morphology J:220330
hepatic steatosis J:220330
liver fibrosis J:220330
pale liver J:220330
\Aldoctm1.1(KOMP)Vlcg/\Aldoctm1.1(KOMP)Vlcg
\Ldlrtm1Her/\Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N) 		decreased liver cholesterol level J:346664
decreased liver triglyceride level J:346664
decreased liver weight J:346664
\Alkbh1tm1b(EUCOMM)Hmgu/\Alkbh1+
(C57BL/6N-Alkbh1tm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Alkbh7tm1.1Klng/\Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J) 		increased liver weight J:198968
\Alms1foz/\Alms1foz
(involves: NOD) 		abnormal hepatocyte morphology J:107058
enlarged liver J:107058
hepatic steatosis J:107058
increased liver weight J:107058
liver fibrosis J:107058
\Alms1Gt(XH152)Byg/\Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver weight J:100403
macrovesicular hepatic steatosis J:100403
microvesicular hepatic steatosis J:100403
\Alms1L2131X/\Alms1L2131X
(involves: C57BL/6 * NOD) 		hepatic steatosis J:118221
\Altretm1.1Hbgl/\Altretm1.1Hbgl
\Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:342907
increased liver tumor incidence J:342907
increased susceptibility to diet-induced hepatic steatosis J:342907
liver fibrosis J:342907
\Amacrtm1Jkh/\Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ) 		enlarged liver J:90370
hepatic necrosis J:90370
\AmfrGt(IST12797A11)Tigm/\AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm) 		abnormal hepatocyte morphology J:221247
abnormal liver morphology J:221247
hepatic steatosis J:221247
increased liver tumor incidence J:221247
liver cirrhosis J:221247
liver fibrosis J:221247
\Anapc2tm1Kna/\Anapc2tm1Kna
\Tg(Ttr-cre/Esr1*)1Vco/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal hepatocyte morphology J:87782
\Anapc2tm1Kna/\Anapc2tm2Kna
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:87782
decreased liver glycogen level J:87782
\Angptl3tm1Kfuj/\Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj) 		increased liver weight J:107479
\Ank1ity16/\Ank1+
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J) 		increased liver iron level J:199427
\Ank1ity16/\Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J) 		increased liver iron level J:199427
liver abscess J:199427
\Ank1nb/\Ank1nb
(either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re)) 		enlarged liver J:30699
\Ank1nb/\Ank1nb
(involves: C57BL/6J * WB/Re) 		increased liver iron level J:3122
\Ank1nb/\Ank1nb
((WB.Cg-Ank1nb/BrkJ x B6.Cg-Ank1nb/BrkJ)F1) 		enlarged liver J:162532
\Ank1Rbc2/\Ank1Rbc2
(involves: 129S1/Sv * BALB/c) 		increased liver iron level J:148127
\Ank2tm2.1Bnt/\Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J) 		increased susceptibility to diet-induced hepatic steatosis J:222913
\Ank2tm3.1Bnt/\Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J) 		increased susceptibility to diet-induced hepatic steatosis J:222913
\Anks6b2b1801.1Clo/\Anks6b2b1801.1Clo
(C57BL/6J-Anks6b2b1801.1Clo) 		abnormal liver morphology J:175213
\Anks6tm1d(KOMP)Wtsi/\Anks6tm1d(KOMP)Wtsi
(involves: C3H * C57BL/6 * C57BL/6N * FVB/N) 		abnormal portal lobule morphology J:307271
hepatic necrosis J:307271
liver fibrosis J:307271
small liver J:307271
\anx/\anx
(B6C3Fe a/a-anx/J) 		abnormal liver morphology J:7689
\anx/\anx
(involves: DW/J * M. m. domesticus poschiavinus * Swiss) 		abnormal liver morphology J:13936
\Anxa7tm1Pll/\Anxa7+
(B6.Cg-Anxa7tm1Pll) 		increased hepatocellular carcinoma incidence J:93685
\ApcMin/\Apc+
(C57BL/6J-ApcMin) 		hepatic steatosis J:86036
\ApcMin/\Apctm1Tno
\Ctnnb1tm4.1Wbm/\Ctnnb1+
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
\Apctm1Rak/\Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:20443
\Apctm1Tno/\Apc+
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
\Apctm1Tno/\Apctm1Tno
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
\Apctm2.1Cip/\Apctm2.1Cip
(involves: 129P2/OlaHsd * C57BL/6N) 		increased hepatocellular carcinoma incidence J:94721
liver hyperplasia J:94721
\Apctm2.1Cip/\Apctm2.1Cip
\Lect2tm1Ymg/\Lect2tm1Ymg
\Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco) 		abnormal liver morphology J:184496
hepatic necrosis J:184496
\Apctm2.1Cip/\Apctm2.1Cip
\Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco) 		abnormal liver morphology J:184496
enlarged liver J:184496
\Apctm2Rfo/\Apc+
(B6.129P2-Apctm2Rfo) 		increased liver tumor incidence J:151494
\Apctm2Rfo/\Apc+
((C57BL/6J x 129P2/OlaHsd)F1) 		increased liver tumor incidence J:151494
\Apctm2Rfo/\Apc+
(129P2/OlaHsd-Apctm2Rfo) 		increased liver tumor incidence J:151494
\Apctm2Tno/\Apc+
(involves: C57BL/6J) 		hepatic steatosis J:86036
\Apex1tm1Djc/\Apex1+
(involves: 129X1/SvJ * NTac:NIHS) 		abnormal liver morphology J:92957
\Apoa1tm1Unc/\Apoa1tm1Unc
\Ldlrtm1Her/\Ldlrtm1Her
(B6.129-Ldlrtm1Her Apoa1tm1Unc) 		abnormal liver morphology J:85174
decreased liver cholesterol level J:85174
\Apobtm1.1Zc/\Apob+
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:65191
\Apobtm1.1Zc/\Apobtm1.1Zc
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:65191
\Apobtm1Zc/\Apob+
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:76047
\Apobtm1Zc/\Apobtm1.1Zc
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:76047
\Apobtm1Zc/\Apobtm1Zc
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:76047
\Apobtm4Sgy/\Apobtm4Sgy
(involves: 129S4/SvJae * C57BL/6) 		herniated liver J:46549
\Apoc1tm1Lmh/\Apoc1tm1Lmh
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:117482
\Apoc1tm1Lmh/\Apoc1tm1Lmh
\Tg(CETP)5203Tall/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J) 		increased liver triglyceride level J:117482
\Apoetm1.1Mae/\Apoetm1.1Mae
\Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev) 		decreased liver cholesterol level J:219838
decreased liver triglyceride level J:219838
\Apoetm1Unc/\Apoetm1Unc
\Cyp19a1tm1Esi/\Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:184647
increased liver weight J:184647
increased susceptibility to age-related hepatic steatosis J:184647
\Apoftm1(KOMP)Vlcg/\Apoftm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased liver cholesterol level J:185314
\Aqp11tm1.1Nlsn/\Aqp11tm1.1Nlsn
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:194939
\Artm1Chc/Y
\Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		increased liver triglyceride level J:98775
\Arb2aem2(IMPC)Ccpcz/\Arb2aem2(IMPC)Ccpcz
(C57BL/6NCrl-Arb2aem2(IMPC)Ccpcz/Ph) 		abnormal liver morphology J:211773
decreased liver weight J:211773
\Arf6tm1Yaka/\Arf6tm1Yaka
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatic cord morphology J:111404
abnormal liver development J:111404
abnormal liver morphology J:111404
decreased liver weight J:111404
liver hypoplasia J:111404
pale liver J:111404
\Arg1tm1Rki/\Arg1tm1Rki
(Not Specified) 		abnormal hepatocyte morphology J:83263
abnormal liver morphology J:83263
enlarged liver J:83263
pale liver J:83263
\Arhgap1tm1Yizh/\Arhgap1tm1Yizh
(involves: 129S6/SvEvTac) 		liver hypoplasia J:101418
\Arhgap1tm1Yizh/\Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6) 		liver hypoplasia J:119516
\Arhgap31tm1.1Itl/\Arhgap31tm1.2Itl
(involves: 129/SvEv * C57BL/6) 		pale liver J:253757
\Arhgap31tm1.2Itl/\Arhgap31tm1.2Itl
(involves: 129/SvEv * C57BL/6) 		pale liver J:253757
\Arhgef2em1(IMPC)Mbp/\Arhgef2em1(IMPC)Mbp
(C57BL/6N-Arhgef2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Arid3atm1Pwt/\Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6) 		liver hypoplasia J:169178
\Arid4atm1Alb/\Arid4atm1Alb
(involves: 129S7/SvEvBrd) 		enlarged liver J:141004
\Arid4atm1Alb/\Arid4atm1Alb
\Arid4btm1Alb/\Arid4b+
(involves: 129S7/SvEvBrd) 		enlarged liver J:141004
\Arih2tm1Mak/\Arih2tm1Mak
(B6.129P2-Arih2tm1Mak) 		liver hypoplasia J:191066
\Armcx3tm1.1Eso/Y
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:345411
\Arnt2em1Btlr/\Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr) 		hepatic steatosis J:268298
increased liver weight J:268298
\Arnttm1Bra/\Arnttm1Bra
\Hprt1tm1(Pck1-cre)Vhh/Y
\Vhltm1Jae/\Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6) 		hepatic steatosis J:97652
\Arrdc3Gt(CSE151)Byg/\Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to hepatic steatosis J:179646
\Arsgtm1Tdi/\Arsgtm1Tdi
(involves: 129S2/SvPas * C57BL/6) 		abnormal hepatocyte morphology J:185592
abnormal liver sinusoidal endothelial cell morphology J:185592
\Arv1tm1.2Geno/\Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		decreased liver cholesterol level J:263695
decreased liver free fatty acids level J:263695
decreased liver triglyceride level J:263695
decreased susceptibility to diet-induced hepatic steatosis J:263695
\Asah1tm1.2Geno/\Asah1tm1.2Geno
(involves: C57BL/6) 		liver fibrosis J:285931
\Asah1tm1Esc/\Asah1+
(involves: 129S1/Sv * C57BL/6) 		abnormal liver morphology J:74647
pale liver J:74647
\Asah1tm1Medin/\Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1) 		hepatic necrosis J:232306
\Asic3em1(IMPC)Mbp/\Asic3em1(IMPC)Mbp
(C57BL/6NCrl-Asic3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Aspscr1em1(IMPC)Tcp/\Aspscr1em1(IMPC)Tcp
(C57BL/6NCrl-Aspscr1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Asxl1tm1.1Mjxu/\Asxl1+
(involves: 129 * C57BL/6) 		abnormal liver morphology J:208085
enlarged liver J:208085
\Atad5Gt(RRF055)Byg/\Atad5+
(involves: 129P2/OlaHsd) 		increased liver adenocarcinoma incidence J:176672
\Atf2tm2Nicj/\Atf2tm2Nicj
\Atf7tm1Nicj/\Atf7tm1Nicj
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:123909
liver hypoplasia J:123909
\Atf4tm1Tow/\Atf4tm1Tow
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		decreased hepatocyte number J:74479
pale liver J:74479
\Atf6tm1.1Rjk/\Atf6tm1.1Rjk
(involves: C57BL/6 * FVB/N) 		hepatic steatosis J:124971
\Atg5tm1Myok/\Atg5tm1Myok
\Tg(CAG-cre)13Miya/?
(involves: 129S/SvEv * C57BL/6) 		abnormal liver morphology J:110050
\Atg5tm1Myok/\Atg5tm1Myok
\Tg(Mx1-cre)1Cgn/?
(involves: 129S/SvEv * C57BL/6 * CBA) 		abnormal liver morphology J:110050
\Atg5tm1Nmz/\Atg5tm1Nmz
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal hepatocyte morphology J:110050
abnormal liver morphology J:110050
\Atg7tm1Tchi/\Atg7tm1Tchi
\Sqstm1tm1Keta/\Sqstm1tm1Keta
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA * CBA/JNCrlj) 		abnormal hepatocyte morphology J:130839
\Atg7tm1Tchi/\Atg7tm1Tchi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal hepatocyte mitochondrial morphology J:100199
abnormal hepatocyte morphology J:130839, J:100199
abnormal liver morphology J:100199
enlarged liver J:100199
increased liver weight J:130839, J:100199
\Atl3em1(IMPC)Tcp/\Atl3em1(IMPC)Tcp
(C57BL/6N-Atl3em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Atmtm1Awb/\Atmtm1Awb
(A.129S6-Atmtm1Awb) 		increased hepatocellular carcinoma incidence J:208539
\Atox1Gt(IRESBetageo)3Pgr/\Atox1Gt(IRESBetageo)3Pgr
(B6.129(Cg)-Atox1Gt(IRESBetageo)3Pgr/Mmucd) 		decreased liver copper level J:74249
\Atp5if1em1Jpy/\Atp5if1em1Jpy
(C57BL/6J-Atp5if1em1Jpy) 		increased liver weight J:313048
\Atp6ap2em1Nira/Y
(C57BL/6J-Atp6ap2em1Nira) 		decreased liver weight J:324587
\Atp6ap2tm1.1Aich/Y
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J) 		abnormal hepatocyte morphology J:274386
enlarged liver J:274386
\Atp6ap2tm1.1Aich/\Atp6ap2tm1.1Aich
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J) 		abnormal hepatocyte morphology J:274386
enlarged liver J:274386
\Atp6v0d1em1Nju/\Atp6v0d1em1Nju
\Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		hepatic steatosis J:346448
increased liver cholesterol level J:346448
increased liver free fatty acids level J:346448
increased liver triglyceride level J:346448
increased liver weight J:346448
\Atp7aMo-blo/Y
(involves: C57BL/6J) 		decreased liver copper level J:36268
\Atp7aMo-blo/\Atp7a+
(involves: C57BL/6J) 		decreased liver copper level J:36268
\Atp7aMo-br/Y
(involves: C57BL) 		decreased liver copper level J:5462
\Atp7aMo-brJ/Y
(involves: C3H/HeJ * C57BL/6J) 		decreased liver copper level J:33276
\Atp7aMo-ml/Y
(involves: C3Hf/He) 		decreased liver copper level J:1132, J:12745
\Atp7aMo-ms/Y
(Not Specified) 		decreased liver copper level J:168658
\Atp7aMo-ms/Y
(involves: CBA/Kw) 		decreased liver copper level J:14875
\Atp7btm1Tcg/\Atp7btm1Tcg
(involves: 129S1/Sv) 		abnormal liver copper level J:57632
abnormal liver morphology J:57632
liver cirrhosis J:57632
\Atp7btx-J/\Atp7btx-J
(C3H/HeJ-Atp7btx-J/J) 		abnormal liver morphology J:130273, J:86701
liver cirrhosis J:24233
\Atp7btx/\Atp7btx
(DL-Atp7btx) 		abnormal hepatocyte morphology J:19226
decreased liver copper level J:7102
increased liver copper level J:40104, J:7102, J:19226
liver cirrhosis J:40104
\Atp7btx/\Atp7btx
(involves: C57BL/6 * DL) 		decreased liver copper level J:7102
increased liver copper level J:7102
\Atp8b1em1(IMPC)Tcp/\Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Atp8b1tm1Nbf/\Atp8b1tm1Nbf
(involves: 129S1/SvImJ * 129S4/SvJae) 		enlarged liver J:89817
\Atp8b1tm1Nbf/\Atp8b1tm1Nbf
\Portm1Wolf/\Portm1Wolf
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased liver weight J:215915
\Atp10aem1Vtrg/\Atp10aem1Vtrg
(C57BL/6J-Atp10aem1Vtrg) 		decreased liver free fatty acids level J:344354
increased liver cholesterol level J:344354
increased liver triglyceride level J:344354
macrovesicular hepatic steatosis J:344354
\Atp11atm1a(KOMP)Wtsi/\Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
liver hypoplasia J:239583
\Atp11cambr/Y
(C57BL/6-Atp11cambr) 		increased hepatocellular carcinoma incidence J:171924
\Atrtm1Bal/\Atrtm2Bal
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		abnormal liver morphology J:123200
\Atrtm1Ofc/\Atrtm1Ofc
(Not Specified) 		decreased liver weight J:151542
\Atxn2tm1.1Aub/\Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:135320
increased liver glycogen level J:135320
\Atxn2tm1Plt/\Atxn2tm1Plt
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:103805
\AurkaGt(XQ0149)Wtsi/\Aurka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatoma incidence J:143099
\Aurkbtm1.2Mama/\Aurkb+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL) 		increased liver adenocarcinoma incidence J:173575
\Axltm1Grl/\Axltm1Grl
\Mertktm1Grl/\Mertktm1Grl
\Tyro3tm1Grl/\Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		liver degeneration J:54681
\Azin1Gt(Ayu17-689)Imeg/\Azin1Gt(Ayu17-689)Imeg
(involves: C57BL/6 * CBA) 		abnormal liver parenchyma morphology J:146570
\b2b386.2Clo/\b2b386.2Clo
(C57BL/6J-b2b386.2Clo) 		abnormal liver morphology J:175213
\b2b386Clo/\b2b386Clo
(C57BL/6J-b2b386Clo) 		abnormal liver morphology J:175213
\b2b1297Clo/\b2b1297Clo
(C57BL/6J-b2b1297Clo) 		abnormal liver morphology J:175213
liver cyst J:175213
\b2b1801Clo/\b2b1801Clo
(C57BL/6J-b2b1801Clo) 		abnormal liver morphology J:175213
\b2b2025Clo/\b2b2025Clo
(C57BL/6J-b2b2025Clo) 		abnormal liver morphology J:175213
\b2b2821Clo/\b2b2821Clo
(C57BL/6J-b2b2821Clo) 		abnormal liver morphology J:175213
\B2mtm1Unc/\B2mtm1Unc
\Hfetm2Nca/\Hfetm2Nca
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver iron level J:62112
\B2mtm1Unc/\B2mtm1Unc
\Prkdcscid/\Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid) 		increased liver iron level J:102141
\B9d1tm1a(EUCOMM)Wtsi/\B9d1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * CD-1) 		abnormal liver morphology J:178421
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal hepatocyte morphology J:123547
\B9d2tm1a(EUCOMM)Wtsi/\B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver morphology J:239583
\Babam1em1(IMPC)Ccpcz/\Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz) 		increased liver weight J:211773
\Bag1tm1Msd/\Bag1tm1Msd
(involves: C57BL/6) 		liver hypoplasia J:95491
\Bag3tm1.1Jhl/\Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl) 		decreased liver weight J:144416
hepatic steatosis J:144416
pale liver J:144416
\Bbs2tm1.1Huss/\Bbs2tm1.1Huss
(involves: 129S6/SvEv * C57BL/6) 		increased liver weight J:296033
\Bbs2tm1Vcs/\Bbs2tm1Vcs
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		hepatic steatosis J:94467
\Bbs4Gt1Nk/\Bbs4Gt1Nk
(involves: 129S7/SvEvBrd) 		abnormal liver morphology J:134093
enlarged liver J:134093
hepatic steatosis J:134093
\Bcar1tm1Hhi/\Bcar1tm1Hhi
(involves: 129S/SvEv * C57BL/6) 		small liver J:48967
\Bckdhatm1a(EUCOMM)Hmgu/\Bckdhatm1a(EUCOMM)Hmgu
\Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB) 		increased liver triglyceride level J:278806
increased liver weight J:278806
\BckdkGt(VICT48)710Lex/\BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex) 		increased liver weight J:117564
\Bcl2l12tm1.1(KOMP)Vlcg/\Bcl2l12tm1.1(KOMP)Vlcg
(C57BL/6N-Bcl2l12tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Bcl2l15tm1b(EUCOMM)Hmgu/\Bcl2l15tm1b(EUCOMM)Hmgu
(C57BL/6N-Bcl2l15tm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Bcl6tm1Gdba/\Bcl6tm1Gdba
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		decreased liver triglyceride level J:271078
decreased liver weight J:271078
decreased susceptibility to diet-induced hepatic steatosis J:271078
\Bco1tm1Dnp/\Bco1tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6) 		macrovesicular hepatic steatosis J:128383
\Bco2tm1Dnp/\Bco2+
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver triglyceride level J:170742
macrovesicular hepatic steatosis J:170742
\Bco2tm1Dnp/\Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:166153
increased liver triglyceride level J:170742
macrovesicular hepatic steatosis J:170742
\Bcrtm1Hkp/\Bcrtm1Hkp
(involves: 129S2/SvPas) 		abnormal liver parenchyma morphology J:23804
\Bcs1ltm1.1Levp/\Bcs1ltm1.1Levp
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:189652
decreased liver glycogen level J:189652
increased liver iron level J:189652
liver fibrosis J:189652
microvesicular hepatic steatosis J:189652
small liver J:189652
\Bcs1ltm1.1Levp/\Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp) 		abnormal hepatocyte mitochondrial morphology J:273501
abnormal hepatocyte morphology J:273501
abnormal liver morphology J:273501
abnormal portal triad morphology J:273501
hepatic necrosis J:273501
liver fibrosis J:273501
\Becn1tm1Blev/\Becn1+
(involves: 129X1/SvJ * C57BL/6J) 		increased hepatocellular carcinoma incidence J:86953
\Becn1tm1Htz/\Becn1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:86982
\Bhlha15tm2(Kras)Skz/\Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6) 		enlarged liver J:105076
increased hepatocellular carcinoma incidence J:105076
increased liver adenoma incidence J:105076
\Bhlha15tm2(Kras)Skz/\Bhlha15+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:105076
\Bhmttm1.2Zei/\Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:177569
hepatic steatosis J:177569
increased hepatocellular carcinoma incidence J:177569
increased liver adenoma incidence J:177569
increased liver tumor incidence J:177569
increased liver weight J:177569
\Bicc1jcpk-67Gso/\Bicc1jcpk-67Gso
\T(2;10)67Gso/\T(2;10)67Gso
(involves: 101/Rl * C3H/Rl * C57BL10a/E * SEC/RlGso) 		abnormal biliary ductule morphology J:75799
abnormal interlobular bile duct morphology J:75799
abnormal liver morphology J:75799
abnormal liver parenchyma morphology J:75799
\Bicc1jcpk-bpk/\Bicc1jcpk-bpk
(BALB/c-Bicc1jcpk-bpk) 		abnormal liver morphology J:13276
\Bicc1jcpk-bpk/\Bicc1jcpk-bpk
(involves: BALB/c * CAST/EiJ) 		pale liver J:36348
\Bicc1jcpk/\Bicc1jcpk-bpk
(involves: 101 * BALB/c * C3H * C57BL/6J * T STOCK) 		abnormal portal lobule morphology J:36348
abnormal portal triad morphology J:36348
pale liver J:36348
\Bicc1jcpk/\Bicc1jcpk
(involves: 101 * C3H * C57BL/6J * T STOCK) 		abnormal portal triad morphology J:36348
\Bidtm1Sjk/\Bidtm1Sjk
\Relatm1Bal/\Relatm1Bal
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:132334
\Bin3tm1Gcp/\Bin3tm1Gcp
(involves: 129 * C57BL/6) 		abnormal hepatocyte morphology J:133313
\Birc6tm1Nai/\Birc6tm1Nai
(involves: 129S4/SvJae * C57BL/6J) 		decreased hepatocyte number J:96768
\Bloc1s2tm1.1(KOMP)Mbp/\Bloc1s2tm1.1(KOMP)Mbp
(B6N(Cg)-Bloc1s2tm1.1(KOMP)Mbp/J) 		pale liver J:211773
\Blvratm1c(EUCOMM)Hmgu/\Blvratm1c(EUCOMM)Hmgu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6J * C57BL/6N) 		decreased liver glycogen level J:237631
hepatic steatosis J:237631
increased liver triglyceride level J:237631
\Bmal1tm1.2Shbi/\Bmal1tm1.2Shbi
(involves: C57BL/6J) 		increased liver triglyceride level J:177865
increased susceptibility to diet-induced hepatic steatosis J:177865
\Bmp4tm2Blh/\Bmp4tm2Blh
(involves: 129S6/SvEvTac * Black Swiss) 		abnormal liver bud morphology J:71204
delayed hepatic development J:71204
\Bmp5se-Ca/\Bmp5se-Ca
(CBA/Ca-Bmp5se-Ca) 		abnormal liver morphology J:5086
\Bmp5se-Ca/\Bmp5se-Ca
(SEACGn.CB-Bmp5se-Ca) 		abnormal liver morphology J:5086
\Bmp5se/\Bmp5se
(Ab/Gn) 		decreased liver weight J:13091
\Bmp5se/\Bmp5se
(SEC/1Gn) 		abnormal liver morphology J:5086
\Bmp5se/\Bmp5se
(SEAC/Gn) 		abnormal liver morphology J:5086
\Bmpr1bem1(IMPC)Mbp/\Bmpr1bem1(IMPC)Mbp
(C57BL/6NCrl-Bmpr1bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Bpnt1tm1Yrk/\Bpnt1tm1Yrk
(involves: 129S/SvEv * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:194247
abnormal hepatocyte morphology J:194247
enlarged liver J:194247
pale liver J:194247
\Braftm1Cpri/\Braf+
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver morphology J:104375
\Braftm1Mmcm/\Braftm1Mmcm
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		hepatosplenomegaly J:211690
\Braftm1Tumg/\Braf+
\Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA) 		decreased liver weight J:216228
hepatic necrosis J:216228
small liver J:216228
\Braftm1Tumg/\Braf+
\Tg(CAG-cre)2Osb/0
(involves: BALB/c * C57BL * C57BL/6J * DBA) 		hepatic necrosis J:226977
\Brca1tm2Cxd/\Brca1tm2Cxd
\Pkmtm1.1Mgvh/\Pkmtm1.1Mgvh
\Trp53tm1Brd/\Trp53+
\Tg(MMTV-cre)4Mam/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased liver tumor incidence J:205213
\Brca1tm3Cxd/\Brca1tm3Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased hepatoma incidence J:94114
\Brca1tm5.1Cxd/\Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased liver tumor incidence J:155810
\Brd1tm1Hko/\Brd1tm1Hko
(B6.129-Brd1tm1Hko) 		small liver J:177092
\Brd2em1(IMPC)Wtsi/\Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg) 		dilated liver sinusoidal space J:239583
\Brd2Gt(RRT234)Byg/\Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg) 		hepatic steatosis J:159964
\Brd4Gt(pGT1.8TM)ST132Nimr/\Brd4+
(involves: 129P2/Ola * C57BL/6J) 		abnormal hepatocyte morphology J:76662
\Brf1tm1Arte/\Brf1tm1Arte
\Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA) 		hepatic necrosis J:285667
small liver J:285667
\Brip1Gt(RRI409)Byg/\Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		hepatic steatosis J:227115
\Bscl2tm1.1Lchan/\Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		enlarged liver J:183701
hepatic steatosis J:183701
\Bscl2tm1.2Gliu/\Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		enlarged liver J:173404
increased liver triglyceride level J:173404
macrovesicular hepatic steatosis J:173404
microvesicular hepatic steatosis J:173404
\Bscl2tm1c(EUCOMM)Hmgu/\Bscl2tm1c(EUCOMM)Hmgu
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		increased liver triglyceride level J:260853
\Bscl2tm1Geno/\Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno) 		enlarged liver J:200947
hepatic steatosis J:200947
increased liver triglyceride level J:200947
increased liver weight J:200947
\Bsgtm1Tmu/\Bsgtm1Tmu
(involves: 129S2/SvPas * C57BL/6J) 		abnormal liver morphology J:46376
small liver J:46376
\Bsgtm1Tmu/\Bsgtm1Tmu
(involves: 129/Sv * 129S2/SvPas) 		abnormal liver morphology J:46376
small liver J:46376
\Bst2em1(IMPC)Mbp/\Bst2em1(IMPC)Mbp
(C57BL/6N-Bst2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Btbd2em1(IMPC)Mbp/\Btbd2em1(IMPC)Mbp
(C57BL/6N-Btbd2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Btbd18em1(IMPC)Ccpcz/\Btbd18em1(IMPC)Ccpcz
(C57BL/6NCrl-Btbd18em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Bub1tm1.1Tvd/\Bub1tm1.1Tvd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased liver tumor incidence J:143035
\Bub1tm1.1Tvd/\Bub1tm1.1Tvd
(B6.129P2-Bub1tm1.1Tvd) 		hepatic necrosis J:143035
pale liver J:143035
\Bub1tm2Jvd/\Bub1tm2Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:135093
\Bub1btm1.1Hsl/\Bub1b+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:201641
\Bub1btm1Jvd/\Bub1btm1Jvd
\Mad2l1bptm1.1Itl/\Mad2l1bptm1.1Itl
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		abnormal hepatocyte morphology J:234643
increased hepatocyte karyomegaly J:234643
\C1qtnf1em1(IMPC)Mbp/\C1qtnf1em1(IMPC)Mbp
(C57BL/6N-C1qtnf1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\C1qtnf1tm1Lex/\C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex) 		decreased liver cholesterol level J:241403
decreased liver triglyceride level J:241403
hepatic steatosis J:241403
increased liver triglyceride level J:241403
\C1qtnf2tm1Lex/\C1qtnf2tm1Lex
(B6.129S5-C1qtnf2tm1Lex) 		decreased liver cholesterol level J:282612
decreased liver triglyceride level J:282612
small liver J:282612
\C1qtnf5tm1(KOMP)Vlcg/\C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased liver triglyceride level J:237401
decreased susceptibility to diet-induced hepatic steatosis J:237401
\C1qtnf7tm1(KOMP)Vlcg/\C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg) 		decreased liver weight J:244352
\C1qtnf9tm1(KOMP)Vlcg/\C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg) 		hepatic steatosis J:212299
increased liver triglyceride level J:212299
\C1qtnf12tm1Gww/\C1qtnf12+
(involves: C57BL/6J * C57BL/6N) 		increased liver cholesterol level J:242627
increased liver triglyceride level J:242627
increased susceptibility to diet-induced hepatic steatosis J:242627
\C2cd5Gt(IST12020E4)Tigm/\C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm) 		hepatic steatosis J:284780
increased liver triglyceride level J:284780
\C3tm1Crr/\C3tm1Crr
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:152533
focal hepatic necrosis J:152533
hepatic steatosis J:152533
\C3tm1Crr/\C3tm1Crr
(involves: 129S4/SvJae) 		decreased susceptibility to alcohol-induced hepatic steatosis J:128218
\C5ar2tm1Gdy/\C5ar2tm1Gdy
(involves: 129 * C57BL/6) 		abnormal liver morphology J:152533
focal hepatic necrosis J:152533
hepatic steatosis J:152533
\C9orf72tm1.1Eggn/\C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N) 		enlarged liver J:240357
\C9orf72tm1Eggn/\C9orf72+
(involves: C57BL/6 * C57BL/6N) 		enlarged liver J:240357
\C9orf72tm1Eggn/\C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N) 		enlarged liver J:240357
\cab/\cab
(STOCK Cacna1smdg) 		abnormal liver morphology J:6195, J:7797
\Cacna1cem1(IMPC)Mbp/\Cacna1c+
(C57BL/6N-Cacna1cem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Cacna1itm1b(KOMP)Wtsi/\Cacna1itm1b(KOMP)Wtsi
(C57BL/6N-Cacna1itm1b(KOMP)Wtsi/Bay) 		small liver J:211773
\Camk1dem1(IMPC)Mbp/\Camk1dem1(IMPC)Mbp
(C57BL/6NCrl-Camk1dem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Camsap3tm1a(EUCOMM)Wtsi/\Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver parenchyma morphology J:239583
\Cand1em1(IMPC)Mbp/\Cand1+
(C57BL/6NCrl-Cand1em1(IMPC)Mbp/Mmucd) 		enlarged liver J:211773
\Capza2tm1b(KOMP)Wtsi/\Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Casp8em1(IMPC)Ccpcz/\Casp8+
(C57BL/6NCrl-Casp8em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
\Casp8kuche/\Casp8kuche
(involves: C57BL/6JAnu * C57BL/10SnJ) 		small liver J:104190
\Casp8tm1Clie/\Casp8tm1Clie
\Ikbkgtm1.1Chtr/\Ikbkgtm1.1Chtr
\Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal liver morphology J:218665
enlarged liver J:218665
hepatic necrosis J:218665
liver fibrosis J:218665
\Casp8tm1Clie/\Casp8tm1Clie
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal liver morphology J:160521
focal hepatic necrosis J:160521
\Casp8tm1Raz/\Casp8tm1Raz
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver morphology J:107455
\Casz1Gt(CJ0565)Wtsi/\Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		liver vascular congestion J:242127
\Catb/\Catb
(C3.Cg-Catb/Anl) 		increased hepatoma incidence J:154291
\Cav1tm1Kur/\Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6) 		decreased liver triglyceride level J:112452
\Cav1tm1Mls/\Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls) 		decreased liver glycogen level J:182288
decreased susceptibility to diet-induced hepatic steatosis J:182288
increased liver glycogen level J:182288
increased liver weight J:182288
\Cav3em1(IMPC)Kmpc/\Cav3em1(IMPC)Kmpc
(C57BL/6NTac-Cav3em1(IMPC)Kmpc/Kmpc) 		absent liver J:211773
\Cavin3tm1Pemi/\Cavin3tm1Pemi
(B6.129S4-Cavin3tm1Pemi) 		hepatic steatosis J:202374
\Cbfbtm1Lhc/\Cbfbtm1Lhc
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal liver morphology J:105040
\Cbfbtm1Ppl/\Cbfb+
(either: (involves: 129/Sv * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6)) 		pale liver J:36594
small liver J:36594
\Cbfbtm1Spe/\Cbfbtm1Spe
\Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1)) 		abnormal liver morphology J:80670
\Cbfbtm1Spe/\Cbfbtm1Spe
\Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster)) 		abnormal liver morphology J:80670
\Cbfbtm1Tno/\Cbfbtm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		abnormal liver development J:40963
\Cbfbtm1Tok/\Cbfbtm1Tok
(involves: 129P2/OlaHsd * C57BL/6J) 		pale liver J:36250
\Cbfbtm3Ppl/\Cbfb+
(involves: 129S6/SvEvTac * C57BL/6) 		pale liver J:160522
\Cbfbtm4Ppl/\Cbfb+
(involves: 129S6/SvEvTac * C57BL/6) 		pale liver J:160522
\Cbltm1Ddlb/\Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6) 		decreased liver triglyceride level J:94416
\Cbltm2Hua/\Cbltm2Hua
\Cblbtm1Hua/\Cblbtm1Hua
\Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR) 		liver fibrosis J:80427
\Cbliftm1a(KOMP)Wtsi/\Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi) 		abnormal hepatocyte morphology J:236022
\Cbstm1Unc/\Cbs+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:23321
\Cbstm1Unc/\Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:23321
enlarged liver J:23321
hepatic steatosis J:101303
increased polyploid hepatocyte number J:23321
liver fibrosis J:101303
microvesicular hepatic steatosis J:23321
pale liver J:23321
\Cbstm1Unc/\Cbstm1Unc
\Tg(CBS)11181Eri/0
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:165612
\Cbx6tm1a(EUCOMM)Wtsi/\Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
\Cbx7tm1Afus/\Cbx7+
(involves: C57BL/6J) 		increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
\Cbx7tm1Afus/\Cbx7tm1Afus
(involves: C57BL/6J) 		increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
increased liver tumor incidence J:184383
\Ccar2Gt(XN876)Byg/\Ccar2Gt(XN876)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:156677
\Ccbe1em1(IMPC)Mbp/\Ccbe1+
(C57BL/6NCrl-Ccbe1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Ccbe1em1(IMPC)Mbp/\Ccbe1em1(IMPC)Mbp
(C57BL/6NCrl-Ccbe1em1(IMPC)Mbp/MbpMmucd) 		pale liver J:211773
\Ccbe1tm1Mlkn/\Ccbe1tm1Mlkn
(either: B6.129-Ccbe1tm1Mlkn or (involves: 129 * C57BL/6)) 		abnormal liver morphology J:196696
small liver J:196696
\Ccdc3tm1Ish/\Ccdc3tm1Ish
(involves: C57BL/6J) 		decreased liver triglyceride level J:220560
decreased liver weight J:220560
decreased susceptibility to age-related hepatic steatosis J:220560
\Ccdc25em1(IMPC)Mbp/\Ccdc25+
(C57BL/6N-Ccdc25em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Ccdc39b2b2025.1Clo/\Ccdc39b2b2025.1Clo
(C57BL/6J-Ccdc39b2b2025.1Clo) 		abnormal liver morphology J:175213
\Ccdc80tm1.1Ftk/\Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6N) 		increased hepatocellular carcinoma incidence J:216704
\Ccdc92tm1a(KOMP)Mbp/\Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp) 		decreased liver triglyceride level J:332421
decreased liver weight J:332421
decreased susceptibility to diet-induced hepatic steatosis J:332421
\Ccdc124tm1b(KOMP)Wtsi/\Ccdc124tm1b(KOMP)Wtsi
(C57BL/6N-Ccdc124tm1b(KOMP)Wtsi/Nju) 		small liver J:211773
\Ccdc134tm1.2Jhua/\Ccdc134tm1.2Jhua
(involves: C57BL/6NTac) 		liver hypoplasia J:256995
small liver J:256995
\Ccdc154ntl/\Ccdc154ntl
(involves: 129S7/SvEvBrd * C57BL/6J) 		enlarged liver J:226596
\Ccdc198em1Iad/\Ccdc198em1Iad
(FVB.Cg-Pde6b+ Tyrc-ch Ccdc198em1Iad/J) 		small liver J:337480
\Cckbrtm1Tom/\Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J) 		increased liver iron level J:142455
\Ccl2tm1Rol/\Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J) 		decreased susceptibility to diet-induced hepatic steatosis J:110277
\Ccl28em1(IMPC)Ccpcz/\Ccl28em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccl28em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Ccn1tm3.1Lfl/\Ccn1tm3.1Lfl
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		liver fibrosis J:204032
\Ccn2tm1.1Alea/\Ccn2tm1.1Alea
\Mob1atm1.1Asuz/\Mob1atm1.1Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA) 		increased liver weight J:228499
liver fibrosis J:228499
\Ccn3em1(IMPC)Mbp/\Ccn3em1(IMPC)Mbp
(C57BL/6N-Ccn3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Ccn3tm1Cabo/\Ccn3+
(involves: 129S/SvEv) 		liver vascular congestion J:135676
\Ccn3tm1Cabo/\Ccn3tm1Cabo
(involves: 129S/SvEv) 		liver vascular congestion J:135676
\Ccnd2tm1Wbg/\Ccnd2tm1Wbg
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
(involves: 129S2/SvPas) 		abnormal liver development J:80994
\Ccndbp1tm1Riet/\Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:121623
increased liver adenoma incidence J:121623
\Ccng1tm1Sst/\Ccng1tm1Sst
(involves: 129S/SvEv * C57BL/6) 		decreased hepatoma incidence J:106007
decreased liver weight J:106007
increased hepatoma incidence J:106007
\Ccnytm1.1Smoc/\Ccnytm1.1Smoc
(involves: C57BL/6) 		decreased liver triglyceride level J:224589
\Ccr1tm1Gao/\Ccr1tm1Gao
(involves: 129S4/SvJae) 		abnormal Kupffer cell morphology J:152548
\Ccr2tm1Brv/\Ccr2tm1Brv
(involves: 129S1/Sv * ICR) 		enlarged liver J:111517
multifocal hepatic necrosis J:111517
\Ccr2tm1Ifc/\Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6) 		hepatic necrosis J:61542
\Ccr5tm1Kuz/\Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal Ito cell morphology J:152548
abnormal Kupffer cell morphology J:152548
\Cd1d1tm1Luc/\Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:93915
\Cd36em1(IMPC)Mbp/\Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Cd36tm1Mfe/\Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe) 		decreased liver free fatty acids level J:135594
decreased liver triglyceride level J:135594
increased liver triglyceride level J:87372
\Cdc20tm1.1Pzg/\Cdc20+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased hepatoma incidence J:150421
\Cdc73tm1Btt/\Cdc73tm1Btt
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		hepatic necrosis J:135255
small liver J:135255
\Cdh5tm3(Cdh5/Ctnna1)Dvst/\Cdh5tm3(Cdh5/Ctnna1)Dvst
(B6.Cg-Cdh5tm3(Cdh5/Ctnna1)Dvst) 		decreased liver weight J:213676
liver hypoplasia J:213676
small liver J:213676
\Cdh11em1(IMPC)Mbp/\Cdh11em1(IMPC)Mbp
(C57BL/6N-Cdh11em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Cdk1tm2.1Kald/\Cdk1tm2.1Kald
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		abnormal hepatocyte morphology J:182141
decreased hepatocyte number J:182141
\Cdk2tm1Kald/\Cdk2tm1Kald
\Cdk4tm1Kiyo/\Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6) 		abnormal liver morphology J:108720
\Cdk2tm1Sgo/\Cdk2tm1Sgo
\Cdk4tm1Bbd/\Cdk4tm1Bbd
\Cdk6tm1Bbd/\Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver hypoplasia J:124678
\Cdk2tm1Sgo/\Cdk2tm1Sgo
\Cdk4tm2.1Bbd/\Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL) 		liver hypoplasia J:125217
liver vascular congestion J:125217
\Cdk4tm1Bbd/\Cdk4tm1Bbd
\Cdk6tm1Bbd/\Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1 * ICR) 		liver hypoplasia J:92529
\Cdk5rap3tm1b(EUCOMM)Hmgu/\Cdk5rap3tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * FVB/N) 		decreased liver weight J:272566
liver hypoplasia J:272566
small liver J:272566
\Cdk5rap3tm1c(EUCOMM)Hmgu/\Cdk5rap3tm1c(EUCOMM)Hmgu
\Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA) 		abnormal hepatic cord morphology J:272566
abnormal hepatocyte morphology J:272566
decreased liver weight J:272566
liver hypoplasia J:272566
small liver J:272566
\Cdk10tm1.2Kald/\Cdk10tm1.2Kald
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver morphology J:262333
\Cdk12em1(IMPC)Tcp/\Cdk12+
(C57BL/6NCrl-Cdk12em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Cdk13tm1a(EUCOMM)Hmgu/\Cdk13tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		small liver J:291583
\Cdk13tm1d(EUCOMM)Hmgu/\Cdk13tm1d(EUCOMM)Hmgu
(involves: C57BL/6N * C57BL/6NTac) 		abnormal liver development J:291583
small liver J:291583
\Cdkal1Gt(6062)Tgen/\Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj) 		decreased liver triglyceride level J:195460
increased liver triglyceride level J:195460
\Cdkn1atm1(HBsAg)Xya/\Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
\Cdkn1atm1(HBsAg)Xya/\Cdkn1atm1(HBsAg)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Cdkn1btm1Ako/\Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas) 		hepatic steatosis J:118516
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Fahtm1Mgo/\Fahtm1Mgo
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:138701
increased hepatocellular carcinoma incidence J:138701
\Cdkn1atm2(HBx)Xya/\Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
\Cdkn1atm2(HBx)Xya/\Cdkn1atm2(HBx)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J) 		abnormal hepatocyte morphology J:33400
\Cdkn2atm1.1Brn/\Cdkn2atm1.1Brn
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N) 		increased liver tumor incidence J:131179
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Rnf2tm1Mvi/\Rnf2tm1Mvi
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL) 		enlarged liver J:130397
\Cdkn2atm2Brn/\Cdkn2a+
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd) 		enlarged liver J:132943
\Cdkn2atm2Brn/\Cdkn2atm2Brn
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd) 		enlarged liver J:132943
\Cebpatm1Gjd/\Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:28320
abnormal liver morphology J:28320
decreased liver glycogen level J:28320
\Cebpatm1Gonz/\Cebpatm1Gonz
\Lepob/\Lepob
\Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased liver cholesterol level J:93579
decreased liver triglyceride level J:93579
decreased susceptibility to diet-induced hepatic steatosis J:93579
increased liver glycogen level J:93579
\Cebpatm1Kgx/\Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal bile canaliculus morphology J:35795
abnormal hepatocyte morphology J:35795
abnormal liver morphology J:35795
decreased liver glycogen level J:35795
\Cebpatm1Timc/\Cebpatm1Timc
(Not Specified) 		hepatic steatosis J:163725
\Cebpatm5Nerl/\Cebpatm5Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:120098
increased liver triglyceride level J:120098
\Cebpatm6Nerl/\Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver glycogen level J:120098
\Cebpatm8.1Nerl/\Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		decreased hepatocyte number J:136134
\Celtm1Dyh/\Celtm1Dyh
\Pnliptm1Dyh/\Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:124658
\Cemip2tm1.1Cya/\Cemip2tm1.1Cya
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		abnormal liver sinusoid morphology J:317425
\Cers2Gt(S16-4B1)Sor/\Cers2Gt(S16-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		increased hepatocellular carcinoma incidence J:156841
increased liver tumor incidence J:156841
\Ces1dtm1Reli/\Ces1dtm1Reli
(involves: 129S6/SvEvTac) 		decreased liver triglyceride level J:158743
decreased liver weight J:158743
\Ces1gtm1Reli/\Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6) 		hepatic steatosis J:262803
increased liver cholesterol level J:262803
increased liver triglyceride level J:262803
liver degeneration J:262803
\Ces2atm1(KOMP)Vlcg/\Ces2atm1(KOMP)Vlcg
(C57BL6/N-Ces2atm1(KOMP)Vlcg) 		increased liver cholesterol level J:335459
increased liver triglyceride level J:335459
increased liver weight J:335459
increased susceptibility to diet-induced hepatic steatosis J:335459
liver fibrosis J:335459
\Cfap45em1Hmd/\Cfap45em1Hmd
(involves: C57BL/6) 		abnormal liver morphology J:297786
\Cfap53em1(IMPC)Wtsi/\Cfap53em1(IMPC)Wtsi
(C57BL/6N-Cfap53em1(IMPC)Wtsi/Wtsi) 		abnormal liver morphology J:239583
dilated liver sinusoidal space J:239583
herniated liver J:239583
\Cfc1tm1Mms/\Cfc1tm1Mms
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J)) 		abnormal liver morphology J:58104
\Cftrtm3Hgu/\Cftrtm3Hgu
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:32766
\Chchd2em1(IMPC)Mbp/\Chchd2em1(IMPC)Mbp
(C57BL/6NCrl-Chchd2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Chd2Gt(RRBO46)Byg/\Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:146743
hepatic necrosis J:146743
\Chfrtm1a(KOMP)Wtsi/\Chfrtm1a(KOMP)Wtsi
(C57BL/6NCrl-Chfrtm1a(KOMP)Wtsi/Ccpcz) 		increased liver weight J:211773
\ChkaGt(XH252)Byg/\Chka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:130726
\Chmp2bem1(IMPC)Mbp/\Chmp2b+
(C57BL/6NCrl-Chmp2bem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Chordc1tm1Mbra/\Chordc1+
(involves: 129 * C57BL/6) 		enlarged liver J:222040
\Chst2em1(IMPC)Mbp/\Chst2em1(IMPC)Mbp
(C57BL/6N-Chst2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Chst14tm1.1Msch/\Chst14tm1.1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:203583
\Chsy1em1(IMPC)Mbp/\Chsy1em1(IMPC)Mbp
(C57BL/6NCrl-Chsy1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Chuktm1Mpa/\Chuktm1Mpa
\Ikbkbtm2Cgn/\Ikbkbtm2Cgn
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		abnormal bile canaliculus morphology J:137861
\Chuktm1Ver/\Chuktm1Ver
\Ikbkbtm1Ver/\Ikbkbtm1Ver
(involves: 129S4/SvJae * C57BL/6J) 		liver degeneration J:63443
\Ciapin1tm1Yzka/\Ciapin1tm1Yzka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		small liver J:90889
\Cidectm1.1Gonz/\Cidectm1.2Gonz
\Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel) 		hepatic steatosis J:226899
\Cidectm1Maka/\Cidectm1Maka
(B6.129P2-Cidectm1Maka) 		decreased susceptibility to diet-induced hepatic steatosis J:140863
\Cirozb2b1167Clo/\Cirozb2b1167Clo
(C57BL/6J-Cirozb2b1167Clo) 		abnormal liver morphology J:175213
\Clasp1em1(IMPC)Mbp/\Clasp1+
(C57BL/6NCrl-Clasp1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Clca2tm1Dgen/\Clca2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:101679
enlarged liver J:101679
increased liver weight J:101679
multifocal hepatic necrosis J:101679
\Clcnkbem1(IMPC)Mbp/\Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Cldn12tm1.1(KOMP)Vlcg/\Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg) 		increased liver weight J:279934
\Clic5jbg/\Clic5jbg
(involves: C3H/HeJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:160186
\Clk2tm1.1Ppgr/\Clk2tm1.1Ppgr
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6NTac * FVB/N) 		decreased liver triglyceride level J:229283
\Cln3tm1.1Mem/\Cln3tm1.1Mem
(involves: 129S/SvEv * CD-1) 		abnormal hepatocyte morphology J:79615
\Cln3tm1Mkat/\Cln3tm1Mkat
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:57155
\Cln8em1(IMPC)Mbp/\Cln8em1(IMPC)Mbp
(C57BL/6N-Cln8em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Clockm1Jt/\Clockm1Jt
(C57BL/6-Clockm1Jt) 		hepatic steatosis J:98343
\Clrn1tm1.1(KOMP)Vlcg/\Clrn1tm1.1(KOMP)Vlcg
(C57BL/6N-Clrn1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Clspntm1(KOMP)Vlcg/\Clspn+
(C57BL/6N-Clspntm1(KOMP)Vlcg) 		increased liver weight J:332163
increased susceptibility to age-related hepatic steatosis J:332163
increased susceptibility to diet-induced hepatic steatosis J:332163
\Cluhtm1.1Eir/\Cluhtm1.1Eir
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: BALB/cJ * C57BL/6 * DBA * SJL) 		abnormal hepatocyte mitochondrial morphology J:249661
\Cluhtm1.2Eir/\Cluhtm1.2Eir
(involves: BALB/cJ * C57BL/6 * SJL) 		abnormal hepatocyte mitochondrial morphology J:249661
\Cmiptm1a(EUCOMM)Wtsi/\Cmiptm1a(EUCOMM)Wtsi
(C57BL/6N-Cmiptm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
\Cndp2em1(IMPC)Mbp/\Cndp2em1(IMPC)Mbp
(C57BL/6NCrl-Cndp2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Cnot3em1(IMPC)Rbrc/\Cnot3+
(C57BL/6NJcl-Cnot3em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Cnot3tm1.1Tya/\Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya) 		decreased susceptibility to diet-induced hepatic steatosis J:180033
small liver J:180033
\Cnot6ltm1Tya/\Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya) 		decreased liver weight J:274297
decreased susceptibility to diet-induced hepatic steatosis J:274297
\Cnot7em1(IMPC)Rbrc/\Cnot7em1(IMPC)Rbrc
(C57BL/6NJcl-Cnot7em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Cnpy2tm1.2Zhli/\Cnpy2tm1.2Zhli
(B6.Cg-Cnpy2tm1.2Zhli) 		decreased susceptibility to diet-induced hepatic steatosis J:277868
decreased susceptibility to hepatic steatosis J:277868
\Cog6tm1a(EUCOMM)Wtsi/\Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
\Col1a1tm1(tetO-Deptor)Dmsa/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		hepatic steatosis J:187378
increased liver weight J:187378
\Col1a1tm1(tetO-Fos)Wag/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/\Gt(ROSA)26Sor+
\Tg(Alb1-cre)7Gsc/0
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver morphology J:210545
\Col1a1tm1(tetO-Lin28a)Gqda/\Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		decreased susceptibility to diet-induced hepatic steatosis J:177113
liver hyperplasia J:166568
\Col1a1tm1(tetO-Tcfap2c)Hsc/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:174049
abnormal hepatocyte morphology J:174049
decreased liver glycogen level J:174049
microvesicular hepatic steatosis J:174049
\Col1a1tm1(tetO-URI1)Ndj/\Col1a1+
\Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		abnormal liver morphology J:217463
increased hepatocellular carcinoma incidence J:217463
increased liver adenoma incidence J:217463
liver fibrosis J:217463
\Col1a1tm1(tetO-URI1)Ndj/\Col1a1+
\Tg(Cebpb-tTA)#Bjd/0
\Trp53tm1Gev/\Trp53+
(B6.Cg-Trp53tm1Gev Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased hepatocellular carcinoma incidence J:217463
\Col1a1tm1(tetO-URI1)Ndj/\Col1a1tm1(tetO-URI1)Ndj
\Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased hepatocellular carcinoma incidence J:217463
\Col1a1tm1(tetO-YAP1*)Fcam/\Col1a1+
\Tg(Cebpb-tTA)#Bjd/0
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:141457
enlarged liver J:141457
increased liver weight J:141457
liver hyperplasia J:141457
\Col1a1tm1Dab/\Col1a1tm1Dab
(C.129S6-Col1a1tm1Dab) 		abnormal liver morphology J:170561
\Col1a1tm2(tetO-Fosl2,-DsRed)Wag/\Col1a1+
\Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		decreased liver triglyceride level J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
\Col1a1tm3(tetO-Fosl1,-DsRed)Wag/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		liver fibrosis J:213764
\Col1a1tm3(tetO-Fosl1,-DsRed)Wag/\Col1a1+
\Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		abnormal liver morphology J:210545
decreased liver triglyceride level J:210545
decreased liver weight J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
increased liver weight J:213764
\Col1a1tm4(tetO-Jun/Fosl2)Wag/\Col1a1+
\Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		decreased liver triglyceride level J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
\Col1a1tm5(tetO-Jun/Fos)Wag/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/\Gt(ROSA)26Sor+
\Tg(Alb1-cre)7Gsc/0
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver morphology J:210545
\Col1a1tm6(tetO-MSI2)Jae/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased liver weight J:163322
\Col2a1em1(IMPC)Ccpcz/\Col2a1em1(IMPC)Ccpcz
(C57BL/6NCrl-Col2a1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver size J:211773
\Col3a1tm1Jae/\Col3a1tm1Jae
(involves: 129S4/SvJae) 		abnormal liver morphology J:39273
\Col27a1em1(IMPC)Mbp/\Col27a1em1(IMPC)Mbp
(C57BL/6N-Col27a1em1(IMPC)Mbp/MbpMmucd) 		pale liver J:211773
\Colgalt1tm1.1Gpt/\Colgalt1tm1.1Gpt
(Not Specified) 		abnormal hepatocyte morphology J:283330
\Commd1tm2.1Bvds/\Commd1tm2.1Bvds
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA * SJL) 		increased liver copper level J:182331
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
\Zbtb11tm1.1Lieg/\Zbtb11tm1.1Lieg
(involves: C57BL/6J * C57BL/10 * CBA/Ca) 		abnormal liver morphology J:343208
\Coro1ctm1a(KOMP)Wtsi/\Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Cox5btm2b(EUCOMM)Hmgu/\Cox5btm2b(EUCOMM)Hmgu
(C57BL/6N-Cox5btm2b(EUCOMM)Hmgu/Bay) 		abnormal liver size J:211773
pale liver J:211773
\Cpm1Btlr/\Cpm1Btlr
(C57BL/6J-Cpm1Btlr) 		increased liver iron level J:173078
\Cptm1Hrs/\Cptm1Hrs
(involves: 129X1/SvJ * Black Swiss) 		abnormal liver copper level J:71807
increased liver iron level J:71807, J:57730
\Cptm1Samd/\Cptm1Samd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased liver iron level J:78092
\Cptm1Yos/\Cptm1Yos
(involves: 129P2/OlaHsd * BALB/c) 		abnormal hepatocyte morphology J:79916
abnormal Kupffer cell morphology J:79916
increased liver iron level J:79916
\Cpt1ctm1Dhwu/\Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:148205
\Cpt1ctm1Mdln/\Cpt1ctm1Mdln
(involves: C57BL/6) 		hepatic steatosis J:109455
\Cpt2tm1Mwol/\Cpt2tm1Mwol
\Rab30em1Mwol/\Rab30em1Mwol
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal hepatocyte morphology J:348980
enlarged liver J:348980
hepatic steatosis J:348980
increased liver triglyceride level J:348980
pale liver J:348980
\Cpt2tm1Mwol/\Cpt2tm1Mwol
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal hepatocyte morphology J:348980
enlarged liver J:348980
hepatic steatosis J:348980
increased liver triglyceride level J:348980
pale liver J:348980
\Crbntm1Csp/\Crbntm1Csp
(B6N.Cg-Crbntm1Csp) 		abnormal liver morphology J:208570
decreased liver triglyceride level J:208570
decreased liver weight J:208570
decreased susceptibility to diet-induced hepatic steatosis J:208570
small liver J:208570
\Creb3Gt1Mbac/\Creb3+
(B6NTac.Cg-Creb3Gt1Mbac) 		decreased liver triglyceride level J:345514
decreased susceptibility to diet-induced hepatic steatosis J:345514
\Crebbptm1Few/\Crebbp+
(Not Specified) 		increased liver glycogen level J:91133
\Crebbptm1Few/\Crebbptm1Few
(Not Specified) 		increased liver glycogen level J:91133
\Creg1em1Yal/\Creg1em1Yal
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased susceptibility to diet-induced hepatic steatosis J:263073
increased liver cholesterol level J:263073
increased liver free fatty acids level J:263073
increased liver weight J:263073
\Creld2tm1.1Emass/\Creld2tm1.1Emass
(B6.129P2(SJL)-Creld2tm1.1Emass) 		abnormal hepatocyte morphology J:316411
decreased liver weight J:316411
decreased susceptibility to diet-induced hepatic steatosis J:316411
dilated liver sinusoidal space J:316411
increased susceptibility to age-related hepatic steatosis J:316411
increased susceptibility to hepatic steatosis J:316411
\Crim1em1(IMPC)Wtsi/\Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl) 		herniated liver J:239583
\Crkltm1Hkp/\Crkltm1Hkp
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:76680
\Crlf2em1(IMPC)Mbp/\Crlf2em1(IMPC)Mbp
(C57BL/6N-Crlf2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Crls1tm1Geno/\Crls1tm1Geno
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		increased liver weight J:266083
\Crpem1Wuy/\Crpem1Wuy
(C57BL/6-Crpem1Wuy) 		abnormal hepatocyte morphology J:341658
\Crtc3tm1Mmy/\Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:167211
\Csf1op/\Csf1op
(B6C3Fe a/a-Csf1op/J) 		abnormal Kupffer cell morphology J:26978
\Csf1tm1.2Sabw/\Csf1tm1.2Sabw
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal Kupffer cell morphology J:180199
\Csnk1a1tm1c(KOMP)Wtsi/\Csnk1a1tm1c(KOMP)Wtsi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * CBA) 		abnormal liver morphology J:216977
\Cspg4tm1Wbst/\Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ) 		hepatic steatosis J:184220
\Ctbstm1Tbec/\Ctbstm1Tbec
(involves: 129S2/SvPas * C57BL/6N) 		abnormal Kupffer cell morphology J:185162
\Cthtm1Iish/\Cthtm1Iish
(B6.129-Cthtm1Iish/Iish) 		abnormal liver morphology J:166184
\Cthrc1em1(IMPC)Mbp/\Cthrc1em1(IMPC)Mbp
(C57BL/6NCrl-Cthrc1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Cthrc1tm1Vli/\Cthrc1tm1Vli
(B6.Cg-Cthrc1tm1Vli) 		abnormal hepatocyte morphology J:192096
liver hypoplasia J:192096
macrovesicular hepatic steatosis J:192096
microvesicular hepatic steatosis J:192096
\Cthrc1tm1Vli/\Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli) 		increased liver glycogen level J:192096
\Ctla4tm1Saka/\Ctla4tm1Saka
\Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		abnormal liver morphology J:140085
\Ctnnb1tm1Mmt/\Ctnnb1+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased hepatoblastoma incidence J:112659
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased hepatoblastoma incidence J:112659
\Ctsatm1Adz/\Ctsatm1Adz
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/NJ)) 		enlarged liver J:29674
\Ctsgtm2.1(PML/RARA)Ley/\Ctsg+
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:84230
\Cul3tm1Jdsr/\Cul3tm1Jdsr
(involves: 129S4/SvJaeSor) 		abnormal liver morphology J:122228
increased liver weight J:122228
\Cul9tm1.2Yxi/\Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased liver tumor incidence J:170976
\Cutaem1(IMPC)Mbp/\Cutaem1(IMPC)Mbp
(C57BL/6N-Cutaem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Cwc22em1(IMPC)Mbp/\Cwc22+
(C57BL/6NCrl-Cwc22em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Cxadrem1(IMPC)Mbp/\Cxadr+
(C57BL/6N-Cxadrem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Cxcl12tm3.1(HBEGF/EGFP)Tng/\Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng) 		hepatic necrosis J:164657
\Cxcl14tm1Tha/\Cxcl14tm1Tha
(involves: C57BL/6 * CBA) 		decreased liver triglyceride level J:126841
decreased liver weight J:126841
\Cxcr2tm1(IL8RB)Dktr/\Cxcr2tm1(IL8RB)Dktr
(involves: 129S2/SvPas * C57BL/6) 		small liver J:113489
\Cybrd1tm1Nca/\Cybrd1tm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac) 		decreased liver iron level J:119528
increased liver weight J:119528
\Cyp1a1tm1.1Dwn/\Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn) 		increased liver weight J:163973
\Cyp1a1tm1.1Dwn/\Cyp1a1tm1.1Dwn
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:122409
\Cyp1a1tm4.1Dwn/\Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn) 		increased liver weight J:163973
\Cyp1atm1Dwn/\Cyp1atm1Dwn
\Tg(CYP1A1,CYP1A2)1Dwn/\Tg(CYP1A1,CYP1A2)1Dwn
(B6.Cg-Cyp1atm1Dwn Tg(CYP1A1,CYP1A2)1Dwn) 		enlarged liver J:122409
\Cyp2a12em1Utr/\Cyp2a12em1Utr
\Cyp2c70em1Utr/\Cyp2c70em1Utr
(C57BL/6J-Cyp2a12em1Utr Cyp2c70em1Utr) 		abnormal liver morphology J:302190
increased liver weight J:302190
\Cyp2b10tm1a(KOMP)Wtsi/\Cyp2b10tm1a(KOMP)Wtsi
(C57BL/6N-Cyp2b10tm1a(KOMP)Wtsi) 		increased susceptibility to alcohol-induced hepatic steatosis J:339440
\Cyp2c70em1Sjka/\Cyp2c70em1Sjka
(C57BL/6-Cyp2c70em1Sjka) 		abnormal liver morphology J:330641
increased liver weight J:330641
liver fibrosis J:330641
\Cyp2c70em1Utr/\Cyp2c70em1Utr
(C57BL/6J-Cyp2c70em1Utr) 		abnormal liver morphology J:302190
hepatic necrosis J:302190
increased liver cholesterol level J:302190
increased liver weight J:302190
\Cyp2e1tm1Gonz/\Cyp2e1tm1Gonz
(involves: 129S4/SvJae) 		abnormal hepatocyte morphology J:118150
hepatic steatosis J:112076
\Cyp4v3em1(IMPC)Mbp/\Cyp4v3em1(IMPC)Mbp
(C57BL/6NCrl-Cyp4v3em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Cyp7a1tm1Rus/\Cyp7a1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal liver morphology J:34342
\Cyp11a1tm1b(EUCOMM)Hmgu/\Cyp11a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp11a1tm1b(EUCOMM)Hmgu/Wtsi) 		dilated liver sinusoidal space J:239583
\Cyp11b1tm1Chjk/\Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver weight J:147610
\Cyp19a1tm1Esi/\Cyp19a1tm1Esi
(involves: 129S6/SvEvTac) 		enlarged liver J:65805
hepatic steatosis J:65805
pale liver J:65805
\Cyp19a1tm1Toda/\Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver lobule morphology J:79603
hepatic steatosis J:79603, J:82070
\Cyp27a1tm1.1(KOMP)Vlcg/\Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd) 		increased liver weight J:211773
\Cyp27a1tm1Elt/\Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J) 		enlarged liver J:115373
increased liver triglyceride level J:115373
increased liver weight J:115373
\Cyp27a1tm1Elt/\Cyp27a1tm1Elt
(B6.129-Cyp27a1tm1Elt/J) 		enlarged liver J:223194
\Cyp27a1tm1Elt/\Cyp27a1tm1Elt
\Cyp2r1tm1(KOMP)Vlcg/\Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		enlarged liver J:223194
\Cyribm1Ivdi/\Cyribm1Ivdi
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J) 		liver abscess J:282597
\Cys1cpk/\Cys1+
(involves: C57BL/6J * CD-1) 		liver cyst J:33739
liver fibrosis J:33739
\Cys1cpk/\Cys1+
(C.B6(Cg)-Cys1cpk) 		liver cyst J:99616
liver fibrosis J:99616
\Cys1cpk/\Cys1cpk
(involves: C57BL/6J * CD-1) 		liver cyst J:33739
\Cys1cpk/\Cys1cpk
(C.B6(Cg)-Cys1cpk) 		liver fibrosis J:99616
\Cys1cpk/\Cys1cpk
(D2J.B6(Cg)-Cys1cpk) 		liver fibrosis J:99620
\Cysltr2em1(IMPC)Mbp/\Cysltr2em1(IMPC)Mbp
(C57BL/6N-Cysltr2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Cyth3tm2a(KOMP)Wtsi/\Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi) 		decreased liver glycogen level J:272118
decreased liver triglyceride level J:272118
\D930028M14Riktm1a(EUCOMM)Wtsi/\D930028M14Riktm1a(EUCOMM)Wtsi
(C57BL/6N-D930028M14Riktm1a(EUCOMM)Wtsi/Wtsi) 		herniated liver J:239583
\Daglatm1a(EUCOMM)Wtsi/\Daglatm1a(EUCOMM)Wtsi
(C57BL/6N-Daglatm1a(EUCOMM)Wtsi/Nju) 		small liver J:211773
\Dancrem1.1Bcgen/\Dancrem1.1Bcgen
(involves: C57BL/6) 		abnormal liver morphology J:329926
\Daw1b2b1584Clo/\Daw1b2b1584Clo
(C57BL/6J-Daw1b2b1584Clo) 		abnormal liver morphology J:175213
\Dbitm1Smdp/\Dbitm1Smdp
(B6JBomTac.129-Dbitm1Smdp) 		increased liver cholesterol level J:168744
increased liver triglyceride level J:168744
\Dbitm1Smdp/\Dbitm1Smdp
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver cholesterol level J:204137
increased liver triglyceride level J:204137
\Dbitm2.1Smdp/\Dbitm2.2Smdp
\Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased liver cholesterol level J:204137
\Dbn1tm1b(KOMP)Wtsi/\Dbn1+
(C57BL/6NCrl-Dbn1tm1b(KOMP)Wtsi/Wtsi) 		abnormal liver morphology J:211773
\Dbn1tm1b(KOMP)Wtsi/\Dbn1tm1b(KOMP)Wtsi
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Dbptm1Schb/\Dbptm1Schb
\Hlftm1Schb/\Hlftm1Schb
\Teftm1Schb/\Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas) 		enlarged liver J:129710
\Dcaf8em1(IMPC)Ccpcz/\Dcaf8em1(IMPC)Ccpcz
(C57BL/6N-Dcaf8em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Ddit3tm1.1Irt/\Ddit3tm1.1Irt
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Tg(Mup3-Plau)350-2Eps/?
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:233146
\Ddit3tm2.1Dron/\Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J) 		hepatic steatosis J:214136
\Ddrgk1tm1b(EUCOMM)Hmgu/\Ddrgk1tm1b(EUCOMM)Hmgu
(involves: C57BL/6N) 		liver hypoplasia J:231701
\Ddx6em1(IMPC)Mbp/\Ddx6+
(C57BL/6N-Ddx6em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
\Decr1tm1Jkh/\Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh) 		increased liver weight J:151622
microvesicular hepatic steatosis J:151622
pale liver J:151622
\Deddtm1Tmiy/\Deddtm1Tmiy
(B6.Cg-Deddtm1Tmiy) 		decreased liver weight J:119734
\Del(1)1Brk/\Steap3tm1.1Mdf
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J) 		increased liver iron level J:103440
\Del(1)1Brk/\Del(1)1Brk
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		abnormal liver iron level J:100202
enlarged liver J:100202
\Del(1)1Brk/\Del(1)1Brk
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J) 		increased liver iron level J:103440
\Del(4C4-C5)1Lap/\+
(involves: 129S6/SvEvTac) 		enlarged liver J:158126
\Del(4C4-C5)1Lap/\Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac) 		enlarged liver J:158126
\Del(5Gtf2i-Fkbp6)1Vcam/\+
(B6.129-Del(5Gtf2i-Fkbp6)1Vcam(J:204278)) 		hepatic steatosis J:216195
\Del(11Hoxb3-Hoxb4)1Karl/\Del(11Hoxb3-Hoxb4)1Karl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:83563
\Del(11Irf1-D11Mit23)1Rub/\Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub) 		enlarged liver J:60187
hepatic steatosis J:60187
increased liver cholesterol level J:60187
increased liver triglyceride level J:60187
increased liver weight J:60187
pale liver J:60187
\Del(11Jmjd6-Mettl23)1Ysfk/\Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6) 		liver hypoplasia J:90288
\Del(16Lipi-Usp25)1Dja/\+
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:184302
\Del(17Abcg5-Abcg8)1Hobb/\Del(17Abcg5-Abcg8)1Hobb
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver cholesterol level J:80679
increased liver cholesterol level J:80679
\Dennd1aem1Jgfu/\Dennd1aem1Jgfu
(Not Specified) 		abnormal liver development J:276703
pale liver J:276703
small liver J:276703
\Dennd5bem1Smgo/\Dennd5bem1Smgo
(involves: C57BL/6 * CBA) 		decreased liver cholesterol level J:276600
decreased liver free fatty acids level J:276600
\Deptortm1.1Mala/\Deptortm1.1Mala
\Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA) 		decreased liver glycogen level J:275931
\Dgat1tm1Far/\Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
decreased susceptibility to diet-induced hepatic steatosis J:111346
\Dgat2tm1Far/\Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver glycogen level J:88742
decreased liver triglyceride level J:88742
\Dguoktm1.1Anka/\Dguoktm1.1Anka
(involves: 129 * C57BL/6N) 		abnormal hepatocyte morphology J:294620
decreased hepatocyte mitochondrial DNA content J:294620
increased hepatocyte karyomegaly J:294620
increased liver weight J:294620
\Dhcr7tm1.1Sbpa/\Dhcr7tm1.1Sbpa
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Dhcr7tm1.1Sbpa Speer6-ps1Tg(Alb-cre)21Mgn) 		decreased liver cholesterol level J:303316
\Dhcr7tm1Gst/\Dhcr7tm1Gst
(involves: 129P2/OlaHsd) 		decreased liver cholesterol level J:71611
\Dhcr7tm1Gst/\Dhcr7tm1Gst
\Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N) 		decreased liver cholesterol level J:141730
\Dhcr24tm1c(EUCOMM)Wtsi/\Dhcr24tm1c(EUCOMM)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Dhcr24tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal liver morphology J:304449
decreased liver cholesterol level J:304449
\Dhfrorana/\Dhfrorana
(involves: C57BL/6JAnu) 		liver hypoplasia J:236197
pale liver J:236197
\Dhtkd1tm1Zgwg/\Dhtkd1tm1Zgwg
(involves: C57BL/6) 		increased liver glycogen level J:267178
\Dhx36tm1.2Pmt/\Dhx36tm1.2Pmt
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca) 		enlarged liver J:185179
pale liver J:185179
\Dicer1tm1Gz/\Dicer1tm1Gz
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:97770
\Dido1tm3Cmar/\Dido1tm3.1Cmar
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
(involves: 129S/SvEv * C57BL/6) 		abnormal hepatocyte morphology J:328215
enlarged liver J:328215
increased hepatocyte karyomegaly J:328215
\Disp3em1(IMPC)Mbp/\Disp3em1(IMPC)Mbp
(C57BL/6N-Disp3em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
\Dlk1tm1Hsul/\Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J)) 		enlarged liver J:77909
hepatic steatosis J:77909
\Dmdem1Cmusr/Y
(BALB/c-Dmdem1Cmusr) 		enlarged liver J:353371
\Dna2tm1.1Lzhg/\Dna2+
(involves: 129S1/Sv) 		increased hepatoma incidence J:198831
\Dnaaf3b2b1739Clo/\Dnaaf3b2b1739Clo
(C57BL/6J-Dnaaf3b2b1739Clo) 		abnormal liver morphology J:175213
\Dnaaf11tm1.2Hmd/\Dnaaf11tm1.2Hmd
(involves: 129S6/SvEvTac * C57BL/6NCrl) 		abnormal liver morphology J:258369
\Dnah5b2b016Clo/\Dnah5b2b016Clo
(C57BL/6J-Dnah5b2b016Clo) 		abnormal liver morphology J:175213
\Dnah5hlb612/\Dnah5hlb612
(involves: C57BL/6J) 		abnormal liver morphology J:130755
\Dnah11b2b1289Clo/\Dnah11b2b1289Clo
(C57BL/6J-Dnah11b2b1289Clo) 		abnormal liver morphology J:175213
\Dnah11iv/\Dnah11iv
(SI/Col Tyrp1b Dnah11iv/J) 		abnormal liver morphology J:148465, J:4058
\Dnajb9Gt(KST256)Byg/\Dnajb9Gt(KST256)Byg
(129P2/OlaHsd-Dnajb9Gt(KST256)Byg) 		decreased liver glycogen level J:226674
decreased liver weight J:226674
\Dnajb9Gt(KST256)Byg/\Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg) 		decreased liver glycogen level J:226674
decreased liver weight J:226674
\Dnajc7tm1.2Neg/\Dnajc7tm1.2Neg
(involves: 129S/SvEv * C57BL/6 * CBA) 		hepatic steatosis J:225381
\Dnajc15Gt(RRN226)Byg/\Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg) 		decreased liver cholesterol level J:204025
decreased susceptibility to hepatic steatosis J:204025
increased liver glycogen level J:204025
increased liver weight J:204025
\Dnase1l3em1(IMPC)Mbp/\Dnase1l3em1(IMPC)Mbp
(C57BL/6NCrl-Dnase1l3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Dnm1lPy/\Dnm1l+
(involves: BALB/cAnNCrl * C3H/HeH) 		liver vascular congestion J:161510
\Dnm1ltm1.2Miha/\Dnm1ltm1.2Miha
(involves: C57BL/6J) 		delayed hepatic development J:158142
\Dnmbpem1(IMPC)Mbp/\Dnmbpem1(IMPC)Mbp
(C57BL/6N-Dnmbpem1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
\Dnmt3btm1Enl/\Dnmt3btm1Enl
(involves: 129S4/SvJae * C57BL/6) 		small liver J:106540
\Dohhtm1.1Sbal/\Dohhtm1.1Sbal
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		focal hepatic necrosis J:236582
hepatic necrosis J:236582
\Dph1tm2Bhr/\Dph1tm2Bhr
(either: 129/Sv or (involves: 129/Sv * C57BL/6)) 		liver degeneration J:88090
\Dram1tm1.1(KOMP)Vlcg/\Dram1tm1.1(KOMP)Vlcg
(C57BL/6N-Dram1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Drd2tm1Low/\Drd2tm1Low
(B6.129S2-Drd2tm1Low/J) 		decreased liver weight J:106832
\Drgxem1(IMPC)Mbp/\Drgx+
(C57BL/6N-Drgxem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Duox2em1(IMPC)Mbp/\Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Dusp1tm1Brv/\Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased liver weight J:129718
decreased susceptibility to age-related hepatic steatosis J:129718
decreased susceptibility to diet-induced hepatic steatosis J:129718
small liver J:129718
\Dusp26em1Jhxia/\Dusp26em1Jhxia
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal liver morphology J:279111
decreased liver glycogen level J:279111
increased liver cholesterol level J:279111
increased liver free fatty acids level J:279111
increased liver triglyceride level J:279111
increased liver weight J:279111
liver fibrosis J:279111
\Dync1li1em1(IMPC)Tcp/\Dync1li1+
(C57BL/6NCrl-Dync1li1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Dyrk1atm1Mla/\Dyrk1a+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver weight J:78597
\Eaf2tm1Zhow/\Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:145228
\Ebf1em1(IMPC)Mbp/\Ebf1+
(C57BL/6N-Ebf1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Ebf1tm1Rug/\Ebf1tm1Rug
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		hepatic steatosis J:147179
\Ebf2em1(IMPC)Mbp/\Ebf2+
(C57BL/6N-Ebf2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Efemp1tm2Lmar/\Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6) 		decreased liver weight J:132043
liver degeneration J:132043
\Egfrtm1Mag/\Egfrtm1Mag
(involves: 129S2/SvPas * CD-1) 		abnormal hepatocyte morphology J:26833
abnormal liver morphology J:26833
\Egln1tm1Kael/\Egln1tm1Kael
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N) 		liver vascular congestion J:179490
\Egln1tm2.1Fsl/\Egln1tm2.1Fsl
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129 * C57BL/6) 		abnormal liver vasculature morphology J:202737
increased liver weight J:202737
\Egln1tm2Fong/\Egln1tm2Fong
\Gt(ROSA)26Sortm1(cre/ERT2)Alj/\Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:132720
dilated liver sinusoidal space J:133568
enlarged liver J:132720
\Egln2tm1Fong/\Egln2tm1Fong
\Egln3tm1Fong/\Egln3tm1Fong
(involves: 129S6/SvEvTac * C57BL/6) 		enlarged liver J:132720
\Egr1tm1Jmi/\Egr1tm1Jmi
(involves: 129 * C57BL/6) 		abnormal liver size J:105638
increased liver triglyceride level J:105638
\Ehbp1l1tm1a(EUCOMM)Wtsi/\Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Ehhadhtm1Jkr/\Ehhadhtm1Jkr
\Hsd17b4tm1Baes/\Hsd17b4tm1Baes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		microvesicular hepatic steatosis J:89945
\Ehmt1tm1.1Tara/\Ehmt1tm1.1Tara
\Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ) 		abnormal liver morphology J:207678
increased liver triglyceride level J:207678
\Ei24tm1Hzha/\Ei24tm1Hzha
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:193420
abnormal hepatocyte morphology J:193420
abnormal liver lobule morphology J:193420
abnormal liver morphology J:193420
enlarged liver J:193420
\Eif2ak3tm1Drc/\Eif2ak3tm1Drc
(involves: 129S6/SvEvTac) 		increased liver glycogen level J:76661
\Eif2ak4tm1Drc/\Eif2ak4tm1Drc
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver weight J:92545
\Eif2ak4tm1Drc/\Eif2ak4tm1Drc
(B6.129S6-Eif2ak4tm1Drc) 		decreased liver weight J:92545
\Eif3etm1Fshb/\Eif3e+
(C57BL/6N-Eif3etm1Fshb) 		small liver J:265010
\Eif3mtm1.1Nju/\Eif3m+
(involves: 129 * FVB/N) 		decreased liver weight J:204915
\Eif3mtm1Nju/\Eif3mtm1Nju
(involves: 129) 		abnormal liver morphology J:204915
\Eif4btm1.2Smoc/\Eif4btm1.2Smoc
(Not Specified) 		small liver J:311140
\Eif6tm1Sbif/\Eif6+
(involves: 129 * C57BL/6) 		decreased liver weight J:141257
liver hypoplasia J:141257
\Eloaem1(IMPC)Mbp/\Eloa+
(C57BL/6N-Eloaem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Eloatm1Aso/\Eloatm1Aso
(involves: 129S/SvEv * C57BL/6) 		delayed hepatic development J:119126
\Elovl5Gt(DTM098)Byg/\Elovl5Gt(DTM098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:149093
\Elovl6Gt(OST222498)Lex/\Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal liver morphology J:130031
hepatic steatosis J:130031
\Embtm1b(KOMP)Wtsi/\Emb+
(C57BL/6N-Embtm1b(KOMP)Wtsi/Ucd) 		abnormal liver morphology J:211773
\Enhotm1.1Butl/\Enho+
(B6.Cg-Enhotm1.1Butl) 		hepatic steatosis J:225402
increased liver triglyceride level J:225402
\Enhotm1.1Butl/\Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl) 		hepatic steatosis J:225402
increased liver triglyceride level J:225402
\Enkurtm1Hmf/\Enkurtm1Hmf
(involves: 129 * C57BL/6J) 		abnormal liver development J:253966
abnormal liver morphology J:253966
\Enpp1asj/\Enpp1asj
(C57BL/6J-Enpp1asj/GrsrJ) 		abnormal liver vasculature morphology J:201689
\Entpd1tm1Rdr/\Entpd1tm1Rdr
(involves: 129S2/SvPas) 		liver fibrosis J:57505
\Entpd5tm1Rre/\Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal hepatocyte morphology J:163795
abnormal Kupffer cell morphology J:163795
enlarged liver J:163795
increased hepatocellular carcinoma incidence J:163795
increased liver adenoma incidence J:163795
\Entr1em1(IMPC)Mbp/\Entr1em1(IMPC)Mbp
(C57BL/6N-Entr1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Epas1tm1Rus/\Epas1tm1Rus
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)) 		liver vascular congestion J:50964
\Epb41tm1Cnby/\Epb41tm1Cnby
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ) 		increased liver iron level J:77852
\Epha3em1(IMPC)Mbp/\Epha3em1(IMPC)Mbp
(C57BL/6N-Epha3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Epha3tm1Abn/\Epha3tm1Abn
(involves: 129S1/Sv * 129S1/SvImJ) 		liver vascular congestion J:119874
\Epha6tm1b(KOMP)Wtsi/\Epha6tm1b(KOMP)Wtsi
(C57BL/6N-Epha6tm1b(KOMP)Wtsi/Tcp) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Epm2atm1Kzy/\Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		hepatic steatosis J:173769
increased liver cholesterol level J:173769
increased liver triglyceride level J:173769
\Epm2aip1Gt(BA0314)Wtsi/\Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver glycogen level J:204966
hepatic steatosis J:204966
\Epotm1Jae/\Epotm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		pale liver J:29254
small liver J:29254
\Eportm1Cos/\Eportm1Cos
(involves: 129S/SvEv * C57BL/6J) 		pale liver J:31156
small liver J:31156
\Eportm1Jae/\Epor+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		pale liver J:29254
\Eportm1Jae/\Eportm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		pale liver J:29254
small liver J:29254
\Eportm1Lizon/\Eportm1Lizon
(involves: 129S4/SvJae * C57BL/6) 		liver hypoplasia J:35594
pale liver J:35594
small liver J:35594
\Erap1tm2b(EUCOMM)Wtsi/\Erap1tm2b(EUCOMM)Wtsi
(C57BL/6N-Erap1tm2b(EUCOMM)Wtsi/Kmpc) 		abnormal liver morphology J:211773
\Ercc1tm1Dwm/\Ercc1tm1Dwm
(involves: 129P2/OlaHsd * BALB/c) 		liver degeneration J:15422
\Ercc1tm1Dwm/\Ercc1tm2Dwm
\Hrhr/\Hrhr
\Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * MF1) 		abnormal hepatocyte morphology J:115849
\Ercc1tm1Jhjh/\Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		hepatic steatosis J:117488
increased liver triglyceride level J:117488
\Ercc1tm1Jhjh/\Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:206925
\Ercc1tm1Jhjh/\Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:206925
\Ercc1tm2Jhjh/\Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:41161
\Ercc1tm2Jhjh/\Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:206925
\Ercc4tm1Fwa/\Ercc4tm1Fwa
(involves: 129S6/SvEvTac) 		abnormal liver morphology J:87684
increased hepatocyte karyomegaly J:87684
\Ercc5tm1Shm/\Ercc5tm1Shm
(involves: 129S2/SvPas * C57BL/6J) 		abnormal hepatocyte morphology J:53756
small liver J:53756
\Ercc6tm1Gvh/\Ercc6tm1Gvh
\Xpatm1Hvs/\Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh) 		hepatic steatosis J:122013
increased liver glycogen level J:122013
\Erfetm1Lex/\Erfetm1Lex
\Hbb-b1tm1Unc/\Hbb-b1+
\Hbb-b2tm1Unc/\Hbb-b2+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		decreased liver iron level J:211331
\Erlin1em1(IMPC)Tcp/\Erlin1em1(IMPC)Tcp
(C57BL/6N-Erlin1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Ern1tm1Rjk/\Ern1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		liver hypoplasia J:106975
\Ern1tm1Rjk/\Ern1tm2.1Rjk
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:171230
hepatic steatosis J:171230
increased liver triglyceride level J:171230
\Espl1tm1.1Kna/\Espl1tm1.1Kna
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:107916
\Esr1tm1Ksk/\Esr1tm1Ksk
\Inhatm1Bay/\Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd) 		abnormal hepatocyte morphology J:84989
hepatic necrosis J:84989
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		enlarged liver J:83617
\Esr2tm1Unc/\Esr2tm1Unc
\Inhatm1Bay/\Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd) 		abnormal liver morphology J:84989
\Esrp2tm1(KOMP)Vlcg/\Esrp2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		abnormal hepatocyte morphology J:228040
abnormal liver development J:228040
abnormal liver morphology J:228040
\Etv6em1(IMPC)Rbrc/\Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
small liver J:211773
\Exoc3l2tm1b(KOMP)Wtsi/\Exoc3l2tm1b(KOMP)Wtsi
(C57BL/6N-Exoc3l2tm1b(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
\Extl3em1(IMPC)Mbp/\Extl3+
(C57BL/6N-Extl3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\F5tm2Dgi/\F5tm2Dgi
(B6.129S2-F5tm2Dgi) 		liver fibrosis J:66260
\F11tm1Gjb/\F11tm1Gjb
\Proctm1Fjc/\Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:67398
hepatic necrosis J:67398
liver fibrosis J:67398
\Fabp1tm1Ddsn/\Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6) 		decreased liver triglyceride level J:87278
\Fabp2tm1Mto/\Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto) 		decreased liver weight J:64975
increased liver weight J:64975
\Fabp3Gt(XE705)Byg/\Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased liver glycogen level J:167535
\Fabp4tm1Brsp/\Fabp4tm1Brsp
\Fabp5tm1Hota/\Fabp5tm1Hota
\Lepob/\Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob) 		decreased liver triglyceride level J:111878
decreased susceptibility to hepatic steatosis J:111878
small liver J:111878
\Fabp5tm1Hota/\Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota) 		decreased liver weight J:81609
\Fabp6tm1Lbal/\Fabp6tm1Lbal
(B6.129-Fabp6tm1Lbal) 		decreased liver cholesterol level J:195544
decreased liver weight J:195544
\Fads2tm1Mtna/\Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J) 		enlarged liver J:153293
increased liver triglyceride level J:153293
increased liver weight J:153293
\Fads3tm1a(KOMP)Wtsi/\Fads3tm1a(KOMP)Wtsi
(C57BL/6-Fads3tm1a(KOMP)Wtsi) 		decreased liver free fatty acids level J:256005
increased liver free fatty acids level J:256005
\Faf2tm1Tfji/\Faf2tm1Tfji
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * CBA * DBA) 		macrovesicular hepatic steatosis J:235325
\Fahem1(IMPC)Mbp/\Fah+
(C57BL/6N-Fahem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Fahtm1Mgo/\Fahtm1Mgo
(involves: 129S7/SvEvBrd * PT) 		pale liver J:77295
\Fahtm1Mgo/\Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:138701
increased hepatocellular carcinoma incidence J:138701
\Fahtm1Mgo/\Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL) 		abnormal hepatocyte mitochondrial morphology J:27735
abnormal hepatocyte morphology J:27735
abnormal liver lobule morphology J:27735
increased hepatocellular carcinoma incidence J:27735
increased hepatoma incidence J:27735
increased liver adenoma incidence J:27735
increased liver tumor incidence J:27735
\Fahtm1Mgo/\Fahtm1Mgo
\Hgdaku/\Hgd+
(involves: 129S7/SvEvBrd * NB) 		abnormal hepatocyte morphology J:77295
abnormal liver morphology J:77295
pale liver J:77295
\Fam20bGt(GST_4283_D8)Lex/\Fam20bGt(GST_4283_D8)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		delayed hepatic development J:186384
\Fam167aem1(IMPC)Ccpcz/\Fam167aem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam167aem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Fam219aem1(IMPC)Ccpcz/\Fam219aem1(IMPC)Ccpcz
(C57BL/6N-Fam219aem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Fan1tm1d(KOMP)Wtsi/\Fan1tm1d(KOMP)Wtsi
(involves: C57BL/6N * FVB/N) 		increased hepatocyte karyomegaly J:232402
\Fancctm1Mab/\Fancctm1Mab
\Sod1tm1Cep/\Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ) 		microvesicular hepatic steatosis J:71134
pale liver J:71134
\Fancmtm1.1Htr/\Fancmtm1.1Htr
(involves: C57BL/6 * FVB) 		increased hepatoma incidence J:151714
\Faslpr/\Faslpr
(B6.MRL-Faslpr/J) 		abnormal hepatocyte morphology J:135830
focal hepatic necrosis J:135830
\Fastm1Ach/\Fastm1Ach
\Tg(Itgax-cre,-EGFP)4097Ach/?
(Not Specified) 		abnormal liver morphology J:123556
\Fastm1Osa/\Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:64296
liver hyperplasia J:64296
\Faslgld/\Faslgld
(B6Smn.C3-Faslgld/J) 		abnormal hepatocyte morphology J:135830
focal hepatic necrosis J:135830
\Fasltm1.1Ast/\Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased liver tumor incidence J:153501
\Fasltm1.1Lest/\Fasltm1.1Lest
(involves: 129 * C57BL/6) 		enlarged liver J:87990
\Fasntm1Sem/\Fasntm1Sem
\Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased liver cholesterol level J:127793
hepatic steatosis J:127793
increased liver weight J:127793
\Fbn2em1(IMPC)Rbrc/\Fbn2em1(IMPC)Rbrc
(C57BL/6NJcl-Fbn2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Fbrsl1em1(IMPC)Tcp/\Fbrsl1em1(IMPC)Tcp
(C57BL/6N-Fbrsl1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Fbxl3em1(IMPC)Ccpcz/\Fbxl3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxl3em1(IMPC)Ccpcz/Ccpcz) 		decreased liver weight J:211773
\Fbxl4tm1.2Lrsn/\Fbxl4tm1.2Lrsn
(involves: C57BL/6N) 		liver degeneration J:303084
\Fbxl5Gt(OST386421)Lex/\Fbxl5+
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased liver iron level J:193752
\Fbxl5tm1Kei/\Fbxl5tm1Kei
\Ireb2tm1Roua/\Ireb2tm1Roua
(B6.129-Fbxl5tm1Kei Ireb2tm1Roua) 		decreased liver iron level J:176655
\Fbxl5tm2.1Kei/\Fbxl5tm2.1Kei
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:176655
abnormal hepatocyte morphology J:176655
hepatic steatosis J:176655
increased liver iron level J:176655
pale liver J:176655
\Fbxo4tm1.1Jadi/\Fbxo4+
(Not Specified) 		increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
\Fbxo4tm1.1Jadi/\Fbxo4tm1.1Jadi
(Not Specified) 		increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
\Fbxo38em1Crmk/\Fbxo38em1Crmk
(C57BL/6N-Fbxo38em1Crmk) 		decreased liver weight J:326445
\Fdx1tm1Xch/\Fdx1+
(involves: C57BL/6) 		hepatic steatosis J:345826
\Fdx2em1(IMPC)Rbrc/\Fdx2+
(C57BL/6-Fdx2em1(IMPC)Rbrc) 		hepatic steatosis J:360976
\Fdx2em1(IMPC)Rbrc/\Fdx2em1(IMPC)Rbrc
(C57BL/6NJcl-Fdx2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Fdx2em1(IMPC)Rbrc/\Fdx2em1(IMPC)Rbrc
(C57BL/6-Fdx2em1(IMPC)Rbrc) 		hepatic steatosis J:360976
\Fdxrtm1Xch/\Fdxr+
(B6.Cg-Fdxrtm1Xch) 		hepatic steatosis J:244082
increased hepatocellular carcinoma incidence J:244082
increased liver iron level J:244082
increased liver tumor incidence J:244082
\Fechm1Pas/\Fechm1Pas
(involves: 129/Sv * BALB/c) 		increased liver weight J:2021
\Fechm1Pas/\Fechm1Pas
\hem6/\hem6+
(involves: 129 * BALB/c * C57BL/6) 		increased liver weight J:142791
\Fechm1Pas/\Fechtm1.1(FECH*)Emi
(involves: 129 * BALB/cJ * C57BL/6J) 		abnormal bile canaliculus morphology J:239515
abnormal liver morphology J:239515
enlarged liver J:239515
\Fen1tm1Bhsh/\Fen1tm1Bhsh
(involves: 129S1/Sv) 		pale liver J:121378
\Fen1tm2.1Bhsh/\Fen1tm2.1Bhsh
(involves: 129S1/Sv) 		increased liver tumor incidence J:218627
\Fen1tm3.1Bhsh/\Fen1tm3.1Bhsh
(Not Specified) 		increased liver tumor incidence J:231218
\Ffar1tm1Dgen/\Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:141957
\Ffar1tm1Heed/\Ffar1tm1Heed
(Not Specified) 		decreased susceptibility to diet-induced hepatic steatosis J:129843
\Ffar3em1(IMPC)Mbp/\Ffar3em1(IMPC)Mbp
(C57BL/6NCrl-Ffar3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Ffar3tm1Reh/\Ffar3tm1Reh
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver triglyceride level J:143567
\Ffar4tm1Gdds/\Ffar4tm1Gdds
(involves: 129 * C57BL/6) 		hepatic steatosis J:182599
increased liver triglyceride level J:182599
increased liver weight J:182599
\Fgatm1Jld/\Fgatm1Jld
(involves: 129P2/OlaHsd * CF-1) 		focal hepatic necrosis J:36591
\Fgatm1Jld/\Fgatm1Jld
\Plgtm1Jld/\Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss * CF-1) 		abnormal liver morphology J:36591
focal hepatic necrosis J:36591
\Fgd5em1(IMPC)Mbp/\Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
decreased liver weight J:211773
small liver J:211773
\Fgf20em1(IMPC)Ccpcz/\Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Fgf21tm1Emf/\Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf) 		hepatic steatosis J:157309
increased liver glycogen level J:157309
increased liver triglyceride level J:157309
increased liver weight J:157309
\Fgf21tm1Nit/\Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit) 		increased liver weight J:157334
\Fgfr2tm2.3Dsn/\Fgfr2+
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver development J:72517
\Fgfr4tm1Cxd/\Fgfr4tm1Cxd
\Tg(Myl2-FGF19)1Dfre/0
(involves: 129S6/SvEvTac * FVB/N) 		decreased liver tumor incidence J:187236
\Fgl1tm1Cuko/\Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal liver weight J:199844
increased liver triglyceride level J:199844
macrovesicular hepatic steatosis J:199844
\Fhip2bem1Wwan/\Fhip2bem1Wwan
(involves: C57BL/6) 		hepatic steatosis J:302658
increased liver cholesterol level J:302658
increased liver triglyceride level J:302658
increased liver weight J:302658
\Fhittm1Tko/\Fhittm1Tko
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:93269
\Fitm2tm1.1Dls/\Fitm2tm1.1Dls
\Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver weight J:212437
pale liver J:212437
\Fkbp1atm1Zuk/\Fkbp1atm1Zuk
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		hepatic necrosis J:45536
\Fl1saA/J/?
(involves: A/JSlc * SM/JNshm) 		increased liver triglyceride level J:124974
increased liver weight J:124974
\Fl1saSM/JNshm/\Fl1saSM/JNshm
(A/J-Chr 12SM/J/Nshm) 		decreased liver triglyceride level J:124974
decreased liver weight J:124974
decreased susceptibility to diet-induced hepatic steatosis J:124974
\Fl2saA/JNshm/\Fl2saA/JNshm
(involves: A/JSlc * SM/JNshm) 		increased liver weight J:124974
\Fli1tm1Dkw/\Fli1tm1Dkw
(either: B6.Cg-Fli1tm1Dkw or (involves: CD-1) or (involves: 129S6/SvEvTac * C57BL/6)) 		pale liver J:63242
small liver J:63242
\Flnatm1.2Caw/\Flna+
(involves: 129S4/SvJae * C57BL/6) 		hepatic necrosis J:118252
\Flt4Chy/\Flt4+
(involves: C3H) 		abnormal liver morphology J:72387
\fm/\fm
(involves: CBA/H) 		abnormal liver morphology J:5417, J:275
\Fmnl1tm1.2Sdb/\Fmnl1tm1.2Sdb
\Lyz2tm1(cre)Ifo/\Lyz2tm1(cre)Ifo
(involves: C3H * C57BL/6 * FVB/N) 		abnormal Kupffer cell morphology J:250144
\Fmo5em1(IMPC)Mbp/\Fmo5em1(IMPC)Mbp
(C57BL/6N-Fmo5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Fndc5em21Gpt/\Fndc5em21Gpt
(C57BL/6JGpt-Fndc5em21Cd/Gpt) 		increased susceptibility to diet-induced hepatic steatosis J:247171
increased susceptibility to hepatic steatosis J:247171
\Fnip1em1(IMPC)Ccpcz/\Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz) 		increased liver weight J:211773
\Fnip1LPAB.1/\Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1) 		increased liver glycogen level J:187318
\Foxa1tm1Khk/\Foxa1tm1Khk
\Foxa2tm1Khk/\Foxa2tm1Khk
\Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased hepatocellular carcinoma incidence J:181296
\Foxa2tm1Dnl/\Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver triglyceride level J:95662
\Foxc1tm1Blh/\Foxc1+
\Foxc2tm1Blh/\Foxc2+
(involves: 129S6/SvEvTac * Black Swiss) 		enlarged liver J:57677
\Foxm1tm1.1Rhc/\Foxm1tm1.1Rhc
(involves: 129X1/SvJ) 		abnormal hepatic cord morphology J:94883
abnormal intrahepatic bile duct morphology J:94883
abnormal liver sinusoid morphology J:94883
\Foxm1tm1Cle/\Foxm1tm1Cle
(Not Specified) 		abnormal hepatocyte morphology J:95612
\Foxm1tm1Rhc/\Foxm1tm1Rhc
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:89472
\Foxm1tm1Rhc/\Foxm1tm1Rhc
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:89472, J:81015
decreased liver tumor incidence J:89472
\Foxm1tm1Rhc/\Foxm1tm1Rhc
\Tg(Alb1-cre)1Khk/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		abnormal hepatic cord morphology J:94883
abnormal intrahepatic bile duct morphology J:94883
abnormal liver sinusoid morphology J:94883
\Foxn1nu/\Foxn1nu
(Not Specified) 		abnormal liver morphology J:5043
\Foxo1tm1Rdp/\Foxo1tm1Rdp
\Foxo3tm1Rdp/\Foxo3tm1Rdp
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased hepatic hemangioma incidence J:118179
\Foxo1tm1Rdp/\Foxo1tm1Rdp
\Foxo4tm1Rdp/\Foxo4tm1Rdp
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased hepatic hemangioma incidence J:118179
\Foxo1tm1Whb/\Foxo1+
(Not Specified) 		decreased liver glycogen level J:79560
\Foxo1tm2.1Dac/\Foxo1tm2.1Dac
(Not Specified) 		decreased liver triglyceride level J:179687
\Foxo1tm2.1Dac/\Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac) 		decreased liver cholesterol level J:179687
\Foxo6tm1(KOMP)Vlcg/\Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg) 		abnormal Kupffer cell morphology J:236585
decreased liver triglyceride level J:236585
decreased susceptibility to diet-induced hepatic steatosis J:236585
\Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR)) 		abnormal hepatic cord morphology J:11262
abnormal liver morphology J:11262
dilated liver sinusoidal space J:11262
enlarged liver J:11262
multifocal hepatic necrosis J:11262
\Foxp3sf/Y
(involves: 101/H * C3H/HeH * STOCK MR) 		abnormal liver morphology J:10398
enlarged liver J:10398
pale liver J:10398
\Fstl3tm1.1(KOMP)Vlcg/\Fstl3tm1.1(KOMP)Vlcg
(C57BL/6N-Fstl3tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Fstl3tm1Alsc/\Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased liver glycogen level J:119526
hepatic steatosis J:119526
macrovesicular hepatic steatosis J:119526
microvesicular hepatic steatosis J:119526
\Fth1tm1.1Lck/\Fth1tm1.1Lck
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Fth1tm1.1Lck Tg(Mx1-cre)1Cgn) 		increased liver weight J:166515
macrovesicular hepatic steatosis J:166515
\Ftl1tm1.1Ruvi/\Ftl1tm1.1Ruvi
(involves: 129 * C57BL/6) 		decreased liver iron level J:244236
\Ftotm1Urt/\Ftotm1Urt
\Lepob/\Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:219118
increased liver weight J:219118
\Fubp1tm1.1Dlev/\Fubp1tm1.1Dlev
(involves: 129 * C57BL/6) 		pale liver J:229985
small liver J:229985
\Fut8em1(IMPC)Wtsi/\Fut8em1(IMPC)Wtsi
(C57BL/6N-Fut8em1(IMPC)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Fuzb2b1273Clo/\Fuzb2b1273Clo
(C57BL/6J-Fuzb2b1273Clo) 		abnormal liver morphology J:175213
\Fzr1tm1.1Mama/\Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL) 		increased liver tumor incidence J:137456
\G0s2tm1(KOMP)Vlcg/\G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		dark liver J:209000
decreased liver triglyceride level J:209000
decreased liver weight J:209000
decreased susceptibility to diet-induced hepatic steatosis J:209000
\G0s2tm1Jgte/\G0s2tm1Jgte
(involves: 129S7/SvEvBrd) 		decreased liver triglyceride level J:219653
decreased liver weight J:219653
decreased susceptibility to diet-induced hepatic steatosis J:219653
\G6pc1em1Jyc/\G6pc1em1Jyc
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver sinusoid morphology J:320697
enlarged liver J:320697
hepatic steatosis J:320697
increased liver glycogen level J:320697
increased liver triglyceride level J:320697
\G6pc1tm1.1Ics/\G6pc1tm1.1Ics
\Albtm1(cre/ERT2)Mtz/\Alb+
(involves: 129S2/SvPas * C57BL/6J) 		abnormal hepatocyte morphology J:195257
enlarged liver J:195257
hepatic steatosis J:195257
increased liver adenoma incidence J:195257
increased liver glycogen level J:195257
increased liver triglyceride level J:195257
increased liver weight J:195257
pale liver J:195257
\G6pc1tm1Jyc/\G6pc1tm1Jyc
(involves: 129S4/SvJae) 		enlarged liver J:33212
hepatic necrosis J:33212
hepatic steatosis J:33212
increased liver glycogen level J:33212
\G6pc1tm2.2Jyc/\G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		increased liver glycogen level J:155990
increased liver weight J:155990
\Gaatm1Rabn/\Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6) 		increased liver glycogen level J:235790
\Gaatm1Rabn/\Gaatm1Rabn
\Stbd1tm1Bsn/\Stbd1tm1Bsn
(involves: 129X1/SvJ * C57BL/6) 		increased liver glycogen level J:235790
\Gab1tm1Wbm/\Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver weight J:68751
\Gab1tm2Wbm/\Gab1tm2Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1) 		decreased liver weight J:125303
\Gab1tm2Wbm/\Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1) 		decreased liver weight J:125303
\Gab1tm3Wbm/\Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1) 		decreased liver weight J:125303
\Gabrg1em1(IMPC)Ccpcz/\Gabrg1em1(IMPC)Ccpcz
(C57BL/6NCrl-Gabrg1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Gaktm2Legr/\Gaktm2Legr
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal liver morphology J:180119
decreased liver glycogen level J:180119
\Gal3st1em1(IMPC)Rbrc/\Gal3st1em1(IMPC)Rbrc
(C57BL/6NJcl-Gal3st1em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
small liver J:211773
\Galctwi/\Galctwi
\Glb1tm1Adz/\Glb1tm1Adz
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		abnormal liver morphology J:63197
enlarged liver J:63197
\Gapvd1em1(IMPC)Mbp/\Gapvd1+
(C57BL/6N-Gapvd1em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Garem1em1(IMPC)Mbp/\Garem1em1(IMPC)Mbp
(C57BL/6N-Garem1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Gas2l2tm1a(KOMP)Wtsi/\Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Gata1Plt13/Y
(BALB/c-Gata1Plt13) 		small liver J:113720
\Gata1tm1Mym/Y
(involves: 129P2/OlaHsd * BALB/c) 		pale liver J:40321
\Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		abnormal liver morphology J:78348
\Gata1tm2Sho/\Gata1tm2Sho
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		abnormal liver morphology J:78348
\Gata1tm7Sho/Y
(involves: 129S1/Sv * C57BL/6) 		liver hypoplasia J:99310
pale liver J:99310
\Gata1tm7Sho/\Gata1tm7Sho
(involves: 129S1/Sv * C57BL/6) 		liver hypoplasia J:99310
pale liver J:99310
\Gata1tm8.2Sho/Y
(involves: 129S1/Sv) 		liver hypoplasia J:99310
pale liver J:99310
\Gata1tm8.2Sho/\Gata1tm8.2Sho
(involves: 129S1/Sv) 		liver hypoplasia J:99310
pale liver J:99310
\Gata4tm1Eno/\Gata4+
\Gata6tm1Eno/\Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6) 		small liver J:111824
\Gata6tm1Sad/\Gata6tm1Sad
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver bud morphology J:97579
\Gatmtm1.1Isb/\Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb) 		decreased liver triglyceride level J:191142
decreased susceptibility to diet-induced hepatic steatosis J:191142
\Gba1tm1.1Pmis/\Gba1tm1.1Pmis
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		enlarged liver J:167081
increased liver weight J:167081
\Gba1tm1.1Pmis/\Gba1tm1.2Pmis
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		enlarged liver J:167081
increased liver weight J:167081
\Gba1tm1Clk/\Gba1tm1.1Clk
\Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J) 		abnormal liver morphology J:117763
\Gba1tm1Karl/\Gba1tm1.1Karl
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		enlarged liver J:113751
pale liver J:113751
\Gba1tm1Rlp/\Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		abnormal Kupffer cell morphology J:76409
enlarged liver J:76409
increased liver weight J:76409
\Gbe1m1Yty/\Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty) 		liver vascular congestion J:167233
\Gbe1tm1.1Hoa/\Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd) 		decreased liver glycogen level J:176889
\Gbe1tm1Hoa/\Gbe1tm1Hoa
(involves: 129S7/SvEvBrd) 		abnormal liver morphology J:176889
increased liver glycogen level J:176889
\Gbe1tm2.1Hoa/\Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:226481
liver fibrosis J:226481
\Gbe1tm2Hoa/\Gbe1tm2Hoa
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:226481
\Gcgrem2Smoc/\Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc) 		increased liver weight J:300368
\Gcgrtm1.1(KOMP)Vlcg/\Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd) 		increased liver weight J:211773
\Gcgrtm1Jcp/\Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp) 		decreased liver weight J:176507
decreased susceptibility to age-related hepatic steatosis J:176507
\Gcgrtm1Mjch/\Gcgrtm1Mjch
\Leprtm1Jke/\Leprtm1Jke
(involves: 129 * 129X1/SvJ * C57BL/6J * SJL) 		increased liver triglyceride level J:216393
\Gch1em1Ypt/\Gch1em1Ypt
(C57BL/6-Gch1em1Ypt) 		abnormal liver morphology J:295169
\GckRgsc210/\GckRgsc210
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hepatic steatosis J:88919
\GckRgsc392/\GckRgsc392
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hepatic steatosis J:88919
\GckRgsc702/\GckRgsc702
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hepatic steatosis J:88919
\Gcktm1.1Mgn/\Gcktm1.1Mgn
\Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased liver glycogen level J:51826
hepatic steatosis J:51826
\Gcktm1.2Mgn/\Gck+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver glycogen level J:51826
hepatic steatosis J:51826
\Gcktm1.2Mgn/\Gcktm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver glycogen level J:51826
hepatic steatosis J:51826
\Gcktm1Tka/\Gcktm1Tka
(involves: 129X1/SvJ * ICR) 		hepatic steatosis J:30334
\Gcktm1Ts/\Gcktm1Ts
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J)) 		decreased liver glycogen level J:29255
microvesicular hepatic steatosis J:29255
\Gckrtm1Bms/\Gckrtm1Bms
(involves: 129S1/Sv * ICR) 		decreased liver glycogen level J:58949
\Gclctm1Tdal/\Gclctm1Tdal
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal liver morphology J:202376
hepatic steatosis J:202376
\Gdf1tm1Sjl/\Gdf1tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:60755
\Gdf15tm1Sjl/\Gdf15tm1Sjl
\Leprdb/\Leprdb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J) 		increased liver weight J:202996
\Gfertm1(KOMP)Mbp/\Gfer+
(involves: C57BL/6J * C57BL/6N) 		abnormal hepatocyte mitochondrial morphology J:224792
decreased hepatocyte mitochondrial DNA content J:224792
\Gfertm1.1Crg/\Gfertm1.1Crg
(involves: 129 * C57BL/6) 		abnormal hepatocyte morphology J:227242
\Gfertm1.1Crg/\Gfertm1.1Crg
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:227242
abnormal liver morphology J:227242
decreased liver cholesterol level J:227242
focal hepatic necrosis J:227242
hepatic necrosis J:227242
hepatic steatosis J:227242
increased hepatocellular carcinoma incidence J:227242
increased liver cholesterol level J:227242
increased liver triglyceride level J:227242
increased liver weight J:227242
liver fibrosis J:227242
macrovesicular hepatic steatosis J:227242
microvesicular hepatic steatosis J:227242
pale liver J:227242
\Gfi1bem1(IMPC)Ccpcz/\Gfi1b+
(C57BL/6NCrl-Gfi1bem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
\GhSma1/\Gh+
(C3HeB/FeJ-GhSma1) 		small liver J:89518
\GhSma1/\GhSma1
(C3HeB/FeJ-GhSma1) 		small liver J:89518
\Ghitmem1Ltk/\Ghitmem1Ltk
(C57BL6J-Ghitmem1Ltk) 		abnormal hepatocyte mitochondrial morphology J:327550
\Ghrtm1.1Jero/\Ghrtm1.1Jero
(B6.129X1-Ghrtm1.1Jero) 		decreased liver weight J:155335
\Ghrtm1.1Masp/\Ghrtm1.1Masp
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased liver triglyceride level J:152627
hepatic steatosis J:152627
increased liver weight J:152627
\Ghrtm1Jjk/\Ghrtm1Jjk
(involves: 129P2/OlaHsd) 		decreased liver weight J:95149
\Ghrtm1Jjk/\Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased liver weight J:105686, J:60207
\Ghrtm1Jjk/\Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased liver weight J:107763
\Ghrtm2Mwat/\Ghrtm2Mwat
(involves: 129X1/SvJ * C57BL) 		decreased liver weight J:95149
\Gimap5m1Btlr/\Gimap5m1Btlr
(involves: C57BL/6J) 		abnormal liver morphology J:160090
\Gimap5m1Btlr/\Gimap5m1Btlr
(either: (involves: BALB/cJ * C57BL/6J) or (involves: C3H/HeN * C57BL/6J) or (C57BL/6J * DBA/2J) or (involves: C57BL/6J * FVB/NJ) or (involves: C57BL/6J * NOD/ShiLtJ)) 		abnormal liver morphology J:160090
\Gimap5tm1Wlr/\Gimap5tm1Wlr
(either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr) 		abnormal liver development J:143620
abnormal liver parenchyma morphology J:143620
hepatic necrosis J:143620
liver degeneration J:143620
pale liver J:143620
\Giptm1Nina/\Giptm1Nina
(involves: C57BL/6) 		abnormal liver morphology J:298236
\Gjb1tm1Kwi/Y
(involves: 129S4/SvJae * C57BL/6) 		increased liver glycogen level J:36146
\Gjb1tm1Kwi/\Gjb1tm1Kwi
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:36146
\Gjb3tm1.1(KOMP)Vlcg/\Gjb3tm1.1(KOMP)Vlcg
(C57BL/6N-Gjb3tm1.1(KOMP)Vlcg/Ucd) 		pale liver J:211773
\Gjb4tm1.1(KOMP)Vlcg/\Gjb4tm1.1(KOMP)Vlcg
(C57BL/6N-Gjb4tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		hepatic steatosis J:43449
\Glatm1Kul/Y
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:39394
\Glb1tm1Jmat/\Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR) 		abnormal hepatocyte morphology J:102576
small liver J:43534
\GlmpGt(P084H04)Wrst/\GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas * C57BL/6) 		abnormal Kupffer cell morphology J:208774
increased liver iron level J:208774
liver fibrosis J:208774
\GlmpGt(P084H04)Wrst/\GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas) 		abnormal hepatocyte morphology J:280713
abnormal liver morphology J:280713
abnormal liver sinusoidal endothelial cell morphology J:280713
abnormal liver vasculature morphology J:280713
\Glmptm1Lex/\Glmptm1Lex
(B6;129S5-Glmptm1Lex/Mmucd) 		small liver J:171883
\Gls2em1(IMPC)Tcp/\Gls2em1(IMPC)Tcp
(C57BL/6N-Gls2em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Gm16364tm1Zhaoy/\Gm16364tm1Zhaoy
(involves: C57BL/6) 		decreased liver weight J:322340
decreased susceptibility to diet-induced hepatic steatosis J:322340
\Gm16364tm2Zhaoy/\Gm16364tm2Zhaoy
(involves: C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:322340
\Gm26330em1Liuq/\Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq) 		hepatic steatosis J:341056
\Gna11tm1Soff/\Gna11tm1Soff
(involves: 129S7/SvEvBrd) 		hepatic steatosis J:172091
increased liver triglyceride level J:172091
\Gna15em1(IMPC)Mbp/\Gna15em1(IMPC)Mbp
(C57BL/6N-Gna15em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Gnai2tm1Lbi/\Gnai2+
\Tg(WTbeta2)4Wjk/0
(B6.Cg-Gnai2tm1Lbi Tg(WTbeta2)4Wjk) 		abnormal liver morphology J:125581
\Gnastm5.1Lsw/\Gnastm5.1Lsw
\Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased liver glycogen level J:102504
increased liver weight J:102504
\Gnastm5.1Lsw/\Gnastm5.1Lsw
\Tg(Fabp4-cre)1Abel/0
(involves: FVB) 		decreased liver triglyceride level J:159612
\Gnf4C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52)) 		decreased liver weight J:99312
\Gnmttm1Ymac/\Gnmt+
(involves: 129/Sv * C57BL/6) 		decreased liver weight J:147857
\Gnmttm1Ymac/\Gnmttm1Ymac
(involves: 129 * C57BL/6) 		abnormal liver morphology J:147857
dilated liver sinusoidal space J:147857
enlarged liver J:147857
hepatic necrosis J:147857
hepatic steatosis J:146081
increased hepatic hemangioma incidence J:146081
increased hepatocellular carcinoma incidence J:146081
increased liver glycogen level J:147857
increased liver weight J:147857
liver degeneration J:147857
liver vascular congestion J:147857
\Golga2tm1(KOMP)Vlcg/\Golga2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal hepatocyte morphology J:270564
abnormal liver morphology J:270564
liver fibrosis J:270564
\Golm1Gt(KST273)Byg/\Golm1Gt(KST273)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:151282
hepatic steatosis J:151282
\Gp2em1(IMPC)Mbp/\Gp2em1(IMPC)Mbp
(C57BL/6N-Gp2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Gpamtm1.1Dali/\Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal hepatocyte morphology J:134068
decreased liver triglyceride level J:134068
\Gpamtm1Rcol/\Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver triglyceride level J:84541
\Gpat3tm1Reg/\Gpat3tm1Reg
(involves: C57BL/6) 		increased liver cholesterol level J:213618
increased liver weight J:213618
\Gpc1em1(IMPC)Mbp/\Gpc1em1(IMPC)Mbp
(C57BL/6N-Gpc1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Gpd2tm1Tka/\Gpd2tm1Tka
\Slc25a13tm1Lct/\Slc25a13tm1Lct
(B6.Cg-Gpd2tm1Tka Slc25a13tm1Lct) 		hepatic steatosis J:124766
increased liver triglyceride level J:124766
\Gper1tm1135.2Arte/\Gper1tm1135.2Arte
(involves: C57BL/6 * C57BL/6N) 		decreased liver weight J:145794
\Gpi1b-m1Neu/\Gpi1b-m1Neu
(C3.Cg-Gpi1b-m1Neu) 		increased liver weight J:35956
\Gpi1b-m2Neu/\Gpi1b-m2Neu
(C3.Cg-Gpi1b-m2Neu) 		increased liver weight J:35956
\Gpr12tm1Dgen/\Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen) 		increased liver triglyceride level J:111942
increased liver weight J:111942
\Gpr45Tn(pb-Act-RFP)1.1Zhu/\Gpr45Tn(pb-Act-RFP)1.1Zhu
(involves: FVB/NJ) 		hepatic steatosis J:237251
increased liver weight J:237251
\Gpr61tm1Dgen/\Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver triglyceride level J:302257
increased liver weight J:302257
\Gpr83em1(IMPC)Ccpcz/\Gpr83em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpr83em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Gpr101em7036Tac/Y
(C57BL/6NTac-Gpr101em7036Tac) 		increased liver weight J:347398
\Gprc5btm1b(EUCOMM)Wtsi/\Gprc5btm1b(EUCOMM)Wtsi
(C57BL/6N-Gprc5btm1b(EUCOMM)Wtsi/Ucd) 		abnormal liver morphology J:211773
\Gprc6atm1Ldq/\Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:144372
increased liver triglyceride level J:144372
\Gpx7tm1Whle/\Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:193993
\Gramd1ctm1a(KOMP)Wtsi/\Gramd1ctm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Gramd1ctm1a(KOMP)Wtsi/JMmucd) 		increased liver cholesterol level J:347902
increased liver triglyceride level J:347902
\Gramd2aem1(IMPC)Tcp/\Gramd2aem1(IMPC)Tcp
(C57BL/6NCrl-Gramd2aem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Grb10Gt(Betageo)1Ward/\Grb10+
(involves: C57BL/6 * CBA) 		enlarged liver J:84425
increased liver glycogen level J:84425
\Grb10Gt(Betageo)1Ward/\Grb10Gt(Betageo)1Ward
(involves: C57BL/6 * CBA) 		enlarged liver J:84425
\Grb10tm1.1Fliu/\Grb10tm1.1Fliu
\Tg(Adipoq-cre)#Pesch/0
(involves: 129S/SvEv * FVB) 		hepatic steatosis J:213603
\Grb10tm1.1Fliu/\Grb10tm1.1Fliu
\Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv) 		hepatic steatosis J:213603
\Grb14tm1Daly/\Grb14tm1Daly
(involves: 129X1/SvJ * C57BL/6) 		decreased liver weight J:87892
\Greb1lem1Cjea/\Greb1lem1Cjea
(involves: C57BL/6J) 		liver hypoplasia J:248902
\Grik5em1(IMPC)Mbp/\Grik5em1(IMPC)Mbp
(C57BL/6N-Grik5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Grntm1.1Aidi/\Grntm1.1Aidi
(involves: C57BL/6J) 		increased liver weight J:268827
\Grntm1.1Geno/\Grntm1.1Geno
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:188420
abnormal liver morphology J:188420
abnormal liver parenchyma morphology J:188420
increased hepatocyte karyomegaly J:188420
\Gsk3atm1.1Jrw/\Gsk3atm1.1Jrw
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver glycogen level J:130033
\Gsk3atm1Dral/\Gsk3atm1Dral
\Gsk3btm1Dral/\Gsk3btm1Dral
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased liver glycogen level J:98263
\Gsk3btm1Jrw/\Gsk3btm1Jrw
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:63274
abnormal liver morphology J:63274
\Gstz1tm1Jmfc/\Gstz1tm1Jmfc
(129S4/SvJae-Gstz1tm1Jmfc) 		abnormal liver morphology J:77040
hepatic steatosis J:77040
macrovesicular hepatic steatosis J:77040
microvesicular hepatic steatosis J:77040
\Gstz1tm1Pgb/\Gstz1tm1Pgb
(BALB/c-Gstz1tm1Pgb/AnuApb) 		abnormal hepatocyte mitochondrial morphology J:91519
hepatic necrosis J:91519
increased liver weight J:91519
macrovesicular hepatic steatosis J:91519
\Gt(ROSA)26Sortm1(CAG-SETBP1*G870S,-EGFP)Ase/\Gt(ROSA)26Sor+
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca) 		abnormal liver morphology J:363041
hepatosplenomegaly J:363041
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sortm1(cre/ERT2)Tyj
\Nus1tm1.1Qrm/\Nus1tm1.1Qrm
(involves: 129 * C57BL/6 * SJL) 		hepatic steatosis J:243753
increased liver free fatty acids level J:243753
increased liver triglyceride level J:243753
\Gt(ROSA)26Sortm1(DTA)Mrc/\Gt(ROSA)26Sor+
\Chrna7tm2.1(cre)Swr/\Chrna7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		enlarged liver J:223063
\Gt(ROSA)26Sortm1(DTA)Riet/\Gt(ROSA)26Sor+
\Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd) 		liver degeneration J:92789
\Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/\Gt(ROSA)26Sor+
\Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA) 		enlarged liver J:129039
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
\Prdm1tm2Masu/\Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ) 		enlarged liver J:167612
\Gt(ROSA)26Sortm1(HBEGF)Awai/\Gt(ROSA)26Sor+
\Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N) 		decreased liver triglyceride level J:169459
decreased liver weight J:169459
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		hepatic steatosis J:237232
increased liver weight J:237232
\Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/\Gt(ROSA)26Sor+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB) 		abnormal liver morphology J:194290
decreased liver glycogen level J:194290
hepatic steatosis J:194290
increased liver triglyceride level J:194290
\Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/\Gt(ROSA)26Sor+
\Tg(CAG-cre)1Nagy/0
\Tg(tetO-Vegfa)90Ala/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR) 		hepatic peliosis J:99607
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J) 		increased hepatocellular carcinoma incidence J:153656
increased liver adenoma incidence J:153656
increased liver tumor incidence J:153656
\Gt(ROSA)26Sortm1(Tfrc*)Nca/\Gt(ROSA)26Sor+
\Hfetm2Nca/\Hfetm2Nca
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		increased liver iron level J:133221
\Gt(ROSA)26Sortm1(Tfrc*)Nca/\Gt(ROSA)26Sortm1(Tfrc*)Nca
(involves: 129S4/SvJae * FVB/N) 		increased liver iron level J:133221
\Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/\Gt(ROSA)26Sor+
\Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J) 		enlarged liver J:185598
\Gt(ROSA)26Sortm1.1(Aco1*)Mwh/\Gt(ROSA)26Sortm1.1(Aco1*)Mwh
(B6.129P2(129S1)-Gt(ROSA)26Sortm1.1(Aco1*)Mwh) 		increased liver iron level J:196374
\Gt(ROSA)26Sortm1.1(CAG-Upp1,-GFP)Gp/\Gt(ROSA)26Sor+
(involves: C57BL/6 * FVB/N) 		microvesicular hepatic steatosis J:195165
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+
\Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		enlarged liver J:202090
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA) 		enlarged liver J:202090
\Gt(ROSA)26Sortm2(ITK/Syk)Hjum/\Gt(ROSA)26Sor+
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal liver morphology J:207306
\Gt(ROSA)26Sortm2(ITK/Syk)Hjum/\Gt(ROSA)26Sor+
\Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR) 		abnormal liver morphology J:207306
\Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		enlarged liver J:137122
\Gt(ROSA)26Sortm2(sb11)Njen/\Gt(ROSA)26Sor+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\TgTn(sb-T2/Onc)68Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		abnormal liver morphology J:147264
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
\Gt(ROSA)26Sortm2(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J) 		liver cirrhosis J:153656
\Gt(ROSA)26Sortm2(sb11)Njen/\Gt(ROSA)26Sor+
\Trp53tm3Tyj/\Trp53+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\TgTn(sb-T2/Onc)68Dla/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		abnormal liver morphology J:147264
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
\Gt(ROSA)26Sortm2Bet/\Gt(ROSA)26Sortm2Bet
\Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: BALB/c * C57BL/6 * DBA) 		abnormal intrahepatic bile duct morphology J:174261
abnormal liver morphology J:174261
decreased hepatocyte number J:174261
increased liver weight J:174261
\Gt(ROSA)26Sortm3(HIF1A*)Kael/\Gt(ROSA)26Sor+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:144666
microvesicular hepatic steatosis J:144666
\Gt(ROSA)26Sortm3(HIF1A*)Kael/\Gt(ROSA)26Sortm4(HIF2A*)Kael
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal liver morphology J:144666
hepatic steatosis J:144666
increased liver weight J:144666
\Gt(ROSA)26Sortm4(CAG-hsb5)Nki/\Gt(ROSA)26Sor+
\Tg(Mx1-cre)1Cgn/0
\Tg(Tal1-tTA)19Dgt/0
\Tg(tetO-BCR/ABL1)2Dgt/0
\TgTn(pb-sb-GrOnc)#aGsva/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J * DBA/2 * FVB/N) 		increased liver weight J:227558
\Gt(ROSA)26Sortm4(HIF2A*)Kael/\Gt(ROSA)26Sor+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal liver morphology J:144666
hepatic steatosis J:144666
increased liver weight J:144666
\Gt(ROSA)26Sortm4(HIF2A*)Kael/\Gt(ROSA)26Sor+
\Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N) 		liver vascular congestion J:179490
\Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky/\Gt(ROSA)26Sor+
\Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc) 		hepatic steatosis J:264410
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/?
\Tnfaip3tm1Homy/\Tnfaip3tm1Homy
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		abnormal liver morphology J:212681
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ) 		enlarged liver J:181546
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		enlarged liver J:181546
\Gtf2ird1Tg(Alb1-Myc)166.8Sst/0
\Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:4527
\Gtf2ird1Tg(Alb1-Myc)166.8Sst/\Gtf2ird1+
(involves: C57BL/6 * CBA) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434, J:101128
increased liver adenoma incidence J:34434
increased liver tumor incidence J:101128
increased liver weight J:34434
\Gtf2ird1Tg(Alb1-Myc)166.8Sst/\Gtf2ird1+
\Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:101128
increased liver tumor incidence J:101128
\Gtf2ird1Tg(Alb1-Myc)166.8Sst/\Gtf2ird1+
\Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434
increased hepatocyte karyomegaly J:34434
increased liver adenoma incidence J:34434
increased liver weight J:34434
multifocal hepatic necrosis J:34434
\Gucy2ctm1Gar/\Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar) 		hepatic steatosis J:178241
increased liver triglyceride level J:178241
\Gys2tm1.1Arte/\Gys2+
(Not Specified) 		increased liver triglyceride level J:208923
\Gys2tm1.1Arte/\Gys2tm1.1Arte
(Not Specified) 		decreased liver glycogen level J:208923
increased liver triglyceride level J:208923
\Gys2tm1.1Pro/\Gys2tm1.1Pro
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		decreased liver weight J:162043
increased liver triglyceride level J:162043
\Gys2tm1a(KOMP)Wtsi/\Gys2tm1a(KOMP)Wtsi
(B6J.B6N-Gys2tm1a(KOMP)Wtsi) 		decreased liver glycogen level J:208923
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl) 		abnormal liver morphology J:88055
enlarged liver J:88055
\H13tm1b(KOMP)Wtsi/\H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
dilated liver sinusoidal space J:239583
\H19tm1Tilg/\H19+
\Tg(CRP-TAg)60-3Urt/0
(involves: 129S/SvEv * BALB/c * C57BL/6 * SJL) 		increased liver tumor incidence J:90036
\Habp2tm1Lex/\Habp2tm1Lex
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		liver fibrosis J:207454
\Hacd3em1(IMPC)Mbp/\Hacd3em1(IMPC)Mbp
(C57BL/6N-Hacd3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
small liver J:211773
\Hadhatm1Jib/\Hadha+
(involves: 129X1/SvJ * NIH Black Swiss) 		abnormal hepatocyte mitochondrial morphology J:101304
hepatic steatosis J:101304
macrovesicular hepatic steatosis J:101304
microvesicular hepatic steatosis J:101304
\Hadhatm1Jib/\Hadhatm1Jib
(involves: 129X1/SvJ * NIH Black Swiss) 		abnormal hepatocyte mitochondrial morphology J:69846
abnormal hepatocyte morphology J:69846
enlarged liver J:69846
hepatic steatosis J:69846
\Hadhbm1Ytc/\Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan) 		hepatic steatosis J:117738
\Hamptm2.1Svl/\Hamptm2.1Svl
(involves: FVB/N) 		increased liver iron level J:211683
\Hand2tm1Cse/\Hand2+
\Tg(DBH-cre)1Cse/0
(involves: 129S1/Sv) 		liver vascular congestion J:155265
\Hat1tm1.1Mrpa/\Hat1+
(B6.Cg-Hat1tm1.1Mrpa) 		increased liver tumor incidence J:296531
\Hbatm1(HBA)Tow/\Hbatm1(HBA)Tow
\Hbbtm2(HBG1,HBB*)Tow/\Hbbtm2(HBG1,HBB*)Tow
(Not Specified) 		abnormal Kupffer cell morphology J:134980
abnormal liver morphology J:134980
focal hepatic necrosis J:134980
increased liver iron level J:134980
liver vascular congestion J:134980
\Hbatm1(HBA)Tow/\Hbatm1(HBA)Tow
\Hbbtm2(HBG1,HBB*)Tow/\Hbbtm2(HBG1,HBB*)Tow
\Slc12a4Rbc10/\Slc12a4+
(involves: 129 * BALB/c * C57BL/6J) 		abnormal liver morphology J:227339
hepatic necrosis J:227339
\Hbatm1Paz/\Hbatm1Paz
\Hbbtm1Tow/\Hbbtm1Tow
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		liver hypoplasia J:204029
small liver J:204029
\Hbatm1Paz/\Hbatm1Paz
\Hbbtm1Tow/\Hbbtm1Tow
\Tg(HBA-HBBs)41Paz/?
(involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N) 		abnormal liver vasculature morphology J:44161
increased liver iron level J:44161
\Hbb-b1MommeD7/\Hbb-b1MommeD7
(involves: FVB/N) 		abnormal liver morphology J:190446
liver hypoplasia J:190446
\Hbb-b1Rbc13/\Hbb-b1Rbc13
(involves: BALB/c * C57BL/6) 		abnormal liver morphology J:190446
liver hypoplasia J:190446
\Hbb-b1tm1Unc/\Hbb-b1+
\Hbb-b2tm1Unc/\Hbb-b2+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased liver iron level J:185154
\Hbb-b1tm1Unc/\Hbb-b1+
\Hbb-b2tm1Unc/\Hbb-b2+
\Tmprss6tm1Otin/\Tmprss6+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		abnormal liver iron level J:185154
\Hbbd3th/\Hbbd3th
\Tg(HBB-AR-HBA2,-HBB*)58Rub/0
\Tg(LCR-HBA2,LCR-HBB)11Cos/0
(involves: FVB/N * Swiss Webster) 		abnormal liver morphology J:94190
enlarged liver J:94190
liver fibrosis J:94190
\Hbbtm1.1(HBG1,HBB*)Ryan/\Hbb+
(involves: C57BL/6J) 		increased liver iron level J:147906
\Hbbtm2Unc/\Hbb+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver iron level J:64295
\Hc0/\Hc0
(B10.D2-Hc0) 		liver fibrosis J:100159
\Hcif1C57BL/6J/\Hcif1C57BR/cdJ
\Hcif2C57BL/6J/\Hcif2C57BR/cdJ
(involves: C57BL/6J * C57BR/cdJ) 		increased hepatoma incidence J:33543
\Hcif1C57BR/cdJ/?
(involves: C57BL/6J * C57BR/cdJ) 		increased hepatoma incidence J:33543
\Hcs1C3H/He/?
(involves: A/J * C3H/He) 		increased hepatoma incidence J:3657
\Hcs2C3H/He/?
(involves: A/J * C3H/He) 		increased hepatoma incidence J:3657
\Hcs3A/J/?
(involves: A/J * C3H/He) 		increased hepatoma incidence J:3657
\Hcs4C3H/He/\Hcs4C57BL/6ByJ
(involves: C3H/He * C57BL/6JBy * M. spretus) 		increased hepatoma incidence J:20738
\Hcs5C3H/He/?
(involves: C3H/He * C57BL/6ByJ * M. spretus) 		increased hepatoma incidence J:20738
\Hcs6M. spretus/?
(involves: C3H/He * C57BL/6ByJ * M. spretus) 		increased hepatoma incidence J:20738
\Hcs7C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased hepatoma incidence J:31507
\Hcs7C3H/HeJ/\Hcs7C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased hepatoma incidence J:91132
\Hcs7C3H/HeJ/\Hcs7C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased hepatoma incidence J:91132
\Hcs7C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		decreased liver tumor incidence J:31507
\Hcs8CBA/J/\Hcs8CBA/J
(involves: C57BL/6J * CBA/J) 		increased hepatoma incidence J:91132
\Hcs9C57BR/cdJ/\Hcs9C57BR/cdJ
(B6.BR-(D1Mit5-D1Mit17)) 		increased hepatoma incidence J:91132
\Hdac3tm1.1Laz/\Hdac3tm1.1Laz
(involves: C57BL/6) 		hepatic steatosis J:206152
\Hdac3tm1Swh/\Hdac3tm1.1Swh
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:134288
decreased liver glycogen level J:134288
enlarged liver J:134288
hepatic steatosis J:134288
increased liver triglyceride level J:134288
increased liver weight J:134288
pale liver J:134288
\Hdac3tm1Swh/\Hdac3tm1.1Swh
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:134288
decreased liver glycogen level J:134288
enlarged liver J:134288
hepatic steatosis J:134288
increased liver weight J:134288
\Hddc3tm1.1(KOMP)Vlcg/\Hddc3tm1.1(KOMP)Vlcg
(C57BL/6N-Hddc3tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Hectd3tm1(NCOM)Cmhd/\Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju) 		small liver J:211773
\Helz2tm1Tesa/\Helz2tm1Tesa
(B6.Cg-Helz2tm1Tesa) 		abnormal liver size J:218127
decreased liver triglyceride level J:218127
hepatic steatosis J:218127
\Hemgnem1Xguo/\Hemgnem1Xguo
(Not Specified) 		decreased liver weight J:326018
\Hephsla/Y
\Hfetm2Nca/\Hfetm2Nca
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver iron level J:62112
\Hephsla/\Hephsla
\Hfetm2Nca/\Hfetm2Nca
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver iron level J:62112
\Hexatm1Cota/\Hexatm1Cota
(involves: 129S2/SvPas * C57BL/6) 		abnormal hepatocyte morphology J:30435
\Hexbtm1Rlp/\Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:29268
abnormal liver morphology J:29268
\Hey2tm1Kkb/\Hey2tm1Kkb
(involves: 129S7/SvEvBrd * C57BL/6) 		liver vascular congestion J:97120
\Hey2tm1Mtc/\Hey2tm1Mtc
(involves: 129X1/SvJ) 		liver vascular congestion J:80681
\Hey2tm1Mtc/\Hey2tm1Mtc
(involves: 129X1/SvJ * C57BL/6) 		liver vascular congestion J:80681
\hf/\hf
(MA/MyJ-hf) 		abnormal liver development J:83
\Hfetm1.1Jrco/\Hfetm1.1Jrco
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:201948
\Hfetm1.1Nca/\Hfetm1.1Nca
(Not Specified) 		increased liver iron level J:62112
\Hfetm1.1Nca/\Hfetm1.1Nca
\Tfrctm1Nca/\Tfrc+
(Not Specified) 		increased liver iron level J:62112
\Hfetm1.1Wsr/\Hfetm1.1Wsr
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver iron level J:132134, J:132141, J:141745
\Hfetm1Gfn/\Hfetm1Gfn
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver iron level J:262906, J:68025
\Hfetm1Sly/\Hfetm1Sly
(Not Specified) 		increased liver iron level J:88143
\Hfetm1Sly/\Hfetm2Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
\Hfetm1Wsr/\Hfetm1Wsr
\Tg(Alb1-cre)7Gsc/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased liver iron level J:132134
\Hfetm2Nca/\Hfe+
(involves: 129S6/SvEvTac) 		increased liver iron level J:62112
\Hfetm2Nca/\Hfetm2Nca
(involves: 129S6/SvEvTac) 		increased liver iron level J:62112, J:133221
\Hfetm2Nca/\Hfetm2Nca
\Slc11a2mk/\Slc11a2mk
(involves: 129S6/SvEvTac * C57BL/6J * MK/ReJ) 		decreased liver iron level J:62112
\Hfetm2Nca/\Hfetm2Nca
\Slc11a2tm1Nca/\Slc11a2tm1Nca
(involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2tm1Nca) 		increased liver iron level J:98088
\Hfetm2Nca/\Hfetm2Nca
\Tfrctm1Nca/\Tfrc+
(involves: 129S6/SvEvTac) 		increased liver iron level J:62112
\Hfetm2Nca/\Hfetm2Nca
\Tg(Ttr-Hfe)1Nca/0
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver iron level J:133221
\Hfetm2Nca/\Hfetm2Nca
\Urodtm1Kush/\Urod+
(involves: C57BL/6J) 		increased liver iron level J:66704
\Hfetm2Sly/\Hfetm2Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
\Hfetm2Sly/\Hfetm3Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
\Hfetm3Sly/\Hfetm3Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
\Hfib1BALB/cJ/\Hfib1BALB/cJ
(involves: A/J * BALB/cJ) 		abnormal liver morphology J:80619
\Hgftm1Cbm/\Hgf+
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:23170
\Hgftm1Cbm/\Hgftm1Cbm
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:23170
abnormal liver morphology J:23170
dilated liver sinusoidal space J:23170
dissociated hepatocytes J:23170
liver hypoplasia J:23170
small liver J:23170
\Hgftm1Kita/\Hgftm1Kita
(involves: 129S4/SvJae * C57BL/6) 		small liver J:23171
\Hgsnattm1a(EUCOMM)Wtsi/\Hgsnattm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		abnormal hepatocyte morphology J:235361
abnormal Kupffer cell morphology J:235361
enlarged liver J:235361
increased liver weight J:235361
\Hhextm1Cwb/\Hhextm1Cwb
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver development J:93580
absent liver J:93580
\Hhextm1Cwb/\Hhextm2Cwb
\Tg(Alb1-cre)1Khk/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal liver morphology J:124126
liver cyst J:124126
\Hhextm1Cwb/\Hhextm2Cwb
\Tg(Foxa3-cre)1Khk/?
(involves: 129X1/SvJ * C57BL/6 * DBA * SJL) 		abnormal intrahepatic bile duct morphology J:124126
abnormal liver morphology J:124126
liver cyst J:124126
liver hypoplasia J:124126
\Hhextm1Ngu/\Hhextm1Ngu
(involves: 129/Sv * C57BL/6) 		abnormal hepatocyte morphology J:65105
abnormal liver bud morphology J:65105
abnormal liver development J:65105
\Hhextm1Rbe/\Hhextm1Rbe
(involves: 129P2/OlaHsd * C57BL/6) 		absent liver J:62027
\Hhextm2Cwb/\Hhextm2Cwb
\Tg(Alb1-cre)1Khk/?
(involves: 129S1/Sv * C57BL/6 * SJL) 		liver cyst J:124126
\Hic1tm1Sbb/\Hic1+
(involves: 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:81448
\Hif1atm3Rsjo/\Hif1atm3Rsjo
(involves: 129S1/Sv * 129X1/SvJ) 		decreased liver glycogen level J:152724
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Hprt1tm1(Pck1-cre)Vhh/Y
\Vhltm1Jae/\Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6) 		hepatic steatosis J:97652
increased hepatic hemangioma incidence J:97652
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Vhltm1Jae/\Vhltm1Jae
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * BALB/c * C57BL/6 * DBA) 		hepatic steatosis J:97652
\Hif1anem1(IMPC)Mbp/\Hif1anem1(IMPC)Mbp
(C57BL/6N-Hif1anem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Hif1antm1.2Rsjo/\Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo) 		decreased liver triglyceride level J:160941
decreased liver weight J:160941
decreased susceptibility to diet-induced hepatic steatosis J:160941
\Hikeshiem1(IMPC)Rbrc/\Hikeshi+
(C57BL/6NJcl-Hikeshiem1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Hint2tm1.1Geno/\Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		abnormal hepatocyte mitochondrial morphology J:237329
abnormal liver morphology J:237329
increased liver triglyceride level J:237329
increased liver weight J:237329
macrovesicular hepatic steatosis J:237329
\Hip1tm4Tsr/\Hip1+
\Runx1tm3Dow/\Runx1+
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal liver morphology J:151974
abnormal liver parenchyma morphology J:151974
enlarged liver J:151974
increased liver weight J:151974
\Hip1tm4Tsr/\Hip1+
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:151974
increased liver tumor incidence J:151974
\Hjvtm1Arbr/\Hjvtm1Arbr
(involves: 129S4/SvJae * 129X1/SvJ) 		increased liver iron level J:100173
\Hjvtm1Kpan/\Hjvtm1Kpan
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver iron level J:231428
\Hjvtm1Nca/\Hjv+
\Tmprss6tm1Dgen/\Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		decreased liver iron level J:160248
\Hjvtm1Nca/\Hjvtm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac) 		increased liver iron level J:100178
\Hjvtm1Nca/\Hjvtm1Nca
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:160248
increased liver iron level J:160248
\Hjvtm1Nca/\Hjvtm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased liver iron level J:231428
\Hjvtm1Nca/\Hjvtm1Nca
\Tmprss6tm1Dgen/\Tmprss6+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:160248
increased liver iron level J:160248
\Hjvtm1Nca/\Hjvtm1Nca
\Tmprss6tm1Dgen/\Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:160248
increased liver iron level J:160248
\Hk1dea/\Hk1dea
(A/J-Hk1dea/J) 		increased liver iron level J:72146
\Hkdc1tm1a(KOMP)Wtsi/\Hkdc1+
(involves: C57BL/6N) 		decreased liver triglyceride level J:240354
\Hlxtm1Rph/\Hlxtm1Rph
(involves: 129P2/OlaHsd) 		abnormal liver bud morphology J:31553
abnormal liver development J:31553
liver hypoplasia J:31553
\Hlxtm1Rph/\Hlxtm1Rph
(FVB.129P2-Hlxtm1Rph) 		abnormal liver development J:119681
\Hmbstm1.1Rjde/\Hmbstm1.1Rjde
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:275245
\Hmbstm2Uam/\Hmbstm3Uam
(C57BL/6-Hmbstm2Uam/Hmbstm3Uam) 		abnormal liver morphology J:275245
\Hmgcltm1Gam/\Hmgcl+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)) 		abnormal hepatocyte morphology J:52117
\Hmgcltm1Gam/\Hmgcltm1Gam
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)) 		abnormal hepatocyte mitochondrial morphology J:52117
abnormal hepatocyte morphology J:52117
\Hmgcltm2Gam/\Hmgcltm2Gam
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Hmgcltm2Gam Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal hepatocyte mitochondrial morphology J:204294
\Hmgcrtm2Ishi/\Hmgcrtm2Ishi
\Tg(Alb1-cre)1Dlr/0
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal liver parenchyma morphology J:201488
decreased liver cholesterol level J:201488
enlarged liver J:201488
hepatic necrosis J:201488
increased liver triglyceride level J:201488
increased liver weight J:201488
microvesicular hepatic steatosis J:201488
pale liver J:201488
\Hmgcs2em1(IMPC)Tcp/\Hmgcs2+
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp) 		increased liver weight J:326918
microvesicular hepatic steatosis J:326918
\Hmgcs2em1(IMPC)Tcp/\Hmgcs2em1(IMPC)Tcp
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp) 		enlarged liver J:326918
hepatic steatosis J:326918
increased liver triglyceride level J:326918
increased liver weight J:326918
microvesicular hepatic steatosis J:326918
pale liver J:326918
\Hmox1tm1.1Hes/\Hmox1tm1.1Hes
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N) 		decreased susceptibility to diet-induced hepatic steatosis J:214639
\Hmox1tm1.1Hes/\Hmox1tm1.1Hes
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		decreased susceptibility to diet-induced hepatic steatosis J:214639
\Hmox1tm1Poss/\Hmox1tm1Poss
(involves: 129S2/SvPas * C57BL/6) 		liver fibrosis J:79254
\Hnf1atm1.1Ylee/\Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J) 		abnormal hepatocyte morphology J:47008
enlarged liver J:47008
\Hnf1atm1.1Ylee/\Hnf1atm2Ylee
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:81639
enlarged liver J:81639
hepatic steatosis J:81639
\Hnf1atm1Mya/\Hnf1atm1Mya
(involves: 129S2/SvPas) 		enlarged liver J:31627
hepatic steatosis J:31627
increased liver weight J:31627
\Hnf1atm2Mya/\Hnf1atm2Mya
(involves: 129S2/SvPas) 		enlarged liver J:31627
hepatic steatosis J:31627
increased liver weight J:31627
\Hnf1btm1Mya/\Hnf1btm3Mya
\Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		abnormal interlobular bile duct morphology J:75935
abnormal intrahepatic bile duct morphology J:75935
enlarged liver J:75935
hepatic necrosis J:75935
\Hnf4atm1.1Gonz/\Hnf4atm1.1Gonz
\Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N) 		abnormal hepatocyte mitochondrial morphology J:67396
abnormal hepatocyte morphology J:67396
abnormal liver morphology J:67396
enlarged liver J:67396
\Hnf4atm1Sad/\Hnf4atm1Sad
\Tg(Alb1-cre)1Khk/0
(involves: C57BL/6 * SJL) 		abnormal hepatocyte morphology J:84076
abnormal liver development J:84076
abnormal liver morphology J:84076
decreased liver glycogen level J:84076
dissociated hepatocytes J:84076
\Hnf4atm2.1Mwei/\Hnf4atm2.1Mwei
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		hepatic steatosis J:106993
\Hoxa4em1(IMPC)Mbp/\Hoxa4em1(IMPC)Mbp
(C57BL/6N-Hoxa4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Hpcal1em1Ylzg/\Hpcal1em1Ylzg
(C57BL/6J-Hpcal1em1Ylzg) 		increased liver weight J:331711
\Hpcr1C57BL/6J/\Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
\Hpcr1C57BL/6J/\Hpcr1DBA/2J
\Hpcr2C57BL/6J/\Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
\Hpcr1DBA/2J/\Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
\Hpcr2C57BL/6J/\Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
\Hpcr2DBA/2J/\Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
\Hprt1tm1(CUX1)Anep/\Hprt1+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB)) 		abnormal liver morphology J:113393
\Hprt1tm1(Pck1-cre)Vhh/Y
\Vhltm1Jae/\Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6) 		hepatic steatosis J:97652
increased hepatic hemangioma incidence J:97652
\Hprt1tm1Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:44728
\Hprt1tm1Detl/\Hprt1tm1Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:44728
\HrUSP/\HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2)) 		abnormal hepatocyte morphology J:21316
\Hrh1tm1Wtn/\Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn) 		increased liver triglyceride level J:107191
\Hs3st3b1em2(IMPC)Mbp/\Hs3st3b1em2(IMPC)Mbp
(C57BL/6N-Hs3st3b1em2(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Hsd3b7tm1Rus/\Hsd3b7tm1Rus
(involves: 129S/SvEv * C57BL/6J) 		increased liver triglyceride level J:122973
\Hsd11b1tm1Yko/\Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1) 		hepatic steatosis J:72402
increased liver glycogen level J:45085
\Hsd17b13tm1Lex/\Hsd17b13tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		hepatic steatosis J:273927
increased liver triglyceride level J:273927
macrovesicular hepatic steatosis J:273927
microvesicular hepatic steatosis J:273927
\Hspa12atm1.1Zdi/\Hspa12atm1.1Zdi
(involves: 129 * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:302786
\Hspg2tm1Ref/\Hspg2tm1Ref
(involves: 129S1/Sv * 129X1/SvJ) 		dilated liver sinusoidal space J:80720
\Htatip2tm1Hx/\Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:87066
\Htatip2tm1Hx/\Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:87066
\hubb/\hubb
(involves: ICR) 		increased liver weight J:8170
\Hyal1tm1Stn/\Hyal1tm1Stn
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:136860
\Hyal2tm1.1Bfla/\Hyal2tm1.1Bfla
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased liver iron level J:146040
\Iars1em2Nsas/\Iars1em2Nsas
(C57BL/6-Iars1em2Nsas) 		increased liver triglyceride level J:340986
microvesicular hepatic steatosis J:340986
\Icmttm1Hzo/\Icmttm1Hzo
(involves: 129S/SvEv) 		abnormal liver bud morphology J:77742
abnormal liver development J:77742
absent liver J:77742
delayed hepatic development J:77742
\Id3em1(IMPC)Mbp/\Id3em1(IMPC)Mbp
(C57BL/6N-Id3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Idstm1Muen/Y
(involves: C57BL/6) 		increased liver weight J:259752
\Iduatm1Clk/\Iduatm1Clk
(involves: 129S1/Sv * 129X1/SvJ) 		pale liver J:39522
\Ifitm1tm1.1Ieg/\Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg) 		increased liver weight J:192287
\Ifngtm1Yiw/\Ifngtm1Yiw
(involves: 129X1/SvJ * C57BL/6) 		hepatic necrosis J:41632
\Ifngtm1Yiw/\Ifngtm1Yiw
(B6.129X1-Ifngtm1Yiw) 		abnormal liver morphology J:50405
focal hepatic necrosis J:91691
\Ifngtm1Yiw/\Ifngtm1Yiw
(C.129X1-Ifngtm1Yiw) 		diffuse hepatic necrosis J:91691
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(involves: 129S7/SvEvBrd) 		liver abscess J:174397
\Ift88Tg737Rpw/\Ift88Tg737Rpw
(FVB/N-Ift88Tg737Rpw) 		abnormal liver parenchyma morphology J:18508, J:37149
liver fibrosis J:18508, J:37149
\Ift88Tg737Rpw/\Ift88Tg737Rpw
(C3.FVB-Ift88Tg737Rpw) 		liver fibrosis J:73583, J:18508
\Ift88Tg737Rpw/\Ift88Tg737Rpw
(involves: C3H * FVB/N) 		abnormal liver morphology J:73583
\Ift88Tg737Rpw/\Ift88tm1Rpw
(involves: 129/Sv * FVB/N) 		abnormal liver morphology J:62025
\Igf1rhyft/\Igf1rhyft
(Not Specified) 		abnormal liver morphology J:75360
\Igf1rtm1Jcbr/\Igf1rtm1Jcbr
\Tg(Fabp4-cre)1Abel/?
(involves: C57BL/6 * FVB/N) 		increased liver weight J:141321
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * C57BL/6J) 		increased liver weight J:77413
\Igf2bp1Gt(OST33739)Lex/\Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal liver lobule morphology J:89882
hepatic steatosis J:89882
\Igf2bp2tm1Mini/\Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini) 		abnormal liver triglyceride level J:271356
decreased susceptibility to diet-induced hepatic steatosis J:271356
increased liver weight J:271356
\Igf2rtm1Arge/\Igf2r+
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
\Igf2rtm1Arge/\Igf2rtm1Arge
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
\Igf2rtm2Arge/\Igf2r+
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
\Igf2rtm2Arge/\Igf2rtm2Arge
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
\Igfbp1tm1Taub/\Igfbp1tm1Taub
(involves: 129X1/SvJ * C57BL/6) 		focal hepatic necrosis J:81123
hepatic necrosis J:81817, J:81123
hepatic steatosis J:81123
\Igfbp2tm1Jep/\Igfbp2tm1Jep
(either: (involves: 129P1/ReJ * 129S/SvEv) or (involves: 129S/SvEv * C57BL/6)) 		increased liver weight J:64338
\Igfbp3tm1Lex/\Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased liver weight J:168345
\Ightm1(Myc)Janz/\Igh+
\Mdm4tm1.1Wahl/\Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6) 		enlarged liver J:150341
\Ightm1(PAX5)Mbu/\Igh+
(B6.Cg-Ightm1(PAX5)Mbu) 		abnormal liver morphology J:118111
\Ightm1(PAX5)Mbu/\Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu) 		abnormal liver morphology J:118111
\Iglon5em1(IMPC)Mbp/\Iglon5em1(IMPC)Mbp
(C57BL/6NCrl-Iglon5em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Igs86tm1Low/\Igs86tm1Low
(B6.129S4-Igs86tm1Low) 		hepatic steatosis J:194013
increased liver weight J:194013
\Igs86tm1Low/\Igs86tm1Low
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		hepatic steatosis J:194013
increased liver weight J:194013
\Iigp1cem1Btlr/\Iigp1cem1Btlr
(C57BL/6J-Iigp1cem1Btlr) 		decreased liver free fatty acids level J:333470
hepatic steatosis J:333470
increased liver triglyceride level J:333470
increased liver weight J:333470
\Iigp1cM1Btlr/\Iigp1c+
(C57BL/6J-Iigp1cM1Btlr) 		increased liver triglyceride level J:333470
\Iigp1cM1Btlr/\Iigp1cM1Btlr
(C57BL/6J-Iigp1cM1Btlr) 		hepatic steatosis J:333470
increased liver triglyceride level J:333470
\Iigp1cM2Btlr/\Iigp1c+
(C57BL/6J-Iigp1cM2Btlr) 		increased liver triglyceride level J:333470
\Iigp1cM2Btlr/\Iigp1cM2Btlr
(C57BL/6J-Iigp1cM2Btlr) 		increased liver triglyceride level J:333470
\Ikbkbtm1Mka/\Ikbkbtm1Mka
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:55737
liver degeneration J:55737
\Ikbkbtm1Trk/\Ikbkbtm1Trk
(involves: 129S1/Sv * C57BL/6) 		abnormal hepatocyte morphology J:55680
liver degeneration J:55680
\Ikbkbtm1Ver/\Ikbkbtm1Ver
(involves: 129S4/SvJae * C57BL/6J) 		dissociated hepatocytes J:54323
liver degeneration J:54323
small liver J:54323
\Ikbkgtm1.1Chtr/Y
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		abnormal liver morphology J:151485
hepatic steatosis J:151485
increased hepatocellular carcinoma incidence J:151485
increased liver weight J:151485
\Ikbkgtm1.1Chtr/\Ikbkgtm1.1Chtr
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		abnormal liver morphology J:151485
hepatic necrosis J:151485
hepatic steatosis J:151485
increased hepatocellular carcinoma incidence J:151485
increased liver weight J:151485
\Ikbkgtm1.1Chtr/\Ikbkgtm1.1Chtr
\Tg(Alb1-cre)7Gsc/0
(involves: FVB/N) 		abnormal liver morphology J:160521
increased hepatocellular carcinoma incidence J:160521
liver fibrosis J:160521
\Ikbkgtm1.1Dwat/Y
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		abnormal hepatocyte morphology J:202106
hepatic steatosis J:202106
liver fibrosis J:202106
macrovesicular hepatic steatosis J:202106
microvesicular hepatic steatosis J:202106
\Ikbkgtm1.1Mpa/\Ikbkgtm1.1Mpa
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		abnormal hepatocyte mitochondrial morphology J:118336
abnormal hepatocyte morphology J:118336
abnormal liver morphology J:118336
hepatic steatosis J:118336
increased hepatocellular carcinoma incidence J:118336
\Ikbkgtm1Mka/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:63054
\Ikzf1plstc/\Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc) 		liver hypoplasia J:84569
\Ikzf1plstc/\Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc) 		liver hypoplasia J:84569
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		multifocal hepatic necrosis J:20671
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c) 		multifocal hepatic necrosis J:20671
\Il1r1tm1Imx/\Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J) 		increased liver weight J:108634
\Il4ratm1Fbb/\Il4ratm2Fbb
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * BALB/c) 		liver fibrosis J:114751
\Il5tm1Kopf/\Il5tm1Kopf
(C57BL/6-Il5tm1Kopf) 		liver fibrosis J:107418
\Il6tm1Kopf/\Il6+
\Ncoa5tm1Hxia/\Ncoa5+
(involves: 129S2/SvPas * C57BL/6) 		increased hepatocellular carcinoma incidence J:207622
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		hepatic necrosis J:122816
liver degeneration J:122816
\Il6tm1Poli/\Il6tm1Poli
(involves: 129S/SvEv * C57BL/6) 		abnormal liver morphology J:37026
hepatic necrosis J:37026
\Il6ratm1.1Jcbr/\Il6ratm1.1Jcbr
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		decreased liver glycogen level J:166367
\Il6sttm1Kish/\Il6sttm1Kish
(involves: 129P2/OlaHsd * ICR) 		decreased liver glycogen level J:54660
\Il9em1(IMPC)Mbp/\Il9em1(IMPC)Mbp
(C57BL/6NCrl-Il9em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Il9rem1(IMPC)Mbp/\Il9rem1(IMPC)Mbp
(C57BL/6N-Il9rem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Il10tm1Cgn/\Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:129479
\Il17aem1(IMPC)Mbp/\Il17aem1(IMPC)Mbp
(C57BL/6N-Il17aem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Il17raem1(IMPC)Mbp/\Il17raem1(IMPC)Mbp
(C57BL/6NCrl-Il17raem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Il18bptm1.1(KOMP)Vlcg/\Il18bptm1.1(KOMP)Vlcg
(involves: C57BL/6N) 		enlarged liver J:261967
\Il22tm1.1Lex/\Il22tm1.1Lex
(involves: 129S5/SvEvBrd) 		multifocal hepatic necrosis J:161073
\Il27ratm1Mak/\Il27ratm1Mak
(B6.129P2-Il27ratm1Mak) 		hepatic necrosis J:88618
\Ilruntm1a(KOMP)Wtsi/\Ilruntm1a(KOMP)Wtsi
(involves: C57BL/6N) 		decreased liver cholesterol level J:302091
decreased liver triglyceride level J:302091
decreased liver weight J:302091
\Imebt1DU6/?
(involves: DU6 * DUKs) 		increased liver weight J:99475
\Imebt2DU6/?
(involves: DU6 * DUKs) 		increased liver weight J:99475
\In(7Oca2;7Sox6)100H/\In(7Oca2;7Sox6)100H
(Not Specified) 		abnormal liver morphology J:115753
\Ing5tm1.1Avo/\Ing5tm1.1Avo
(B6.Cg-Ing5tm1.1Avo) 		liver hypoplasia J:345308
\Inhatm1Bay/\Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:20450
diffuse hepatic necrosis J:20450
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Jja/\Ins2tm1Jja
(involves: 129S2/SvPas) 		enlarged liver J:40377
hepatic steatosis J:40377
\Ins2Akita/?
(involves: C57BL/6NSlc) 		decreased liver triglyceride level J:130021
\Ins2tm1Delt/\Ins2+
(involves: 129S2/SvPas * Black Swiss) 		hepatic steatosis J:94589
\Insig1tm1Mbjg/\Insig1tm1Mbjg
\Insig2tm1Mbjg/\Insig2tm1Mbjg
\Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL) 		abnormal liver morphology J:101203
increased liver cholesterol level J:101203
increased liver triglyceride level J:101203
pale liver J:101203
\Insrtm1Dac/\Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6) 		hepatic steatosis J:33408
\Insrtm1Dac/\Insrtm1Dac
\Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		decreased liver glycogen level J:91350
enlarged liver J:91350
hepatic steatosis J:91350
liver degeneration J:91350
\Insrtm1Dac/\Insrtm1Dac
\Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		decreased liver glycogen level J:91350
enlarged liver J:91350
hepatic steatosis J:91350
liver degeneration J:91350
\Insrtm1Jja/\Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased liver glycogen level J:32538
enlarged liver J:32538
hepatic steatosis J:32538, J:80773
\Insrtm1Jja/\Insrtm1Jja
\Tg(PAH-INSR)1Rjv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2) 		decreased liver glycogen level J:80773
hepatic steatosis J:80773
\Insrtm1Khn/\Insrtm1Khn
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB) 		abnormal hepatocyte morphology J:63878
abnormal liver morphology J:63878
dark liver J:63878
small liver J:63878
\Insrtm1Khn/\Insrtm1Khn
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		abnormal liver morphology J:234643
decreased liver glycogen level J:234643
\Insrtm1Khn/\Insrtm1Khn
\Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB) 		decreased liver glycogen level J:169404
hepatic steatosis J:169404
\Invsinv/\Invs+
(FVB/N-Invsinv) 		abnormal liver morphology J:48533
\Invsinv/\Invsinv
(FVB/N-Invsinv) 		abnormal liver morphology J:48533
\Iqgap1tm1Aber/\Iqgap1tm1Aber
\Iqgap2tm1Vs/\Iqgap2tm1Vs
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:132670
\Iqgap2tm1Vs/\Iqgap2tm1Vs
(either: 129S4/SvJae-Iqgap2tm1Vs or B6.129S4-Iqgap2tm1Vs) 		abnormal hepatocyte mitochondrial morphology J:132670
decreased hepatocyte number J:132670
increased hepatocellular carcinoma incidence J:132670
\Iqgap2tm1Vs/\Iqgap2tm1Vs
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:205882
\Irag1em1(IMPC)Ccpcz/\Irag1em1(IMPC)Ccpcz
(C57BL/6NCrl-Irag1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Ireb2tm1.1Eal/\Ireb2tm1.1Eal
(B6J.129-Ireb2tm1.1Eal) 		increased liver iron level J:217335
\Ireb2tm1.2Mwh/\Ireb2tm1.2Mwh
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL) 		increased liver iron level J:103414
\Ireb2tm1Mwh/\Ireb2tm1Mwh
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver iron level J:105124
\Ireb2tm1Roua/\Ireb2tm1Roua
(involves: C57BL/6) 		increased liver iron level J:67313
\Ireb2tm1Roua/\Ireb2tm1Roua
(B6.Cg-Ireb2tm1Roua) 		increased liver iron level J:176655
\Irf2bp2Gt(IST11591C1)Tigm/\Irf2bp2Gt(IST11591C1)Tigm
(involves: C57BL/6 * C57BL/6N * FVB/N) 		abnormal liver morphology J:228010
\Irf8tm1Hor/\Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		hepatosplenomegaly J:36038
\Irs1tm1Mfw/\Irs1tm1Mfw
\Irs2tm2Mfw/\Irs2tm2Mfw
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased liver glycogen level J:137845
\Irs2tm2Mfw/\Irs2tm2Mfw
\Irs4tm1.1Mfw/Y
\Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		hepatic steatosis J:221293
\Irx3tm1Hui/\Irx3tm1Hui
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to diet-induced hepatic steatosis J:208887
\Irx6tm1b(KOMP)Mbp/\Irx6tm1b(KOMP)Mbp
(C57BL/6N-Irx6tm1b(KOMP)Mbp/Kmpc) 		abnormal liver morphology J:211773
\Itgb1tm1Ross/\Itgb1tm1Ross
\Myl2tm1(cre)Krc/\Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss) 		liver vascular congestion J:82534
\Itgb3tm1Hyn/\Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		hepatic necrosis J:52262
\Itih4tm1Mish/\Itih4tm1Mish
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6 * NIH Black Swiss) 		decreased liver tumor incidence J:132133
\Itprid2tm1Sawa/\Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa) 		decreased liver triglyceride level J:144968
decreased susceptibility to diet-induced hepatic steatosis J:144968
\Jag1Ndr/\Jag1Ndr
(involves: C3HeB/FeJ * C57BL/6) 		abnormal liver morphology J:277897
abnormal liver vasculature morphology J:277897
\Jag1tm1Frad/\Jag1tm1Frad
\Tg(Tagln-cre)1Her/0
(B6.Cg-Jag1tm1Frad Tg(Tagln-cre)1Her) 		hepatic necrosis J:166890
\Jag1tm1Grid/\Jag1+
\Notch2tm1Grid/\Notch2+
(involves: 129S1/Sv * C57BL/6J) 		abnormal liver morphology J:74574
\Jak1M1Mhda/\Jak1+
(C3HeB/FeJ-Jak1M1Mhda) 		abnormal hepatocyte morphology J:199153
abnormal liver morphology J:199153
abnormal liver vasculature morphology J:199153
dilated liver sinusoidal space J:199153
liver hyperplasia J:199153
\Jak2tm2.1Kpf/\Jak2tm2.1Kpf
(involves: 129P2/OlaHsd) 		small liver J:207710
\Jarid2jumonji/\Jarid2jumonji
(C.129P2-Jarid2jumonji) 		abnormal liver morphology J:42772
decreased hepatocyte number J:85152
dilated liver sinusoidal space J:42772
hepatic necrosis J:42772
liver hypoplasia J:42772
small liver J:85152
\Jarid2jumonji/\Jarid2jumonji
(either: B6.129P2-Jarid2jumonji or D2.129P2-Jarid2jumonji) 		liver hypoplasia J:42772
\Juntm1Wag/\Juntm1Wag
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6)) 		abnormal liver development J:14538
dissociated hepatocytes J:14538
hepatic necrosis J:14538
\Juntm4Wag/\Juntm4Wag
\Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		decreased liver weight J:75863
\Jundtm1Mya/\Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J) 		decreased liver triglyceride level J:210545
decreased liver weight J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
\Jundtm1Mya/\Jundtm1Mya
\Tg(H2-K-Fosl1)1Wag/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		liver vascular congestion J:95691
\Juptm1.1Shou/\Juptm1.1Shou
\Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J) 		liver vascular congestion J:177567
\Juptm1Kem/\Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ) 		small liver J:38047
\Juptm1Kem/\Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		small liver J:38047
\Juptm1Ruiz/\Juptm1Ruiz
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:64280
\Kat6atm1Iki/\Kat6atm1Iki
(Not Specified) 		liver hypoplasia J:108699
small liver J:108699
\Kat8em1(IMPC)Mbp/\Kat8+
(C57BL/6N-Kat8em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Katnb1tm1a(EUCOMM)Hmgu/\Katnb1tm1a(EUCOMM)Hmgu
(C57BL/6-Katnb1tm1a(EUCOMM)Hmgu) 		pale liver J:220901
\Kbtbd2m1Btlr/\Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr) 		enlarged liver J:236520
hepatic steatosis J:236520
increased liver triglyceride level J:236520
increased liver weight J:236520
pale liver J:236520
\Kcnh8em1(IMPC)Mbp/\Kcnh8em1(IMPC)Mbp
(C57BL/6N-Kcnh8em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
\Kcnn4em1(IMPC)Ccpcz/\Kcnn4em1(IMPC)Ccpcz
(C57BL/6NCrl-Kcnn4em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
\Kcnq1ot1tm1.1Mjh/\Kcnq1ot1+
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		decreased liver weight J:79882
\Kdm1atm1(NCOM)Mfgc/\Kdm1a+
(C57BL/6N-Kdm1atm1(NCOM)Mfgc/Nju) 		small liver J:211773
\Kdm1atm1.1Sho/\Kdm1atm1.1Sho
\Eportm1.1(EGFP/icre)Uk/\Epor+
(involves: 129 * BALB/cJ) 		abnormal liver morphology J:201572
pale liver J:201572
\Kdm3atm1.1Yzha/\Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha) 		hepatic steatosis J:147295
\Kdrtm1Jrt/\Kdr+
\Tg(tetO-Kdr*)4377.5Rwng/0
\Tg(Cebpb-tTA)5Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * NMRI) 		abnormal liver development J:100427
\Kif9em1(IMPC)Mbp/\Kif9em1(IMPC)Mbp
(C57BL/6N-Kif9em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Kifbptm1a(KOMP)Wtsi/\Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Kiss1tm1Coll/\Kiss1tm1Coll
(involves: 129S/SvEv * 129S6/SvEvTac) 		decreased liver weight J:122381
\Kiss1rtm1.1Lex/\Kiss1rtm1.1Lex
(involves: 129S4/SvJae) 		decreased liver weight J:181650
\KitMhdasco5/\KitMhdasco5
(C3HeB/FeJ-KitMhdasco5) 		hepatic steatosis J:125831
\Kittm1Alf/\KitMhdasow3
(involves: 129S2/SvPas * C3HeB/FeJ) 		hepatic steatosis J:125831
\KitW/\KitW-v
(involves: C57BL/6J) 		hepatic steatosis J:125831
\KitWhc1/\KitWhc1
(involves: C3HeB/Fe * C57BL/6) 		hepatic steatosis J:125831
\KitlSl-20J/\KitlSl-20J
(C57BL/6J-KitlSl-20J/J) 		pale liver J:86436
\Kitltm1.1Sjm/\Kitl+
(BKa.129S6-Kitltm1.1Sjm) 		liver hypoplasia J:180431
\Kitltm1.1Sjm/\Kitltm1.1Sjm
(BKa.129S6-Kitltm1.1Sjm) 		liver hypoplasia J:180431
\Kitltm2.1Sjm/\Kitltm2.1Sjm
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6 * C57BL/Ka * SJL) 		liver hypoplasia J:180431
\Klkl/\Klkl
(involves: C3H/J * C57BL/6J) 		decreased liver weight J:66078
\Klbtm1.2Sakl/\Klb+
\Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		decreased liver cholesterol level J:189018
decreased liver triglyceride level J:189018
decreased liver weight J:189018
decreased susceptibility to diet-induced hepatic steatosis J:189018
\Klbtm1.2Sakl/\Klbtm1.2Sakl
\Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		abnormal liver morphology J:189018
\Klf1Nan/\Klf1+
(involves: 101/H * C3H/HeH * PT) 		increased liver iron level J:13933
\Klf1tm1Nimr/\Klf1tm1Nimr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CBA) or (involves: 129P2/OlaHsd * FVB)) 		pale liver J:25650
small liver J:25650
\Klf2tm1Ling/\Klf2tm1Ling
(involves: 129P2/OlaHsd * C57BL/6J) 		pale liver J:51402
\Klf3Gt(CH0516)Wtsi/\Klf3Gt(CH0516)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver weight J:206507
\Klf3Gt(XS0187)Wtsi/\Klf3Gt(XS0187)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver weight J:206507
\Klf6tm1Fdmn/\Klf6+
(Not Specified) 		increased liver weight J:122903
\Klf6tm1Fdmn/\Klf6tm1Fdmn
(involves: C57BL/6) 		abnormal liver development J:122926
\Klf15tm1Jain/\Klf15tm1Jain
(B6.129X1-Klf15tm1Jain) 		decreased liver glycogen level J:129763
\Klk11em1(IMPC)Ccpcz/\Klk11em1(IMPC)Ccpcz
(C57BL/6N-Klk11em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Klrb1tm1b(EUCOMM)Wtsi/\Klrb1tm1b(EUCOMM)Wtsi
(C57BL/6N-Klrb1tm1b(EUCOMM)Wtsi/Ieg) 		abnormal liver morphology J:211773
\Kmt2atm1(MLL1/ERT)Divo/?
(involves: 129S4/SvJae * C57BL/6) 		enlarged liver J:189329
\Kmt2atm1.1(Sh3gl1)Lcc/\Kmt2a+
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		enlarged liver J:205605
\Kmt2atm1.1Brad/\Kmt2atm1.1Brad
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver development J:149811
\Kmt2atm1.1Mlc/\Kmt2atm1.1Mlc
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:183048
\Kmt2atm2(MLLT3)Thr/\Kmt2a+
(involves: 129P2/OlaHsd) 		enlarged liver J:56340
\Kmt2bGena263/\Kmt2b+
(involves: BALB/c * C3H/HeH) 		abnormal hepatocyte morphology J:203736
hepatic steatosis J:203736
increased liver free fatty acids level J:203736
increased liver triglyceride level J:203736
increased liver weight J:203736
\Kmt2bm1H/\Kmt2b+
(involves: BALB/c * C3H/HeH) 		increased liver weight J:203736
\Krastm1Tyj/\Kras+
\Nrastm1Rak/\Nrastm1Rak
(involves: 129/Sv * C57BL/6) 		abnormal hepatocyte morphology J:43433
\Krastm1Tyj/\Krastm1Tyj
(involves: 129S2/SvPas) 		liver hypoplasia J:43433
pale liver J:43433
small liver J:43433
\Krastm4Tyj/\Kras+
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		hepatosplenomegaly J:247853
\Krastm4Tyj/\Kras+
\Krt19tm1(cre/ERT)Ggu/\Krt19+
\Ptentm2Mak/\Ptentm2Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac) 		abnormal liver morphology J:254370
\Krastm4Tyj/\Kras+
\Meox2tm1(cre)Sor/\Meox2+
(involves: 129S4/SvJae * 129S4/SvJaeSor) 		liver hypoplasia J:119477
\Krastm4Tyj/\Kras+
\Pggt1btm1Mbrg/\Pggt1b+
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:122107
\Krastm4Tyj/\Kras+
\Ptentm2Mak/\Pten+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:254370
increased liver tumor incidence J:254370
\Krastm4Tyj/\Kras+
\Ptentm2Mak/\Ptentm2Mak
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		enlarged liver J:254370
increased liver tumor incidence J:254370
\Krastm4Tyj/\Kras+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased liver tumor incidence J:254370
\Krastm4Tyj/\Kras+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		enlarged liver J:87429
\Krastm4Tyj/\Kras+
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\Ptf1atm1.1(cre)Cvw/\Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		hepatic necrosis J:116129
\Krastm4Tyj/\Krastm4Tyj
\Yap1tm1.1Dupa/\Yap1tm1.1Dupa
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:162628
\Krt8tm1Rgo/\Krt8tm1Rgo
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:106541, J:44938, J:86719, J:121813
hepatic necrosis J:86719, J:22116
hepatic steatosis J:86719
increased polyploid hepatocyte number J:106541
\Krt18tm1Tmm/\Krt18+
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:309021
abnormal liver morphology J:309021
hepatic steatosis J:309021
increased liver tumor incidence J:309021
Mallory bodies J:309021
\Krt18tm1Tmm/\Krt18tm1Tmm
(involves: 129/Sv * 129P2/OlaHsd * MF1) 		enlarged liver J:46610
\Krt18tm1Tmm/\Krt18tm1Tmm
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:309021
abnormal liver morphology J:309021
abnormal liver parenchyma morphology J:309021
focal hepatic necrosis J:309021
hepatic steatosis J:309021
increased hepatocellular carcinoma incidence J:309021
increased liver tumor incidence J:309021
Mallory bodies J:309021
\Krt72em1(IMPC)Ccpcz/\Krt72em1(IMPC)Ccpcz
(C57BL/6N-Krt72em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Lactb2Tg(Igh-Meis1)2770Amb/\Lactb2Tg(Igh-Meis1)2770Amb
(FVB/NJ-Lactb2Tg(Igh-Meis1)2770Amb) 		enlarged liver J:79618
microvesicular hepatic steatosis J:79618
pale liver J:79618
\Lamp2tm1Amcu/Y
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		decreased liver glycogen level J:215605
enlarged liver J:215605
hepatic steatosis J:215605
increased liver triglyceride level J:215605
increased liver weight J:215605
pale liver J:215605
\Larp1em1(IMPC)Mbp/\Larp1+
(C57BL/6N-Larp1em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
\Lats1tm1Noj/\Lats1tm1Noj
\Lats2tm1.1Dupa/\Lats2tm1.1Dupa
(involves: 129P2/OlaHsd * 129S2/SvPas) 		enlarged liver J:223215
increased liver weight J:223215
\Lats1tm1Noj/\Lats1tm1Noj
\Lats2tm1.1Dupa/\Lats2tm1.1Dupa
\Wwtr1tm1.2Eno/\Wwtr1tm1.2Eno
\Yap1tm1.1Dupa/\Yap1tm1.1Dupa
(involves: 129P2/OlaHsd * 129S/SvEv * 129S2/SvPas) 		enlarged liver J:223215
\Lcattm1Hgc/\Lcattm1Hgc
\Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		enlarged liver J:93775
\Lcn2tm1Aade/\Lcn2tm1Aade
(B6.129P2-Lcn2tm1Aade) 		hepatic steatosis J:169355
increased liver triglyceride level J:169355
increased liver weight J:169355
\Ldhaa-m1Neu/\Ldhaa-m1Neu
(C3.Cg-Ldhaa-m1Neu) 		increased liver weight J:14326
\Ldlrtm1Her/\Ldlr+
\Lepob/\Lepob
(B6.Cg-Lepob Ldlrtm1Her) 		increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
\Ldlrtm1Her/\Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		increased liver cholesterol level J:175559
increased liver triglyceride level J:175559
increased liver weight J:175559
liver fibrosis J:175559
macrovesicular hepatic steatosis J:175559
microvesicular hepatic steatosis J:175559
\Ldlrtm1Her/\Ldlrtm1Her
(B6.129S7-Ldlrtm1Her) 		hepatic steatosis J:130278
increased liver cholesterol level J:72027
increased liver triglyceride level J:130278
\Ldlrtm1Her/\Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J) 		hepatic steatosis J:85174
increased liver cholesterol level J:85174
\Ldlrtm1Her/\Ldlrtm1Her
\Lepob/\Lepob
(B6.Cg-Lepob Ldlrtm1Her) 		increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
\Ldlrtm1Her/\Ldlrtm1Her
\Npc1m1N/\Npc1m1N
(involves: 129S7/SvEvBrd * BALB/c) 		increased liver cholesterol level J:130969
\Ldlrtm1Her/\Ldlrtm1Her
\Npc1m1N/\Npc1m1N
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		increased liver weight J:100351
\Ldlrtm1Her/\Ldlrtm1Her
\Nr1h3tm1.1Djm/\Nr1h3tm1.1Djm
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA) 		increased liver cholesterol level J:184536
\Ldlrtm1Her/\Ldlrtm1Her
\Nr5a2tm3.1Sjns/\Nr5a2tm3.1Sjns
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N) 		increased liver cholesterol level J:215556
\Ldlrtm1Her/\Ldlrtm1Her
\Scd1ab-2J/\Scd1ab-2J
(B6.Cg-Ldlrtm1Her Scd1ab-2J) 		decreased liver triglyceride level J:130278
\Ldlrtm1Her/\Ldlrtm1Her
\Scd1ab-J/\Scd1ab-J
(B6.Cg-Ldlrtm1Her Scd1ab-J) 		decreased liver triglyceride level J:130278
\Leap2em1Jmz/\Leap2em1Jmz
(C57BL/6N-Leap2em1Jmz) 		macrovesicular hepatic steatosis J:322589
\Lect2tm1Ymg/\Lect2tm1Ymg
\Tg(Pklr-Myc)73Ak/0
(B6.Cg-Lect2tm1Ymg Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
\Lefty1tm1Hmd/\Lefty1tm1Hmd
(involves: 129P2/OlaHsd * C57BL/6Cr) 		abnormal liver morphology J:49052
\Lefty2tm2Hmd/\Lefty2tm2Hmd
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:70483
\Lepm1Yst/\Lepm1Yst
(C57BL/6J-Lepm1Yst) 		hepatic steatosis J:167736
increased liver weight J:167736
pale liver J:167736
\Lepob/\Lep+
(involves: 129X1/SvJ * C57BL/6) 		increased liver weight J:76479
\Lepob/\Lepob
(involves: C57BL/6J) 		hepatic steatosis J:219118
increased liver weight J:219118
\Lepob/\Lepob
(B6.Cg-Lepob/J) 		abnormal liver weight J:22377
\Lepob/\Lepob
(involves: 129X1/SvJ * C57BL/6) 		increased liver weight J:107169
\Lepob/\Lepob
(involves: 129 * C57BL/6) 		hepatic steatosis J:121534
\Lepob/\Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs) 		decreased liver triglyceride level J:199803
decreased susceptibility to hepatic steatosis J:199803
increased liver triglyceride level J:199803
\Lepob/\Lepob
(involves: C57BL/6) 		increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
\Lepob/\Lepob
(B6.Cg-Lepob/JRj) 		hepatic steatosis J:277927
liver fibrosis J:277927
macrovesicular hepatic steatosis J:277927
\Lepob/\Lepob
\Mogat1tm1Far/\Mogat1tm1Far
(involves: 129S4/SvJae) 		increased liver triglyceride level J:231617
\Lepob/\Lepob
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(B6.Cg-Nfe2l2tm1Mym Lepob) 		decreased liver triglyceride level J:208590
hepatic steatosis J:208590
\Lepob/\Lepob
\Npy2rtm1.1Hhz/\Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased liver weight J:107169
\Lepob/\Lepob
\Pmchtm1Emf/\Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6) 		hepatic steatosis J:85176
\Lepob/\Lepob
\Ppargtm1Avp/\Pparg+
(involves: 129S2/SvPas * C57BL/6) 		hepatic steatosis J:116568
increased liver weight J:116568
\Lepob/\Lepob
\Ppargtm2Avp/\Ppargtm2Avp
(involves: 129 * C57BL/6) 		abnormal liver morphology J:121534
decreased liver triglyceride level J:121534
hepatic steatosis J:121534
\Lepob/\Lepob
\Rcan2tm1Ypt/\Rcan2tm1Ypt
(involves: 129 * C57BL/6) 		decreased liver weight J:169558
\Lepob/\Lepob
\Sesn2Gt(RRJ141)Byg/\Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:189021
increased liver triglyceride level J:189021
\Lepob/\Lepob
\Slc22a18tm1Tgot/\Slc22a18tm1Tgot
(involves: C57BL/6) 		decreased liver weight J:349247
\Lepob/\Lepob
\Steap4tm1Dgen/\Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		hepatic steatosis J:187736
\Lepob/\Lepob
\Tg(Eno2-Pomc)1Mobb/?
(involves: C3H * C57BL/6) 		abnormal liver size J:86303
\Leprdb-9J/\Leprdb-9J
(involves: C57BL/6 * CBA * SWR) 		hepatic steatosis J:129982
increased liver glycogen level J:129982
\Leprdb-lb/\Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl) 		hepatic steatosis J:171755
\Leprdb-Nokl/\Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl) 		increased liver triglyceride level J:313303
increased susceptibility to diet-induced hepatic steatosis J:313303
\Leprdb-Pas/\Leprdb-Pas
(involves: DW/Pas) 		enlarged liver J:174584
\Leprdb/\Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl) 		increased liver triglyceride level J:313303
increased susceptibility to diet-induced hepatic steatosis J:313303
\Leprdb/\Leprdb
(involves: C57BLKS/J) 		increased liver weight J:232827
\Leprdb/\Leprdb
(B6.BKS(D)-Leprdb/JOrlRj) 		hepatic steatosis J:277927
liver fibrosis J:277927
macrovesicular hepatic steatosis J:277927
microvesicular hepatic steatosis J:277927
\Leprdb/\Leprdb
(B6NTac.BKS(D)-Leprdb) 		increased liver triglyceride level J:313303
increased susceptibility to diet-induced hepatic steatosis J:313303
\Leprdb/\Leprdb
\Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * C57BLKS/J * CBA) 		hepatic steatosis J:232827
increased liver triglyceride level J:232827
increased liver weight J:232827
\Leprm1Clo/\Leprm1Clo
(STOCK Leprm1Clo/GrsrJ) 		hepatic steatosis J:232775
\Leprm5Btlr/\Leprm5Btlr
(C57BL/6-Leprm5Btlr) 		increased liver weight J:166105
\Leprm8Btlr/\Leprm8Btlr
(C57BL/6J-Leprm8Btlr) 		hepatic steatosis J:267679
\LeprTg(Mth11)1Aig/\LeprTg(Mth11)1Aig
(involves: Him:OF1) 		enlarged liver J:61119
\Leprtm1.1Chua/\Leprtm1.1Chua
\Tg(Agrp-cre)1Gsb/0
(involves: 129 * FVB/N) 		decreased liver triglyceride level J:199803
\Leprtm1b(EUCOMM)Wtsi/\Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H) 		enlarged liver J:211773
\Leprtm1Jke/\Leprtm1Jke
(involves: 129X1/SvJ * C57BL/6J) 		increased liver triglyceride level J:184572
\Leprtm1Jke/\Leprtm1Jke
(involves: 129X1/SvJ) 		increased liver triglyceride level J:216393
\Leprtm1Jke/\Leprtm1Jke
\Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased liver triglyceride level J:184572
increased liver triglyceride level J:184572
\Leprtm1Rck/\Leprtm1.1Rck
\Tg(Syn1-cre)671Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		hepatic steatosis J:72241
\Leprottm1.2Damj/\Leprottm1.2Damj
(involves: 129S2/SvPas * C57BL/6N * FVB/N) 		decreased susceptibility to diet-induced hepatic steatosis J:349250
\Letmd1em1Mbp/\Letmd1em1Mbp
(C57BL/6J-Letmd1em1Mbp) 		hepatic steatosis J:321533
increased liver weight J:321533
\Lexis1tm1.1Pton/\Lexis1tm1.1Pton
(B6.Cg-Lexis1tm1.1Pton) 		hepatic steatosis J:233670
increased liver cholesterol level J:233670
\Lgals3tm1Ftl/\Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1) 		abnormal hepatocyte morphology J:116073
abnormal liver morphology J:221030, J:116073
focal hepatic necrosis J:221030, J:116073
hepatic steatosis J:221030, J:116073
increased hepatocellular carcinoma incidence J:221030
increased liver triglyceride level J:116073
increased liver weight J:116073
liver fibrosis J:221030
Mallory bodies J:116073
\Lgmntm1Ihn/\Lgmntm1Ihn
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver weight J:143886
\Lgr4Gt(pGT0TMpfs)1Wcs/\Lgr4Gt(pGT0TMpfs)1Wcs
(involves: 129P2/Ola * C57BL/6) 		decreased liver weight J:92077
\Lhcgrtm1(KOMP)Vlcg/\Lhcgrtm1(KOMP)Vlcg
(C57BL/6N-Lhcgrtm1(KOMP)Vlcg/Nju) 		small liver J:211773
\Lhx2tm1Dra/\Lhx2tm1Dra
(involves: 129S4/SvJae) 		liver hypoplasia J:64676
small liver J:64676
\Liftm1Stw/\Liftm1Stw
(involves: 129S1/Sv * BALB/c) 		abnormal hepatocyte morphology J:136940
hepatic necrosis J:136940
liver vascular congestion J:136940
\Lifrtm1Imx/\Lifrtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd * C57BL/6) 		increased liver glycogen level J:25253
\Lig1m1Anu/\Lig1m1Anu
(involves: C3H/HeH * C57BL/6JAnu) 		pale liver J:199856
\Lig1tm1Dwm/\Lig1tm1Dwm
(involves: 129P2/OlaHsd * BALB/c) 		abnormal liver development J:76371
liver hypoplasia J:76371
small liver J:76371
\Lima1tm1Blsg/\Lima1tm1Blsg
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2) 		decreased liver cholesterol level J:263730
\Lims1tm1.1Chen/\Lims1tm1.1Chen
\Lims2tm1.1Chen/\Lims2tm1.1Chen
\Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		enlarged liver J:167114
liver vascular congestion J:167114
\Lingo2em1(IMPC)Kmpc/\Lingo2em1(IMPC)Kmpc
(C57BL/6NTac-Lingo2em1(IMPC)Kmpc/Kmpc) 		abnormal liver morphology J:211773
\Lipatm1c(EUCOMM)Hmgu/\Lipatm1c(EUCOMM)Hmgu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		abnormal hepatocyte morphology J:270182
decreased liver triglyceride level J:270182
enlarged liver J:270182
hepatic steatosis J:270182
increased liver cholesterol level J:270182
increased liver weight J:270182
liver fibrosis J:270182
pale liver J:270182
\Lipatm1Hodu/\Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1) 		abnormal hepatocyte morphology J:49674, J:68812
abnormal Kupffer cell morphology J:68812
abnormal liver morphology J:49674
abnormal liver sinusoid morphology J:49674
hepatic steatosis J:68812
hepatosplenomegaly J:68812
increased liver cholesterol level J:49674
increased liver triglyceride level J:49674
increased liver weight J:49674, J:68812
\Lipetm1Gam/\Lipetm1Gam
(involves: 129S4/SvJae * BALB/c) 		decreased liver triglyceride level J:82299
\Lipetm1Rze/\Lipetm1Rze
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased liver triglyceride level J:74644
\Lipetm1Rze/\Lipetm1Rze
(involves: 129P2/OlaHsd) 		decreased liver triglyceride level J:84822
\Lipilpd1/\Lipilpd1
(involves: CD-1) 		hepatic steatosis J:46789
increased liver triglyceride level J:46789
\Livq1MH/?
(involves: C57BL/6J * MH) 		increased liver weight J:55483
\Livq2MH/?
(involves: C57BL/6J * MH) 		increased liver weight J:55483
\Livq3MH/?
(involves: C57BL/6J * MH) 		decreased liver weight J:55483
\Lmnaem1Fenz/\Lmna+
(C57BL/6-Lmnaem1Fenz) 		hepatic steatosis J:338760
increased liver triglyceride level J:338760
\LmnaGt(S7-1F1)Sor/\LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased liver glycogen level J:221850
\Lmo2tm2(cre)Thr/\Lmo2+
\Kmt2atm1Thr/\Kmt2a+
\Mllt1tm1Thr/\Mllt1+
(involves: 129S/SvEv) 		pale liver J:84518
\Lmr3BALB/cHeA/?
(involves: BALB/cHeA * STS/A) 		enlarged liver J:82715
\Lmr14CcS16/Dem/?
(involves: BALB/cHeA * STS/A) 		enlarged liver J:82716
\Lmr15CcS16/Dem/?
(involves: BALB/cHeA * STS/A) 		enlarged liver J:82716
\Lncenc1em1Smoc/\Lncenc1em1Smoc
(C57BL/6J-Lncenc1em1Smoc) 		decreased liver cholesterol level J:306153
decreased liver triglyceride level J:306153
decreased liver weight J:306153
decreased susceptibility to diet-induced hepatic steatosis J:306153
\Loricrintm1.1(KOMP)Vlcg/\Loricrin+
(C57BL/6N-Loricrintm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Loxl2tm1.2Acan/\Loxl2tm1.2Acan
(Not Specified) 		abnormal liver vasculature morphology J:220689
\Lpcat3tm1c(EUCOMM)Wtsi/\Lpcat3tm1c(EUCOMM)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * SJL) 		hepatic steatosis J:220827
increased liver cholesterol level J:220827
increased liver triglyceride level J:220827
\Lpin1fld-2J/\Lpin1fld-2J
(C3H/HeJ-Lpin1fld-2J/J) 		enlarged liver J:66739
hepatic steatosis J:66739
\Lpin1fld/\Lpin1fld
(BALB/cByJ-Lpin1fld) 		enlarged liver J:82882, J:63448
increased liver triglyceride level J:147417, J:82882
pale liver J:82882
\Lpin1fld/\Lpin1fld
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		decreased liver triglyceride level J:220917
\Lpin1fld/\Lpin1fld
\Lpin3tm1Reue/\Lpin3tm1Reue
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		decreased liver triglyceride level J:220917
\Lpin2tm1Reue/\Lpin2tm1Reue
(involves: C57BL/6J) 		increased liver triglyceride level J:189894
\Lpltm1Bres/\Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J) 		abnormal liver morphology J:30062
\Lpltm1Sem/\Lpltm1Sem
(involves: 129P2/OlaHsd * C57BL/6J) 		liver vascular congestion J:25652
\Lpoem1Zlu/\Lpoem1Zlu
(involves: C57BL/6 * SJL) 		abnormal liver parenchyma morphology J:307289
abnormal liver vasculature morphology J:307289
\Lpptm1b(KOMP)Wtsi/\Lpptm1b(KOMP)Wtsi
(C57BL/6NCrl-Lpptm1b(KOMP)Wtsi/Ccpcz) 		abnormal liver morphology J:211773
\Lrp1tm2Ajmr/\Lrp1tm2Ajmr
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:144146
\Lrp1tm2Her/\Lrp1tm2Her
\Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased liver triglyceride level J:127398
\Lrp1tm3Ajmr/\Lrp1tm3Ajmr
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver perisinusoidal space morphology J:144146
decreased hepatocyte number J:144146
liver degeneration J:144146
\Lrp6Gt(LST067)Byg/\Lrp6+
(B6.Cg-Lrp6Gt(LST067)Byg) 		abnormal liver morphology J:182772
decreased liver triglyceride level J:182772
\Lrp6tm1Arma/\Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma) 		abnormal liver morphology J:225450
enlarged liver J:210538
hepatic steatosis J:210538, J:225450
increased liver cholesterol level J:210538, J:225450
increased liver triglyceride level J:210538
liver fibrosis J:225450
\Lrrc8ctm1Maim/\Lrrc8ctm1Maim
(B6J.129S2-Lrrc8ctm1Maim) 		decreased liver weight J:247160
\Lrrtm2em1(IMPC)Mbp/\Lrrtm2em1(IMPC)Mbp
(C57BL/6N-Lrrtm2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Lsrtm1Mdar/\Lsrtm1Mdar
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1)) 		liver hypoplasia J:92354
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(involves: 129 * C57BL/6J) 		enlarged liver J:112797
hepatic steatosis J:112797
increased liver weight J:112797
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(involves: 129 * C57BL/6J) 		enlarged liver J:112797
hepatic steatosis J:112797
increased liver weight J:112797
\Ltbtm1Kpf/\Ltbtm1Kpf
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:42508
\Ltbp1tm1Rawe/\Ltbp1tm1Rawe
(B6.129X1-Ltbp1tm1Rawe) 		liver fibrosis J:133255
\Ltftm1Omc/\Ltftm1Omc
(either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6)) 		increased liver iron level J:81005
\Luc7lem1(IMPC)Mbp/\Luc7lem1(IMPC)Mbp
(C57BL/6N-Luc7lem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Lwq9CAST/EiJ/\Lwq9CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		increased liver weight J:117545
\Lwq14L6/\Lwq14L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq15L6/\Lwq15L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq15L6/\Lwq15M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq16L6/\Lwq16L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq17L6/\Lwq17L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq17L6/\Lwq17M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq18L6/\Lwq18L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq19L6/\Lwq19L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq19L6/\Lwq19M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq20L6/\Lwq20L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq21L6/\Lwq21L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq22L6/\Lwq22L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq23L6/\Lwq23L6
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq23L6/\Lwq23M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
\Lwq24NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
\Ly6etm1c(EUCOMM)Hmgu/\Ly6etm1c(EUCOMM)Hmgu
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio) 		abnormal liver morphology J:291868
hepatic necrosis J:291868
pale liver J:291868
\Lyplal1em1Espel/\Lyplal1em1Espel
(C57BL/6J-Lyplal1em1Espel) 		decreased liver triglyceride level J:340413
decreased susceptibility to diet-induced hepatic steatosis J:340413
\Lyz2tm1(HBEGF)Mtka/\Lyz2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:145285
\Lztfl1tm1.2Zpl/\Lztfl1tm1.2Zpl
\Tg(Camk2a-cre)#Stl/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL * C57BL/6 * C57BL/6N) 		abnormal interlobular bile duct morphology J:287261
hepatic steatosis J:287261
\Lztfl1tm1.3Zpl/\Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N) 		abnormal interlobular bile duct morphology J:287261
hepatic steatosis J:287261
\Lzts1tm1Cro/\Lzts1+
(involves: 129 * C57BL/6J) 		increased hepatocellular carcinoma incidence J:119989
\Lzts1tm1Cro/\Lzts1tm1Cro
(involves: 129 * C57BL/6J) 		increased hepatocellular carcinoma incidence J:119989
\Macroh2a1tm1Mbou/\Macroh2a1tm1Mbou
(involves: 129P2/OlaHsd * C57BL/6) 		macrovesicular hepatic steatosis J:195833
\Macroh2a2em1(IMPC)Hmgu/\Macroh2a2em1(IMPC)Hmgu
(C57BL/6NCrl-Macroh2a2em1(IMPC)Hmgu/Ieg) 		abnormal liver morphology J:211773
decreased liver weight J:211773
\Mad1l1tm1.1Ktj/\Mad1l1+
(involves: BALB/c * C57BL/6J) 		increased hepatocellular carcinoma incidence J:117337
\Mad2l1bptm1.1Itl/\Mad2l1bptm1.1Itl
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac) 		decreased liver glycogen level J:234643
decreased liver triglyceride level J:234643
\Mad2l1bptm1.2Itl/\Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		abnormal hepatocyte morphology J:234643
decreased liver glycogen level J:234643
\Maf1tm1.1Lnh/\Maf1tm1.1Lnh
(involves: C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:222253
\Mafem1(IMPC)Mbp/\Maf+
(C57BL/6N-Mafem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Mafem1(IMPC)Mbp/\Mafem1(IMPC)Mbp
(C57BL/6N-Mafem1(IMPC)Mbp/MbpMmucd) 		abnormal liver size J:211773
\Malrd1em1(IMPC)Mbp/\Malrd1em1(IMPC)Mbp
(C57BL/6N-Malrd1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Man2a1tm1Jxm/\Man2a1tm1Jxm
\Man2a2tm1Mfu/\Man2a2tm1Mfu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:111055
\Man2b1tm1Psa/\Man2b1tm1Psa
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:56659
abnormal Kupffer cell morphology J:56659
abnormal liver morphology J:56659
\Man2c1tm1.1Tbec/\Man2c1+
(B6N.129P2-Man2c1tm1.1Tbec) 		hepatic steatosis J:205550
\Man2c1tm1.1Tbec/\Man2c1tm1.1Tbec
(B6N.129P2-Man2c1tm1.1Tbec) 		abnormal hepatocyte morphology J:205550
hepatic steatosis J:205550
increased liver glycogen level J:205550
\Manbatm1Khf/\Manbatm1Khf
(B6.129-Manbatm1Khf) 		abnormal hepatocyte morphology J:105427
abnormal Kupffer cell morphology J:105427
abnormal liver sinusoidal endothelial cell morphology J:105427
\Map2k4tm1Lizon/\Map2k4tm1Lizon
(involves: 129S1/Sv) 		abnormal liver bud morphology J:48772
abnormal liver development J:48772
decreased hepatocyte number J:48772
dilated liver sinusoidal space J:48772
\Map2k4tm1Pngr/\Map2k4tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver development J:51597
\Map3k7tm1Aki/\Map3k7tm1Aki
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal hepatocyte morphology J:160521
focal hepatic necrosis J:160521
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal hepatocyte morphology J:160521
abnormal liver morphology J:160521
focal hepatic necrosis J:160521
increased hepatocellular carcinoma incidence J:160521
liver fibrosis J:160521
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:238318
\Mapk1tm1Melo/\Mapk1+
\Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
\Tg(Tek-cre)12Flv/0
(involves: 129S2/SvPas * C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
\Mapk3tm1Gpg/\Mapk3+
\Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
\Tg(Tek-cre)12Flv/0
(involves: 129/Sv * C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
\Tg(Tek-cre)12Flv/0
(involves: 129/Sv * C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
\Mapk6tm1Melo/\Mapk6tm1Melo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:153218
\Mapk8tm1Jcbr/\Mapk8tm1Jcbr
\Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased liver triglyceride level J:158650
decreased liver weight J:158650
decreased susceptibility to diet-induced hepatic steatosis J:158650
\Mapk8ip1tm3.1Rjd/\Mapk8ip1tm3.1Rjd
(B6.129S6-Mapk8ip1tm3.1Rjd) 		abnormal liver morphology J:163808
decreased liver triglyceride level J:163808
decreased liver weight J:163808
decreased susceptibility to diet-induced hepatic steatosis J:163808
\Mapk11tm1Jsca/\Mapk11tm1Jsca
\Mapk14tm2Nbr/\Mapk14tm2Nbr
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver morphology J:176023
small liver J:176023
\Mapk14tm1Mka/\Mapk14tm1Mka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		pale liver J:63425
small liver J:63425
\Mark2tm1Hpw/\Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to age-related hepatic steatosis J:120128
\Mark3tm1Hpw/\Mark3tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		decreased liver glycogen level J:163905
decreased susceptibility to diet-induced hepatic steatosis J:163905
\Marveld2tm1.1Sria/\Marveld2tm1.1Sria
(involves: 129X1/SvJ * C57BL/6J) 		increased liver weight J:201580
\Mat1atm1Jmm/\Mat1atm1Jmm
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:69408
increased liver weight J:69408
macrovesicular hepatic steatosis J:69408
\Mbd5tm1.2Gxu/\Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J) 		decreased liver weight J:192212
\Mbtd1tm1Homy/\Mbtd1tm1Homy
(B6.Cg-Ptprca Mbtd1tm1Homy) 		abnormal liver development J:169112
liver hypoplasia J:169112
\Mbtps1tm1Jdh/\Mbtps1tm1Jdh
\Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL) 		decreased liver triglyceride level J:72930
\Mc4rtm1Lowl/\Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatocellular carcinoma incidence J:177386
increased liver triglyceride level J:177386
increased liver weight J:177386
liver fibrosis J:177386
microvesicular hepatic steatosis J:177386
\Mc4rtm1Matsu/\Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu) 		hepatic steatosis J:285412
increased liver triglyceride level J:285412
increased liver weight J:285412
liver fibrosis J:285412
\Mcm4chaos3/\Mcm4chaos3
(C3.B6-Mcm4chaos3) 		increased hepatocellular carcinoma incidence J:117494
\Mcm9Gt(AW0655)Wtsi/\Mcm9Gt(AW0655)Wtsi
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
\Mcm9Gt(AW0655)Wtsi/\Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
\Mcm9Gt(XG743)Byg/\Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
\Mdktm1Tmu/\Mdktm1Tmu
(B6.129S2-Mdktm1Tmu) 		decreased hepatocyte number J:102069
decreased liver weight J:102069
\Mdm2tm1.1Ypz/\Mdm2tm1.1Ypz
\Tg(IghMyc)22Bri/0
(B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri) 		enlarged liver J:164200
\Mdm2tm1Bay/\Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased liver weight J:81065
\Mdm2tm1Mep/\Mdm2tm1.1Mep
(involves: 129S7/SvEvBrd * C57BL/6 * FVB) 		decreased liver weight J:81065
\Mdm2tm2.1Snj/\Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:189297
\Mdm2tm3.1Glo/\Mdm2tm3.1Glo
\Trp53tm3.1Glo/\Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo) 		increased liver adenocarcinoma incidence J:164201
increased liver adenoma incidence J:164201
\Mdm2tm4.1Glo/\Mdm2tm4.1Glo
\Trp53tm3.1Glo/\Trp53+
(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo) 		increased liver adenocarcinoma incidence J:164201
\Mecomtm1Mmor/\Mecomtm1Mmor
(involves: 129S2/SvPas * CF-1) 		abnormal liver bud morphology J:42030
\Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased liver triglyceride level J:198551
\Mecp2tm1.1Irsf/\Mecp2+
(involves: 129S2/SvPas * C57BL/6) 		increased liver weight J:220859
\Mecp2tm1.1Jae/Y
(B6.Cg-Mecp2tm1.1Jae) 		increased liver triglyceride level J:198551
\Med1tm1Jkr/\Med1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6) 		dilated liver sinusoidal space J:74328
\Med1tm1Rgr/\Med1tm1Rgr
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * 129X1/SvJ)) 		abnormal liver development J:61840
\Med1tm2Jkr/\Med1tm2Jkr
\Tg(Alb1-cre)1Dlr/0
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:94123
\Med13tm1Eno/\Med13tm1Eno
\Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6 * FVB/N) 		increased liver triglyceride level J:186193
increased liver weight J:186193
\Med16tm1b(KOMP)Wtsi/\Med16tm1b(KOMP)Wtsi
(C57BL/6N-Med16tm1b(KOMP)Wtsi/Ucd) 		pale liver J:211773
\Med19tm1c(EUCOMM)Wtsi/\Med19tm1c(EUCOMM)Wtsi
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		enlarged liver J:298822
hepatic steatosis J:298822
increased liver triglyceride level J:298822
increased liver weight J:298822
pale liver J:298822
\Meg3tm1Kono/\Meg3+
(involves: 129P2/OlaHsd * C57BL/6N * DBA/2) 		hepatic necrosis J:147577
\Megf8hlb611/\Megf8hlb611
(involves: C57BL/6J * C3H/HeJ) 		abnormal liver morphology J:146957
\Meis1tm1Mtor/\Meis1tm1Mtor
(involves: CD-1) 		liver hypoplasia J:98307
\Meis1tm1Ngc/\Meis1tm1Ngc
(involves: 129 * C57BL/6NCr) 		abnormal liver morphology J:87890
\Meis2tm1.2Zkoz/\Meis2tm1.2Zkoz
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J) 		abnormal liver morphology J:229604
small liver J:229604
\Meis3tm1b(EUCOMM)Hmgu/\Meis3tm1b(EUCOMM)Hmgu
(C57BL/6N-Meis3tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
\Men1tm1Zqw/\Men1tm1Zqw
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		delayed hepatic development J:83882
\Meox2tm1(cre)Sor/\Meox2+
\Ptrh2tm1Eruo/\Ptrh2tm1.1Eruo
(B6.Cg-Ptrh2tm1Eruo Ptrh2tm1.1Eruo Meox2tm1(cre)Sor) 		abnormal hepatocyte morphology J:220518
\Meox2tm1(cre)Sor/\Meox2+
\Slc40a1tm2Nca/\Slc40a1tm2Nca
(involves: 129S4/SvJae * 129S6/SvEvTac) 		abnormal liver iron level J:129846
\Mettm1.1Sst/\Mettm1.1Sst
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver development J:89236
\Mettm1Cbm/\Mettm1Cbm
(involves: 129P2/OlaHsd) 		decreased liver weight J:68751
\Mettm1Cbm/\Mettm1Cbm
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver parenchyma morphology J:28570
small liver J:28570
\Mettm1Kln/\Mettm1Kln
(involves: 129/Sv * C57BL/6 * CD-1) 		abnormal liver development J:94030
decreased liver weight J:94030
dilated liver sinusoidal space J:94030
\Mettm2Cbm/\Mettm2.1Cbm
\Tg(Mx1-cre)1Cgn/?
(involves: C57BL/6 * CBA) 		microvesicular hepatic steatosis J:91484
\Mettm2Kln/\Mettm2Kln
(involves: 129/Sv * C57BL/6 * CD-1) 		abnormal liver development J:94030
decreased liver weight J:94030
dilated liver sinusoidal space J:94030
\Mfsd1em1(IMPC)Tcp/\Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Mfsd1tm1a(KOMP)Wtsi/\Mfsd1tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal hepatocyte morphology J:280713
abnormal liver morphology J:280713
abnormal liver parenchyma morphology J:280713
abnormal liver perisinusoidal space morphology J:280713
abnormal liver sinusoid morphology J:280713
abnormal liver sinusoidal endothelial cell morphology J:280713
abnormal liver vasculature morphology J:280713
increased liver tumor incidence J:280713
liver fibrosis J:280713
\Mfsd1tm1d(KOMP)Wtsi/\Mfsd1tm1d(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal liver morphology J:280713
\Mfsd2atm1Dls/\Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls) 		abnormal liver morphology J:194781
decreased susceptibility to hepatic steatosis J:194781
\Mfsd8tm1a(EUCOMM)Hmgu/\Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		abnormal liver morphology J:211608
\Mgat3tm1Pst/\Mgat3tm1Pst
(involves: 129/Sv * C57BL/6 * CD-1 * SJL) 		decreased liver weight J:86643
\Mgat4atm1.1Jxm/\Mgat4atm1.1Jxm
(B6.Cg-Mgat4atm1.1Jxm) 		hepatic steatosis J:117542
\mgb/\mgb
(involves: C57BL/6 * FVB/N) 		abnormal liver morphology J:130545
\Mglltm1.1Rzim/\Mglltm1.1Rzim
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver triglyceride level J:172679
\Mia2tm1Zhxu/\Mia2tm1Zhxu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:268333
abnormal liver morphology J:268333
enlarged liver J:268333
hepatic steatosis J:268333
increased liver cholesterol level J:268333
increased liver triglyceride level J:268333
pale liver J:268333
\Mipeptm1.1Yhig/\Mipeptm1.1Yhig
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		hepatic steatosis J:365489
increased liver weight J:365489
\Mir32em1Gpt/\Mir32em1Gpt
\Albem1(icre)Gpt/\Alb+
(C57BL/6JGpt-Mir32em1Gpt Albem1(icre)Gpt) 		decreased liver cholesterol level J:344660
decreased liver triglyceride level J:344660
decreased liver weight J:344660
decreased susceptibility to diet-induced hepatic steatosis J:344660
\Mir100em1Nju/\Mir100em1Nju
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased hepatocyte karyomegaly J:281439
\Mir122tm1.1Apts/\Mir122tm1.1Apts
(involves: 129 * C57BL/6) 		abnormal Ito cell morphology J:190066
abnormal liver morphology J:190066
decreased liver glycogen level J:190066
hepatic steatosis J:190066
increased hepatocellular carcinoma incidence J:190066
increased liver cholesterol level J:190066
increased liver triglyceride level J:190066
liver fibrosis J:190066
\Mir122tm1.1Kgh/\Mir122+
(involves: 129S1/Sv * 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:190067
\Mir122tm1.1Kgh/\Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ) 		hepatic steatosis J:190067
increased hepatocellular carcinoma incidence J:190067
increased liver triglyceride level J:190067
liver fibrosis J:190067
\Mir122tm1.2Kgh/\Mir122+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:190067
\Mir122tm1.2Kgh/\Mir122tm1.2Kgh
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased liver glycogen level J:190067
increased hepatocellular carcinoma incidence J:190067
increased liver triglyceride level J:190067
increased liver tumor incidence J:190067
liver fibrosis J:190067
microvesicular hepatic steatosis J:190067
\Mir378atm1.1Eno/\Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:190154
\Mirc13tm1.1Mtm/\Mirc13tm1.1Mtm
(Not Specified) 		decreased liver triglyceride level J:256444
decreased liver weight J:256444
decreased susceptibility to diet-induced hepatic steatosis J:256444
\Mirc36tm1.1Jcav/\Mirc36+
(B6.129-Mirc36tm1.1Jcav) 		increased liver glycogen level J:216177
\Mirc54tm1.1Syu/\Mirc54tm1.1Syu
(Not Specified) 		decreased liver triglyceride level J:310890
decreased susceptibility to diet-induced hepatic steatosis J:310890
\MitfTg(Tff3-Tmem207)2Tamo/\Mitf+
(involves: C57BL/6) 		liver cyst J:244533
\MitfTg(Tff3-Tmem207)2Tamo/\MitfTg(Tff3-Tmem207)2Tamo
(involves: C57BL/6) 		liver cyst J:244533
\Mks1hlb614/\Mks1hlb614
(involves: C3H * C57BL/6) 		abnormal liver morphology J:167534
liver cyst J:167534
\Mks1tm1a(EUCOMM)Wtsi/\Mks1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		liver fibrosis J:196290
\Mllt6em1(IMPC)Tcp/\Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Mllt10em1(IMPC)Mbp/\Mllt10+
(C57BL/6N-Mllt10em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Mlxipltm1Kuy/\Mlxipltm1Kuy
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver glycogen level J:89865
increased liver weight J:89865
\Mlxipltm1Kuy/\Mlxipltm1Kuy
(B6.129S6-Mlxipltm1Kuy/J) 		decreased liver triglyceride level J:273754
\Mmetm1Cge/\Mmetm1Cge
(involves: 129S4/SvJae * C57BL/6) 		diffuse hepatic necrosis J:70516
\Mmp21b2b2458Clo/\Mmp21b2b2458Clo
(C57BL/6J-Mmp21b2b2458Clo) 		abnormal liver morphology J:175213
\Mmuttm1Cpv/\Mmuttm1Cpv
(Not Specified) 		abnormal liver morphology J:147338
\Mmuttm1Cpv/\Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		abnormal hepatocyte mitochondrial morphology J:147313
hepatic steatosis J:147313
\Mmuttm1Pai/\Mmuttm1Pai
(involves: 129S1/Sv * C57BL/6) 		abnormal liver parenchyma morphology J:87081
\Mmuttm1Pai/\Mmuttm1Pai
\Tg(MUT)AHlps/0
\Tg(MUT*R403X)#Hlps/0
(involves: 129S1/Sv * C57BL/6) 		increased liver weight J:191879
\Mob1atm1.1Asuz/\Mob1atm1.1Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn) 		enlarged liver J:228499
increased hepatocellular carcinoma incidence J:228499
increased hepatocyte number J:228499
increased liver adenoma incidence J:228499
liver fibrosis J:228499
\Mob1atm1.1Asuz/\Mob1atm1.1Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Tgfbr2tm1Roes/\Tgfbr2tm1Roes
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased liver weight J:228499
liver fibrosis J:228499
\Mob1atm1.1Asuz/\Mob1atm1.1Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
\Wwtr1tm1Hku/\Wwtr1tm1Hku
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased liver weight J:228499
liver fibrosis J:228499
\Mob1atm1.1Asuz/\Mob1atm1.1Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1bGt(CC0690)Wtsi
\Yap1tm1c(KOMP)Mbp/\Yap1tm1c(KOMP)Mbp
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * DBA) 		increased liver weight J:228499
liver fibrosis J:228499
\Mob1atm1.2Asuz/\Mob1atm1.2Asuz
\Mob1bGt(CC0690)Wtsi/\Mob1b+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver tumor incidence J:193981
\Mocosem2(IMPC)Ics/\Mocos+
(involves: C57BL/6N) 		decreased liver weight J:336718
\Mocosem2(IMPC)Ics/\Mocosem2(IMPC)Ics
(involves: C57BL/6N) 		decreased liver weight J:336718
\Mogat2tm1Far/\Mogat2tm1Far
(B6.129S4-Mogat2tm1Far) 		decreased susceptibility to hepatic steatosis J:149373
\Morc2aem1(IMPC)Wtsi/\Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu) 		abnormal liver morphology J:239583
abnormal liver vasculature morphology J:239583
liver cyst J:239583
\Morf4l1tm1Kto/\Morf4l1tm1Kto
(involves: 129S7/SvEvBrd) 		liver vascular congestion J:97640
\mpc186H/\mpc186H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		hepatic steatosis J:234901
\Mpv17/\Mpv17
(CFW-Mpv17/J) 		abnormal hepatocyte morphology J:143355
abnormal liver lobule morphology J:143355
abnormal liver sinusoid morphology J:143355
abnormal portal triad morphology J:143355
decreased hepatocyte mitochondrial DNA content J:143355
\Mpzl3rc/\Mpzl3rc
(C57BL/6J-Mpzl3rc/J) 		abnormal liver morphology J:210832
\Mpzl3tm1Tacz/\Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz) 		abnormal liver morphology J:199257
decreased liver triglyceride level J:199257
decreased susceptibility to diet-induced hepatic steatosis J:199257
\Mrap2tm1.1Maj/\Mrap2tm1.1Maj
(either: B6.129-Mrap2tm1.1Maj or (involves: 129 * 129S6/SvEvTac)) 		hepatic steatosis J:199365
\Mraptm1.2Geno/\Mraptm1.2Geno
(involves: C57BL/6) 		decreased liver glycogen level J:278935
\Mrgprb2em1(IMPC)Tcp/\Mrgprb2em1(IMPC)Tcp
(C57BL/6NCrl-Mrgprb2em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Mrps12em1.2Afi/\Mrps12em1.2Afi
(B6N(Cg)-Mrps12em1.2Afi) 		abnormal hepatocyte morphology J:284101
\Mrps34m1Anu/\Mrps34m1Anu
(C57BL/6J-Mrps34m1Anu) 		hepatic steatosis J:222643
liver fibrosis J:222643
\Mrs2em1Muma/\Mrs2em1Muma
(B6.Cg-Mrs2em1Muma) 		abnormal hepatocyte morphology J:298361
\MrtfbGt(RRJ478)Byg/\MrtfbGt(RRJ478)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:117226
\Ms4a7em1.1Jddl/\Ms4a7em1.1Jddl
(B6.Cg-Ms4a7em1.1Jddl) 		abnormal liver morphology J:347975
decreased susceptibility to diet-induced hepatic steatosis J:347975
\Ms4a7em1Jddl/\Ms4a7em1Jddl
\Lyz2tm1(cre)Ifo/\Lyz2+
(B6.Cg-Lyz2tm1(cre)Ifo Ms4a7em1Jddl) 		abnormal liver morphology J:347975
decreased susceptibility to diet-induced hepatic steatosis J:347975
\Msh2tm1Htr/\Msh2+
(involves: 129P2/OlaHsd) 		increased liver tumor incidence J:45433
\Msh2tm1Rak/\Msh2+
(involves: 129P2/OlaHsd) 		increased liver adenoma incidence J:64667
\Msi2em1(IMPC)Mbp/\Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Mss51tm1(KOMP)Vlcg/\Mss51tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		hepatic steatosis J:280597
increased liver weight J:280597
\Mst1tm1Jab/\Mst1tm1Jab
(involves: 129P2/OlaHsd * Black Swiss) 		abnormal hepatocyte morphology J:46185
\Mst1rtm2(Mst1r*)Sew/\Mst1rtm2(Mst1r*)Sew
(FVB.129P2(Cg)-Mst1rtm2(Mst1r*)Sew) 		hepatic necrosis J:215969
\Mstnem1(IMPC)Hmgu/\Mstnem1(IMPC)Hmgu
(C57BL/6NCrl-Mstnem1(IMPC)Hmgu/Ieg) 		decreased liver weight J:211773
\Mstnlean/\Mstnlean
(C57BL/6J-Mstnlean) 		decreased susceptibility to diet-induced hepatic steatosis J:146513
\Mstntm1Sjl/\Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:75178
\Msx1tm2.1(cre/ERT2)Bero/\Msx1tm1Bero
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		abnormal liver development J:194129
\Mt1tm1Bri/\Mt1tm1Bri
\Mt2tm1Bri/\Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri) 		abnormal liver morphology J:16487
hepatic necrosis J:16487
liver degeneration J:16487
\Mt1tm1Bri/\Mt1tm1Bri
\Mt2tm1Bri/\Mt2tm1Bri
(involves: 129S7/SvEvBrd) 		abnormal hepatocyte morphology J:120459
abnormal liver zinc level J:34407
hepatic necrosis J:120459
\Mt1tm1Bri/\Mt1tm1Bri
\Mt2tm1Bri/\Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		enlarged liver J:126620
\Mt1tm1Rch/\Mt1tm1Rch
\Mt2tm1Rch/\Mt2tm1Rch
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:120459
hepatic necrosis J:120459
\mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		hepatic steatosis J:344247
\Mta1em1(IMPC)Ccpcz/\Mta1+
(C57BL/6NCrl-Mta1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
\Mtapem1(IMPC)Mbp/\Mtap+
(C57BL/6N-Mtapem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\MtapGt(RRK081)Byg/\Mtap+
(129P2/OlaHsd-MtapGt(RRK081)Byg) 		abnormal liver morphology J:123675
\Mtarc1tm1.1Vlcg/\Mtarc1tm1.1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal liver morphology J:346201
decreased liver triglyceride level J:346201
\Mtbcq2NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
\Mtbcq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
\Mtbcq6NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		decreased liver weight J:122125
\Mtdhtm1.2Dsar/\Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)) 		decreased liver tumor incidence J:216688
\Mtf1tm1Wsc/\Mtf1tm1Wsc
(involves: 129 * C57BL/6) 		hepatic necrosis J:48216
\Mtf1tm1Wsc/\Mtf1tm1Wsc
(Not Specified) 		dilated liver sinusoidal space J:91119
hepatic necrosis J:91119
\Mtfmtem1Heb/\Mtfmt+
(C57BL/6-Mtfmtem1Heb) 		abnormal liver morphology J:334467
decreased liver triglyceride level J:334467
\Mtgq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
\Mthfd2tm1b(EUCOMM)Wtsi/\Mthfd2tm1b(EUCOMM)Wtsi
(C57BL/6N-Mthfd2tm1b(EUCOMM)Wtsi/Bay) 		pale liver J:211773
\Mthfd2tm1Rmk/\Mthfd2tm1Rmk
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		pale liver J:76786
small liver J:76786
\Mthfrtm1Rzn/\Mthfr+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		microvesicular hepatic steatosis J:67779
\Mthfrtm1Rzn/\Mthfrtm1Rzn
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		microvesicular hepatic steatosis J:67779
\Mtss1Gt(CSC156)Byg/\Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg) 		enlarged liver J:186118
\Mttptm1Sgy/\Mttp+
(involves: 129S4/SvJae) 		hepatic steatosis J:48934
increased liver cholesterol level J:48934
increased liver triglyceride level J:48934
\Mttptm2Sgy/\Mttptm2Sgy
\Tg(Mx1-cre)1Cgn/\Tg(Mx1-cre)1Cgn
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased liver cholesterol level J:83459
increased liver triglyceride level J:83459
increased liver weight J:83459
\Muc5bem1(IMPC)Mbp/\Muc5bem1(IMPC)Mbp
(C57BL/6N-Muc5bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Mug1tm1Vln/\Mug1tm1Vln
(B.129P2-Mug1tm1Vln) 		hepatic necrosis J:57485
\Mug1tm2Vln/\Mug1tm2Vln
\Pzptm1Vln/\Pzptm1Vln
(B.129P2-Pzptm1Vln Mug1tm2Vln) 		hepatic necrosis J:57485
\Mybtm1Jof/\Mybtm1Jof
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:85344
\Mybtm1Jof/\Mybtm1Ssp
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:85344
\Mybtm1Ssp/\Mybtm1Ssp
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)) 		abnormal liver sinusoid morphology J:43747
small liver J:43747
\Mybphltm1b(KOMP)Wtsi/\Mybphltm1b(KOMP)Wtsi
(C57BL/6N-Mybphltm1b(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Myctm2.1Atp/\Myctm2.1Atp
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		liver hypoplasia J:137630
\Myctm2.1Atp/\Myctm2.1Atp
\Tg(Tek-cre)1Rwng/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal liver morphology J:137630
liver hypoplasia J:137630
small liver J:137630
\Mycntm1Fwa/\Mycntm1Fwa
(involves: 129S/SvEv) 		abnormal liver development J:46520
abnormal liver morphology J:46520
liver hypoplasia J:46520
small liver J:46520
\Mycntm1Knd/\Mycntm1Knd
(involves: 129P2/OlaHsd * BALB/c) 		abnormal liver development J:11859
small liver J:11859
\Myd88tm1Aki/\Myd88tm1Aki
(involves: 129P2/OlaHsd) 		decreased liver tumor incidence J:103464
\Myh6tm1Jse/\Myh6+
\Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6) 		liver vascular congestion J:153302
\Myh10tm2Rsad/\Myh10tm2Rsad
(involves: 129S4/SvJae * C57BL/6J) 		dark liver J:44181
liver vascular congestion J:44181
\Myh10tm3.1Rsad/\Myh10+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		herniated liver J:245570
\Myh10tm3.1Rsad/\Myh10tm3.1Rsad
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		dilated liver sinusoidal space J:245570
herniated liver J:245570
liver vascular congestion J:245570
\Myl1tm1(cre)Sjb/0
\Ndufab1tm1Xiwa/\Ndufab1tm1Xiwa
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		decreased liver glycogen level J:293657
\Myl2tm1(cre)Krc/\Myl2+
\Txnrd2tm1Marc/\Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6) 		liver vascular congestion J:94136
\Myl9tm1Mzhu/\Myl9tm1Mzhu
\Tg(Acta2-cre)#Xya/0
(involves: C57BL/6 * CBA) 		dark liver J:308237
\Myo10m1J/\Myo10m1J
(involves: C57BL/6J) 		absent liver J:256438
\Myo18atm1b(KOMP)Wtsi/\Myo18atm1b(KOMP)Wtsi
(C57BL/6N-Myo18atm1b(KOMP)Wtsi/Tcp) 		pale liver J:211773
\Mzf1tm1Ppp/\Mzf1tm1Ppp
(involves: 129) 		increased hepatocellular carcinoma incidence J:70407
\Naa10em1(IMPC)Mbp/Y
(C57BL/6NCrl-Naa10em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Naa40tm1Qwzh/\Naa40tm1Qwzh
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh) 		decreased liver free fatty acids level J:183119
decreased liver triglyceride level J:183119
decreased susceptibility to age-related hepatic steatosis J:183119
\Nab2tm1b(EUCOMM)Hmgu/\Nab2tm1b(EUCOMM)Hmgu
(C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics) 		abnormal liver morphology J:211773
\Nabp2tm1.1Kkha/\Nabp2tm1.1Kkha
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		increased hepatocellular carcinoma incidence J:195140
\Nadk2tm1a(EUCOMM)Wtsi/\Nadk2tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		enlarged liver J:255700
hepatic steatosis J:255700
increased liver triglyceride level J:255700
liver degeneration J:255700
liver fibrosis J:255700
pale liver J:255700
\Naglutm1Efn/\Naglutm1Efn
(either: (involves: 129S/SvEv * C57BL/6) or (involves: C57BL/6)) 		abnormal hepatocyte morphology J:58950
abnormal Kupffer cell morphology J:58950
\Nbntm1Zqw/\Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased liver adenocarcinoma incidence J:86563
increased liver adenoma incidence J:86563
\Ncf1tm1Hbd/\Ncf1tm1Hbd
(involves: 129) 		liver abscess J:74593
\Nckap1lm1Iri/\Nckap1lm1Iri
(involves: C57BL/6) 		abnormal liver morphology J:141377
\Ncoa3tm1.1Bwo/\Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J) 		increased liver glycogen level J:161276
increased liver triglyceride level J:161276
\Ncoa3tm1Jxu/\Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver weight J:144060
decreased susceptibility to diet-induced hepatic steatosis J:144060
small liver J:144060
\Ncoa5tm1Hxia/\Ncoa5+
(involves: 129 * C57BL/6) 		abnormal liver morphology J:207622
hepatic steatosis J:207622
increased hepatocellular carcinoma incidence J:207622
increased liver triglyceride level J:207622
liver fibrosis J:207622
\Ncoa5tm1Hxia/\Ncoa5+
(C.129(B6)-Ncoa5tm1Hxia) 		increased hepatocellular carcinoma incidence J:207622
\Ncoa6tm1.1Jkr/\Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal liver bud morphology J:81217
abnormal liver morphology J:81217
decreased hepatocyte number J:81217
small liver J:81217
\Ncoa6tm1Hhs/\Ncoa6tm1Hhs
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6)) 		abnormal liver development J:91083
\Ncoa6tm2Jxu/\Ncoa6tm2Jxu
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:129067
abnormal liver morphology J:129067
increased liver weight J:129067
\Ncor1tm1.1Ics/\Ncor1tm1.1Ics
(involves: 129 * C57BL/6J) 		decreased liver glycogen level J:206152
hepatic steatosis J:206152
\Ncor1tm1Rsd/\Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal hepatocyte morphology J:65417
small liver J:65417
\Ncor2Gt(RRM275)Byg/\Ncor2+
(B6.129P2-Ncor2Gt(RRM275)Byg) 		decreased susceptibility to diet-induced hepatic steatosis J:164558
\Ndfip1Gt(RRD002)Byg/\Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:116617
increased liver weight J:116617
\Ndfip2tm1a(EUCOMM)Hmgu/\Ndfip2tm1a(EUCOMM)Hmgu
(C57BL/6N-Ndfip2tm1a(EUCOMM)Hmgu) 		abnormal liver iron level J:235779
decreased liver iron level J:235779
increased liver iron level J:235779
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Rpl11tm1.1Srn/\Rpl11tm1.1Srn
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1) 		increased liver iron level J:292575
\Ndrg2tm1Kmori/\Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased hepatocellular carcinoma incidence J:210264
\Ndrg2tm1Kmori/\Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased hepatocellular carcinoma incidence J:210264
\Ndst1tm1Je/\Ndst1tm1Je
\Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		herniated liver J:208012
\Ndufa1tm1.1Nay/Y
(involves: 129S1/SvImJ * 129S4/SvJaeSor * 129S6/SvEvTac) 		decreased liver cholesterol level J:257477
\Negr1m1H/\Negr1m1H
(C3.Cg-Negr1m1H) 		decreased liver triglyceride level J:189719
decreased liver weight J:189719
\Neil1tm1Rsld/\Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6) 		abnormal liver morphology J:106077
enlarged liver J:106077
hepatic steatosis J:106077
pale liver J:106077
\Neu1a/\Neu1a
(SM/J) 		abnormal Kupffer cell morphology J:147881
\Neu1tm1Adz/\Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI)) 		abnormal Kupffer cell morphology J:76937
\Neu2em1Kyp/\Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp) 		hepatic steatosis J:321653
increased liver free fatty acids level J:321653
liver fibrosis J:321653
\Neurl3em1Luda/\Neurl3em1Luda
(B6N.Cg-Neurl3em1Luda) 		hepatic necrosis J:344721
\Neurl4em1(IMPC)Mbp/\Neurl4em1(IMPC)Mbp
(C57BL/6NCrl-Neurl4em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Nf1tm1Fcr/\Nf1+
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Nf1tm1Fcr Ptentm1Hwu) 		abnormal liver morphology J:232645
enlarged liver J:232645
increased liver weight J:232645
\Nf1tm1Fcr/\Nf1tm1Fcr
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J)) 		delayed hepatic development J:18048
focal hepatic necrosis J:18048
liver hypoplasia J:18048
pale liver J:18048
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased hepatoma incidence J:18542
\Nf1tm1Tyj/\Nf1+
\Suz12Gt(Betageo)1Khe/\Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased hepatocellular carcinoma incidence J:217077
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd) 		enlarged liver J:132943
\Nf2tm2Gth/\Nf2tm2Gth
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal liver morphology J:162628
enlarged liver J:162628
increased hepatocellular carcinoma incidence J:162628
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		enlarged liver J:132943
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		enlarged liver J:132943
\Nf2tm2Gth/\Nf2tm2Gth
\Yap1tm1.1Dupa/\Yap1+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		enlarged liver J:162628
\Nf2tm2Gth/\Nf2tm2Gth
\Yap1tm2.1Dupa/\Yap1tm2.1Dupa
(involves: 129P2/OlaHsd) 		enlarged liver J:223215
\Nfe2l1tm1Jefc/\Nfe2l1tm1Ywk
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		hepatic necrosis J:97188
hepatic steatosis J:97188
increased hepatocellular carcinoma incidence J:97188
increased liver adenoma incidence J:97188
liver fibrosis J:97188
\Nfe2l1tm1Mym/\Nfe2l1tm1Mym
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		hepatic steatosis J:143468
\Nfe2l1tm1Ywk/\Nfe2l1tm1Ywk
(involves: 129X1/SvJ * C57BL/6J) 		pale liver J:46990
small liver J:46990
\Nfe2l2em1(IMPC)Ccpcz/\Nfe2l2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nfe2l2em1(IMPC)Ccpcz/Ccpcz) 		decreased liver weight J:211773
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(involves: 129P2/OlaHsd) 		increased liver iron level J:95372
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6) 		macrovesicular hepatic steatosis J:136120
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
\Tg(Alb1-cre)1Dlr/0
\n-TUtca2tm2Mym/\n-TUtca2tm2.1Mym
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		abnormal hepatocyte morphology J:130723
liver degeneration J:130723
pale liver J:130723
\Nfe2l2tm1Ywk/\Nfe2l2tm1Ywk
(involves: 129X1/SvJ) 		decreased liver weight J:130473
\Nficem1(IMPC)Ccpcz/\Nficem1(IMPC)Ccpcz
(C57BL/6NCrl-Nficem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
decreased liver weight J:211773
small liver J:211773
\Ngfrtm1Jae/\Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae) 		abnormal Kupffer cell morphology J:120368
\Ngfrtm1Jae/\Ngfrtm1Jae
\Plgtm1Jld/\Plgtm1Jld
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		hepatic necrosis J:120368
\Nhil1C57BL/6JOla/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
\Nhil2SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
\Nhil3SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
\Nhil4SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
\Nhil5SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
\Nhlrc1tm1Bmin/\Nhlrc1tm1Bmin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		increased liver glycogen level J:181674
\Ninj2em1Cqxu/\Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu) 		decreased liver glycogen level J:332575
increased susceptibility to diet-induced hepatic steatosis J:332575
\Nipal2em1(IMPC)Ccpcz/\Nipal2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nipal2em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Nkapd1tm1.1Tak/\Nkapd1tm1.1Tak
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6J * C57BL/10 * CBA/Ca) 		small liver J:350073
\Nlrp3tm1Bhk/\Nlrp3tm1Bhk
(B6.129S6-Nlrp3tm1Bhk/J) 		abnormal liver morphology J:256504
hepatic steatosis J:256504
increased liver triglyceride level J:256504
increased liver weight J:256504
\Nlrp3tm1Wstr/\Nlrp3+
(involves: C57BL/6) 		enlarged liver J:150053
\Nme2tm1.1(KOMP)Vlcg/\Nme2tm1.1(KOMP)Vlcg
(C57BL/6N-Nme2tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Nmf15/\Nmf15+
(C57BL/6J-Nmf15/J) 		hepatic steatosis J:82238
\nmf356/\nmf356
(C57BL/6J-nmf356/J) 		liver degeneration J:87349
\Nmutm1Mko/\Nmutm1Mko
(involves: 129 * C57BL/6) 		hepatic steatosis J:93213
\Nocttm1Bjc/\Nocttm1Bjc
(B6.129S2-Nocttm1Bjc) 		decreased susceptibility to hepatic steatosis J:122301
\Nodaltm1Hmd/\Nodal+
\Tg(Rr443-Lefty1,-lacZ)36Hmd/0
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ)) 		abnormal liver morphology J:82703
\Nodaltm1Hmd/\Nodaltm1Hmd
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ)) 		abnormal liver morphology J:82703
\Nodaltm1Mku/\Nodaltm1.1Mku
(either: (involves: 129S1/Sv * FVB/N) or (involves: 129S1/Sv * C57BL/6J * FVB/N)) 		pale liver J:73506
small liver J:73506
\NonoGt(YHA266)Byg/Y
(involves: 129P2/OlaHsd) 		decreased liver weight J:294120
\Nos1tm1Plh/\Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:133437
abnormal liver morphology J:133437, J:104558
\Nos1tm1Plh/\Nos1tm1Plh
\Nos2tm1Mrl/\Nos2tm1Mrl
\Nos3tm1Plh/\Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		liver vascular congestion J:100308
\Nos2tm1Mrl/\Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6) 		liver fibrosis J:94156
\Nos3tm1Plh/\Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:133437
abnormal liver morphology J:133437
hepatic steatosis J:133437
\Nos3tm2.1Plh/\Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6) 		increased liver weight J:198075
\Notch1tm2Rko/\Notch1tm3(cre)Rko
(involves: 129X1/SvJ * C57BL/6) 		abnormal hepatic cord morphology J:171829
abnormal liver lobule morphology J:171829
abnormal liver morphology J:171829
abnormal liver parenchyma morphology J:171829
dilated liver sinusoidal space J:171829
pale liver J:171829
\Notch2tm2Grid/\Notch2tm3Grid
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		focal hepatic necrosis J:133171
\Notch2tm3Grid/\Notch2tm3.1Grid
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		focal hepatic necrosis J:133171
\Notch3tm1.1(KOMP)Vlcg/\Notch3tm1.1(KOMP)Vlcg
(C57BL/6N-Notch3tm1.1(KOMP)Vlcg/Ucd) 		decreased liver weight J:211773
\Npbwr1tm1Rck/\Npbwr1tm1Rck
(involves: 129P/Ola * C57BL/6J) 		enlarged liver J:94820
hepatic steatosis J:94820
\Npc1m1N/\Npc1m1N
(involves: BALB/c) 		enlarged liver J:91430
hepatic steatosis J:100351
increased liver cholesterol level J:130969
increased liver weight J:76733
pale liver J:91430
\Npc1m1N/\Npc1m1N
(involves: 129S1/Sv * BALB/c * C57BL/6) 		increased liver cholesterol level J:89617
\Npc1m1N/\Npc1m1N
(BALB/cNctr-Npc1m1N/J) 		decreased liver cholesterol level J:179744
enlarged liver J:179744
increased liver cholesterol level J:179744
\Npc1m1N/\Npc1m1N
(B6.C-Npc1m1N) 		increased liver cholesterol level J:221855
\Npc1m1N/\Npc1m1N
(BALB/c-Npc1m1N) 		abnormal hepatocyte morphology J:221855
increased liver cholesterol level J:221855
\Npc1m1N/\Npc1m1N
\Npc2tm1Plob/\Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6) 		increased liver cholesterol level J:89617
\Npc1nmf164/\Npc1nmf164
(C57BL/6J-Npc1nmf164/J) 		decreased liver cholesterol level J:179744
enlarged liver J:179744
increased liver cholesterol level J:179744
\Npc1spm/\Npc1spm
(C57BLKS/J-Npc1spm/J) 		enlarged liver J:7245
increased liver cholesterol level J:102782, J:7245
\Npc1tm1.1Dso/\Npc1tm1.1Dso
(B6.129-Npc1tm1.1Dso) 		abnormal hepatocyte morphology J:221855
increased liver cholesterol level J:221855
\Npc1tm1Mbjg/\Npc1tm1Mbjg
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver cholesterol level J:176587
\Npc1tm1Tacf/\Npc1tm1Tacf
(B6(Cg)-Npc1tm1Tacf) 		abnormal liver morphology J:266795
dilated liver sinusoidal space J:266795
increased liver cholesterol level J:266795
\Npc1tm1Tacf/\Npc1tm2Tacf
(B6(Cg)-Npc1tm1Tacf Npc1tm2Tacf) 		increased liver cholesterol level J:266795
\Npc1l1tm1Swa/\Npc1l1tm1Swa
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver cholesterol level J:89712
\Npc1l1tm1Yaio/\Npc1l1tm1Yaio
(C57BL/6-Npc1l1tm1Yaio) 		decreased susceptibility to diet-induced hepatic steatosis J:98568
\Npc2tm1Plob/\Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6) 		increased liver cholesterol level J:89617
\Npm1tm1Gsva/\Npm1+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		enlarged liver J:172071
increased liver weight J:172071
\Npm1tm1Ppp/\Npm1tm1Ppp
(involves: 129S1/Sv * C57BL/6) 		absent liver J:101494
\Nprl2tm1.2Bpt/\Nprl2tm1.2Bpt
(involves: C57BL/6) 		pale liver J:224837
\Nprl3tm1.1Drhi/\Nprl3tm1.1Drhi
(involves: 129P2/OlaHsd) 		herniated liver J:183988
\Npy5rtm1Rpa/\Npy5rtm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		hepatic steatosis J:87803
\Npy6rtm1Hhzg/\Npy6rtm1Hhzg
(involves: 129S/SvEvBrd * C57BL/6) 		hepatic steatosis J:210546
increased liver weight J:210546
\Npytm1(rtTA,tetO-cre/EGFP)Snby/\Npy+
\Npy2rtm1Hhz/\Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased liver triglyceride level J:162000
\Nr0b2tm1Ddm/\Nr0b2tm1Ddm
(involves: 129 * C57BL/6) 		increased liver triglyceride level J:77065
\Nr1d1tm1Schb/\Nr1d1tm1Schb
(involves: 129S2/SvPas) 		decreased liver cholesterol level J:153064
decreased liver triglyceride level J:153064
\Nr1h2tm1Djm/\Nr1h2tm1Djm
\Nr1h3tm1Djm/\Nr1h3tm1Djm
(involves: 129S6/SvEvTac) 		increased liver cholesterol level J:64343
\Nr1h3tm1.1Djm/\Nr1h3tm1.1Djm
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA) 		increased liver cholesterol level J:184536
increased liver weight J:184536
\Nr1h3tm1.1Gstr/\Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		enlarged liver J:82096
increased liver cholesterol level J:82096
pale liver J:82096
\Nr1h3tm1Djm/\Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic steatosis J:47971
increased liver cholesterol level J:243753, J:47971
increased liver weight J:47971
liver degeneration J:47971
pale liver J:47971
\Nr1h3tm1Djm/\Nr1h3tm1Djm
\Nus1tm1.1Qrm/\Nus1tm1.1Qrm
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		increased liver cholesterol level J:243753
\Nr1h3tm1Wexi/\Nr1h3tm1Wexi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:155709
\Nr1h4tm1.1Mbj/\Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj) 		abnormal liver perisinusoidal space morphology J:200842
abnormal liver sinusoid morphology J:200842
hepatic steatosis J:200842
increased liver triglyceride level J:200842
increased liver weight J:200842
liver degeneration J:200842
\Nr1h4tm1.2Auw/\Nr1h4tm1.2Auw
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:157882
\Nr1h4tm1Gonz/\Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N) 		abnormal liver morphology J:64792
enlarged liver J:121075
hepatic steatosis J:64792
increased hepatocellular carcinoma incidence J:121075
increased liver adenoma incidence J:121075
increased liver cholesterol level J:64792
increased liver triglyceride level J:64792
increased liver tumor incidence J:121075
\Nr1h4tm1Gonz/\Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:118204
enlarged liver J:118204
focal hepatic necrosis J:118204
increased hepatocellular carcinoma incidence J:118204
increased liver adenoma incidence J:118204
increased liver tumor incidence J:118204
\Nr2c2tm1Amj/\Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj) 		decreased liver triglyceride level J:169333
decreased susceptibility to age-related hepatic steatosis J:169333
decreased susceptibility to diet-induced hepatic steatosis J:169333
\Nr3c1Gt(ESKN92)Hgs/\Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs) 		increased liver triglyceride level J:141205
\Nr4a1tm1Jmi/\Nr4a1tm1Jmi
\Nr4a3tm1Omc/\Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		enlarged liver J:121903
\Nrastm1.1Emfu/\Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N) 		pale liver J:189834
\Nrastm1Tyj/\Nras+
\Meox2tm1(cre)Sor/\Meox2+
(B6.Cg-Nrastm1Tyj Meox2tm1(cre)Sor) 		hepatic necrosis J:305401
small liver J:305401
\Nrbf2Gt(Ayu21-W143)Imeg/\Nrbf2Gt(Ayu21-W143)Imeg
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal liver morphology J:220500
focal hepatic necrosis J:220500
\Nrbp1tm1.1Dja/\Nrbp1tm1.1Dja
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J) 		abnormal liver morphology J:184685
\Nrbp1tm1.1Dja/\Nrbp1tm1.2Dja
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		abnormal liver morphology J:184685
\Nrsn2em1(IMPC)Kmpc/\Nrsn2em1(IMPC)Kmpc
(C57BL/6NTac-Nrsn2em1(IMPC)Kmpc/Kmpc) 		abnormal liver morphology J:211773
\Nsmce2Gt(AA0032)Wtsi/\Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver tumor incidence J:227197
\Nt5c2em1(IMPC)Hmgu/\Nt5c2em1(IMPC)Hmgu
(C57BL/6N-Nt5c2em1(IMPC)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Nthl1em1(IMPC)Mbp/\Nthl1em1(IMPC)Mbp
(C57BL/6NCrl-Nthl1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Ntmt1tm1(NCOM)Mfgc/\Ntmt1tm1(NCOM)Mfgc
(involves: C57BL/6J * C57BL/6NCrl) 		abnormal liver morphology J:239287
liver degeneration J:239287
\Ntrk2tm1Mini/\Ntrk2+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:210229
\Ntrk2tm2Kln/\Ntrk2tm2Kln
\Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		hepatic steatosis J:210229
increased liver weight J:210229
\Nucb1em1(IMPC)Mbp/\Nucb1em1(IMPC)Mbp
(C57BL/6NCrl-Nucb1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Nucks1tm1.2Vter/\Nucks1tm1.2Vter
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NSlc * FVB/N * SJL) 		hepatic steatosis J:211777
\Nudt1tm1Tts/\Nudt1tm1Tts
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased liver tumor incidence J:71836
\Nup210em1(IMPC)Mbp/\Nup210em1(IMPC)Mbp
(C57BL/6NCrl-Nup210em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Nus1tm1.1Qrm/\Nus1tm1.1Qrm
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		decreased liver cholesterol level J:243753
increased liver free fatty acids level J:243753
increased liver triglyceride level J:243753
\Nwd1em2.1Sisa/\Nwd1em2.1Sisa
(involves: C57BL/6 * C57BL/6N * DBA/2) 		abnormal hepatocyte morphology J:363603
abnormal Kupffer cell morphology J:363603
enlarged liver J:363603
hepatic steatosis J:363603
increased liver cholesterol level J:363603
increased liver triglyceride level J:363603
liver fibrosis J:363603
\Nxntm1b(EUCOMM)Wtsi/\Nxntm1b(EUCOMM)Wtsi
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
\Nynrinem1(IMPC)Mbp/\Nynrinem1(IMPC)Mbp
(C57BL/6N-Nynrinem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Obrq13A/J/\Obrq13A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased susceptibility to hepatic steatosis J:145148
\Obrq14A/J/\Obrq14A/J
(C57BL/6J-Chr 17A/J/NaJ) 		hepatic steatosis J:145148
\Obrq16A/J/\Obrq16A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased liver triglyceride level J:145148
\Oca2p-23DFiOD/\Oca2p-x
(Not Specified) 		increased liver weight J:66645
\Oca2p-30PUb/\Oca2p-x
(Not Specified) 		hepatic steatosis J:89922
increased liver weight J:89922
\Ociad1tm1.1Msin/\Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal liver morphology J:279239
\Odad3tm1b(EUCOMM)Hmgu/\Odad3tm1b(EUCOMM)Hmgu
(C57BL/6N-Odad3tm1b(EUCOMM)Hmgu/Cnrm) 		abnormal liver morphology J:278798
\Ola1Gt(OST312288)Lex/\Ola1Gt(OST312288)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		delayed hepatic development J:236306
\Oma1tm1Otin/\Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		hepatic steatosis J:184716
\Onecut1tm1Flem/\Onecut1tm1Flem
\Onecut2tm1Flem/\Onecut2tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		abnormal hepatic cord morphology J:100352
\Onecut2tm1Flem/\Onecut2tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		abnormal liver morphology J:100352
\Opa3m1Votr/\Opa3m1Votr
(involves: C3H * C57BL/6JCrl) 		abnormal liver morphology J:181670
decreased liver glycogen level J:181670
increased liver triglyceride level J:188346
increased liver weight J:188346
macrovesicular hepatic steatosis J:188346
\Oprl1em1(IMPC)Mbp/\Oprl1em1(IMPC)Mbp
(C57BL/6N-Oprl1em1(IMPC)Mbp/MbpMmucd) 		small liver J:211773
\Or1e1cem1(IMPC)Mbp/\Or1e1cem1(IMPC)Mbp
(C57BL/6NCrl-Or1e1cem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Or4m1em1Tshu/\Or4m1em1Tshu
(involves: C57BL/6J) 		decreased liver cholesterol level J:279017
decreased liver triglyceride level J:279017
\Or9g4em1(IMPC)Mbp/\Or9g4em1(IMPC)Mbp
(C57BL/6N-Or9g4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Or12d17em1Cya/\Or12d17em1Cya
(C57BL/6N-Or12d17em1Cya) 		decreased liver weight J:321591
decreased susceptibility to diet-induced hepatic steatosis J:321591
\Orc1tm1.1Gle/\Orc1tm1.1Gle
\Albtm1(cre/ERT2)Mtz/\Alb+
(involves: 129S2/SvPas * C57BL/6 * SJL) 		decreased hepatocyte number J:272584
increased hepatocyte karyomegaly J:272584
\Orc1tm1.1Gle/\Orc1tm1.1Gle
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		decreased hepatocyte number J:272584
increased hepatocyte karyomegaly J:272584
\Orc1tm1.1Gle/\Orc1tm1.2Gle
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		decreased hepatocyte number J:272584
increased hepatocyte karyomegaly J:272584
\Orgwq3M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
\Orgwq4M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
\Orgwq7M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
\Orgwq8M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
\Orm2em1Bcgen/\Orm2+
(involves: C57BL/6J) 		increased liver triglyceride level J:333118
\Orm2em1Bcgen/\Orm2em1Bcgen
(involves: C57BL/6J) 		hepatic steatosis J:333118
increased liver triglyceride level J:333118
increased liver weight J:333118
liver fibrosis J:333118
\Osmrtm1Mtan/\Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan) 		decreased liver glycogen level J:214124
hepatic steatosis J:214124
increased liver cholesterol level J:214124
increased liver triglyceride level J:214124
increased liver weight J:214124
\Otcspf-ash/Y
(Not Specified) 		enlarged liver J:26976
increased liver weight J:26976
\Otcspf/Y
(Not Specified) 		abnormal liver morphology J:23017
\Otcspf/Y
(involves: CD-1) 		abnormal liver morphology J:21306
\P2ry13tm1Loma/\P2ry13tm1Loma
(B6.129-P2ry13tm1Loma) 		decreased liver cholesterol level J:166205
\Padi4em1(IMPC)Mbp/\Padi4em1(IMPC)Mbp
(C57BL/6N-Padi4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
small liver J:211773
\Pafah2tm1Arai/\Pafah2tm1Arai
(B6.129P2-Pafah2tm1Arai) 		hepatic necrosis J:130728
\Pank1em1(IMPC)Mbp/\Pank1em1(IMPC)Mbp
(C57BL/6N-Pank1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pank1tm1.1Suja/\Pank1tm1.1Suja
(involves: 129S/SvEv * C57BL/6J) 		decreased liver triglyceride level J:161798
hepatic steatosis J:161798
increased liver triglyceride level J:161798
\Pank1tm1.1Suja/\Pank1tm1.1Suja
\Pank2tm1.1Suja/\Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		decreased liver weight J:189609
hepatic steatosis J:189609
increased liver triglyceride level J:189609
small liver J:189609
\Pank4em1(IMPC)Kmpc/\Pank4em1(IMPC)Kmpc
(C57BL/6NTac-Pank4em1(IMPC)Kmpc/Kmpc) 		abnormal liver morphology J:211773
\Pappa2tm1Lex/\Pappa2tm1Lex
(C57BL/6-Pappa2tm1Lex) 		increased liver weight J:174887
\Parltm1Bdes/\Parltm1Bdes
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		liver degeneration J:269785
\Pasktm1Weng/\Pasktm1Weng
(B6.129S6-Pasktm1Weng) 		decreased susceptibility to diet-induced hepatic steatosis J:125307
\Pax6em1(IMPC)Mbp/\Pax6+
(C57BL/6N-Pax6em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pbrm1tm1Rtj/\Pbrm1tm1Rtj
(Not Specified) 		small liver J:95332
\Pbx1em1Dunw/\Pbx1em1Dunw
(C57BL/6J-Pbx1em1Dunw) 		liver hypoplasia J:320934
\Pbx1tm1Mlc/\Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6) 		liver hypoplasia J:71996
\Pbx1tm1Mlc/\Pbx1tm2.1Mlc
(involves: 129S6/SvEvTac) 		abnormal liver development J:132963
\Pccatm1Tmiy/\Pccatm1Tmiy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver glycogen level J:71660
hepatic steatosis J:71660
\Pck1tm1.1Lre/\Pck1tm1.1Lre
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased liver triglyceride level J:73977
\Pck1tm1.1Mgn/\Pck1tm1.1Mgn
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac) 		decreased liver glycogen level J:63929
enlarged liver J:63929
increased liver triglyceride level J:63929
increased liver weight J:63929
pale liver J:63929
\Pck1tm1.2Mgn/\Pck1tm1.2Mgn
(involves: 129S6/SvEvTac) 		decreased liver glycogen level J:63929
pale liver J:63929
\Pck1tm1Mgn/\Pck1tm1.2Mgn
(involves: 129S6/SvEvTac) 		enlarged liver J:63929
pale liver J:63929
\Pck1tm1Mgn/\Pck1tm1Mgn
(involves: 129S6/SvEvTac) 		enlarged liver J:63929
\Pck1tm1Rwh/\Pck1tm1Rwh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:145210
decreased liver glycogen level J:145210
hepatic steatosis J:145210
\Pctptm1Bor/\Pctptm1Bor
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal bile canaliculus morphology J:115285
\Pctptm1Bor/\Pctptm1Bor
(involves: 129P2/OlaHsd * FVB/NJ) 		abnormal bile canaliculus morphology J:115285
\Pcxtm1c(EUCOMM)Wtsi/\Pcxtm1c(EUCOMM)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA * SJL) 		hepatic steatosis J:332296
increased liver triglyceride level J:332296
\Pcyt2tm1.1Suja/\Pcyt2tm1.1Suja
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		hepatic steatosis J:155630
increased liver cholesterol level J:155630
increased liver triglyceride level J:155630
pale liver J:155630
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon) 		enlarged liver J:66979
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(involves: 129S2/SvPas) 		hepatic necrosis J:222944
\Pdcd1tm1Hon/\Pdcd1tm1Hon
\Vsirtm1Lex/\Vsirtm1Lex
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6) 		hepatic necrosis J:222944
\Pdcd7em1(IMPC)Mbp/\Pdcd7+
(C57BL/6NCrl-Pdcd7em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pde5aem1(IMPC)Mbp/\Pde5a+
(C57BL/6N-Pde5aem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pdgfbtm1Cbet/\Pdgfbtm1Cbet
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:20017
\Pdgfctm1b(EUCOMM)Hmgu/\Pdgfc+
(C57BL/6N-Pdgfctm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Pdik1lem1(IMPC)Mbp/\Pdik1lem1(IMPC)Mbp
(C57BL/6NCrl-Pdik1lem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Pdk2em1(IMPC)Mbp/\Pdk2em1(IMPC)Mbp
(C57BL/6N-Pdk2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Pdk4tm1Rhar/\Pdk4tm1Rhar
(B6.129-Pdk4tm1Rhar) 		decreased liver glycogen level J:115895
\Pdlim7em1(IMPC)Mbp/\Pdlim7em1(IMPC)Mbp
(C57BL/6N-Pdlim7em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pdss1em1(IMPC)Mbp/\Pdss1+
(C57BL/6NCrl-Pdss1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Pdss2kd/\Pdss2kd
(CBA/H-Pdss2kd) 		decreased hepatocyte mitochondrial DNA content J:197578
\Pdx1tm1Cvw/\Pdx1tm1Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal liver development J:32017
\Pdx1tm2Cvw/\Pdx1tm2Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal liver development J:32017
\Pdzk1tm1Dls/\Pdzk1tm1Dls
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal liver morphology J:107125
\Pebp1em1(IMPC)Tcp/\Pebp1em1(IMPC)Tcp
(C57BL/6NCrl-Pebp1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Pecam1tm1Mak/\Pecam1tm1Mak
(B6.129P2-Pecam1tm1Mak) 		liver vascular congestion J:95226
\Pemttm1J/\Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:83870
abnormal liver morphology J:83870, J:73735
hepatic steatosis J:83870
\Pex1tm1.1Hrw/\Pex1tm1.1Hrw
(involves: C57BL/6NTac) 		abnormal liver morphology J:278655
decreased liver glycogen level J:278655
enlarged liver J:278655
hepatic necrosis J:278655
increased liver adenoma incidence J:278655
increased liver cholesterol level J:278655
increased liver triglyceride level J:278655
liver fibrosis J:278655
\Pex1tm1.1Sjms/\Pex1tm1.1Sjms
(involves: 129 * C57BL/6N) 		microvesicular hepatic steatosis J:210296
\Pex1tm1e.1(EUCOMM)Hmgu/\Pex1+
(C57BL/6NCrl-Pex1tm1e.1(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Pex2tm1Plf/\Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		abnormal liver morphology J:83644
decreased liver cholesterol level J:87591
hepatic steatosis J:83644
\Pex2tm1Plf/\Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:44975
\Pex5tm1Baes/\Pex5tm1Baes
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:42719
\Pex5tm1Pec/\Pex5tm1Pec
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal liver morphology J:112503
enlarged liver J:112503
increased liver tumor incidence J:112503
liver hyperplasia J:112503
\Pex7tm1Nbra/\Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6) 		enlarged liver J:158845
hepatic steatosis J:158845
liver degeneration J:158845
\Pex11atm1Itl/\Pex11atm1Itl
(C57BL/6-Pex11atm1Itl) 		abnormal hepatocyte morphology J:195940
hepatic steatosis J:195940
increased liver triglyceride level J:195940
\Pex11atm1Sjg/\Pex11atm1Sjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:80124
\Pex11btm1Sjg/\Pex11btm1Sjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver glycogen level J:76782
delayed hepatic development J:76782
\Pex13tm1.1Crne/\Pex13tm1.1Crne
(involves: 129T2/SvEms * C57BL/6J) 		macrovesicular hepatic steatosis J:84795
\Pfkmem1(IMPC)Mbp/\Pfkm+
(C57BL/6N-Pfkmem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pgrmc1em1Ejho/\Pgrmc1em1Ejho
(involves: C57BL/6N) 		hepatic steatosis J:268130
increased liver triglyceride level J:268130
liver fibrosis J:268130
\PhipGt(RRJ571)Byg/\PhipGt(RRJ571)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:164354
\Phkbem1(IMPC)J/\Phkb+
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax) 		abnormal liver morphology J:330539
decreased liver triglyceride level J:330539
enlarged liver J:330539
increased liver glycogen level J:330539
increased liver weight J:330539
\Phkg1tm1.1(KOMP)Vlcg/\Phkg1tm1.1(KOMP)Vlcg
(C57BL/6N-Phkg1tm1.1(KOMP)Vlcg/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Phyhtm1Safe/\Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N) 		liver degeneration J:142512
macrovesicular hepatic steatosis J:142512
microvesicular hepatic steatosis J:142512
\Pierce1Gt(OST3440)Lex/\Pierce1Gt(OST3440)Lex
(either: (involves: 129S5/SvEvBrd * C57BL/6J) or (involves: 129S5/SvEvBrd * C57BL/6J * FVB/N)) 		abnormal liver lobule morphology J:252050
\Pignem1(IMPC)Mbp/\Pign+
(C57BL/6N-Pignem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pik3c2gtm1Ehi/\Pik3c2gtm1Ehi
(involves: 129 * C57BL/6) 		decreased liver glycogen level J:223018
decreased liver weight J:223018
hepatic steatosis J:223018
\Pik3c3tm1c(EUCOMM)Wtsi/\Pik3c3tm1c(EUCOMM)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		abnormal liver morphology J:182628
decreased liver glycogen level J:182628
enlarged liver J:182628
hepatic steatosis J:182628
pale liver J:182628
\Pik3cbtm1.1Ehi/\Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi) 		decreased liver glycogen level J:152332
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic necrosis J:65523
\Pik3r1tm2Dfr/\Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6)) 		hepatic necrosis J:94077
\Pilratm1Osb/\Pilratm1Osb
(B6.129-Pilratm1Osb) 		abnormal hepatic cord morphology J:191085
\Pinx1tm1.1Kplu/\Pinx1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased liver tumor incidence J:171997
\Pinx1tm1.1Kplu/\Pinx1+
\Trp53tm1Brd/\Trp53+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased hepatocellular carcinoma incidence J:171997
increased liver tumor incidence J:171997
\Pinx1tm1.1Kplu/\Pinx1+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased hepatocellular carcinoma incidence J:171997
increased liver tumor incidence J:171997
\Pip4k2ctm1b(KOMP)Wtsi/\Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		pale liver J:234283
\PitpnaGt(OST1152)Lex/\PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		abnormal hepatocyte morphology J:85204
microvesicular hepatic steatosis J:85204
\Pitpnatm1Vab/\Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		abnormal hepatocyte morphology J:85204
microvesicular hepatic steatosis J:85204
\Pitx2tm1Rsd/\Pitx2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:57673
\Pitx3eyl/\Pitx3eyl
(involves: C3H/He * C57BL/6) 		hepatic steatosis J:156878
\Pja1em1(IMPC)Mbp/Y
(C57BL/6NCrl-Pja1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Pkd1tm1.1Djmp/\Pkd1tm1.2Djmp
\Tg(Cdh16-cre/ERT2)F427Djmp/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N) 		liver cyst J:130079
\Pkd1tm1Bdgz/\Pkd1+
(involves: 129S1/Sv * 129X1/SvJ) 		liver cyst J:130086
\Pkd1tm1Ggg/\Pkd1+
\Pkhd1tm1.1Ggg/\Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:125113
liver cyst J:125113
\Pkd1tm1Jzh/\Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)) 		dissociated hepatocytes J:52573
liver cyst J:52573
\Pkd1tm1Rsa/\Pkd1+
(involves: 129S4/SvJaeSor) 		liver cyst J:72238
\Pkd1tm1Som/\Pkd1+
\Pkd2tm2Som/\Pkd2+
(involves: 129/Sv * C57BL/6 * SJL) 		liver cyst J:78422
\Pkd1tm2Ggg/\Pkd1tm2Ggg
\Tg(MMTV-cre)4Mam/0
(involves: 129S4/SvJae * FVB) 		liver cyst J:103719
\Pkd1tm2Jzh/\Pkd1+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		liver cyst J:72627
\Pkd2tm1.1Gwu/\Pkd2tm1.1Gwu
\Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		liver cyst J:265516
\Pkd2tm1Dwo/\Pkd2tm1Dwo
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal liver development J:77401
\Pkd2tm1Gwu/\Pkd2tm1Gwu
(involves: C57BL/6) 		abnormal liver morphology J:143124
liver cyst J:143124
\Pkd2tm1Som/\Pkd2tm1Som
(involves: 129/Sv * C57BL/6J * SJL) 		liver cyst J:47035
\Pkd2tm1Som/\Pkd2tm2Som
(involves: 129/Sv * C57BL/6J * SJL) 		enlarged liver J:158354
increased liver weight J:158354
liver cyst J:47035, J:158354
liver fibrosis J:158354
\Pkd2tm2Som/\Pkd2+
(involves: 129/Sv * C57BL/6J * SJL) 		liver cyst J:47035, J:59314
\Pkd2tm2Som/\Pkd2+
(involves: 129/Sv * C57BL/6 * SJL) 		liver cyst J:78422
\Pkdccem1(IMPC)Mbp/\Pkdcc+
(C57BL/6N-Pkdccem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pkhd1cyli/\Pkhd1cyli
(D2.Cg-(D4Mit42-D4Smh6b) Pkhd1cyli/EiJ) 		enlarged liver J:343537
liver cyst J:343537
\Pkhd1em1Mrug/\Pkhd1+
(involves: C57BL/6J) 		liver cyst J:281464
\Pkhd1em1Mrug/\Pkhd1em1Mrug
(involves: C57BL/6J) 		liver fibrosis J:281464
\Pkhd1tm1.1Ggg/\Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		liver cyst J:125113
liver fibrosis J:125113
\Pkhd1tm1Cjwa/\Pkhd1tm1Cjwa
(involves: 129S6/SvEvTac * FVB/N) 		abnormal liver morphology J:140302
enlarged liver J:140302
liver cyst J:140302
liver fibrosis J:140302
\Pkhd1tm1Gwu/\Pkhd1tm1Gwu
(Not Specified) 		abnormal liver morphology J:143124
hepatic necrosis J:143394
liver cyst J:143394
liver fibrosis J:143394
\Pkhd1tm1Rbu/\Pkhd1tm1Rbu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver development J:112509
liver cyst J:112509
liver fibrosis J:112509
\Pkhd1tm1Som/\Pkhd1tm1Som
(involves: 129S/SvEv * C57BL/6) 		liver cyst J:131370
liver fibrosis J:131370
\Pkhd1tm1Sswi/\Pkhd1tm1Sswi
(B6.Cg-Pkhd1tm1Sswi) 		abnormal intrahepatic bile duct morphology J:186064
liver fibrosis J:186064
\Pkhd1tm2Cjwa/\Pkhd1tm2Cjwa
(either: B6.129(Cg)-Pkhd1tm2Cjwa or C.129(Cg)-Pkhd1tm2Cjwa) 		increased liver weight J:187735
liver cyst J:187735
liver fibrosis J:187735
\Pklrem1Appsc/\Pklrem1Appsc
(involves: C57BL/6J) 		decreased susceptibility to diet-induced hepatic steatosis J:342736
\Pkmyt1em1(IMPC)J/\Pkmyt1em1(IMPC)J
(C57BL/6NJ-Pkmyt1em1(IMPC)J/Mmjax) 		pale liver J:211773
\Pknox1Gt(OST71835)Lex/\Pknox1Gt(OST71835)Lex
(B6.129S5-Pknox1Gt(OST71835)Lex) 		abnormal liver development J:111418
\Pla1aem1Appsc/\Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc) 		enlarged liver J:333902
\Pla2g1btm1Dyh/\Pla2g1btm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6) 		decreased liver weight J:80216
\Pla2g12bhlb218/\Pla2g12bhlb218
(C57BL/6J-Pla2g12bhlb218/J) 		hepatic steatosis J:187708
\Pla2g15tm1.1Jash/\Pla2g15tm1.1Jash
(involves: 129S1/Sv * C57BL/6) 		hepatic steatosis J:111561
\Plaat1em1Ueda/\Plaat1em1Ueda
(C57BL/6NCrSlc-Plaat1em1Ueda) 		dark liver J:343807
decreased liver triglyceride level J:343807
decreased liver weight J:343807
decreased susceptibility to diet-induced hepatic steatosis J:343807
\Plaat3em1Ueda/\Plaat3em1Ueda
(C57BL/6NCrSlc-Plaat3em1Ueda) 		enlarged liver J:343807
increased liver weight J:343807
increased susceptibility to diet-induced hepatic steatosis J:343807
pale liver J:343807
\Plaat3tm1.1Hsul/\Plaat3tm1.1Hsul
(B6.129P2-Pla2g16tm1.1Hsul) 		decreased liver triglyceride level J:239202
enlarged liver J:239202
hepatic steatosis J:239202
pale liver J:239202
\Plautm1.1Bug/\Plautm1.1Bug
(involves: C57BL/6) 		liver fibrosis J:164542
\Plautm1Mlg/\Plautm1Mlg
(B6.129S2-Plautm1Mlg) 		decreased liver glycogen level J:164542
liver fibrosis J:164542
\Plaurtm1Jld/\Plaurtm1Jld
(B6.129P2-Plaurtm1Jld) 		liver fibrosis J:164542
\Plbcq1M16i/?
(involves: FVB/NJ * M16i) 		increased liver weight J:132804
\Plbcq6M16i/?
(involves: FVB/NJ * M16i) 		decreased liver weight J:132804
\Plbcq7M16i/?
(involves: FVB/NJ * M16i) 		increased liver weight J:132804
\Plcb1em1(IMPC)Mbp/\Plcb1+
(C57BL/6N-Plcb1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Pld3em1Nemz/\Pld3em1Nemz
\Pld4tm1.2Nemz/\Pld4tm1.2Nemz
(B6.Cg-Pld3em1Nemz Pld4tm1.1Nemz) 		hepatic steatosis J:281205
\Plekhn1tm1.1Hkon/\Plekhn1tm1.1Hkon
(B6.Cg-Plekhn1tm1.1Hkon) 		increased liver weight J:251603
\Plgtm1.1Fjc/\Plgtm1.1Fjc
(involves: C57BL/6 * C57BL/6JJcl) 		liver fibrosis J:210802
\Plgtm1Dco/\Plgtm1Dco
(involves: 129S2/SvPas * C57BL/6J) 		liver fibrosis J:30174
\Plgtm1Dco/\Plgtm1Dco
(involves: 129S2/SvPas) 		liver fibrosis J:210802, J:120780
\Plgtm1Jld/\Plgtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss) 		abnormal liver morphology J:39419
hepatic necrosis J:39419
\Plgtm1Jld/\Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss) 		abnormal liver morphology J:36591
\Plin1tm1Cdl/\Plin1tm1Cdl
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:69629
\Plin2tm1.1Asg/\Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg) 		decreased liver triglyceride level J:196302
decreased susceptibility to diet-induced hepatic steatosis J:196302
\Plin2tm1Chan/\Plin2tm1Chan
(B6.129-Plin2tm1Chan) 		decreased liver triglyceride level J:105572
decreased susceptibility to diet-induced hepatic steatosis J:105572
decreased susceptibility to hepatic steatosis J:105572
\Plin4tm1.1(KOMP)Wtsi/\Plin4tm1.1(KOMP)Wtsi
(C57BL/6N-Plin4tm1.1(KOMP)Wtsi/Ucd) 		abnormal liver morphology J:211773
\Plin5tm1Tosu/\Plin5tm1Tosu
(involves: C57BL/6JJcl) 		decreased liver free fatty acids level J:188390
decreased liver triglyceride level J:188390
increased liver free fatty acids level J:188390
increased liver triglyceride level J:188390
\Plk3tm1Dai/\Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6) 		increased liver tumor incidence J:136425
\Plxna4em1(IMPC)Mbp/\Plxna4em1(IMPC)Mbp
(C57BL/6NCrl-Plxna4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pmltm1Ppp/\Pml+
\Trp53tm3.1Glo/\Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		hepatosplenomegaly J:317504
\Pmltm1Ppp/\Pmltm1Ppp
\Trp53tm3.1Glo/\Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		hepatosplenomegaly J:317504
\Pmm2tm1.1Jins/\Pmm2tm2.1Jins
(involves: 129S6/SvEvTac * C57BL/6J) 		Mallory bodies J:236704
\Pms2tm1.1Wed/\Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased liver adenoma incidence J:162378
\Pnliptm1Dyh/\Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:124658
\Pnpla2tm1Gam/\Pnpla2tm1Gam
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA) 		abnormal hepatocyte morphology J:185116
increased liver triglyceride level J:185116
increased liver weight J:185116
macrovesicular hepatic steatosis J:185116
microvesicular hepatic steatosis J:185116
\Pnpla2tm1Rze/\Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:108546
increased liver triglyceride level J:108546
\Pnpla2tm1Rze/\Pnpla2tm1Rze
(involves: 129P2/OlaHsd) 		increased liver triglyceride level J:176252, J:160725
\Pnpla3tm1.1Hobb/\Pnpla3tm1.1Hobb
(involves: 129 * C57BL/6J) 		hepatic steatosis J:264475
increased liver triglyceride level J:264475
\Pnpla3tm2.1Hobb/\Pnpla3+
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:264475
\Pnpla3tm2.1Hobb/\Pnpla3tm2.1Hobb
(involves: 129 * C57BL/6J) 		hepatic steatosis J:264475
increased liver triglyceride level J:264475
\Pnpla7tm1.2Murm/\Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm) 		decreased liver triglyceride level J:333442
increased liver glycogen level J:333442
\Pnpla8tm1Rigr/\Pnpla8tm1Rigr
(involves: 129X1/SvJ) 		decreased liver triglyceride level J:333442
\Pnrc2tm1Shch/\Pnrc2tm1Shch
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:130294
\Pof1bem1(IMPC)Mbp/\Pof1bem1(IMPC)Mbp
(C57BL/6N-Pof1bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Pogztm1.2Jrk/\Pogztm1.2Jrk
(involves: 129S1/Sv * C57BL/6J) 		liver hypoplasia J:271614
\Pold4em1Zzho/\Pold4em1Zzho
(C57BL/6-Pold4em1Zzho) 		decreased liver tumor incidence J:331883
\Pole2em1(IMPC)Mbp/\Pole2+
(C57BL/6NCrl-Pole2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Polgtm1.1Suom/\Polgtm1.1Suom
(involves: C57BL/6JOlaHsd) 		decreased hepatocyte mitochondrial DNA content J:365276
hepatic necrosis J:365276
\Polr1bem1(IMPC)Tcp/\Polr1b+
(C57BL/6NCrl-Polr1bem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Polr2mtm1.1Rgr/\Polr2mtm1.1Rgr
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased hepatocyte karyomegaly J:291184
\Polr2mtm1.1Rgr/\Polr2mtm1.1Rgr
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:291184
abnormal liver morphology J:291184
\Pon3tm1Dmsh/\Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh) 		decreased liver triglyceride level J:234615
increased liver cholesterol level J:234615
\Portm1Ding/\Portm1Ding
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		abnormal liver morphology J:84422
hepatic necrosis J:84422
hepatic steatosis J:84422
increased liver weight J:84422
pale liver J:84422
\Portm1Wolf/\Portm1Wolf
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		enlarged liver J:82951
macrovesicular hepatic steatosis J:82951
microvesicular hepatic steatosis J:82951
pale liver J:82951
\Portm2Ding/\Portm2Ding
(involves: 129S1/Sv * C57BL/6) 		hepatic steatosis J:119630
\Portm2Wolf/\Portm1Wolf
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		enlarged liver J:82951
macrovesicular hepatic steatosis J:82951
microvesicular hepatic steatosis J:82951
pale liver J:82951
\Pou2f1tm1Shrp/\Pou2f1tm1Shrp
(involves: 129S4/SvJae * C57BL/6) 		small liver J:87664
\Pou3f2tm1Tno/\Pou3f2tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		hepatic steatosis J:30429
\Pparatm1Gonz/\Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6N) 		abnormal hepatocyte morphology J:25516
decreased liver glycogen level J:50024
enlarged liver J:25516
hepatic steatosis J:50024, J:25516
\Pparatm1Gonz/\Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz) 		enlarged liver J:56056
hepatic steatosis J:72185, J:56056
\Pparatm1Gonz/\Pparatm1Gonz
(B6.129S4-Pparatm1Gonz) 		hepatic steatosis J:72185
\Ppardtm1Jps/\Ppardtm1Jps
(involves: 129/Sv * C57BL/6N) 		decreased liver cholesterol level J:89827
decreased liver triglyceride level J:89827
\Ppargtm1Auw/\Ppargtm1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J)) 		enlarged liver J:86705
increased liver triglyceride level J:86705
macrovesicular hepatic steatosis J:86705
\Ppargtm1Avp/\Pparg+
(involves: 129S2/SvPas * C57BL/6) 		hepatic steatosis J:116568
increased liver weight J:116568
\Ppargtm1Lja/\Pparg+
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver triglyceride level J:98786
macrovesicular hepatic steatosis J:98786
microvesicular hepatic steatosis J:98786
\Ppargtm1Tka/\Pparg+
(involves: C57BL/6 * CBA) 		decreased susceptibility to diet-induced hepatic steatosis J:58222
\Ppargtm2(tTA)Yba/\Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		abnormal hepatocyte morphology J:125992
enlarged liver J:125992
\Ppargtm2Rev/\Ppargtm2Rev
\Tg(Fabp4-cre)1Rev/0
(involves: 129S4/SvJae * C57BL/6) 		enlarged liver J:88210
hepatic steatosis J:88210
\Ppargtm2Rev/\Ppargtm2Rev
\Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		pale liver J:123403
\Ppargtm3(tTA)Yba/\Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		enlarged liver J:125992
\Ppargc1atm1.1Javi/\Ppargc1atm1.1Javi
\Tg(Fabp4-cre)1Rev/0
(B6.Cg-Ppargc1atm1.1Javi Tg(Fabp4-cre)1Rev) 		decreased liver weight J:180984
\Ppargc1atm1Brsp/\Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		decreased liver triglyceride level J:93896
\Ppargc1atm1Dpk/\Ppargc1atm1Dpk
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:96306
\Ppargc1btm1.1Avp/\Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		hepatic steatosis J:116167
increased liver weight J:116167
\Ppargc1btm1.1Rev/\Ppargc1btm1.1Rev
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:120079
increased liver weight J:120079
macrovesicular hepatic steatosis J:120079
\Ppargc1btm1Lowl/\Ppargc1btm1Lowl
(involves: C57BL/6) 		increased liver triglyceride level J:129775
\Ppdpftm1Nju/\Ppdpftm1Nju
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		hepatic steatosis J:307283
increased liver triglyceride level J:307283
increased liver weight J:307283
increased susceptibility to diet-induced hepatic steatosis J:307283
\Ppme1em1(IMPC)Rbrc/\Ppme1+
(C57BL/6NJcl-Ppme1em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Ppp1r3ctm1Ars/\Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars) 		decreased liver glycogen level J:83297
\Ppp1r3gtm1Nju/\Ppp1r3gtm1Nju
(B6.129-Ppp1r3gtm1Nju) 		decreased liver glycogen level J:249135
decreased susceptibility to diet-induced hepatic steatosis J:249135
\Ppp1r15btm1Dron/\Ppp1r15btm1Dron
(involves: 129P2/OlaHsd) 		abnormal liver morphology J:144954
\Ppp2catm1.1Nju/\Ppp2catm1.1Nju
\Tg(Tek-cre)12Flv/0
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:171578
pale liver J:171578
\Ppp2r5aGt(IST13127C10)Tigm/\Ppp2r5aGt(IST13127C10)Tigm
(C57BL/6N-Ppp2r5aGt(IST13127C10)Tigm) 		enlarged liver J:254808
\Ppp4r3btm1b(EUCOMM)Hmgu/\Ppp4r3btm1b(EUCOMM)Hmgu
(C57BL/6N-Ppp4r3btm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Ppt1tm1Aj/\Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:95522
\Ppt2tm1Hof/\Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal liver morphology J:86202
enlarged liver J:86202
\Pptc7em1Pagd/\Pptc7em1Pagd
(C57BL/6J-Pptc7em1Pagd) 		abnormal hepatocyte mitochondrial morphology J:277086
abnormal liver morphology J:277086
\Pptc7em2Pagd/\Pptc7em2Pagd
(C57BL/6J-Pptc7em2Pagd) 		abnormal hepatocyte mitochondrial morphology J:277086
abnormal liver morphology J:277086
\Prdm16tm1.1Brsp/\Prdm16tm1.1Brsp
\Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N) 		hepatic steatosis J:208683
increased liver triglyceride level J:208683
\Prdx1tm1Rave/\Prdx1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:84677
\Prdx1tm1Rave/\Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:84677
\Prdx5tm1Dsle/\Prdx5tm1Dsle
(involves: C57BL/6) 		increased liver triglyceride level J:294801
increased liver weight J:294801
increased susceptibility to diet-induced hepatic steatosis J:294801
\PrepGt(RRM213)Byg/\Prep+
(B6.129P2-PrepGt(RRM213)Byg) 		increased liver weight J:151643
\Prex1tm1Hcew/\Prex1tm1Hcew
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:102214
\Prkab1tm1Eihl/\Prkab1tm1Eihl
(involves: C57BL/6) 		decreased liver triglyceride level J:158295
decreased susceptibility to diet-induced hepatic steatosis J:158295
\Prkab2tm1.1Grst/\Prkab2tm1.1Grst
(involves: C57BL/6) 		decreased liver glycogen level J:167339
\Prkacatm3Gsm/\Prkacatm3Gsm
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		decreased liver glycogen level J:103418
\Prkag1tm1.2Mfor/\Prkag1tm1.2Mfor
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N) 		abnormal Kupffer cell morphology J:167779
increased liver iron level J:167779
\Prkag2tm1.1Geno/\Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno) 		hepatic steatosis J:235379
\Prkag2tm2.1Mrl/?
(C57BL/6-Prkag2tm2.1Mrl/Tac) 		decreased susceptibility to diet-induced hepatic steatosis J:237375
\Prkag2tm3.1Mrl/?
(C57BL/6-Prkag2tm3.1Mrl/Tac) 		decreased susceptibility to diet-induced hepatic steatosis J:237375
\Prkar1atm1Gsm/\Prkar1a+
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:93393
\Prkar2btm1Gsm/\Prkar2btm1Gsm
(Not Specified) 		decreased susceptibility to diet-induced hepatic steatosis J:34751
\Prkar2btm1Gsm/\Prkar2btm1Gsm
(B6.129-Prkar2btm1Gsm) 		decreased liver triglyceride level J:72414
decreased susceptibility to diet-induced hepatic steatosis J:72414
\Prkar2btm3Gsm/\Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm) 		decreased liver triglyceride level J:196157
decreased susceptibility to hepatic steatosis J:196157
\Prkcdtm1Qxu/\Prkcdtm1Qxu
(B6.129P2-Prkcdtm1Qxu) 		decreased liver triglyceride level J:173902
\Prkcitm1Rfar/\Prkci+
\Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		hepatic steatosis J:123964
\Prkcitm1Rfar/\Prkcitm1Rfar
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		hepatic steatosis J:123964
\Prkcshtm1Som/\Prkcshtm1Som
\Sec63tm1.1Som/\Sec63tm1.1Som
\Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * ICR) 		liver cyst J:188763
\Prkcshtm1Som/\Prkcshtm1Som
\Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver cyst J:188763
\Prkdcscid/\Prkdcscid
\Gnrh1hpg/\Gnrh1hpg
(STOCK Prkdcscid Gnrh1hpg/Bm) 		decreased liver weight J:138840
\Prltm1Hmn/\Prltm1Hmn
(involves: 129S2/SvPas) 		decreased liver weight J:83246
\Prlhtm1Taon/\Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon) 		hepatic steatosis J:144729
increased liver triglyceride level J:144729
\Prmt7tm1a(EUCOMM)Wtsi/\Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
\Proctm1Fjc/\Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		focal hepatic necrosis J:50527
liver degeneration J:50527
liver fibrosis J:50527
\Pros1tm1.1Ansc/\Pros1tm1.1Ansc
(involves: 129/Sv * C57BL/6J * FVB/N) 		decreased hepatocyte number J:152423
hepatic necrosis J:152423
\Prox1tm1Gco/\Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		hepatic steatosis J:102652
increased liver triglyceride level J:102652
\Prox1tm1Gco/\Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal liver development J:63128
small liver J:63128
\Prrc2btm1a(EUCOMM)Wtsi/\Prrc2btm1a(EUCOMM)Wtsi
(C57BL/6N-Prrc2btm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Psaptm1Suz/\Psaptm1Suz
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:113052
decreased liver weight J:106511
\Psaptm2Suz/\Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J) 		abnormal liver morphology J:198242
\Psaptm4.1Ggb/\Psaptm4.1Ggb
(involves: 129S/SvEv * C57BL/6J) 		abnormal liver morphology J:198242
\Psmb9tm1Stl/\Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:73945
\Psme4b2b1508Clo/\Psme4b2b1508Clo
(C57BL/6J-Psme4b2b1508Clo) 		abnormal liver morphology J:175213
\Psmg1tm1.1Smta/\Psmg1tm1.1Smta
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * CBA * DBA) 		abnormal hepatic cord morphology J:162790
abnormal hepatocyte morphology J:162790
abnormal liver sinusoid morphology J:162790
\Psphtm1a(EUCOMM)Hmgu/\Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi) 		herniated liver J:239583
\Pstpip1em1(IMPC)Ccpcz/\Pstpip1em1(IMPC)Ccpcz
(C57BL/6N-Pstpip1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Pstpip2em1(IMPC)Tcp/\Pstpip2em1(IMPC)Tcp
(C57BL/6NCrl-Pstpip2em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Ptcd1tm1(KOMP)Vlcg/\Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg) 		abnormal hepatocyte mitochondrial morphology J:256004
hepatic steatosis J:256004
liver fibrosis J:256004
\Ptcd2Gt(RRF537)Byg/\Ptcd2Gt(RRF537)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:143946
\Ptentm1Hwu/\Ptentm1Hwu
\Smad4tm2.1Cxd/\Smad4tm2.1Cxd
\Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		enlarged liver J:111718
hepatic steatosis J:111718
increased liver weight J:111718
\Ptentm1Hwu/\Ptentm1Hwu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal liver morphology J:218587
enlarged liver J:171445, J:88441
hepatic steatosis J:88441, J:218587, J:160759
increased hepatocellular carcinoma incidence J:218587
increased liver glycogen level J:88441
increased liver triglyceride level J:88441, J:160759
increased liver tumor incidence J:218587
increased liver weight J:88441, J:160759
macrovesicular hepatic steatosis J:171445
pale liver J:88441
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * FVB/N) 		increased hepatocellular carcinoma incidence J:111718
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N) 		enlarged liver J:135172
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Ptentm1Hwu) 		abnormal liver size J:232645
increased liver weight J:232645
\Ptentm1Rps/\Pten+
(involves: 129S1/Sv * C57BL/6J) 		increased liver adenoma incidence J:53065
\Ptentm2Mak/\Ptentm2Mak
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:138099
abnormal liver morphology J:138099
enlarged liver J:138099
hepatic steatosis J:138099
increased hepatocellular carcinoma incidence J:138099
increased liver adenoma incidence J:138099
increased liver cholesterol level J:138099
increased liver triglyceride level J:138099
liver fibrosis J:138099
Mallory bodies J:138099
pale liver J:138099
\Ptentm2Mak/\Ptentm2Mak
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA) 		abnormal hepatocyte morphology J:90905
abnormal liver sinusoid morphology J:90905
enlarged liver J:90905
increased hepatocellular carcinoma incidence J:90905
increased hepatocyte number J:90905
increased liver adenoma incidence J:90905
increased liver triglyceride level J:90905
increased liver weight J:90905
Mallory bodies J:90905
microvesicular hepatic steatosis J:90905
pale liver J:90905
\Ptentm2Mak/\Ptentm2Mak
\Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		hepatic steatosis J:143082
increased hepatocellular carcinoma incidence J:143082
increased liver weight J:143082
\Ptger4tm1Bhk/\Ptger4tm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv) 		liver vascular congestion J:44108
macrovesicular hepatic steatosis J:44108
microvesicular hepatic steatosis J:44108
\Ptgs2tm1Unc/\Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:67208
\Pth1rtm1a(EUCOMM)Hmgu/\Pth1rtm1a(EUCOMM)Hmgu
(C57BL/6N-Pth1rtm1a(EUCOMM)Hmgu/Wtsi) 		herniated liver J:239583
\Pthlhtm1a(KOMP)Wtsi/\Pthlhtm1a(KOMP)Wtsi
(C57BL/6N-Pthlhtm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Ptk2tm1Heen/\Ptk2tm1Heen
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:157804
delayed hepatic development J:157804
\Ptntm1Tmu/\Ptntm1Tmu
(B6.Cg-Ptntm1Tmu) 		decreased liver weight J:102069
\Ptpn11tm1.1Ics/\Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		decreased liver triglyceride level J:216593
\Ptpn11tm1Bgn/\Ptpn11+
(involves: 129S4/SvJae * C57BL/6J) 		hepatic necrosis J:91609
\Ptpn11tm1Bgn/\Ptpn11tm1Bgn
(involves: 129S4/SvJae * C57BL/6J) 		hepatic necrosis J:91609
small liver J:91609
\Ptpn11tm1Ckq/\Ptpn11+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		enlarged liver J:177285
\Ptpn11tm1Gsf/\Ptpn11tm1Gsf
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:172422
abnormal liver morphology J:172422
abnormal liver parenchyma morphology J:172422
focal hepatic necrosis J:172422
hepatic necrosis J:172422
increased liver adenoma incidence J:172422
liver fibrosis J:172422
liver hyperplasia J:172422
\Ptpn11tm1Gsf/\Ptpn11tm1Gsf
\Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal liver morphology J:94738
enlarged liver J:94738
hepatic steatosis J:94738
increased liver glycogen level J:94738
increased liver triglyceride level J:94738
\Ptpn11tm6Bgn/\Ptpn11+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal liver sinusoid morphology J:148430
enlarged liver J:148430
\Ptpn12tm1Mtr/\Ptpn12tm1Mtr
(involves: 129S4/SvJae * BALB/c) 		abnormal liver development J:119668
\Pwwp2btm1.1Bcgen/\Pwwp2btm1.1Bcgen
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		abnormal liver morphology J:319940
\Pygltm1a(KOMP)Wtsi/\Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi) 		abnormal hepatocyte morphology J:284765
abnormal liver sinusoid morphology J:284765
abnormal liver vasculature morphology J:284765
enlarged liver J:284765
increased liver glycogen level J:330539, J:284765
increased liver weight J:284765
liver fibrosis J:284765
\Pzptm1Vln/\Pzptm1Vln
(involves: 129P2/OlaHsd * C57BL) 		enlarged liver J:28328
hepatic steatosis J:28328
\Pzptm1Vln/\Pzptm1Vln
(B.129P2-Pzptm1Vln) 		hepatic necrosis J:57485
\Rab39bem1(IMPC)Tcp/\Rab39bem1(IMPC)Tcp
(C57BL/6NCrl-Rab39bem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Rac2em1(IMPC)Mbp/\Rac2em1(IMPC)Mbp
(C57BL/6N-Rac2em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
\Rad17tm1Maas/\Rad17tm1Maas
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:93156
\Rad50tm1Jpt/\Rad50tm3Jpt
\Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:144766
liver hypoplasia J:144766
\Rad50tm4.1Jpt/\Rad50+
(involves: 129/Sv * C57BL/6) 		increased hepatoblastoma incidence J:209141
increased liver adenoma incidence J:209141
increased liver tumor incidence J:209141
\Rad50tm4Jpt/\Rad50+
(involves: 129/Sv * C57BL/6) 		increased liver adenoma incidence J:209141
increased liver tumor incidence J:209141
\Raf1tm1Bacc/\Raf1tm1Bacc
(involves: 129P2/OlaHsd * 129/Sv) 		abnormal hepatocyte morphology J:69056
abnormal liver sinusoid morphology J:69056
liver hypoplasia J:69056
pale liver J:69056
small liver J:69056
\Raf1tm1Bacc/\Raf1tm1Bacc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:69056
abnormal liver sinusoid morphology J:69056
liver hypoplasia J:69056
pale liver J:69056
small liver J:69056
\Raf1tm1Ulb/\Raf1tm1Ulb
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:89619
\Rag1tm1Mom/\Rag1tm1Mom
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased hepatocellular carcinoma incidence J:141515
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Cd4-NPM/ALK)N1Ingh/0
\Tg(TcraTcrb)1100Mjb/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster) 		increased hepatocellular carcinoma incidence J:235890
\Ralgapa1tm1.1Schen/\Ralgapa1tm1.1Schen
(involves: C57BL/6J) 		increased liver cholesterol level J:287672
increased liver triglyceride level J:287672
\Ramp2tm1.1Tash/\Ramp2tm1.1Tash
(involves: C57BL/6) 		abnormal liver morphology J:130931
\Ranbp2tm1Jvd/\Ranbp2tm1.1Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:137482
\Ranbp2tm1Jvd/\Ranbp2tm1Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:137482
\Rap1gds1tm1Ytk/\Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA) 		increased liver weight J:62244
liver vascular congestion J:62244
\Rapgef2tm1.1Hous/\Rapgef2tm1.1Hous
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		pale liver J:165879
\Rapgef2tm1.2Hous/\Rapgef2tm1.2Hous
(involves: 129S1/Sv) 		abnormal liver development J:165879
\Rasa3tm1a(KOMP)J/\Rasa3tm1a(KOMP)J
\Tg(CMV-cre)1Cgn/?
((C57BL/6N-Rasa3tm1a(KOMP)J/J x B6.C-Tg(CMV-cre)1Cgn/J)F2) 		pale liver J:301035
\Rasal2Gt(463C12)Cmhd/\Rasal2Gt(463C12)Cmhd
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl) 		increased hepatocellular carcinoma incidence J:202603
increased liver tumor incidence J:202603
\Rasgrp1lag/\Rasgrp1lag
(involves: 129 * C57BL/6) 		enlarged liver J:85189
\Rassf1tm1Gpp/\Rassf1tm1Gpp
(involves: 129S1/SvImJ) 		increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
\Rassf1tm1Gpp/\Rassf1tm1Gpp
\Sav1tm1.1Gpp/\Sav1+
(involves: 129S1/Sv * 129S1/SvImJ) 		increased hepatoblastoma incidence J:231761
increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
\Rassf2tm1Dlim/\Rassf2tm1Dlim
(B6.Cg-Rassf2tm1Dlim) 		liver fibrosis J:181952
\Rassf5tm1Kina/\Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased hepatocellular carcinoma incidence J:168749
\Rb1tm1Brd/\Rb1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased hepatocyte number J:2516
dilated liver sinusoidal space J:2516
small liver J:2516
\Rb1tm1Mlh/\Rb1tm1Mlh
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		decreased hepatocyte number J:20542
dilated liver sinusoidal space J:2498
\Rb1tm1Tyj/\Rb1tm1Tyj
(involves: 129S2/SvPas) 		liver hypoplasia J:81643
\Rb1tm1Tyj/\Rb1tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		abnormal liver morphology J:2511
small liver J:2511
\Rb1tm1Tyj/\Rb1tm2Tyj
(chimera involves: 129S2/SvPas * C57BL/6) 		abnormal hepatocyte morphology J:59268
\Rb1tm2Mlh/\Rb1tm2Mlh
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		decreased hepatocyte number J:20542
dilated liver sinusoidal space J:2498
\Rb1tm3Tyj/\Rb1tm3Tyj
\Rbl1tm1Tyj/\Rbl1tm1Tyj
\Rbl2tm2.1Tyj/\Rbl2tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:177573
\Rb1tm3Tyj/\Rb1tm3Tyj
\Tg(tetO-MYC)36aBop/0
\Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		increased hepatocellular carcinoma incidence J:172430
increased liver tumor incidence J:172430
\Rb1cc1tm1.1Guan/\Rb1cc1tm1.1Guan
\Tg(Tek-cre)12Flv/0
(B6.Cg-Rb1cc1tm1.1Guan Tg(Tek-cre)12Flv) 		abnormal liver morphology J:167258
pale liver J:167258
\Rb1cc1tm1.2Guan/\Rb1cc1tm1.2Guan
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:114498
abnormal liver morphology J:114498
decreased hepatocyte number J:114498
dissociated hepatocytes J:114498
liver degeneration J:114498
\Rbbp4em1(IMPC)Mbp/\Rbbp4+
(C57BL/6NCrl-Rbbp4em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Rbl1tm1Mru/\Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/c) 		hepatic steatosis J:129672
\Rbm3tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Rbm3tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Rbm7em1Aki/\Rbm7em1Aki
(B6.Cg-Rbm7em1Aki) 		liver fibrosis J:288329
\Rbm10em1(IMPC)Mbp/\Rbm10+
(C57BL/6NCrl-Rbm10em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Rbm22em1(IMPC)Mbp/\Rbm22+
(C57BL/6NCrl-Rbm22em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Rbm38tm1.1Xch/\Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N) 		increased hepatoma incidence J:216929
\Rbm38tm1.1Xch/\Rbm38tm1.1Xch
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		hepatic steatosis J:216929
\Rbp1tm1Ipc/\Rbp1tm1Ipc
(involves: 129S2/SvPas) 		abnormal liver morphology J:57825
\Rc3h1san/\Rc3h1san
(involves: C57BL/6JSfdAnu) 		hepatic necrosis J:199407
\Rcan2tm1Ypt/\Rcan2tm1Ypt
(B6.129-Rcan2tm1Ypt) 		decreased liver weight J:169558
decreased susceptibility to diet-induced hepatic steatosis J:169558
\Rcbtb2tm1.1Xyw/\Rcbtb2+
(involves: C57BL/6 * CBA) 		increased liver tumor incidence J:282928
\Rcbtb2tm1.1Xyw/\Rcbtb2tm1.1Xyw
(involves: C57BL/6 * CBA) 		increased liver tumor incidence J:282928
\Rdh1tm1.1Jln/\Rdh1tm1.1Jln
(B6.129P2-Rdh1tm1.1Jln) 		increased liver weight J:134843
\Rdh10tm1.1Ics/\Rdh10tm1.1Ics
(involves: C57BL/6 * SJL) 		liver hypoplasia J:177362
\Rdh10tm2Ics/\Rdh10tm2Ics
(Not Specified) 		liver hypoplasia J:177362
\Rdh10trex/\Rdh10trex
(involves: 129S1/Sv * C57BL/6 * FVB/NJ) 		abnormal liver parenchyma morphology J:121229
small liver J:121229
\Rdxtm1Sts/\Rdxtm1Sts
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:77485
\Recktm1Ito/\Recktm1.1Noda
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver vasculature morphology J:163845
\Reg3bem1(IMPC)Mbp/\Reg3bem1(IMPC)Mbp
(C57BL/6NCrl-Reg3bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Reltm1Brv/\Reltm1Brv
(involves: 129S1/Sv) 		abnormal liver morphology J:46911
\Relatm1Bal/\Relatm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		liver degeneration J:28390
\Relatm1Bal/\Relatm1Bal
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
(involves: 129S4/SvJae * C57BL/6) 		focal hepatic necrosis J:60742
\Relatm1Yuo/\Relatm1Yuo
(involves: 129S/SvEv) 		abnormal hepatocyte morphology J:63099
abnormal liver morphology J:63099
\Relatm2.1Gho/\Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic necrosis J:163663
liver fibrosis J:163663
liver hypoplasia J:163663
\Relatm2.1Gho/\Relatm2.1Gho
\Tnfrsf1atm1Mak/\Tnfrsf1atm1Mak
(involves: 129S2/SvPas * 129S6/SvEvTac) 		liver fibrosis J:163663
\Relbshep/\Relbshep
(A;C-Relbshep/GrsrJ) 		liver cirrhosis J:171971
pale liver J:171971
\RelbTg(H2-K1/GH1)106Bri/\RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri) 		liver fibrosis J:76450
pale liver J:76450
\Relbtm1Brv/\Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6) 		liver fibrosis J:22675
\Retntm1Laz/\Retntm1Laz
(involves: 129S/SvEv * C57BL/6) 		decreased liver triglyceride level J:90033
\Retnlbtm1Lex/\Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex) 		enlarged liver J:235058
\Rexo1em1(IMPC)J/\Rexo1em1(IMPC)J
(C57BL/6NJ-Rexo1em1(IMPC)J/Mmjax) 		pale liver J:211773
\Rfx5tm1.1Ifo/\Rfx5tm1.1Ifo
(involves: 129 * C57BL/6) 		abnormal Kupffer cell morphology J:67941
\Rgl1em1(IMPC)Mbp/\Rgl1+
(C57BL/6N-Rgl1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Rgntm1Aish/Y
(involves: 129P2/OlaHsd) 		abnormal hepatocyte mitochondrial morphology J:88791
abnormal hepatocyte morphology J:88791
abnormal liver vasculature morphology J:88791
hepatic steatosis J:88791
increased liver cholesterol level J:88791
increased liver triglyceride level J:88791
\Rgs9em1(IMPC)Ccpcz/\Rgs9em1(IMPC)Ccpcz
(C57BL/6NCrl-Rgs9em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
increased liver weight J:211773
\Rhbdd1tm1.1Mfm/\Rhbdd1tm1.1Mfm
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to hepatic steatosis J:325547
\Rhbdd3tm1Caox/\Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox) 		hepatic necrosis J:197348
\Rictortm1.1Mnh/\Rictortm1.1Mnh
\Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev) 		increased liver weight J:150064
macrovesicular hepatic steatosis J:150064
\Rigiem1(IMPC)Mbp/\Rigiem1(IMPC)Mbp
(C57BL/6N-Rigiem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Rigitm1Aki/\Rigitm1Aki
(Not Specified) 		liver degeneration J:100539
\Rint1tm1Whl/\Rint1+
(Not Specified) 		increased hepatocellular carcinoma incidence J:122805
\Ripk1tm1.1Vmd/\Ripk1+
\Ripk3tm2Vmd/\Ripk3tm2Vmd
(involves: C57BL/6N) 		decreased liver glycogen level J:209137
\Rnaseh2btm1a(EUCOMM)Wtsi/\Rnaseh2btm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		liver hypoplasia J:186986
\Rnd2em1(IMPC)Mbp/\Rnd2em1(IMPC)Mbp
(C57BL/6NCrl-Rnd2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Rnf139tm1(KOMP)Wtsi/\Rnf139tm1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		liver fibrosis J:231404
\Rpeem1(IMPC)Mbp/\Rpe+
(C57BL/6NCrl-Rpeem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Rpgrip1ltm1a(EUCOMM)Wtsi/\Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
liver cyst J:239583
\Rpgrip1ltm1Urt/\Rpgrip1ltm1Urt
(involves: 129S1/Sv * 129X1/SvJ) 		liver fibrosis J:123018
\Rpl5Skax23-Jus/\Rpl5+
(129S6.B6-Rpl5Skax23-Jus) 		liver hypoplasia J:330162
\Rpl12em1(IMPC)Mbp/\Rpl12+
(C57BL/6NCrl-Rpl12em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Rplp1tm1.1Melt/\Rplp1tm1.2Melt
(Not Specified) 		abnormal liver morphology J:218949
\Rps6tm1Om/\Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal hepatocyte morphology J:100952
\Rps27lGt(IST11658B7)Tigm/\Rps27lGt(IST11658B7)Tigm
(C57BL/6-Rps27lGt(IST11658B7)Tigm) 		liver hypoplasia J:223276
small liver J:223276
\Rps27lGt(IST11658B7)Tigm/\Rps27lGt(IST11658B7)Tigm
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		enlarged liver J:223276
\Rptortm1.1Dmsa/\Rptortm1.1Dmsa
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:167208
small liver J:167208
\Rptortm1Rueg/\Rptortm1Rueg
\Tg(Fabp4-cre)1Rev/0
(involves: 129S1/SvImJ * C57BL/6J) 		decreased liver triglyceride level J:143749
\Rr28tm1Tilg/\Rr28+
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		increased liver weight J:77413
\Rr28tm1Tilg/\Rr28+
\Tg(CRP-TAg)60-3Urt/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		increased liver tumor incidence J:138826
\Rr104tm1.2Mym/\Rr104tm1.2Mym
(Not Specified) 		abnormal liver morphology J:175070
pale liver J:175070
small liver J:175070
\Rr143tm1.1Sson/\Rr143+
\Zbed6tm1.2Sson/\Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6) 		increased liver weight J:265506
\Rr249tm1.1Ebres/\Rr249tm1.1Ebres
(involves: 129 * BALB/cJ * C57BL/6) 		liver hypoplasia J:191756
small liver J:191756
\Rr250em1Ebres/\Rr250em1Ebres
(C57BL/6N-Rr250em1Ebres) 		decreased liver weight J:270526
\Rr320tm1.1Mkg/\Rr320+
(involves: 129) 		pale liver J:60714
\Rr349tm1Wgw/\Rr349tm1Wgw
(involves: 129P2/OlaHsd) 		abnormal liver development J:80121
\Rr594em2Mrub/\Rr594em2Mrub
\Rr596tm1.1Low/\Rr596tm1.1Low
(C57BL/6J-Rr594em2Mrub Rr596tm1.1Low) 		increased liver weight J:357475
\Rr596tm1.1Low/\Rr596tm1.1Low
(C57BL/6J-Rr596tm1.1Low) 		increased liver weight J:357475
\Rr609m1H/\Rr609+
(involves: C3H/HeH * C57BL/6J) 		abnormal hepatocyte morphology J:208708
\Rrm2btm1Ynak/\Rrm2btm1Ynak
(involves: 129 * C57BL/6J) 		abnormal liver morphology J:84841
\Rtn4rl1Gt(OST188035)Lex/\Rtn4rl1Gt(OST188035)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal hepatocyte morphology J:103485
hepatic steatosis J:103485
\Rtp4tm1b(EUCOMM)Hmgu/\Rtp4tm1b(EUCOMM)Hmgu
(C57BL/6N-Rtp4tm1b(EUCOMM)Hmgu/Kmpc) 		abnormal liver morphology J:211773
\Rttnem1(IMPC)Tcp/\Rttn+
(C57BL/6NCrl-Rttnem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Rubcnlem1Qsun/\Rubcnlem1Qsun
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Rubcnlem1Qsun) 		hepatic steatosis J:272052
increased liver glycogen level J:272052
increased liver triglyceride level J:272052
increased liver weight J:272052
liver fibrosis J:272052
\Rundc1tm1b(EUCOMM)Wtsi/\Rundc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Rundc1tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Runx1tm1.1(RUNX1*)Homy/\Runx1tm1.1(RUNX1*)Homy
(B6.129P2-Runx1tm1.1(RUNX1*)Homy) 		pale liver J:164806
\Runx1tm1.1Gss/\Runx1tm1.1Gss
(involves: 129S4/SvJae * C57BL/6) 		pale liver J:157660
\Runx1tm1Dow/\Runx1tm1Dow
(involves: 129P2/OlaHsd * C57BL/6) 		pale liver J:31130
\Runx1tm2Dow/\Runx1+
(involves: 129P2/OlaHsd * C57BL/6) 		pale liver J:79160
\Runx1tm3Spe/\Runx1tm3Spe
\Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6) 		pale liver J:145700
\Runx2tm1Kish/\Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:53069
small liver J:53069
\Rxfp2tm1b(EUCOMM)Wtsi/\Rxfp2tm1b(EUCOMM)Wtsi
(C57BL/6N-Rxfp2tm1b(EUCOMM)Wtsi/Ieg) 		abnormal liver morphology J:211773
\Rxratm1Rev/\Rxratm1Rev
(involves: 129S4/SvJae * C57BL/6) 		delayed hepatic development J:18047
small liver J:18047
\Rxratm4Ipc/\Rxratm4Ipc
\Rxrbtm1Pcn/\Rxrbtm1Pcn
\Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S2/SvPas) 		enlarged liver J:102470
\S100a4tm1Amba/\S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased hepatocellular carcinoma incidence J:89563
\S100a16em1.1Gpt/\S100a16+
(involves: C57BL/6JGpt * FVB/N) 		liver fibrosis J:330793
\Saa3tm1(KOMP)Vlcg/\Saa3tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased liver weight J:220630
\Safbtm1So/\Safbtm1So
(involves: 129 * C57BL/6J) 		abnormal liver morphology J:97633
\Samd1tm1Pfi/\Samd1tm1Pfi
(involves: C57BL/6J * C57BL/6N) 		abnormal liver development J:333561
\Samd4m1Btlr/\Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr) 		hepatic steatosis J:208616
\Sar1bem2Emle/\Sar1b+
(C57BL/6N-Sar1bem2Emle) 		increased liver cholesterol level J:319817
\Saraftm1c(KOMP)Wtsi/\Saraftm1c(KOMP)Wtsi
\Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N) 		increased susceptibility to age-related hepatic steatosis J:337869
\Sav1tm1.1Gpp/\Sav1+
(involves: 129S1/Sv) 		increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
\Sav1tm1.1Rjo/\Sav1tm1.1Rjo
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		increased hepatocellular carcinoma incidence J:156531
increased liver weight J:156531
\Sav1tm1.1Rjo/\Sav1tm1.1Rjo
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * CD-1 * SJL) 		increased liver tumor incidence J:156531
\Sav1tm1.1Rjo/\Sav1tm1.1Rjo
\Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL) 		increased liver tumor incidence J:156531
\Sav1tm1Dlim/\Sav1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased hepatoma incidence J:160325
increased liver tumor incidence J:160325
\Sav1tm1Dlim/\Sav1tm1Dlim
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver tumor incidence J:160325
\Sav1tm2.1Dlim/\Sav1tm2.1Dlim
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal hepatocyte morphology J:160325
abnormal liver morphology J:160325
abnormal portal lobule morphology J:160325
enlarged liver J:160325
increased hepatocellular carcinoma incidence J:238319
increased hepatoma incidence J:160325
increased liver weight J:160325
\Sbdstm1Aljw/\Sbdstm1.1Aljw
\Tg(Mx1-cre)1Cgn/0
(involves: BALB/cJ * C57BL/6 * DBA) 		abnormal liver morphology J:171416
hepatic necrosis J:171416
\Sbf1em1(IMPC)Mbp/\Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Sc5dtm1Fdp/\Sc5dtm1Fdp
(involves: 129S1/Sv * 129X1/SvJ) 		decreased liver glycogen level J:84450
increased liver weight J:84450
\Scaptm1Mbjg/\Scaptm1Mbjg
\Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL) 		decreased liver cholesterol level J:69592
decreased liver triglyceride level J:69592
\Scd1tm1Ntam/\Scd1tm1Ntam
(involves: C57BL/6) 		decreased liver triglyceride level J:130441
decreased susceptibility to diet-induced hepatic steatosis J:130441
\Scd1tm1Ntam/\Scd1tm1Ntam
\Sirt3tm1.1Fwa/\Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver triglyceride level J:178653
\Scd1tm2Ntam/\Scd1tm2Ntam
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Scd1tm2Ntam) 		decreased liver glycogen level J:130441
decreased liver triglyceride level J:130441
decreased susceptibility to diet-induced hepatic steatosis J:130441
\Scd2tm1Myz/\Scd2tm1Myz
(129S6.129-Scd2tm1Myz) 		decreased liver triglyceride level J:101158
\Scg5tm1Led/\Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		enlarged liver J:77510
hepatic necrosis J:77510
hepatic steatosis J:53349, J:77510
increased liver glycogen level J:77510
\Scmh1tm1e.1(EUCOMM)Hmgu/\Scmh1tm1e.1(EUCOMM)Hmgu
(C57BL/6N-Scmh1tm1e.1(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Scn5atm1.1Iba/\Scn5a+
(involves: 129 * C57BL/6) 		liver vascular congestion J:266290
\Sco1tm1c(KOMP)Wtsi/\Sco1tm1c(KOMP)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		abnormal liver morphology J:222036
decreased liver copper level J:222036
hepatic steatosis J:222036
increased liver cholesterol level J:222036
increased liver iron level J:222036
increased liver triglyceride level J:222036
\Sco2tm1.1Easc/\Sco2tm2.1Easc
(129X1/SvJ-Sco2tm1.1Easc/Sco2tm2.1Easc) 		increased liver copper level J:155116
\Scp2tm1Fsch/\Scp2tm1Fsch
(B6.129P2-Scp2tm1Fsch) 		abnormal hepatocyte morphology J:126573
\Scp2tm1Kier/\Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr) 		abnormal liver morphology J:124895
decreased hepatocyte number J:124895
decreased liver triglyceride level J:124895
enlarged liver J:124895
\Scp2tm1Usee/\Scp2tm1Usee
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver cholesterol level J:73460, J:47280
decreased liver triglyceride level J:47280
\Sec24dem1(IMPC)Rbrc/\Sec24d+
(C57BL/6NJcl-Sec24dem1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Sec61a1m1Gek/\Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek) 		enlarged liver J:164159
hepatic steatosis J:164159
liver cirrhosis J:164159
pale liver J:164159
\Sec61a1m1Gek/\Sec61a1m1Gek
\Tg(Ins2-Sec61a1)#Gek/0
(C57BL/6-Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek) 		enlarged liver J:164159
hepatic steatosis J:164159
liver cirrhosis J:164159
\Sec63tm1Som/\Sec63tm1Som
\Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver cyst J:188763
\Seletm2Alb/\Seletm2Alb
\Selltm2Alb/\Selltm2Alb
\Selptm1Bay/\Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		hepatic necrosis J:106550
\Selenbp1tm1Hyama/\Selenbp1tm1Hyama
(C57BL/6-Selenbp1tm1Hyama) 		decreased liver weight J:202420
\Selptm1Bay/\Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		hepatic necrosis J:101979
\Sema6cem1(IMPC)Mbp/\Sema6cem1(IMPC)Mbp
(C57BL/6N-Sema6cem1(IMPC)Mbp/MbpMmucd) 		small liver J:211773
\Senp1Gt(XG001)Byg/\Senp1Gt(XG001)Byg
(involves: 129P2/OlaHsd) 		small liver J:141453
\Senp1tm1.1Wami/\Senp1tm1.1Wami
(involves: 129 * C57BL/6) 		decreased liver weight J:163428
pale liver J:163428
small liver J:163428
\Sephs1tm1.1Dhat/\Sephs1tm1.1Dhat
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver iron level J:245139
decreased liver manganese level J:245139
\Serac1em1Bcgen/\Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen) 		abnormal hepatocyte morphology J:326672
abnormal liver morphology J:326672
decreased hepatocyte mitochondrial DNA content J:326672
increased liver cholesterol level J:326672
increased liver glycogen level J:326672
increased liver triglyceride level J:326672
\Serpina12tm1Jwada/\Serpina12+
(B6JJcl.129P2-Serpina12tm1Jwada) 		increased liver triglyceride level J:208508
\Serpina12tm1Jwada/\Serpina12tm1Jwada
(B6JJcl.129P2-Serpina12tm1Jwada) 		increased liver triglyceride level J:208508
increased liver weight J:208508
\Serpinb10em1(IMPC)Mbp/\Serpinb10em1(IMPC)Mbp
(C57BL/6NCrl-Serpinb10em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Serpinc1tm1Dwr/\Serpinc1tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:115658
hepatic necrosis J:115658
macrovesicular hepatic steatosis J:115658
\Serpinc1tm1Sai/\Serpinc1tm1Sai
(involves: 129S2/SvPas * C57BL/6J) 		liver degeneration J:65092
\Serpine1tm1Mlg/\Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		decreased liver triglyceride level J:87982
\Serpine1tm1Mlg/\Serpine1tm1Mlg
(B6.129S2-Serpine1tm1Mlg/J) 		liver fibrosis J:123733
\Sertad2Gt(OST98734)Lex/\Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex) 		decreased liver triglyceride level J:194928
decreased liver weight J:194928
decreased susceptibility to diet-induced hepatic steatosis J:194928
\Sesn2Gt(RRJ141)Byg/\Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd) 		decreased hepatocyte mitochondrial DNA content J:189021
increased liver triglyceride level J:189021
macrovesicular hepatic steatosis J:189021
\Setd5tm1a(EUCOMM)Wtsi/\Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Sfmbt2em1(IMPC)Mbp/\Sfmbt2+
(C57BL/6NCrl-Sfmbt2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\SfnEr/\SfnEr
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:6200
\Sgms1Gt(E201D11)Wrst/\Sgms1Gt(E201D11)Wrst
(B6.129P2-Sgms1Gt(E201D11)Wrst) 		decreased liver weight J:249941
\Sgms2tm1Kenw/\Sgms2tm1Kenw
(B6.129S2-Sgms2tm1Kenw) 		decreased susceptibility to diet-induced hepatic steatosis J:175924
\Sgshmps3a/\Sgshmps3a
(involves: 129X1/SvJ * CD-1 * C57BL/6 * SJL) 		enlarged liver J:72142
\Sh3pxd2atm1b(EUCOMM)Wtsi/\Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi) 		abnormal liver morphology J:239583
abnormal liver vasculature morphology J:239583
dilated liver sinusoidal space J:239583
herniated liver J:239583
liver hypoplasia J:239583
\Shank1em1(IMPC)Mbp/\Shank1em1(IMPC)Mbp
(C57BL/6N-Shank1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Sharpincpdm/\Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm) 		abnormal liver morphology J:31745, J:14539
\Shhtm1(EGFP/cre)Cjt/\Shhtm1(EGFP/cre)Cjt
(Not Specified) 		abnormal liver development J:241569
\Shld1em1(IMPC)Mbp/\Shld1em1(IMPC)Mbp
(C57BL/6NCrl-Shld1em1(IMPC)Mbp/Mmucd) 		enlarged liver J:211773
\Shroom3Gt(ROSA53)Sor/\Shroom3Gt(ROSA53)Sor
(involves: 129S4/SvJaeSor) 		herniated liver J:58691
\Siah1atm1Ddlb/\Siah1atm1Ddlb
(involves: 129S1/Sv * C57BL/6J) 		small liver J:75489
\Sidt1tm1.1(KOMP)Vlcg/\Sidt1tm1.1(KOMP)Vlcg
(C57BL/6N-Sidt1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Sidt2tm1.1Hzha/\Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal hepatocyte morphology J:236042
abnormal liver morphology J:236042
hepatic necrosis J:236042
hepatic steatosis J:236042
increased liver free fatty acids level J:236042
increased liver triglyceride level J:236042
liver fibrosis J:236042
\Sik3tm1Htake/\Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N) 		abnormal hepatocyte morphology J:183827
abnormal liver morphology J:183827
decreased liver cholesterol level J:183827
decreased liver triglyceride level J:183827
decreased liver weight J:183827
decreased susceptibility to diet-induced hepatic steatosis J:183827
increased liver cholesterol level J:183827
increased polyploid hepatocyte number J:183827
\Sin3btm1.2Rdp/\Sin3btm1.2Rdp
(involves: 129 * C57BL/6 * FVB/N * SJL) 		pale liver J:154855
\Sinhcaftm1.2Hmd/\Sinhcaftm1.2Hmd
(involves: 129 * C57BL/6) 		small liver J:313620
\Sirpatm1Nog/\Sirpatm1Nog
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:79592
\Sirt1tm1.2Cxd/\Sirt1tm1.2Cxd
\Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * FVB/N) 		hepatic steatosis J:179193
increased liver triglyceride level J:179193
\Sirt2tm1.1Cxd/\Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		increased hepatocellular carcinoma incidence J:177486
\Sirt3tm1.1Fwa/\Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac) 		increased liver cholesterol level J:178653
increased liver triglyceride level J:178653
liver fibrosis J:178653
macrovesicular hepatic steatosis J:178653
\Sirt6tm1.1Cxd/\Sirt6tm1.1Cxd
\Tg(Alb1-cre)1Dlr/0
(involves: 129S6/SvEvTac * FVB/N) 		abnormal liver morphology J:166368
hepatic steatosis J:166368
increased liver weight J:166368
\Sirt7tm1Fwa/\Sirt7tm1Fwa
(involves: 129S1/Sv) 		abnormal hepatocyte morphology J:205529
enlarged liver J:205529
hepatic steatosis J:205529
increased liver triglyceride level J:205529
pale liver J:205529
\Sisem1(IMPC)J/\Sisem1(IMPC)J
(C57BL/6NJ-Sisem1(IMPC)J) 		decreased liver triglyceride level J:344683
\skimp/\skimp
(involves: C3H/HeH) 		abnormal liver morphology J:77535
\Skp2tm1Kin/\Skp2tm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:75027, J:62130
\Slc2a4tm1Abel/\Slc2a4tm1Abel
\Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6) 		increased liver glycogen level J:75418
\Slc2a4tm1Mch/\Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL) 		hepatic steatosis J:43650
macrovesicular hepatic steatosis J:43650
\Slc2a9tm1Khm/\Slc2a9tm1Khm
\Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J) 		hepatic steatosis J:221544
increased liver free fatty acids level J:221544
increased liver triglyceride level J:221544
liver fibrosis J:221544
\Slc5a7tm1a(KOMP)Wtsi/\Slc5a7tm1a(KOMP)Wtsi
(C57BL/6N-Slc5a7tm1a(KOMP)Wtsi/Wtsi) 		herniated liver J:239583
\Slc5a10tm1Csk/\Slc5a10tm1Csk
(C57BL/6-Slc5a10tm1Csk) 		hepatic steatosis J:199406
increased liver triglyceride level J:199406
increased liver weight J:199406
\Slc7a7em1Lbu/\Slc7a7em1Lbu
(involves: 129/SvEv * C57BL/6) 		delayed hepatic development J:293773
\Slc9b1em1(IMPC)Mbp/\Slc9b1em1(IMPC)Mbp
(C57BL/6N-Slc9b1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Slc10a1em1(IMPC)Mbp/\Slc10a1em1(IMPC)Mbp
(C57BL/6N-Slc10a1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Slc11a2mk/\Slc11a2mk
(129S6.MK-Slc11a2mk) 		increased liver iron level J:98088
\Slc11a2tm1Nca/\Slc11a2+
(involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2tm1Nca) 		decreased liver iron level J:98088
\Slc11a2tm2Nca/\Slc11a2tm2Nca
\Tg(Vil1-cre)20Syr/?
(involves: 129S6.129S4-Slc11a2tm2Nca * C57BL/6 * DBA/2) 		decreased liver iron level J:98088
\Slc13a1tm1Mark/\Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J) 		increased liver weight J:86561
\Slc13a5tm1.2Helf/\Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf) 		abnormal hepatocyte mitochondrial morphology J:176732
abnormal liver morphology J:176732
decreased liver triglyceride level J:176732
\Slc16a1tm2.1Lupel/\Slc16a1+
(B6.129P2-Slc16a1tm2.1Lupel) 		decreased liver weight J:205481
decreased susceptibility to diet-induced hepatic steatosis J:205481
\Slc16a13em1Tac/\Slc16a13em1Tac
(C57BL/6N-Slc16a13em1Tac) 		decreased susceptibility to diet-induced hepatic steatosis J:309785
\Slc19a1tm1Gold/\Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL) 		pale liver J:68666
\Slc19a3tm1Said/\Slc19a3tm1Said
(involves: C57BL/6) 		abnormal liver parenchyma morphology J:170952
hepatic necrosis J:170952
\Slc20a1tm1.2Lbek/\Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J) 		abnormal liver development J:157997
dilated liver sinusoidal space J:157997
liver hypoplasia J:157997
pale liver J:157997
small liver J:157997
\Slc20a1tm1Lbek/\Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J) 		liver hypoplasia J:157997
\Slc20a2tm1a(EUCOMM)Wtsi/\Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc20a2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
\Slc22a5jvs/\Slc22a5jvs
(C3.OH-H2o2 Slc22a5jvs) 		abnormal hepatocyte morphology J:31026
hepatic steatosis J:31000
pale liver J:14288
\Slc22a18tm1Tgot/\Slc22a18tm1Tgot
(B6.Cg-Slc22a18tm1Tgot) 		decreased liver triglyceride level J:349247
\Slc25a13tm1Lct/\Slc25a13tm1Lct
(B6.129-Slc25a13tm1Lct) 		hepatic steatosis J:124766
increased liver triglyceride level J:124766
\Slc25a17Gt(XB686)Byg/\Slc25a17Gt(XB686)Byg
(involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster) 		abnormal Kupffer cell morphology J:291257
enlarged liver J:291257
hepatic steatosis J:291257
\Slc25a20tm1a(EUCOMM)Wtsi/\Slc25a20tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a20tm1a(EUCOMM)Wtsi/Wtsi) 		herniated liver J:239583
\Slc25a24tm1Sinos/\Slc25a24tm1Sinos
(B6(Cg)-Slc25a24tm1Sinos) 		decreased liver triglyceride level J:312208
decreased liver weight J:312208
\Slc25a28tm1.1Dwrd/\Slc25a28tm1.1Dwrd
\Slc25a37tm1.1Kapl/\Slc25a37tm1.1Kapl
\Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA) 		decreased liver iron level J:300667
\Slc25a28tm1.1Dwrd/\Slc25a28tm1.1Dwrd
\Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA) 		decreased liver iron level J:300667
\Slc25a28tm1.2Dwrd/\Slc25a28tm1.2Dwrd
(involves: 129S6/SvEvTac * C57BL/6NCrl) 		decreased liver iron level J:300667
\Slc25a34em1Duna/\Slc25a34em1Duna
(C57BL/6J-Slc25a34em1Duna) 		hepatic steatosis J:344152
increased liver weight J:344152
\Slc25a37tm1.1Kapl/\Slc25a37tm1.1Kapl
\Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA) 		decreased liver iron level J:300667
\Slc25a37tm1.1Kapl/\Slc25a37tm1.2Kapl
\Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * DBA) 		enlarged liver J:173284
liver fibrosis J:173284
\Slc26a1tm1Mark/\Slc26a1tm1Mark
(involves: 129X1/SvJ * CD-1) 		hepatic necrosis J:158567
\Slc27a5tm1Asta/\Slc27a5tm1Asta
(involves: 129/Sv * C57BL/6) 		abnormal hepatocyte morphology J:124917
decreased liver cholesterol level J:124917
decreased liver triglyceride level J:124917
\Slc29a3em1(IMPC)Mbp/\Slc29a3em1(IMPC)Mbp
(C57BL/6NCrl-Slc29a3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
increased liver weight J:211773
\Slc30a10tm1.1Sommu/\Slc30a10tm1.1Sommu
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA) 		abnormal hepatocyte morphology J:243657
decreased liver glycogen level J:243657
increased liver manganese level J:243657
liver degeneration J:243657
\Slc31a1tm1Djt/\Slc31a1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver iron level J:69897
\Slc31a1tm2Djt/\Slc31a1tm2Djt
\Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * FVB/N * SJL) 		abnormal liver copper level J:129741
\Slc37a1tm1b(EUCOMM)Hmgu/\Slc37a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc37a1tm1b(EUCOMM)Hmgu/Orl) 		abnormal liver morphology J:211773
\Slc37a4tm1Jyc/\Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		enlarged liver J:86005
increased liver glycogen level J:86005
\Slc39a2tm1Gka/\Slc39a2tm1Gka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal liver iron level J:121899
\Slc39a4tm2Gka/\Slc39a4tm2Gka
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal liver morphology J:187178
decreased liver copper level J:187178
increased liver copper level J:187178
increased liver iron level J:187178
\Slc39a5tm1.1Gka/\Slc39a5tm1.1Gka
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal liver zinc level J:209760
\Slc39a5tm1Gka/\Slc39a5tm1Gka
\Tg(Cela1-cre/ERT)1Lgdn/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver iron level J:209760
\Slc39a14tm1Lex/\Slc39a14tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal liver zinc level J:236296
decreased liver weight J:236296
\Slc39a14tm1Thir/\Slc39a14tm1Thir
(involves: 129 * C57BL/6) 		abnormal liver zinc level J:171670
\Slc40a1ffe/\Slc40a1+
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J)) 		increased liver iron level J:118592
\Slc40a1Pcm/\Slc40a1+
(A.Cg-Slc40a1Pcm) 		decreased liver iron level J:98335
\Slc40a1Pcm/\Slc40a1Pcm
(A.Cg-Slc40a1Pcm) 		decreased liver iron level J:98335
increased liver iron level J:89185
\Slc40a1tm1.1Mmfe/\Slc40a1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver iron level J:215585
\Slc40a1tm1.1Mmfe/\Slc40a1tm1.1Mmfe
(involves: 129P2/OlaHsd * C57BL/6) 		dark liver J:215585
increased liver iron level J:215585
\Slc40a1tm1Nca/\Slc40a1+
(involves: 129S4/SvJae * 129S6/SvEvTac) 		decreased liver iron level J:129846
\Slc40a1tm2Nca/\Slc40a1tm2Nca
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased liver iron level J:129846
\Slc47a1Gt(IST12634F2)Tigm/\Slc47a1Gt(IST12634F2)Tigm
(B6.B6N-Slc47a1Gt(IST12634F2)Tigm) 		abnormal liver morphology J:206792
\Slc48a1em1Ih/\Slc48a1em1Ih
(involves: 129 * C57BL/6J) 		dark liver J:282829
increased liver iron level J:282829
\Slit3tm1.1Dor/\Slit3tm1.1Dor
(involves: 129S1/Sv * C57BL/6J) 		herniated liver J:83292
\Slit3tm1Dor/\Slit3tm1Dor
(involves: 129S1/Sv * C57BL/6J) 		absent falciform ligament J:83292
herniated liver J:83292
\Slntm1Peri/\Slntm1Peri
(involves: C57BL/6J) 		hepatic steatosis J:193427
\Slu7tm1a(KOMP)Wtsi/\Slu7+
(C57BL/6NTac-Slu7tm1a(KOMP)Wtsi/WtsiPh) 		decreased liver glycogen level J:345496
\Smad2tm1.1Epb/\Smad2tm1.1Epb
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129/Sv * C57BL/6 * DBA * SJL) 		abnormal hepatocyte morphology J:119642
\Smad2tm1Cxd/\Smad2+
\Smad3tm1Cxd/\Smad3+
(involves: 129S6/SvEvTac * NIH Black Swiss) 		abnormal hepatic cord morphology J:70388
abnormal liver morphology J:70388
delayed hepatic development J:106308
dilated liver sinusoidal space J:70388
liver hypoplasia J:70388, J:106308
small liver J:70388
\Smap1tm1.1Sata/\Smap1tm1.1Sata
(B6.Cg-Smap1tm1.1Sata) 		enlarged liver J:196385
\Smarca4enu1/\Smarca4tm1Mag
(involves: 129S/Sv * C57BL/10 * CBA/Cbi) 		abnormal liver morphology J:103896
\Smarcb1tm1Mya/\Smarcb1tm2Mya
\Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N) 		abnormal hepatocyte morphology J:103919
decreased liver glycogen level J:103919
dissociated hepatocytes J:103919
\Smarcb1tm1Sho/\Smarcb1tm3Sho
\Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal liver morphology J:80224
enlarged liver J:80224
\Smarcd1tm1.1Jddl/\Smarcd1tm1.1Jddl
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased liver cholesterol level J:228944
\Smg1Gt(AG0297)Wtsi/\Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:193626
hepatic steatosis J:193626
\Smg9tm1b(EUCOMM)Wtsi/\Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
liver cyst J:239583
\Smpd1tm1Wst/\Smpd1tm1Wst
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:26748
hepatosplenomegaly J:26748
\Smurf2Gt(RRA098)Byg/\Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:189320
\Snap25tm1.1Bark/\Snap25tm1.1Bark
(Not Specified) 		hepatic steatosis J:226064
\Snord50a/Snord50btm1.1Soen/\Snord50a/Snord50btm1.1Soen
(B6.129P2-Snord50a/Snord50btm1.1Soen) 		decreased liver weight J:206419
\Snord50a/Snord50btm1.1Soen/\Snord50a/Snord50btm1.1Soen
(B6.129P2-Snord50a/Snord50btm1.1Soen) 		decreased liver weight J:206419
\Snord116tm1.1Uta/\Snord116+
(involves: C57BL/6J) 		decreased liver weight J:131662
small liver J:131662
\Snord116tm1Uta/\Snord116+
\Tg(Zp3-cre)93Knw/0
(involves: C57BL/6J) 		decreased liver weight J:131427
small liver J:131427
\Snrktm1.1Hxu/\Snrktm1.1Hxu
\Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr) 		hepatic steatosis J:257980
\Snx27tm1Lslo/\Snx27tm1Lslo
(involves: 129P2/OlaHsd) 		small liver J:171001
\Soat1tm1Far/\Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:37049
\Soat2tm1.1Llr/\Soat2tm1.1Llr
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased liver cholesterol level J:184908
decreased liver triglyceride level J:184908
\Soat2tm1.1Llr/\Soat2tm1.1Llr
\Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL) 		decreased liver cholesterol level J:184908
decreased liver triglyceride level J:184908
\Soat2tm1Far/\Soat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased susceptibility to diet-induced hepatic steatosis J:82032
\Socs1tm1Jni/\Socs1+
(Not Specified) 		abnormal liver morphology J:91651
increased hepatoma incidence J:91651
\Socs1tm1Kish/\Socs1tm1Kish
(involves: 129P2/OlaHsd * C57BL/6J) 		enlarged liver J:51685
\Socs1tm1Kish/\Socs1tm1Kish
(B6.129P2-Socs1tm1Kish) 		enlarged liver J:69472
\Socs1tm1Kish/\Socs1tm1Kish
\Stat1tm1Rds/\Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		enlarged liver J:69472
\Socs1tm1Kish/\Socs1tm1Kish
\Stat6tm1Aki/\Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:69472
\Socs1tm1Wehi/\Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6) 		hepatic necrosis J:57474
hepatic steatosis J:57474, J:51281
liver degeneration J:51281
\Socs2tm1Wehi/\Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J) 		decreased liver triglyceride level J:186227
decreased susceptibility to diet-induced hepatic steatosis J:186227
\Socs3tm1Jni/\Socs3tm1Jni
(involves: 129P2/OlaHsd) 		abnormal liver morphology J:57476
\Socs3tm1Wsa/\Socs3tm1Wsa
(either: C57BL/6-Socs3tm1Wsa or (involves: 129 * C57BL/6)) 		liver hypoplasia J:70667
small liver J:70667
\Sod1m1H/\Sod1m1H
(involves: C3H/HeH * C57BL/6J) 		abnormal liver morphology J:219360
increased hepatocellular carcinoma incidence J:219360
increased liver tumor incidence J:219360
\Sod1tm1Cep/\Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ) 		hepatic steatosis J:71134
\Sod2tm1Cje/\Sod2tm1Cje
(involves: C57BL/6J * CD-1) 		hepatic steatosis J:29899
increased liver weight J:29899
\Sod2tm1Cje/\Sod2tm1Cje
(involves: C57BL/6J) 		hepatic steatosis J:45913
\Sod2tm1Cje/\Sod2tm1Cje
(D2.Cg-Sod2tm1Cje) 		hepatic steatosis J:73998
\Sod2tm1Leb/\Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J) 		abnormal hepatocyte morphology J:36148
\Sowahaem1(IMPC)Mbp/\Sowahaem1(IMPC)Mbp
(C57BL/6N-Sowahaem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Sox17SHIVA/\Sox17+
(either: C57BL/6-Sox17SHIVA or (involves: C57BL/6 * C3H/HeN)) 		decreased liver triglyceride level J:219119
\Sox17tm1Sjm/\Sox17tm1Sjm
(BKa.129-Sox17tm1Sjm) 		liver hypoplasia J:123050
\Sox17tm1Ysk/\Sox17+
(B6.129S1-Sox17tm1Ysk) 		abnormal hepatocyte morphology J:194071
abnormal liver development J:194071
abnormal liver lobule morphology J:194071
decreased liver weight J:194071
\Sox17tm2Sjm/\Sox17+
\Tg(Pdx1-cre)6Tuv/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal liver morphology J:241569
\Sox21em1(IMPC)Mbp/\Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Sp1tm1Phi/\Sp1+
\Sp3tm1Sus/\Sp3+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver sinusoid morphology J:123073
decreased liver weight J:123073
small liver J:123073
\Sp3tm1Sus/\Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:84837
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Tg(CAG-cat,-Creg1)#Yal/0
(involves: C57BL/6J * DBA) 		decreased liver cholesterol level J:263073
decreased liver free fatty acids level J:263073
decreased liver triglyceride level J:263073
decreased liver weight J:263073
increased liver glycogen level J:263073
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Tg(CAG-Dusp26)#Jhxia/0
(involves: C57BL/6 * DBA) 		decreased liver cholesterol level J:279111
decreased liver free fatty acids level J:279111
decreased liver triglyceride level J:279111
decreased liver weight J:279111
decreased susceptibility to diet-induced hepatic steatosis J:279111
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Tor1aip1tm1.1Wtd/\Tor1aip1tm1.1Wtd
(Not Specified) 		abnormal hepatocyte morphology J:345574
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
\Trmutm1Tomik/\Trmutm1Tomik
(involves: C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:235644
hepatic necrosis J:235644
increased hepatocyte karyomegaly J:235644
\Spentm1Hon/\Spentm1Hon
(involves: 129P2/OlaHsd * C57BL/6J) 		liver hypoplasia J:82332
small liver J:82332
\Spi1tm1.1Dgt/\Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ) 		enlarged liver J:90331
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6) 		abnormal liver morphology J:90331
increased liver weight J:90331
liver hyperplasia J:90331
\Spi1tm1Ram/\Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6) 		dark liver J:36473
\Spi1tm1Rpd/\Spi1tm1Rpd
(involves: 129/Sv * C57BL/6 * Black Swiss) 		liver hyperplasia J:123079
\Spin4em1Jbn/Y
(involves: C57BL/6J) 		increased liver weight J:347154
\Spin4em2Jbn/Y
(involves: C57BL/6J) 		increased liver weight J:347154
\Spp1tm1Rit/\Spp1tm1Rit
(B6.129S7-Spp1tm1Rit) 		abnormal liver morphology J:93915
\Spred2em1(IMPC)Mbp/\Spred2em1(IMPC)Mbp
(C57BL/6N-Spred2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Spta1ihj/\Spta1ihj
(involves: HRS/J * LAH) 		enlarged liver J:105409
\Spta1sph-3J/\Spta1sph-3J
(NOD.Cg-H2b Spta1sph-3J) 		increased liver iron level J:157766
\Spta1sph-4J/\Spta1sph-4J
(C57BL/6J-Spta1sph-4J/Llp) 		increased liver iron level J:157766
\Spta1sph-Dem/\Spta1sph-Dem
(CcS3/Dem-Spta1sph-Dem) 		liver degeneration J:66966
\Spta1sph-ha/\Spta1sph-ha
(involves: DBA/1J) 		enlarged liver J:30699
\Spta1sph-ha/\Spta1sph-ha
((WB.D1-Spta1sph-ha/Brk x B6.D1-Spta1sph-ha/Brk)F1) 		enlarged liver J:162532
\Spta1sph/\Spta1sph
(involves: C3H) 		dark liver J:12276
dilated liver sinusoidal space J:12276
enlarged liver J:12276
liver vascular congestion J:12276
\Spta1sph/\Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1) 		enlarged liver J:162532
focal hepatic necrosis J:44313
increased liver iron level J:44313
\Sptbja/\Sptbja
(129/Sv-Sptbja) 		enlarged liver J:305
multifocal hepatic necrosis J:305
\Sptbja/\Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1) 		enlarged liver J:162532, J:44313
\Sptbm1Jus/\Sptbm1Jus
(involves: 129S6/SvEvTac * C57BL/6) 		enlarged liver J:159750
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:132133
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac) 		abnormal liver morphology J:166879
increased hepatocellular carcinoma incidence J:166879
increased liver tumor incidence J:166879
\Sptbn1tm1Mish/\Sptbn1tm1Mish
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		abnormal liver morphology J:81747
liver hypoplasia J:81747
\Sqstm1em1Kmts/\Sqstm1+
(involves: C57BL/6N) 		enlarged liver J:342766
\Sqstm1tm2.1Jmos/\Sqstm1tm2.1Jmos
\Tg(Fabp4-cre)1Rev/0
(Not Specified) 		hepatic steatosis J:194291
\Sra1tm1a(EUCOMM)Hmgu/\Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N) 		abnormal liver morphology J:214131
decreased liver free fatty acids level J:214131
decreased liver triglyceride level J:214131
decreased liver weight J:214131
decreased susceptibility to diet-induced hepatic steatosis J:214131
\Srebf1Gt(XC354)Byg/\Srebf1Gt(XC354)Byg
(either: B6.129P2-Srebf1Gt(XC354)Byg or (involves: 129P2/OlaHsd * C57BL/6)) 		decreased liver triglyceride level J:152612
\Srebf1tm1Jdh/\Srebf1tm1Jdh
(involves: 129S/SvEvBrd * C57BL/6) 		increased liver cholesterol level J:43570
\Srebf1tm1Mbr/\Srebf1tm1Mbr
(involves: 129S6/SvEvTac) 		increased liver cholesterol level J:75320
\Srebf1tm2Jdh/\Srebf1tm2Jdh
(involves: 129S/SvEvBrd * C57BL/6) 		increased liver cholesterol level J:43570
\Srebf2lop13/\Srebf2lop13
(STOCK Srebf2lop13/J) 		decreased liver cholesterol level J:176249
\Srebf2tm1Jdh/\Srebf2tm1Jdh
\Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased liver cholesterol level J:241873
decreased liver triglyceride level J:241873
\Srpxtm1Hzi/\Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased hepatoma incidence J:119999
\Srrm1em1(IMPC)Mbp/\Srrm1+
(C57BL/6NCrl-Srrm1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Srsf3tm1Pjln/\Srsf3tm1Pjln
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA) 		abnormal bile canaliculus morphology J:205756
abnormal hepatocyte morphology J:205756
abnormal liver morphology J:205756
abnormal liver sinusoid morphology J:205756
decreased liver cholesterol level J:205756
decreased liver glycogen level J:205756
decreased liver triglyceride level J:205756
pale liver J:205756
small liver J:205756
\Srsf10tm1Jalm/\Srsf10tm1Jalm
(involves: 129P2/OlaHsd * C57BL/6) 		liver degeneration J:149480
\Ssr1em1(IMPC)Mbp/\Ssr1+
(C57BL/6N-Ssr1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Ssr2tm1b(EUCOMM)Wtsi/\Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Ssu72tm1Cwl/\Ssu72tm1Cwl
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal hepatocyte morphology J:309624
abnormal Ito cell morphology J:309624
abnormal liver development J:309624
abnormal liver morphology J:309624
hepatic necrosis J:309624
hepatic steatosis J:309624
increased hepatocyte karyomegaly J:309624
increased liver weight J:309624
liver fibrosis J:309624
\St14tm1.1(KOMP)Vlcg/\St14tm1.1(KOMP)Vlcg
(C57BL/6N-St14tm1.1(KOMP)Vlcg/MbpMmucd) 		abnormal liver size J:211773
pale liver J:211773
\Stab1tm1.1Cger/\Stab1tm1.1Cger
\Stab2tm1.1Cger/\Stab2tm1.1Cger
(B6.129S2-Stab2tm1.1Cger Stab1tm1.1Cger) 		liver fibrosis J:171818
\Stab1tm1.1Cger/\Stab1tm1.1Cger
\Stab2tm1.1Cger/\Stab2tm1.1Cger
(C.129S2-Stab2tm1.1Cger Stab1tm1.1Cger) 		liver fibrosis J:171818
\Stag1Gt(P099A04)Wrst/\Stag1+
(involves: 129S2/SvPas) 		increased hepatocellular carcinoma incidence J:184720
\Stard3tm1Jfs/\Stard3tm1Jfs
(involves: 129X1/SvJ * C57BL/6J) 		increased liver cholesterol level J:89362
\Stard4tm1.2Bres/\Stard4tm1.2Bres
(involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL) 		decreased liver weight J:160807
\Stard10tm1Saaa/\Stard10tm1Saaa
(B6.Cg-Stard10tm1Saaa) 		decreased liver cholesterol level J:198860
decreased liver triglyceride level J:198860
decreased liver weight J:198860
decreased susceptibility to diet-induced hepatic steatosis J:198860
\Stat1tm1Dlv/\Stat1tm1Dlv
(either: (involves: 129S/SvEv * C57BL/6) or (involves: 129S/SvEv * C57BL/6 * CD-1)) 		multifocal hepatic necrosis J:31325
\Stat3tm1Flv/\Stat3tm1Flv
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		enlarged liver J:89242
hepatic steatosis J:89242
\Stat3tm1Jbha/\Stat3tm1Jbha
\Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv * C57BL/6) 		increased liver weight J:136030
\Stat5atm2Mam/\Stat5atm2Mam
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased liver iron level J:138904
\Stat5btm1Hwd/\Stat5btm1Hwd
(involves: 129 * BALB/c) 		enlarged liver J:41784
pale liver J:41784
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased liver iron level J:138904
\Steap3fred/\Steap3fred
(C57BL/6-Steap3fred) 		increased liver copper level J:145194
increased liver iron level J:145194
\Steap3tm1.1Mdf/\Steap3tm1.1Mdf
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J) 		increased liver iron level J:103440
\Steap4tm1Dgen/\Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		hepatic steatosis J:187736
increased liver triglyceride level J:187736
increased liver weight J:187736
\Stk3tm1.1Jav/\Stk3+
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
liver hyperplasia J:153945
\Stk3tm1.1Jav/\Stk3tm1.1Jav
\Stk4Gt(AJ0315)Wtsi/\Stk4+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
\Stk3tm1.1Jav/\Stk3tm1Jav
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
liver hyperplasia J:153945
\Stk3tm1.1Rjo/\Stk3tm1.1Rjo
\Stk4tm1.1Rjo/\Stk4tm1.1Rjo
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		abnormal hepatocyte morphology J:156531
abnormal liver morphology J:156531
abnormal liver sinusoid morphology J:156531
increased hepatocellular carcinoma incidence J:156531
increased liver tumor incidence J:156531
increased liver weight J:156531
\Stk3tm1.1Yy/\Stk3tm1Yy
\Stk4tm1.1Yy/\Stk4tm1.1Yy
(involves: C57BL/6 * CBA) 		increased liver tumor incidence J:156541
\Stk3tm1.1Yy/\Stk3tm1Yy
\Stk4tm1.1Yy/\Stk4tm1.1Yy
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * CBA * DBA) 		abnormal hepatocyte morphology J:156541
abnormal liver morphology J:156541
enlarged liver J:156541
\Stk3tm1.1Yy/\Stk3tm1Yy
\Stk4tm1.1Yy/\Stk4tm1.1Yy
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		enlarged liver J:156541
increased hepatocellular carcinoma incidence J:156541
increased liver tumor incidence J:156541
\Stk3tm1Jav/\Stk3tm1Jav
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
liver hyperplasia J:153945
\Stk3tm1Jav/\Stk3tm1Jav
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
liver hyperplasia J:153945
\Stk3tm1Jav/\Stk3tm1Jav
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:238319
\Stk11tm1.1Mlfr/\Stk11+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		enlarged liver J:104347
\Stk11tm1Mmt/\Stk11+
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:76202
\Stk11tm1Mmt/\Stk11+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * 129X1/SvJ) 		abnormal hepatocyte morphology J:107275
increased hepatocellular carcinoma incidence J:107275
increased liver tumor incidence J:107275
\Stk11tm1Tpm/\Stk11+
(Not Specified) 		increased hepatocellular carcinoma incidence J:79074
increased liver adenoma incidence J:79074
\Stx2tm1Dcru/\Stx2tm1Dcru
(involves: 129X1/SvJ * C57BL/6J) 		increased liver weight J:110376
\Sucla2Gt(IST10208H1)Tigm/\Sucla2+
(involves: 129S/SvEv * C57BL/6N) 		decreased hepatocyte mitochondrial DNA content J:241325
\Sucla2Gt(IST10208H1)Tigm/\Sucla2+
\Suclg2Gt(Ayu21-KBW131)Imeg/\Suclg2+
(involves: 129S/SvEv * C57BL/6 * C57BL/6N) 		decreased hepatocyte mitochondrial DNA content J:241325
\Sufutm1b(KOMP)Wtsi/\Sufutm1b(KOMP)Wtsi
(C57BL/6N-Sufutm1b(KOMP)Wtsi/Ucd) 		abnormal liver size J:211773
pale liver J:211773
\Sugcttm1.2Kald/\Sugcttm1.2Kald
(B6.Cg-Sugcttm1.2Kald) 		hepatic steatosis J:293423
\Sugp1em1(IMPC)Mbp/\Sugp1+
(C57BL/6NCrl-Sugp1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Sun5em1(IMPC)Mbp/\Sun5em1(IMPC)Mbp
(C57BL/6N-Sun5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Surf4em1Bcgen/\Surf4em1Bcgen
(C57BL/6J-Surf4em1Bcgen) 		increased liver cholesterol level J:302969
\Syktm1.1(cre)Fkfr/\Syktm1.1(cre)Fkfr
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sortm1(EYFP)Cos
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver development J:159112
decreased liver weight J:159112
liver hypoplasia J:159112
\Taar8bem1(IMPC)Mbp/\Taar8bem1(IMPC)Mbp
(C57BL/6N-Taar8bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Taar8cem1(IMPC)Mbp/\Taar8cem1(IMPC)Mbp
(C57BL/6N-Taar8cem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Tab2tm1Aki/\Tab2tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:81816
\Tacc3tm1Jni/\Tacc3tm1Jni
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:74762
\Tbk1tm1Yeh/\Tbk1tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J) 		liver degeneration J:91653
\Tbl1xr1tm1.1Arte/\Tbl1xr1tm1.1Arte
\Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		increased liver triglyceride level J:198124
\Tbl1xr1tm1b(EUCOMM)Hmgu/\Tbl1xr1+
(C57BL/6N-Tbl1xr1tm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Tbx3tm1Pa/\Tbx3tm1Pa
(either: (involves: 129 * 129S1/Sv * 129X1/SvJ) or (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6NTac)) 		small liver J:82458
\Tcea1tm1Skmz/\Tcea1tm1Skmz
(involves: 129P2/OlaHsd * C57BL/6JJcl) 		liver hypoplasia J:107421
pale liver J:107421
\Tcf3tm1(PBX1)Mlc/\Tcf3+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:226241
\Tcf3tm1(PBX1)Mlc/\Tcf3+
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6) 		enlarged liver J:226241
\Tcf3tm1(PBX1)Mlc/\Tcf3+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J) 		enlarged liver J:226241
\Tcf7l2tm1a(EUCOMM)Wtsi/\Tcf7l2tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Tchptm1Inag/\Tchptm1Inag
(B6.129P2-Tchptm1Inag) 		decreased susceptibility to diet-induced hepatic steatosis J:304307
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi) 		abnormal hepatocyte morphology J:135830
focal hepatic necrosis J:135830
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:93915
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
\Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
\TcraLn1Ogu/\Tcra+
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:152041
\Terf2tm1Tdl/\Terf2tm1.1Tdl
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:112957
\Terf2iptm1.2Tdl/\Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N) 		hepatic steatosis J:199372
\Terttm1Rdp/\Terttm1Rdp
(B6.Cg-Terttm1Rdp) 		decreased liver tumor incidence J:108914
\Tet1tm1.1Gxu/\Tet1tm1.1Gxu
(involves: 129 * 129P2/OlaHsd * C57BL/6J) 		increased liver iron level J:315675
\Tet2Gt(AN0709)Wtsi/\Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi) 		enlarged liver J:174052
liver fibrosis J:174052
\Tet2Gt(AN0709)Wtsi/\Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi) 		enlarged liver J:174052
\Tet2tm1.1Mjxu/\Tet2tm1.1Mjxu
(involves: 129 * C57BL/6) 		enlarged liver J:178415
\Tet2tm1Ics/\Tet2tm1Ics
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal liver sinusoid morphology J:174052
enlarged liver J:174052
\Tfr2em1(IMPC)Rbrc/\Tfr2em1(IMPC)Rbrc
(C57BL/6N-Tfr2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Tfr2tm1.1Anro/\Tfr2tm1.1Anro
(129.Cg-Tfr2tm1.1Anro) 		increased liver iron level J:160785
\Tfr2tm1.1Nsub/\Tfr2tm1.1Nsub
(involves: 129T2/SvEms * C57BL/6) 		increased liver iron level J:114330
\Tfr2tm1.1Nsub/\Tfr2tm1.1Nsub
(involves: 129T2/SvEms) 		increased liver iron level J:160785
\Tfr2tm1Slu/\Tfr2tm1Slu
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:78360
\Tfrctm1Nca/\Tfrc+
(either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6)) 		decreased liver iron level J:54107
\Tg(Abcg1)80-90Ssf/?
(C57BL/6-Tg(Abcg1)80-90Ssf) 		increased liver cholesterol level J:94077
\Tg(Abcg1)123Ssf/?
(C57BL/6-Tg(Abcg1)123Ssf) 		increased liver cholesterol level J:94077
\Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: C57BL/6J * SJL) 		decreased susceptibility to diet-induced hepatic steatosis J:78963
\Tg(Ace2-ACE2)1Cqin/0
(involves: ICR) 		hepatic necrosis J:141460
\Tg(ACTB-Eif4e)#Ppp/?
(Not Specified) 		increased liver adenoma incidence J:89878
\Tg(Actb-Ptma)T12Clwu/\Tg(Actb-Ptma)T12Clwu
(involves: FVB/N) 		increased liver weight J:128557
\Tg(Adipoq-LPL)1Fnln/?
(B6.Cg-Tg(Adipoq-LPL)1Fnln) 		decreased liver triglyceride level J:226970
increased liver triglyceride level J:226970
\Tg(Alb1-cre)7Gsc/0
\Tfr2tm1.1Anro/\Tfr2tm1.1Anro
(involves: 129/Sv * C57BL/6 * FVB/N) 		increased liver iron level J:160785
\Tg(Alb1-Myc)#Sst/0
(involves: C57BL/6 * CBA) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434
increased liver adenoma incidence J:34434
increased liver weight J:34434
\Tg(Alb1-Myc)#Sst/0
\Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434
increased hepatocyte karyomegaly J:34434
increased liver adenoma incidence J:34434
increased liver weight J:34434
multifocal hepatic necrosis J:34434
\Tg(Alb1-Myc)#Sst/0
\Tg(MtTGFA)Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:176432
\Tg(Alb1HBV)43Bri/0
(involves: C57BL/6J) 		abnormal liver morphology J:86165
increased liver tumor incidence J:86165
\Tg(Alb1HBV)44Bri/0
(involves: C57BL/6J * SJL/J) 		abnormal liver morphology J:86165
increased hepatocellular carcinoma incidence J:86165
increased liver adenoma incidence J:86165
increased liver tumor incidence J:86165
\Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J) 		increased hepatocellular carcinoma incidence J:223921
increased liver adenoma incidence J:223921
increased liver tumor incidence J:223921
\Tg(ALB-cre,CMV-rtTA)#Wcyy/0
\Tg(CMV-EGFP,Rnu6-siAbca1)#Wcyy/0
(involves: ICR) 		hepatic steatosis J:93624
\Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6J * CBA/J) 		increased hepatocellular carcinoma incidence J:65354, J:101128
increased liver adenoma incidence J:65354
increased liver tumor incidence J:65354, J:101128
macrovesicular hepatic steatosis J:65354
\Tg(Alb-HBx)A112Tfts/0
(involves: C57BL/6) 		abnormal liver morphology J:104728
hepatic steatosis J:104728
increased hepatocellular carcinoma incidence J:104728
liver hyperplasia J:104728
\Tg(Alb-HRAS*G12V)28Yu/0
(involves: C57BL/6J * CBA/J) 		increased hepatocellular carcinoma incidence J:107083, J:238319
increased liver adenoma incidence J:107083, J:238319
increased liver tumor incidence J:107083, J:238319
\Tg(Alb-Nos2)1Mkan/?
(FVB-Tg(Alb-Nos2)1Mkan) 		decreased liver glycogen level J:177591
increased liver triglyceride level J:177591
\Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6) 		abnormal Ito cell morphology J:96979
abnormal liver morphology J:96979, J:211984
abnormal liver sinusoid morphology J:96979, J:211984
abnormal liver vasculature morphology J:211984
enlarged liver J:96979
hepatic steatosis J:96979
increased hepatocellular carcinoma incidence J:96979, J:211984
liver fibrosis J:96979, J:211984
liver vascular congestion J:211984
macrovesicular hepatic steatosis J:96979
microvesicular hepatic steatosis J:96979
\Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:242582
\Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6) 		abnormal liver morphology J:249664, J:185313
enlarged liver J:249664, J:185313
hepatic steatosis J:249664, J:185313
\Tg(Alb-TAg)1Gjh/0
(C3.Cg-Tg(Alb-TAg)1Gjh) 		increased hepatocellular carcinoma incidence J:105110
\Tg(Alb-TAg)#Arnd/0
(C3Fe.Cg-Tg(Alb-TAg)#Arnd) 		increased hepatocellular carcinoma incidence J:171880
\Tg(Amy1TAg)354Knw/0
(C57BL/6J-Tg(Amy1TAg)354Knw) 		increased hepatoma incidence J:90326
\Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL) 		abnormal hepatocyte morphology J:50770
abnormal liver lobule morphology J:50770
abnormal liver morphology J:249664
enlarged liver J:50770, J:249664
hepatic steatosis J:50770, J:249664
increased liver triglyceride level J:50770
increased liver weight J:50770
pale liver J:50770
\Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2) 		abnormal liver morphology J:16979
liver fibrosis J:16979
liver vascular congestion J:135124
\Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2) 		decreased liver glycogen level J:57075
decreased liver triglyceride level J:57075
decreased liver weight J:57075
\Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N) 		small liver J:69591
\Tg(APOC1)1Lmh/\Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh) 		enlarged liver J:65036
\Tg(APOE-ABCA1)30Ssf/?
(C57BL/6N-Tg(APOE-ABCA1)30Ssf) 		increased liver cholesterol level J:70494
\Tg(APOE-ABCG1)1Ssf/?
(C57BL/6-Tg(APOE-ABCG1)1Ssf) 		increased liver cholesterol level J:94077
\Tg(APOE-DGAT1)1Far/0
(involves: C57BL/6NHsd) 		increased liver triglyceride level J:124005
\Tg(APOE-DGAT2)1Far/0
(involves: C57BL/6NHsd) 		enlarged liver J:124005
hepatic steatosis J:124005
pale liver J:124005
\Tg(APOE-DGAT2)24Far/0
(involves: C57BL/6NHsd) 		enlarged liver J:124005
hepatic steatosis J:124005
pale liver J:124005
\Tg(Apoe-Fgf21)1Sakl/0
(Not Specified) 		increased liver glycogen level J:150831
\Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
(involves: C57BL/6 * DBA) 		hepatic steatosis J:172091
increased liver triglyceride level J:172091
\Tg(AR*100Q)C25Als/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:89772
\Tg(AZIP/F)1Vsn/0
(involves: FVB/N) 		hepatic steatosis J:50807
increased liver triglyceride level J:50807
increased liver weight J:50807
\Tg(CAG-Btc)2Ewo/0
(FVB/N-Tg(CAG-Btc)2Ewo) 		increased liver weight J:103364
\Tg(CAG-Btc)4Ewo/0
(FVB/N-Tg(CAG-Btc)4Ewo) 		increased liver weight J:103364
\Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
\Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
small liver J:142212
\Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N) 		increased liver tumor incidence J:158388
\Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB) 		hepatic steatosis J:80609
\Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB) 		hepatic steatosis J:80609
\Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB) 		hepatic steatosis J:80609
\Tg(CAG-S100a16)#Gpt/0
(C57BL/6J-Tg(CAG-S100a16)#Gpt) 		liver fibrosis J:330793
\Tg(CAG-SAC/EGFP)35Rang/0
(involves: C3H * C57BL/6) 		decreased liver tumor incidence J:125633
\Tg(CD2-NPM/ALK)4Sudt/0
(involves: C57BL/6J * CBA) 		increased liver tumor incidence J:181238
\Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J) 		abnormal liver morphology J:123440
increased liver weight J:123440
\Tg(Cd4-NPM/ALK)N1Ingh/0
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster) 		increased hepatocellular carcinoma incidence J:235890
\Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6) 		abnormal liver morphology J:79703
\Tg(Cebpb-tTA)5Bjd/0
\Tg(tetO-MYC,-OVAL)#Gtgm/0
(B6J.Cg-Tg(Cebpb-tTA)5Bjd Tg(tetO-MYC,-OVAL)#Gtgm) 		increased hepatocellular carcinoma incidence J:186226
\Tg(CETP)5203Tall/0
(involves: C57BL/6 * CBA/J) 		decreased liver triglyceride level J:117482
\Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr) 		increased liver triglyceride level J:71205
\Tg(CMV-cre)1Cgn/0
\Tg(Kit*D814V)1Roer/0
(involves: BALB/cJ * C57BL/6) 		abnormal liver morphology J:169611
\Tg(CMV-cre)1Cgn/0
\Tg(Kit*D814V)3Roer/0
(involves: BALB/cJ * C57BL/6) 		abnormal liver morphology J:169611
\Tg(CMV-tTA)3Bjd/0
\Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased liver adenoma incidence J:94953
increased liver tumor incidence J:94953
\Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove) 		enlarged liver J:94602
\Tg(CTSG-PML/RARA)135Ley/?
(Not Specified) 		enlarged liver J:77881
\Tg(CTSG-ZBTB16/RARA)#Sjch/0
(involves: C57BL/6) 		abnormal liver morphology J:55196
\Tg(Fabp1-Ccnd1)2Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)2Rdb) 		abnormal hepatocyte morphology J:70394
increased liver adenoma incidence J:70394
increased liver weight J:70394
Mallory bodies J:70394
\Tg(Fabp1-Ccnd1)4Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)4Rdb/J) 		abnormal hepatocyte morphology J:70394
increased hepatocellular carcinoma incidence J:70394
increased liver adenoma incidence J:70394
increased liver weight J:70394
Mallory bodies J:70394
\Tg(Fabp1-Nr1h3)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:135594
hepatic steatosis J:135594
increased liver triglyceride level J:135594
\Tg(Fabp1-Nr1h3)#Wexi/?
\Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:135594
increased liver triglyceride level J:135594
\Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:135594
hepatic steatosis J:135594
increased liver triglyceride level J:135594
\Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul) 		increased liver triglyceride level J:344362
increased susceptibility to diet-induced hepatic steatosis J:344362
\Tg(Fabp4-Ccl2)BYt/0
(involves: C57BL/6N) 		increased liver triglyceride level J:110277
\Tg(Fabp4-ENPP1)#Naba/0
(involves: C57BL/6J) 		hepatic steatosis J:182179
increased liver triglyceride level J:182179
\Tg(Fabp4-LEP)F8Ffc/0
(involves: C57BL/6J * DBA/2J) 		small liver J:67311
\Tg(Fabp4-Phb)#Smis/0
(involves: CD-1) 		hepatic steatosis J:230172
\Tg(Fabp4-Serpina12)1Jwada/0
(involves: C57BL/6JJcl) 		decreased liver triglyceride level J:208508
decreased liver weight J:208508
decreased susceptibility to diet-induced hepatic steatosis J:208508
\Tg(Fabp4-SREBF1)#Dajl/0
(involves: FVB) 		enlarged liver J:189510
\Tg(Fabp4-TLE3)#aPton/0
(involves: C57BL/6) 		decreased liver weight J:172245
decreased susceptibility to diet-induced hepatic steatosis J:172245
\Tg(Gh-Gal)4599Vron/\Tg(Gh-Gal)4599Vron
(B6.Cg-Tg(Gh-Gal)4599Vron) 		enlarged liver J:210298
hepatic steatosis J:210298
pale liver J:210298
\Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr) 		abnormal liver morphology J:67478
enlarged liver J:67478
\Tg(H2-K-Fosl1)1Wag/0
(involves: C57BL/6 * CBA) 		liver cirrhosis J:64494
\Tg(H2-K-Fosl2,-EGFP)13Wag/0
(either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag) 		liver fibrosis J:139032
\Tg(HBV-HCV)21Kko/0
(C57BL/6N-Tg(HBV-HCV)21Kko) 		hepatic steatosis J:94426, J:52686
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
\Tg(HBV-HCV)49Kko/0
(C57BL/6N-Tg(HBV-HCV)49Kko) 		hepatic steatosis J:94426, J:52686
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
\Tg(HBV-HCV)Kko/0
(C57BL/6N-Tg(HBV-HCV)Kko) 		abnormal hepatocyte morphology J:69727
hepatic steatosis J:94426, J:52686
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
\Tg(HBVX*,-Myc)#Skp/0
(Not Specified) 		increased hepatocellular carcinoma incidence J:81098
\Tg(HBVX*,-Myc)#Skp/\Tg(HBVX*,-Myc)#Skp
(Not Specified) 		abnormal hepatocyte mitochondrial morphology J:202732
abnormal hepatocyte morphology J:81098
abnormal liver lobule morphology J:81098
abnormal liver morphology J:81098
abnormal liver sinusoid morphology J:81098
decreased liver glycogen level J:81098
enlarged liver J:81098
focal hepatic necrosis J:81098
increased hepatocellular carcinoma incidence J:81098
increased liver iron level J:81098
increased liver weight J:81098
liver vascular congestion J:81098
microvesicular hepatic steatosis J:81098
\Tg(HBx)3Yu/0
(involves: C57BL/6 * DBA) 		abnormal liver morphology J:56196
increased hepatocellular carcinoma incidence J:56196
\Tg(Hnf1a-RB1*)XMiu/?
(Not Specified) 		abnormal hepatocyte morphology J:180294
increased liver adenoma incidence J:180294
\Tg(Hnrnpa2b1-rtTA2S*M2)9Jstr/0
\Tg(tetO-FMR1*,-EGFP)#Rkhu/0
(involves: C57BL/6JRj * FVB/N) 		abnormal liver morphology J:229379
hepatic steatosis J:229379
pale liver J:229379
\Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified) 		enlarged liver J:178816
\Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6) 		enlarged liver J:76574
\Tg(IghMyc)22Bri/0
\Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N) 		abnormal liver morphology J:89049
\Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL) 		hepatic steatosis J:141527
\Tg(IRS1)1Mhep/0
(FVB-Tg(IRS1)1Mhep) 		increased liver weight J:92999
\Tg(IRS1)1Mhep/0
\Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * FVB * ICR) 		hepatic steatosis J:227278
increased hepatocellular carcinoma incidence J:227278
\Tg(ITGAM-HBEGF/EGFP)34Lan/0
(involves: FVB/N) 		liver fibrosis J:95141
\Tg(KB1430A10)1Ped/0
(involves: BALB/cJ * C57BL/6) 		decreased liver triglyceride level J:117028
\Tg(KRT14-Tslp)1Pcn/0
(involves: C57BL/6 * SJL) 		enlarged liver J:102470
\Tg(KRT18*R89C)22Rgo/0
(involves: FVB/N) 		abnormal hepatocyte morphology J:241700
abnormal liver vasculature morphology J:241700
hepatic necrosis J:241700
\Tg(KRT18*R89C)30Rgo/0
(involves: FVB/N) 		abnormal hepatocyte morphology J:241700
abnormal liver vasculature morphology J:241700
hepatic necrosis J:241700
\Tg(KRT18*R89C)50Rgo/0
(involves: FVB/N) 		abnormal hepatocyte morphology J:241700
abnormal liver vasculature morphology J:241700
hepatic necrosis J:241700
\Tg(Lck-LMO1)11Sjk/0
\Tg(STIL-TAL1)A5.3Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros) 		enlarged liver J:40868
\Tg(Lck-Tal1)4709Led/0
(FVB/N-Tg(Lck-Tal1)4709Led) 		enlarged liver J:36076
\Tg(Lck-Tax)53Hall/0
(involves: C57BL/6) 		enlarged liver J:129531
hepatosplenomegaly J:129531
\Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf) 		abnormal liver morphology J:120962
\Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea) 		increased liver weight J:72982
\Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA) 		abnormal liver morphology J:144382
increased hepatoma incidence J:144382
\Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA) 		abnormal liver morphology J:144382
increased hepatoma incidence J:144382
\Tg(Mafg-Nfe2l1)1Mym/0
(involves: C57BL/6J * DBA/2) 		increased liver weight J:230118
\Tg(Mafg-Nfe2l1)6Mym/0
(involves: C57BL/6J * DBA/2) 		increased liver weight J:230118
\Tg(Mt1-GH1)#Jjk/0
(C57BL/6J-Tg(Mt1-GH1)#Jjk) 		increased liver weight J:132437
\Tg(Mt1-IL6)28Gci/0
(involves: C57BL/6 * DBA/2) 		enlarged liver J:177825
\Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CD-1) 		increased liver tumor incidence J:2578
\Tg(MtTGFA)42Lmb/0
(involves: CD-1 * FVB/N) 		increased liver tumor incidence J:2578
\Tg(MtTGFA)42Lmb/\Tg(MtTGFA)42Lmb
(involves: CD-1) 		abnormal hepatocyte morphology J:28452
abnormal liver morphology J:28452
enlarged liver J:28452
increased hepatocellular carcinoma incidence J:28452
increased hepatocyte karyomegaly J:28452
\Tg(Mup3-Plau)350-2Eps/0
(involves: C57BL/6) 		increased liver tumor incidence J:66132
pale liver J:66132
\Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps) 		abnormal hepatocyte morphology J:233146
hepatic necrosis J:233146
hepatic steatosis J:233146
increased hepatocellular carcinoma incidence J:233146
increased liver adenoma incidence J:233146
increased liver cholesterol level J:233146
increased liver free fatty acids level J:233146
increased liver triglyceride level J:233146
increased liver tumor incidence J:233146
liver fibrosis J:233146
liver hyperplasia J:233146
\Tg(Mx1-cre)1Cgn/0
\Thoc5tm1Tate/\Thoc5tm1Tate
(involves: C57BL/6 * CBA) 		pale liver J:169944
\Tg(Myh6-ACE2)1Rbre/0
(involves: FVB/N) 		focal hepatic necrosis J:128793
\Tg(Myh6-ACE2)2Rbre/0
(involves: FVB/N) 		focal hepatic necrosis J:128793
\Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1) 		dark liver J:133881
hepatic necrosis J:133881
liver vascular congestion J:133881
\Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns) 		liver vascular congestion J:133093
\Tg(Myh6-GAL4)G#2Vmc/0
(FVB-Tg(Myh6-GAL4)G#2Vmc) 		abnormal liver parenchyma morphology J:330678
\Tg(Myh6-Gnaq*Q209L)52Ejne/?
(involves: FVB) 		liver vascular congestion J:204274
\Tg(Myh6-IGF1)34Pia/0
(FVB/N-Tg(Myh6-IGF1)34Pia) 		increased liver weight J:35215
\Tg(Myh6-Med13)1Eno/0
(B6.Cg-Tg(Myh6-Med13)1Eno) 		abnormal liver triglyceride level J:186193
\Tg(Myh6-Mef2d)2Eno/0
(Not Specified) 		liver vascular congestion J:130825
\Tg(Myh6-Pln*R9C)#Ces/0
(involves: FVB/N) 		enlarged liver J:82353
\Tg(Myh6-STK4)28Jusa/0
(involves: C57BL/6) 		increased liver weight J:139414
liver vascular congestion J:139414
\Tg(Myh6-tTA)6Smbf/0
\Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6 * CBA) 		liver vascular congestion J:131245
\Tg(Myl2-FGF19)1Dfre/?
(involves: FVB) 		abnormal liver morphology J:76323, J:77160
decreased liver triglyceride level J:76323
increased hepatocellular carcinoma incidence J:187236, J:77160
increased liver tumor incidence J:77160
\Tg(Neurog3-cre)C1Able/0
\Tg(RNU6-EGFP,-RNAi:Dpp7)#Bhub/0
(involves: 129 * C57BL/6 * CD-1) 		hepatic steatosis J:158215
increased liver weight J:158215
\Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J) 		liver cyst J:157952
liver fibrosis J:157952
\Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J) 		liver cyst J:157952
liver fibrosis J:157952
\Tg(Pklr-HRAS*G12V)23Ak/0
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:44803
increased hepatoma incidence J:44803
\Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:185488
increased hepatoma incidence J:185488
\Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
\Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:185488
increased hepatoma incidence J:185488
\Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA) 		decreased susceptibility to diet-induced hepatic steatosis J:182671
\Tg(RP23-326M22)760She/0
(B6.Cg-Tg(RP23-326M22)760She) 		abnormal hepatocyte morphology J:161765
\Tg(rPEPCKSREBF2)788Reh/0
(Not Specified) 		increased liver cholesterol level J:86518
increased liver triglyceride level J:86518
pale liver J:86518
\Tg(SERPINA1*E342K)#Slcw/0
(involves: C57BL/6 * ICR) 		abnormal hepatocyte morphology J:208016, J:149132
hepatic necrosis J:149132
\Tg(SERPINA1*E342K)#Slcw/\Tg(SERPINA1*E342K)#Slcw
(involves: C57BL/6 * ICR) 		liver fibrosis J:208016
\Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * ICR) 		abnormal liver morphology J:90305
\Tg(SERPINA1-TAg)1812Jtsb/0
(involves: C3H * C57BL/6 * ICR) 		increased hepatocellular carcinoma incidence J:101633
\Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2) 		abnormal liver morphology J:101541
increased hepatocellular carcinoma incidence J:101541
\Tg(SERPINC1-SV40)A1Pbr/\Tg(SERPINC1-SV40)A1Pbr
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:101541
X/\Tg(SERPINC1-SV40)BPbr
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:84204, J:101541
increased liver adenoma incidence J:84204
\Tg(Sirt1)ASrn/?
(involves: C57BL/6 * CBA) 		decreased susceptibility to diet-induced hepatic steatosis J:137868
\Tg(SREBP1a)7343Reh/0
(involves: C57BL/6J * SJL/J) 		abnormal hepatocyte morphology J:35770
enlarged liver J:35770
increased liver cholesterol level J:35770
increased liver triglyceride level J:35770
increased liver weight J:35770
pale liver J:35770
\Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh) 		enlarged liver J:100328
\Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		enlarged liver J:93775
\Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA) 		increased liver weight J:77977
\Tg(Tal1-cre/ERT)1Jrg/0
\Tsc1tm1Djk/\Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6) 		increased liver tumor incidence J:231316
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp) 		pale liver J:72817
\Tg(Tek-cre)1Ywa/0
\Thbdtm2Rdr/\Thbdtm2Wlr
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal liver morphology J:71269
\Tg(tetO-BCR/ABL1)2Dgt/0
\Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		enlarged liver J:96511
\Tg(tetO-Kdr*)4377.5Rwng/0
\Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		abnormal hepatocyte morphology J:100427
abnormal liver morphology J:100427
dark liver J:100427
\Tg(tetO-MET)23Rwng/0
\Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		abnormal hepatocyte morphology J:69731
enlarged liver J:69731
focal hepatic necrosis J:69731
hepatic steatosis J:69731
increased hepatocellular carcinoma incidence J:69731
\Tg(tetO-MYC)36aBop/0
\Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		increased hepatoblastoma incidence J:93899
increased hepatocellular carcinoma incidence J:172430, J:186226, J:190067, J:93899
increased liver tumor incidence J:172430, J:93899
\Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1) 		decreased liver weight J:73757
\Tg(Ttr-IGF1)1Sykr/0
(FVB/N-Tg(Ttr-IGF1)1Sykr) 		increased liver weight J:157350
\Tg(Ttr-KLF6)1Fdmn/?
(Not Specified) 		decreased hepatocyte number J:122903
decreased liver weight J:122903
\Tg(Ttr-SMYD3)1Ital/?
(Not Specified) 		hepatic steatosis J:82809
pale liver J:82809
\Tg(Vav1-Asxl1*Y588X)#Fcy/0
(C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy) 		hepatosplenomegaly J:257690
\Tgfb1tm1Doe/\Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1) 		multifocal hepatic necrosis J:2892
\Tgfb1tm1Doe/\Tgfb1tm1Doe
(C.129S2-Tgfb1tm1Doe) 		hepatic necrosis J:69346
\Tgfb1tm1Jmu/\Tgfb1tm1Jmu
(involves: 129S6/SvEvTac * C57BL/6 * Swiss Webster) 		abnormal liver morphology J:120085
\Tgfb1tm1N/\Tgfb1tm1N
(involves: 129S/SvEv) 		abnormal liver morphology J:120085
\Tgfb1tm1N/\Tgfb1tm1N
(involves: 129S/SvEv * C57BL/6J * NIH/Ola) 		delayed hepatic development J:26913
\Tgfbr2em1(IMPC)Rbrc/\Tgfbr2+
(C57BL/6NJcl-Tgfbr2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
small liver J:211773
\Tgfbr3em1(IMPC)Mbp/\Tgfbr3em1(IMPC)Mbp
(C57BL/6N-Tgfbr3em1(IMPC)Mbp/MbpMmucd) 		pale liver J:211773
\Tgfbr3tm1Stv/\Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:83727
\Thtm1Rpa/\Thtm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		liver vascular congestion J:24347
\Thtm2Rpa/\Thtm2Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		liver vascular congestion J:24347
\Thap1tm1.1Meeh/\Thap1tm1.2Meeh
(involves: 129S/SvEv * BALB/cJ * C3H * C57BL/6) 		absent liver J:226849
\Thap1tm1.2Meeh/\Thap1tm1.2Meeh
(involves: 129S/SvEv * BALB/cJ * C3H * C57BL/6) 		absent liver J:226849
\Thbs1tm1.1(KOMP)Vlcg/\Thbs1tm1.1(KOMP)Vlcg
(C57BL/6N-Thbs1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Thbs1tm1Hyn/\Thbs1tm1Hyn
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased liver adenocarcinoma incidence J:72391
\Them4tm1Hem/\Them4tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:149552
\Them5tm1Hem/\Them5tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:186657
\ThimTg(Myh6-TGFB1)1Ljf/\Thim+
(involves: C3HeB/FeJ) 		abnormal liver morphology J:59903
\Thoc2em1Gecz/Y
(C57BL/6JArc-Thoc2em1Gecz) 		decreased liver weight J:345229
small liver J:345229
\Thratm4.1Ven/\Thratm4.1Ven
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N) 		decreased liver weight J:166513
\Thrap3tm1c(KOMP)Wtsi/\Thrap3tm1c(KOMP)Wtsi
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		decreased liver cholesterol level J:339439
decreased liver triglyceride level J:339439
decreased susceptibility to diet-induced hepatic steatosis J:339439
increased hepatocyte mitochondrial DNA content J:339439
\Ticam1Lps2/\Ticam1Lps2
(C57BL/6J-Ticam1Lps2) 		decreased susceptibility to alcohol-induced hepatic steatosis J:138963
\Timm13em1(IMPC)Tcp/\Timm13+
(C57BL/6NCrl-Timm13em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Timo/\Timo
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ)) 		hepatic steatosis J:127183
\Timp3tm1Rkho/\Timp3tm1Rkho
(B6.129-Timp3tm1Rkho) 		abnormal liver lobule morphology J:92948
hepatic necrosis J:92948
\TiparpGt(ROSA)79Sor/\TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J) 		enlarged liver J:250417
hepatic steatosis J:250417
liver degeneration J:250417
\Tjp1tm1.1Whun/\Tjp1tm1.1Whun
\Tjp2tm2Whun/\Tjp2tm2Whun
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2) 		abnormal bile canaliculus morphology J:306936
abnormal hepatic cord morphology J:306936
abnormal hepatocyte morphology J:306936
abnormal liver morphology J:306936
abnormal liver sinusoid morphology J:306936
increased liver weight J:306936
small liver J:306936
\Tk2tm1Anka/\Tk2tm1Anka
(involves: 129X1/SvJ * C57BL/6) 		abnormal hepatocyte morphology J:137664
\Tkttm1Jpi/\Tkt+
(involves: 129X1/SvJ * C57BL/6J) 		decreased liver weight J:78430
\Tle4em1(IMPC)Mbp/\Tle4em1(IMPC)Mbp
(C57BL/6NCrl-Tle4em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Tlr2tm1Aki/\Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki) 		decreased liver tumor incidence J:143870
hepatic steatosis J:158035
\Tlr2tm1Aki/\Tlr2tm1Aki
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:135830
\Tlr2tm1Kir/\Tlr2tm1Kir
(B6.129-Tlr2tm1Kir) 		decreased susceptibility to hepatic steatosis J:162168
\Tlr4Lps-d/\Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d) 		abnormal hepatocyte morphology J:135830
decreased liver triglyceride level J:126488
focal hepatic necrosis J:135830
\Tlr5tm1Flv/\Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		hepatic steatosis J:158055
\Tm6sf2tm1a(KOMP)Wtsi/\Tm6sf2+
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi) 		increased liver triglyceride level J:234195
\Tm6sf2tm1a(KOMP)Wtsi/\Tm6sf2tm1a(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi) 		hepatic steatosis J:234195
increased liver triglyceride level J:234195
\Tmc7em1(IMPC)Mbp/\Tmc7em1(IMPC)Mbp
(C57BL/6NCrl-Tmc7em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Tmed6em1(IMPC)Rbrc/\Tmed6em1(IMPC)Rbrc
(C57BL/6NJcl-Tmed6em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Tmem14cGt(E295C12)Wrst/\Tmem14cGt(E295C12)Wrst
(B6;129P2-Tmem14cGt(E295C12)Wrst/Llp) 		pale liver J:212530
\Tmem30atm1.1Xjz/\Tmem30atm1.1Xjz
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA) 		abnormal liver morphology J:249038
decreased liver weight J:249038
liver fibrosis J:249038
\Tmem63cem1(IMPC)Rbrc/\Tmem63cem1(IMPC)Rbrc
(C57BL/6NJcl-Tmem63cem1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Tmem68tm1a(EUCOMM)Wtsi/\Tmem68tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem68tm1a(EUCOMM)Wtsi) 		decreased liver triglyceride level J:339870
\Tmem132bem1(IMPC)Ccpcz/\Tmem132bem1(IMPC)Ccpcz
(C57BL/6N-Tmem132bem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Tmem150bem1(IMPC)Ccpcz/\Tmem150bem1(IMPC)Ccpcz
(C57BL/6N-Tmem150bem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Tmem240em1(IMPC)Ccpcz/\Tmem240em1(IMPC)Ccpcz
(C57BL/6N-Tmem240em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
\Tmem248tm1.1(KOMP)Vlcg/\Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd) 		decreased liver weight J:211773
\Tmem263em1Gww/\Tmem263em1Gww
(C57BL/6J-Tmem263em1Gww) 		decreased liver weight J:345905
\Tmod3Gt(RRF004)Byg/\Tmod3Gt(RRF004)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:208725
small liver J:208725
\Tmprss6hem8/\Tmprss6hem8
(C57BL/6J-Tmprss6hem8) 		decreased liver iron level J:237155
\Tmprss6hem8/\Tmprss6tm1Dgen
(involves: C57BL/6 * C57BL/6J) 		decreased liver iron level J:237155
\Tmprss6tm1Dgen/\Tmprss6+
(B6.129P2-Tmprss6tm1Dgen/Crl) 		decreased liver iron level J:160248
\Tmprss6tm1Dgen/\Tmprss6tm1Dgen
(B6.129P2-Tmprss6tm1Dgen/Crl) 		decreased liver iron level J:237155, J:160248
\Tmprss6tm1Dgen/\Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		decreased liver iron level J:160248
\Tnftm1.1Sned/\Tnftm1.1Sned
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		hepatic necrosis J:95684
\Tnftm2Jods/\Tnftm2Jods
(involves: C57BL/6 * C57BL/6J) 		decreased liver free fatty acids level J:112797
\Tnfaip3tm1.1Gvl/\Tnfaip3tm1.1Gvl
\Tg(Vil1-cre)997Gum/0
(B6.Cg-Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum) 		liver degeneration J:163410
\Tnfaip3tm1Homy/\Tnfaip3tm1Homy
\Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		enlarged liver J:212681
\Tnfaip8l1em1(IMPC)Mbp/\Tnfaip8l1em1(IMPC)Mbp
(C57BL/6N-Tnfaip8l1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
small liver J:211773
\Tnfrsf11adel8/\Tnfrsf11adel8
(involves: 129) 		enlarged liver J:111512
\Tnip1tm1.1Ama/\Tnip1tm1.1Ama
(involves: C57BL/6J) 		liver hypoplasia J:145539
\Tnip1tm1.1Pcoh/\Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6) 		liver fibrosis J:176826
\Tnk1tm1Sksuf/\Tnk1+
(involves: 129X1/SvJ * C57BL/6) 		increased hepatocellular carcinoma incidence J:140639
increased hepatoma incidence J:140639
\Tnk1tm1Sksuf/\Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6) 		increased hepatocellular carcinoma incidence J:140639
\Tnnem1(IMPC)Mbp/\Tnnem1(IMPC)Mbp
(C57BL/6NCrl-Tnnem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Top2aem2(IMPC)Tcp/\Top2a+
(C57BL/6NCrl-Top2aem2(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Tor1atm3.1Wtd/\Tor1a+
\Tor1aip1tm1.1Wtd/\Tor1aip1tm1.1Wtd
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		abnormal hepatocyte morphology J:345574
hepatic steatosis J:345574
\Tor1atm3.1Wtd/\Tor1atm3.1Wtd
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		hepatic steatosis J:345574
\Tor1atm3.1Wtd/\Tor1atm3.1Wtd
\Tor1aip1tm1.1Wtd/\Tor1aip1+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		hepatic steatosis J:345574
\Tor1atm3.1Wtd/\Tor1atm3.1Wtd
\Tor1aip1tm1.1Wtd/\Tor1aip1tm1.1Wtd
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		abnormal hepatocyte morphology J:345574
hepatic steatosis J:345574
\Toxtm1b(KOMP)Wtsi/\Toxtm1b(KOMP)Wtsi
(C57BL/6N-Toxtm1b(KOMP)Wtsi/Tcp) 		decreased liver weight J:211773
\Tph2em1(IMPC)Mbp/\Tph2+
(C57BL/6N-Tph2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Tpx2Gt(D028B03)Wrst/\Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		increased hepatocellular carcinoma incidence J:184948
\Traf3tm1Bshp/\Traf3tm1Bshp
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL) 		abnormal liver morphology J:124329
\Traf6tm1Mak/\Traf6tm1Mak
(involves: 129P3/J) 		enlarged liver J:54467
\Traf6tm2a(EUCOMM)Wtsi/\Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi) 		herniated liver J:239583
\Traj18em1Hwata/\Traj18em1Hwata
(C57BL/6-Traj18em1Hwata) 		abnormal liver morphology J:256533
\Trap1Gt(E150H04)Wrst/\Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:226880
liver hyperplasia J:226880
\Trappc1em1(IMPC)Mbp/\Trappc1+
(C57BL/6NCrl-Trappc1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Trex1em1(IMPC)Ccpcz/\Trex1em1(IMPC)Ccpcz
(C57BL/6NCrl-Trex1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Trex1tm1.1Fwpe/\Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac) 		liver vascular congestion J:220965
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd) 		hepatic necrosis J:92264
\Trib1tm1Aki/\Trib1tm1Aki
(involves: 129P2/OlaHsd) 		increased liver iron level J:196449
\Trim24em1Schen/\Trim24em1Schen
(C57BL/6J-Trim24em1Schen) 		decreased susceptibility to diet-induced hepatic steatosis J:345293
\Trim24em2Schen/\Trim24em2Schen
(C57BL/6J-Trim24em2Schen) 		decreased susceptibility to diet-induced hepatic steatosis J:345293
\Trim24tm1.1Los/\Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL) 		increased hepatocellular carcinoma incidence J:130210
increased liver adenoma incidence J:130210
increased liver tumor incidence J:130210
\Trim37Gt(RRO307)Byg/\Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		abnormal liver morphology J:232482
dilated liver sinusoidal space J:232482
enlarged liver J:232482
hepatic steatosis J:232482
increased liver triglyceride level J:232482
\Trim55tm1Slbt/\Trim55tm1Slbt
\Trim63tm1Slbt/\Trim63tm1Slbt
(involves: 129 * C57BL/6) 		abnormal liver morphology J:130921
\Trim61em1(IMPC)Mbp/\Trim61em1(IMPC)Mbp
(C57BL/6N-Trim61em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Trim62tm1Akil/\Trim62+
(involves: 129S/SvEv * C57BL/6) 		increased hepatocellular carcinoma incidence J:204336
increased liver adenocarcinoma incidence J:204336
\Trim62tm1Akil/\Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6) 		increased liver adenocarcinoma incidence J:204336
\Trim72tm1Rpx/\Trim72tm1Rpx
(involves: 129/SvJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:342778
\Trmt1tm1b(EUCOMM)Hmgu/\Trmt1+
(C57BL/6N-Trmt1tm1b(EUCOMM)Hmgu/Ics) 		abnormal liver morphology J:211773
\Trp53tm1.1Xlu/\Trp53tm1.1Xlu
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * FVB/N) 		increased liver tumor incidence J:166152
liver hyperplasia J:166152
\Trp53tm1.2Awbr/\Trp53+
(involves: C57BL/6) 		hepatic steatosis J:173271
liver cirrhosis J:173271
\Trp53tm1.2Awbr/\Trp53tm1.2Awbr
(involves: C57BL/6) 		hepatic steatosis J:173271
liver cirrhosis J:173271
\Trp53tm1Ldo/\Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased liver weight J:73757
liver hypoplasia J:73757
\Trp53tm1Tyj/\Trp53+
\Trp73tm1Fmc/\Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:98958
\Trp53tm1Yjc/\Trp53tm1Yjc
(B6.129S1-Trp53tm1Yjc) 		enlarged liver J:195018
\Trp53tm3.1Glo/\Trp53+
(B6.129S7-Trp53tm3.1Glo) 		hepatosplenomegaly J:317504
\Trp53tm3.1Tyj/\Trp53+
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:95316
\Trp53inp1tm1Acar/\Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:233434
increased liver weight J:233434
\Trp53inp2em1(IMPC)Mbp/\Trp53inp2em1(IMPC)Mbp
(C57BL/6N-Trp53inp2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Trpc4apem1Cya/\Trpc4apem1Cya
(C57BL/6J-Trpc4apem1Cya/Cya) 		decreased susceptibility to diet-induced hepatic steatosis J:300649
\Trpm2tm1.1Alp/\Trpm2tm1.1Alp
(B6.129P2-Trpm2tm1.1Alp) 		liver abscess J:174397
\Trpv1tm1Jul/\Trpv1tm1Jul
(involves: 129X1/SvJ) 		decreased susceptibility to diet-induced hepatic steatosis J:137026
\Tsc1tm1.1Djk/\Tsc1+
(either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J)) 		increased hepatic hemangioma incidence J:75243
\Tsc1tm1.1Djk/\Tsc1tm1.1Djk
(either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J)) 		liver hypoplasia J:75243
\Tsc1tm1Chdl/\Tsc1+
(involves: 129P2/OlaHsd * C57BL/6JOlaHsd) 		increased hepatic hemangioma incidence J:99796
\Tsc1tm1Chdl/\Tsc1+
(involves: 129P2/OlaHsd * Balb/cOlaHsd * C57BL/6JOlaHsd) 		increased hepatic hemangioma incidence J:99796
\Tsc1tm1Chdl/\Tsc1+
(involves: 129P2/OlaHsd * C3H/HeNHsd * C57BL/6JOlaHsd) 		increased hepatic hemangioma incidence J:99796
\Tsc1tm1Djk/\Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:167208
enlarged liver J:167208
\Tsc1tm1Djk/\Tsc1tm1Djk
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:171445
enlarged liver J:171445
\Tsc1tm1Hin/\Tsc1+
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatic hemangioma incidence J:70463
\Tsc1tm1Hin/\Tsc1tm1Hin
(involves: 129S4/SvJae * C57BL/6J) 		liver hypoplasia J:70463
\Tsc2tm1Djk/\Tsc2+
(either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J)) 		increased hepatic hemangioma incidence J:57631
\Tsc2tm1Djk/\Tsc2tm1Djk
(either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J)) 		liver hypoplasia J:57631
\Tsc2tm1Tno/\Tsc2+
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatic hemangioma incidence J:52464
\Tsc2tm2.2Djk/\Tsc2tm2.2Djk
(involves: 129S4/SvJae * C57BL/6) 		liver hypoplasia J:149326
\Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ) 		decreased susceptibility to diet-induced hepatic steatosis J:223992
\Tspan32em1(IMPC)Mbp/\Tspan32em1(IMPC)Mbp
(C57BL/6N-Tspan32em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Tspan33tm1Stsa/\Tspan33tm1Stsa
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver tumor incidence J:143158
\Ttc7fsn-Jic/\Ttc7fsn-Jic
(C3.INT-Ttc7fsn-Jic) 		liver hypoplasia J:115742
pale liver J:115742
\Ttc7fsn/\Ttc7fsn
(CByJ.A-Ttc7fsn) 		enlarged liver J:29200
\Ttc7hea/\Ttc7hea
(WBB6F1) 		abnormal hepatocyte morphology J:92699
\Tubtub/\Tubtub
(C57BL/6J-Tubtub) 		hepatic steatosis J:13772
increased liver glycogen level J:13772
\Tulp4tm1a(KOMP)Wtsi/\Tulp4+
(involves: C57BL/6N * C57BL/6NRj) 		abnormal liver vasculature morphology J:344151
\Twist2tm1(cre)Dor/\Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ) 		abnormal hepatocyte morphology J:81485
decreased liver glycogen level J:81485
\TxnipHyplip1/\Txnip+
(involves: CAST/Ei * HcB19/Dem) 		increased hepatocellular carcinoma incidence J:112292
\TxnipHyplip1/\TxnipHyplip1
(HcB19/Dem-TxnipHyplip1) 		increased hepatocellular carcinoma incidence J:112292
\TxnipHyplip1/\TxnipHyplip1
(involves: CAST/Ei * HcB19/Dem) 		increased hepatocellular carcinoma incidence J:112292
\TxnipHyplip1/\TxnipHyplip1
(B6.HcB19-TxnipHyplip1) 		increased liver weight J:102224
\Txniptm1Jjy/\Txniptm1Jjy
(involves: C57BL/6 * CBA) 		hepatic steatosis J:104563
liver degeneration J:104563
macrovesicular hepatic steatosis J:104563
microvesicular hepatic steatosis J:104563
\Txnrd2tm1.1Marc/\Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:94136
\Tysnd1tm1.1Arte/\Tysnd1tm1.1Arte
(involves: C57BL/6J * C57BL/6N) 		abnormal hepatocyte morphology J:223054
enlarged liver J:223054
hepatic steatosis J:223054
pale liver J:223054
\Uacatm1Kiy/\Uacatm1Kiy
(B6.129P2-Uacatm1Kiy) 		abnormal Kupffer cell morphology J:157049
enlarged liver J:157049
increased hepatocellular carcinoma incidence J:157049
\Ubctm1Rrk/\Ubctm1Rrk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver development J:122574
\Ube2fem1(IMPC)Mbp/\Ube2f+
(C57BL/6NCrl-Ube2fem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Ube2g1tm1b(EUCOMM)Hmgu/\Ube2g1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ube2g1tm1b(EUCOMM)Hmgu/Rbrc) 		small liver J:211773
\Ube2j2em1(IMPC)Rbrc/\Ube2j2em1(IMPC)Rbrc
(C57BL/6NJcl-Ube2j2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Ubqln4em1(IMPC)Mbp/\Ubqln4em1(IMPC)Mbp
(C57BL/6NCrl-Ubqln4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Ubr2tm1e.1(KOMP)Mbp/\Ubr2+
(C57BL/6N-Ubr2tm1e.1(KOMP)Mbp/Tcp) 		abnormal liver morphology J:211773
\Ubr4tm1.2Nkt/\Ubr4tm1.2Nkt
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		abnormal liver parenchyma morphology J:203460
abnormal liver vasculature morphology J:203460
dilated liver sinusoidal space J:203460
liver hypoplasia J:203460
\Ubtfem1(IMPC)Mbp/\Ubtf+
(C57BL/6NCrl-Ubtfem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Ucn3tm1Pbl/\Ucn3tm1Pbl
(Not Specified) 		decreased susceptibility to diet-induced hepatic steatosis J:119417
\Ucp2tm1Lowl/\Ucp2tm1Lowl
(B6.129S4-Ucp2tm1Lowl) 		liver cyst J:272325
\Ufl1tm1a(EUCOMM)Wtsi/\Ufl1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		small liver J:238253
\Uggt1em1(IMPC)Mbp/\Uggt1+
(C57BL/6N-Uggt1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
\Uggt2tm1b(KOMP)Wtsi/\Uggt2tm1b(KOMP)Wtsi
(C57BL/6N-Uggt2tm1b(KOMP)Wtsi/Ieg) 		abnormal liver morphology J:211773
\Unc93b1tm1.1Kmiy/\Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:174308
multifocal hepatic necrosis J:174308
\Unc119tm1.1(KOMP)Vlcg/\Unc119tm1.1(KOMP)Vlcg
(C57BL/6N-Unc119tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
\Urahplt2/\Urahplt2
(C57BL/6-Urahplt2) 		increased hepatocellular carcinoma incidence J:164423
increased liver weight J:164423
\Uri1tm1.1Ndj/\Uri1tm1.1Ndj
\Albtm1(cre/ERT2)Mtz/\Alb+
(B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj) 		abnormal liver morphology J:217463
hepatic necrosis J:217463
\Urostm1Cged/\Urostm1Cged
(involves: 129S2/SvPas) 		enlarged liver J:105776
hepatic steatosis J:105776
\Usp8tm1.1Kpk/\Usp8tm1.1Kpk
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N) 		abnormal hepatocyte morphology J:122732
hepatic necrosis J:122732
\Usp20em1Gpt/\Usp20em1Gpt
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6JGpt * DBA) 		abnormal liver morphology J:299971
decreased liver cholesterol level J:299971
decreased liver triglyceride level J:299971
decreased liver weight J:299971
\Usp24Gt(XB614)Byg/\Usp24+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver tumor incidence J:303991
\Usp44tm1.2Pjgl/\Usp44tm1.2Pjgl
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		increased hepatoma incidence J:193965
\Uts2tm1Ags/\Uts2tm1Ags
(B6.129P2-Uts2tm1Ags) 		decreased susceptibility to diet-induced hepatic steatosis J:214289
\Vdac3em1(IMPC)Hmgu/\Vdac3em1(IMPC)Hmgu
(C57BL/6N-Vdac3em1(IMPC)Hmgu/Ieg) 		abnormal liver morphology J:211773
\Vegfatm2Gne/\Vegfatm2Gne
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA) 		abnormal liver development J:52793
\Vhltm1.1Jae/\Vhl+
(involves: 129S4/SvJae * BALB/c) 		hepatic steatosis J:67505
increased hepatic hemangioma incidence J:67505
\Vhltm1.1Lss/\Vhl+
(involves: BALB/c) 		increased hepatic hemangioma incidence J:85513
\Vhltm1.1Lss/\Vhl+
(involves: A/J) 		abnormal liver morphology J:85513
\Vhltm1Jae/\Vhltm1Jae
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA) 		abnormal liver morphology J:67505
enlarged liver J:67505
hepatic steatosis J:67505, J:97652
\Vhltm1Jae/\Vhltm1Jae
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:144666
abnormal liver morphology J:144666
hepatic steatosis J:144666
increased liver weight J:144666
\Vhltm1Lss/\Vhltm1.1Lss
(involves: 129X1/SvJ * C57BL/6) 		increased hepatic hemangioma incidence J:85513
\Vhltm1Lss/\Vhltm1.1Lss
\Tg(ACTB-cre)1Tes/0
(involves: 129X1/SvJ * C3H * C57BL/6) 		abnormal liver morphology J:85513
increased hepatic hemangioma incidence J:85513
\Vhltm1Lss/\Vhltm1.1Lss
\Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ) 		focal hepatic necrosis J:110518
\Vhltm1Mcs/\Vhltm1Mcs
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		abnormal liver morphology J:130780
\Vmbic8C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		increased liver iron level J:87918
\Vps13bem1(IMPC)Tcp/\Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
\Vps26cem1(IMPC)J/\Vps26cem1(IMPC)J
(C57BL/6NJ-Vps26cem1(IMPC)J/Mmjax) 		pale liver J:211773
\Vps54wr/\Vps54wr
(multiple strains) 		abnormal hepatocyte morphology J:6388
\Vrk3em1(IMPC)Mbp/\Vrk3em1(IMPC)Mbp
(C57BL/6NCrl-Vrk3em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Vsirtm1Lex/\Vsirtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		hepatic necrosis J:222944
\Vti1btm1Gfvm/\Vti1btm1Gfvm
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:84574
liver cyst J:84574
\Wars1tm1b(EUCOMM)Hmgu/\Wars1+
(C57BL/6N-Warstm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
enlarged liver J:211773
increased liver weight J:211773
\Wasf1Gt(VICTR37)1Kwak/\Wasf1Gt(VICTR37)1Kwak
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:83377
\Wbp11em1Gcha/\Wbp11+
(involves: C57BL/6J * FVB/N) 		small liver J:300837
\Wdfy2tm1.1Wgz/\Wdfy2tm1.1Wgz
(involves: C57BL/6J) 		decreased liver glycogen level J:296933
hepatic steatosis J:296933
increased liver cholesterol level J:296933
increased liver triglyceride level J:296933
increased liver weight J:296933
\Wdfy3em1(IMPC)Mbp/\Wdfy3+
(C57BL/6N-Wdfy3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Wdhd1em1(IMPC)Rbrc/\Wdhd1+
(C57BL/6NJcl-Wdhd1em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
\Wdr11em1(IMPC)Mbp/\Wdr11em1(IMPC)Mbp
(C57BL/6NCrl-Wdr11em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
\Wdr11Gt(Ayu21-KBW205)Imeg/\Wdr11+
(B6.Cg-Wdr11Gt(Ayu21-KBW205)Imeg) 		increased liver weight J:257035
microvesicular hepatic steatosis J:257035
\Wdr49em1(IMPC)Ccpcz/\Wdr49em1(IMPC)Ccpcz
(C57BL/6N-Wdr49em1(IMPC)Ccpcz/Ccpcz) 		increased liver weight J:211773
\Whrnwi/\Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs) 		decreased liver glycogen level J:5538
increased liver weight J:5037
\Wipi1em1(IMPC)Mbp/\Wipi1em1(IMPC)Mbp
(C57BL/6NCrl-Wipi1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Wnt5atm1Amc/\Wnt5atm1Amc
(involves: 129S7/SvEvBrd) 		abnormal liver morphology J:153152
enlarged liver J:153152
\Wt1tm1Mlh/\Wt1tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver development J:135449
liver hypoplasia J:135449
\Wwc1tm1Arsc/\Wwc1tm1Arsc
\Wwc2tm1.1Arte/\Wwc2tm1.1Arte
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129 * C57BL/6 * C57BL/6J * DBA) 		abnormal liver morphology J:305034
abnormal portal triad morphology J:305034
increased liver tumor incidence J:305034
increased liver weight J:305034
liver fibrosis J:305034
\Wwoxem1Mald/\Wwoxem1Mald
(FVB/N-Wwoxem1Mald) 		liver degeneration J:339564
\Wwoxtm1.1Mald/\Wwoxtm1.1Mald
(involves: C57BL/6 * FVB/N) 		decreased liver weight J:155406
\Xbp1tm1Glm/\Xbp1tm1Glm
(involves: 129S2/SvPas) 		abnormal liver development J:59916
liver hypoplasia J:59916
small liver J:59916
\Xirp2tm1Jl/\Xirp2tm1Jl
(B6.129-Xirp2tm1Jl) 		decreased liver weight J:158491
\Xpatm1Hvs/\Xpatm1Hvs
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:28710
\Xpatm1Tnka/\Xpatm1Tnka
(C3.Cg-Xpatm1Tnka) 		increased liver adenoma incidence J:76206
increased liver tumor incidence J:76206
\Xpnpep1tm1a(KOMP)Wtsi/\Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
\Xrcc5em1(IMPC)Ccpcz/\Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz) 		increased liver weight J:211773
\Xrn1em1Tya/\Xrn1em1Tya
\Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6N * FVB/N) 		abnormal liver morphology J:342928
increased liver weight J:342928
\Xylt2tm1Meh/\Xylt2tm1Meh
(involves: 129P2/OlaHsd) 		increased liver weight J:122291
liver cyst J:122291
liver fibrosis J:122291
liver hyperplasia J:122291
\Yap1tm1.1Dupa/\Yap1tm1.1Dupa
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:162628
enlarged liver J:162628
liver cirrhosis J:162628
liver fibrosis J:162628
macrovesicular hepatic steatosis J:162628
pale liver J:162628
\Ybx1tm1Ley/\Ybx1tm1Ley
(either: 129X1/SvJ-Ybx1tm1Ley or (involves: 129X1/SvJ * C57BL/6)) 		liver hypoplasia J:99099
\Ybx1tm1Tuch/\Ybx1tm1Tuch
(involves: 129S/SvEv * C57BL/6) 		small liver J:117725
\Ythdf3em1(IMPC)Mbp/\Ythdf3em1(IMPC)Mbp
(C57BL/6N-Ythdf3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Ywhabem1Gpt/\Ywhabem1Gpt
\Albem1(icre)Gpt/\Alb+
(C57BL/6JGpt-Ywhabem1Gpt Albem1(icre)Gpt) 		decreased liver glycogen level J:323777
\Zbed6tm1.2Sson/\Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6) 		increased liver weight J:265506
\Zbtb16em1(IMPC)Mbp/\Zbtb16em1(IMPC)Mbp
(C57BL/6NCrl-Zbtb16em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Zbtb20tm1.1Wpjz/\Zbtb20tm1.1Wpjz
(involves: 129S4/SvJae * C57BL/6) 		decreased liver glycogen level J:148992
\Zbtb22em1Yga/\Zbtb22em1Yga
(Not Specified) 		decreased liver triglyceride level J:344976
decreased liver weight J:344976
decreased susceptibility to diet-induced hepatic steatosis J:344976
\Zc3h8em1(IMPC)Ccpcz/\Zc3h8+
(C57BL/6N-Zc3h8em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
\Zc3h12atm1c(EUCOMM)Hmgu/\Zc3h12atm1c(EUCOMM)Hmgu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		abnormal liver parenchyma morphology J:304105
enlarged liver J:304105
liver fibrosis J:304105
\Zc3hav1ltm1b(EUCOMM)Wtsi/\Zc3hav1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Zc3hav1ltm1b(EUCOMM)Wtsi/Tcp) 		abnormal liver morphology J:211773
\Zdhhc13skc4/\Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6) 		abnormal Kupffer cell morphology J:161519
enlarged liver J:161519
\Zfc3h1em1(IMPC)Mbp/\Zfc3h1+
(C57BL/6N-Zfc3h1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Zfp14tm1Xch/\Zfp14+
(involves: C57BL/6) 		hepatic steatosis J:331393
\Zfp14tm1Xch/\Zfp14tm1Xch
(involves: C57BL/6) 		hepatic steatosis J:331393
\Zfp36tm4.1Pjb/\Zfp36tm4.1Pjb
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		focal hepatic necrosis J:188677
\Zfp36l2tm2Pjb/\Zfp36l2tm2Pjb
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:152911
pale liver J:152911
\Zfp236em1(IMPC)Mbp/\Zfp236+
(C57BL/6NCrl-Zfp236em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Zfp521tm1Nohk/\Zfp521tm1Nohk
(B6J.Cg-Zfp521tm1Nohk) 		decreased liver weight J:214267
\Zfp871tm1a(EUCOMM)Wtsi/\Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd) 		hepatic steatosis J:317166
\Zfpm1tm1Sho/\Zfpm1tm1Sho
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6)) 		pale liver J:47281
small liver J:47281
\Zfpm1tm2Sho/\Zfpm1tm2Sho
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6)) 		pale liver J:47281
small liver J:47281
\Zfpm2tm1Sho/\Zfpm2tm1Sho
(involves: 129S1/Sv) 		small liver J:62879
\Zic3tm1Bca/Y
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:75951
\Zic3tm1Bca/\Zic3+
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:75951
\Zic3tm1Bca/\Zic3tm1Bca
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:75951
\Zmynd11em1(IMPC)Wtsi/\Zmynd11em1(IMPC)Wtsi
(C57BL/6N-Zmynd11em1(IMPC)Wtsi/WtsiIeg) 		abnormal biliary ductule morphology J:239583
dilated liver sinusoidal space J:239583
herniated liver J:239583
\Zrsr2em1(IMPC)Mbp/\Zrsr2em1(IMPC)Mbp
(C57BL/6N-Zrsr2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
\Zscan10Gt(285B6)1.1Cmhd/\Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased liver weight J:221010
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory